Document and Entity Information
Document and Entity Information - USD ($) shares in Millions, $ in Billions | 12 Months Ended | ||
Dec. 31, 2022 | Feb. 17, 2023 | Jun. 30, 2022 | |
Document Information [Line Items] | |||
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Period End Date | Dec. 31, 2022 | ||
Document Fiscal Year Focus | 2022 | ||
Document Fiscal Period Focus | FY | ||
Trading Symbol | MPW | ||
Entity Registrant Name | Medical Properties Trust, Inc | ||
Entity Central Index Key | 0001287865 | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Shell Company | false | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Entity Common Stock, Shares Outstanding | 598.3 | ||
Entity Public Float | $ 9.1 | ||
Title of 12(b) Security | Common stock, par value $0.001 per share, of Medical Properties Trust, Inc. | ||
Security Exchange Name | NYSE | ||
Entity File Number | 001-32559 | ||
Entity Tax Identification Number | 20-0191742 | ||
Entity Address, Address Line One | 1000 Urban Center Drive | ||
Entity Address, Address Line Two | Suite 501 | ||
Entity Address, City or Town | Birmingham | ||
Entity Address, State or Province | AL | ||
Entity Address, Postal Zip Code | 35242 | ||
City Area Code | 205 | ||
Local Phone Number | 969-3755 | ||
Entity Incorporation, State or Country Code | MD | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Entity Interactive Data Current | Yes | ||
Auditor Name | PricewaterhouseCoopers LLP | ||
Auditor Location | Birmingham, Alabama | ||
Auditor Firm ID | 238 | ||
Document Type | 10-K | ||
Documents Incorporated by Reference | Portions of the definitive Proxy Statement of Medical Properties Trust, Inc. for the Annual Meeting of Stockholders to be held on May 25, 2023 are incorporated by reference into Items 10 through 14 of Part III, of this Annual Report on Form 10-K. | ||
MPT Operating Partnership, L.P. [Member] | |||
Document Information [Line Items] | |||
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Period End Date | Dec. 31, 2022 | ||
Document Fiscal Year Focus | 2022 | ||
Document Fiscal Period Focus | FY | ||
Entity Registrant Name | MPT Operating Partnership, L.P. | ||
Entity Central Index Key | 0001524607 | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Shell Company | false | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Entity File Number | 333-177186 | ||
Entity Tax Identification Number | 20-0242069 | ||
Entity Address, Address Line One | 1000 Urban Center Drive | ||
Entity Address, Address Line Two | Suite 501 | ||
Entity Address, City or Town | Birmingham | ||
Entity Address, State or Province | AL | ||
Entity Address, Postal Zip Code | 35242 | ||
City Area Code | 205 | ||
Local Phone Number | 969-3755 | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Interactive Data Current | Yes | ||
Auditor Name | PricewaterhouseCoopers LLP | ||
Auditor Location | Birmingham, Alabama | ||
Auditor Firm ID | 238 | ||
Document Type | 10-K |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Real estate assets | ||
Land | $ 1,948,216 | $ 1,961,478 |
Buildings and improvements | 10,352,308 | 10,581,992 |
Construction in progress | 167,420 | 101,439 |
Intangible lease assets | 1,394,471 | 1,417,813 |
Investment in financing leases | 1,691,323 | 2,053,327 |
Real estate held for sale | 0 | 1,096,505 |
Mortgage loans | 364,101 | 213,211 |
Gross investment in real estate assets | 15,917,839 | 17,425,765 |
Accumulated depreciation | (1,008,340) | (853,879) |
Accumulated amortization | (184,972) | (139,221) |
Net investment in real estate assets | 14,724,527 | 16,432,665 |
Cash and cash equivalents | 235,668 | 459,227 |
Interest and rent receivables | 167,035 | 56,229 |
Straight-line rent receivables | 787,166 | 728,522 |
Investments in unconsolidated real estate joint ventures | 1,497,903 | 1,152,927 |
Investments in unconsolidated operating entities | 1,444,872 | 1,289,434 |
Other loans | 227,839 | 67,317 |
Other assets | 572,990 | 333,480 |
Total Assets | 19,658,000 | 20,519,801 |
Liabilities | ||
Debt, net | 10,268,412 | 11,282,770 |
Accounts payable and accrued expenses | 621,324 | 607,792 |
Deferred revenue | 27,727 | 25,563 |
Obligations to tenants and other lease liabilities | 146,130 | 158,005 |
Total Liabilities | 11,063,593 | 12,074,130 |
Commitments and Contingencies | ||
Equity / Capital | ||
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding | ||
Common stock, $0.001 par value. Authorized 750,000 shares; issued and outstanding - 597,476 shares at December 31, 2022 and 596,748 shares at December 31, 2021 | 597 | 597 |
Additional paid-in capital | 8,535,140 | 8,564,009 |
Retained earnings (deficit) | 116,285 | (87,691) |
Accumulated other comprehensive loss | (59,184) | (36,727) |
Total Medical Properties Trust, Inc. Stockholders' Equity (MPT Operating Partnership, L.P. capital) | 8,592,838 | 8,440,188 |
Non-controlling interests | 1,569 | 5,483 |
Total Equity / Capital | 8,594,407 | 8,445,671 |
Total Liabilities and Equity / Capital | 19,658,000 | 20,519,801 |
MPT Operating Partnership, L.P. [Member] | ||
Real estate assets | ||
Land | 1,948,216 | 1,961,478 |
Buildings and improvements | 10,352,308 | 10,581,992 |
Construction in progress | 167,420 | 101,439 |
Intangible lease assets | 1,394,471 | 1,417,813 |
Investment in financing leases | 1,691,323 | 2,053,327 |
Real estate held for sale | 1,096,505 | |
Mortgage loans | 364,101 | 213,211 |
Gross investment in real estate assets | 15,917,839 | 17,425,765 |
Accumulated depreciation | (1,008,340) | (853,879) |
Accumulated amortization | (184,972) | (139,221) |
Net investment in real estate assets | 14,724,527 | 16,432,665 |
Cash and cash equivalents | 235,668 | 459,227 |
Interest and rent receivables | 167,035 | 56,229 |
Straight-line rent receivables | 787,166 | 728,522 |
Investments in unconsolidated real estate joint ventures | 1,497,903 | 1,152,927 |
Investments in unconsolidated operating entities | 1,444,872 | 1,289,434 |
Other loans | 227,839 | 67,317 |
Other assets | 572,990 | 333,480 |
Total Assets | 19,658,000 | 20,519,801 |
Liabilities | ||
Debt, net | 10,268,412 | 11,282,770 |
Accounts payable and accrued expenses | 444,354 | 430,908 |
Deferred revenue | 27,727 | 25,563 |
Obligations to tenants and other lease liabilities | 146,130 | 158,005 |
Payable due to Medical Properties Trust, Inc. | 176,580 | 176,494 |
Total Liabilities | 11,063,203 | 12,073,740 |
Commitments and Contingencies | ||
Equity / Capital | ||
General partner - issued and outstanding - 5976 units at December 31, 2022 and 5,968 units at December 31, 2021 | 86,599 | 84,847 |
Limited Partners - issued and outstanding - 591,500 units at December 31, 2022 and 590,780 units at December 31, 2021 | 8,565,813 | 8,392,458 |
Accumulated other comprehensive loss | (59,184) | (36,727) |
Total Medical Properties Trust, Inc. Stockholders' Equity (MPT Operating Partnership, L.P. capital) | 8,593,228 | 8,440,578 |
Non-controlling interests | 1,569 | 5,483 |
Total Equity / Capital | 8,594,797 | 8,446,061 |
Total Liabilities and Equity / Capital | $ 19,658,000 | $ 20,519,801 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - $ / shares | Dec. 31, 2022 | Dec. 31, 2021 |
Preferred stock, par value | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized | 10,000,000 | 10,000,000 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, par value | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 750,000,000 | 750,000,000 |
Common stock, shares issued | 597,476,000 | 596,748,000 |
Common stock, shares outstanding | 597,476,000 | 596,748,000 |
General Partner [Member] | MPT Operating Partnership, L.P. [Member] | ||
General partner, units issued | 5,976,000 | 5,968,000 |
General partner, units outstanding | 5,976,000 | 5,968,000 |
Common Units | MPT Operating Partnership, L.P. [Member] | ||
Limited Partners, units issued | 591,500,000 | 590,780,000 |
Limited Partners, units outstanding | 591,500,000 | 590,780,000 |
Consolidated Statements of Net
Consolidated Statements of Net Income - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Revenues | |||
Rent billed | $ 968,874 | $ 931,942 | $ 741,311 |
Straight-line rent | 204,159 | 241,433 | 158,881 |
Income from financing leases | 203,580 | 202,599 | 206,550 |
Interest and other income | 166,238 | 168,695 | 142,496 |
Total revenues | 1,542,851 | 1,544,669 | 1,249,238 |
Expenses | |||
Interest | 359,036 | 367,393 | 328,728 |
Real estate depreciation and amortization | 332,977 | 321,249 | 264,245 |
Property-related | 45,697 | 39,098 | 24,890 |
General and administrative | 160,494 | 145,638 | 131,663 |
Total expenses | 898,204 | 873,378 | 749,526 |
Other income (expense) | |||
Gain (loss) on sale of real estate | 536,755 | 52,471 | (2,833) |
Real estate and other impairment charges, net | (268,375) | (39,411) | (19,006) |
Earnings from equity interests | 40,800 | 28,488 | 20,417 |
Debt refinancing and unutilized financing costs | (9,452) | (27,650) | (28,180) |
Other (including fair value adjustments on securities) | 15,344 | 45,699 | (6,782) |
Total other income (expense) | 315,072 | 59,597 | (36,384) |
Income before income tax | 959,719 | 730,888 | 463,328 |
Income tax expense | (55,900) | (73,948) | (31,056) |
Net income | 903,819 | 656,940 | 432,272 |
Net income attributable to non-controlling interests | (1,222) | (919) | (822) |
Net income attributable to MPT common stockholders (Operating Partnership partners) | $ 902,597 | $ 656,021 | $ 431,450 |
Earnings per common share (units) basic | |||
Net income attributable to MPT common stockholders (Operating Partnership partners), basic | $ 1.50 | $ 1.11 | $ 0.81 |
Earnings per common share (units) diluted | |||
Net income attributable to MPT common stockholders (Operating Partnership partners), diluted | $ 1.50 | $ 1.11 | $ 0.81 |
Weighted average shares (units) outstanding basic | 598,634 | 588,817 | 529,239 |
Weighted average shares (units) outstanding diluted | 598,837 | 590,139 | 530,461 |
MPT Operating Partnership, L.P. [Member] | |||
Revenues | |||
Rent billed | $ 968,874 | $ 931,942 | $ 741,311 |
Straight-line rent | 204,159 | 241,433 | 158,881 |
Income from financing leases | 203,580 | 202,599 | 206,550 |
Interest and other income | 166,238 | 168,695 | 142,496 |
Total revenues | 1,542,851 | 1,544,669 | 1,249,238 |
Expenses | |||
Interest | 359,036 | 367,393 | 328,728 |
Real estate depreciation and amortization | 332,977 | 321,249 | 264,245 |
Property-related | 45,697 | 39,098 | 24,890 |
General and administrative | 160,494 | 145,638 | 131,663 |
Total expenses | 898,204 | 873,378 | 749,526 |
Other income (expense) | |||
Gain (loss) on sale of real estate | 536,755 | 52,471 | (2,833) |
Real estate and other impairment charges, net | (268,375) | (39,411) | (19,006) |
Earnings from equity interests | 40,800 | 28,488 | 20,417 |
Debt refinancing and unutilized financing costs | (9,452) | (27,650) | (28,180) |
Other (including fair value adjustments on securities) | 15,344 | 45,699 | (6,782) |
Total other income (expense) | 315,072 | 59,597 | (36,384) |
Income before income tax | 959,719 | 730,888 | 463,328 |
Income tax expense | (55,900) | (73,948) | (31,056) |
Net income | 903,819 | 656,940 | 432,272 |
Net income attributable to non-controlling interests | (1,222) | (919) | (822) |
Net income attributable to MPT common stockholders (Operating Partnership partners) | $ 902,597 | $ 656,021 | $ 431,450 |
Earnings per common share (units) basic | |||
Net income attributable to MPT common stockholders (Operating Partnership partners), basic | $ 1.50 | $ 1.11 | $ 0.81 |
Earnings per common share (units) diluted | |||
Net income attributable to MPT common stockholders (Operating Partnership partners), diluted | $ 1.50 | $ 1.11 | $ 0.81 |
Weighted average shares (units) outstanding basic | 598,634 | 588,817 | 529,239 |
Weighted average shares (units) outstanding diluted | 598,837 | 590,139 | 530,461 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Net income | $ 903,819 | $ 656,940 | $ 432,272 |
Other comprehensive income: | |||
Unrealized gain (loss) on interest rate swaps, net of tax | 100,550 | 52,288 | (33,091) |
Foreign currency translation (loss) gain | (123,007) | (37,691) | 44,672 |
Total comprehensive income | 881,362 | 671,537 | 443,853 |
Comprehensive income attributable to non-controlling interests | (1,222) | (919) | (822) |
Comprehensive income attributable to MPT common stockholders (Operating Partnership Partners) | 880,140 | 670,618 | 443,031 |
MPT Operating Partnership, L.P. [Member] | |||
Net income | 903,819 | 656,940 | 432,272 |
Other comprehensive income: | |||
Unrealized gain (loss) on interest rate swaps, net of tax | 100,550 | 52,288 | (33,091) |
Foreign currency translation (loss) gain | (123,007) | (37,691) | 44,672 |
Total comprehensive income | 881,362 | 671,537 | 443,853 |
Comprehensive income attributable to non-controlling interests | (1,222) | (919) | (822) |
Comprehensive income attributable to MPT common stockholders (Operating Partnership Partners) | $ 880,140 | $ 670,618 | $ 443,031 |
Consolidated Statements of Equi
Consolidated Statements of Equity / Capital - USD ($) shares in Thousands | Total | MPT Operating Partnership, L.P. [Member] | MPT Operating Partnership, L.P. [Member] General Partner [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member] MPT Operating Partnership, L.P. [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member] MPT Operating Partnership, L.P. [Member] General Partner [Member] | Common Par Value [Member] | Common Par Value [Member] MPT Operating Partnership, L.P. [Member] Limited Partner [Member] | Common Par Value [Member] Cumulative Effect, Period of Adoption, Adjustment [Member] MPT Operating Partnership, L.P. [Member] Limited Partner [Member] | Additional Paid-in Capital [Member] | Retained Earnings (Deficit) [Member] | Retained Earnings (Deficit) [Member] Cumulative Effect, Period of Adoption, Adjustment [Member] | Accumulated Other Comprehensive Loss [Member] | Accumulated Other Comprehensive Loss [Member] MPT Operating Partnership, L.P. [Member] | Non-Controlling Interests [Member] | Non-Controlling Interests [Member] MPT Operating Partnership, L.P. [Member] | Long Term Incentive Plan [Member] MPT Operating Partnership, L.P. [Member] Limited Partner [Member] |
Beginning balance at Dec. 31, 2019 | $ 7,028,154,000 | $ 7,028,544,000 | $ 70,939,000 | $ 518,000 | $ 7,020,403,000 | $ 7,007,422,000 | $ 83,012,000 | $ (62,905,000) | $ (62,905,000) | $ 107,000 | $ 107,000 | ||||||
Beginning balance (Accounting Standards Update 2016-13) at Dec. 31, 2019 | $ (8,399,000) | $ (84,000) | $ (8,315,000) | ||||||||||||||
Beginning balance (in shares) at Dec. 31, 2019 | 5,176 | 517,456 | 512,280 | 232 | |||||||||||||
Net income | 432,272,000 | 432,272,000 | $ 4,315,000 | $ 427,135,000 | 431,450,000 | 822,000 | 822,000 | ||||||||||
Unrealized gain (loss) on interest rate swaps, net of tax | (33,091,000) | (33,091,000) | (33,091,000) | (33,091,000) | |||||||||||||
Foreign currency translation gain (loss) | 44,672,000 | 44,672,000 | 44,672,000 | 44,672,000 | |||||||||||||
Stock (Unit) vesting and amortization of stock-based compensation | 47,154,000 | 47,154,000 | $ 472,000 | $ 2,000 | $ 46,682,000 | 47,152,000 | |||||||||||
Stock (Unit) vesting and amortization of stock (unit)-based compensation (shares) | 29 | 2,893 | 2,864 | ||||||||||||||
Sale of non-controlling interests | 5,097,000 | 5,097,000 | 5,097,000 | 5,097,000 | |||||||||||||
Redemption of MOP units | (4,928,000) | (4,928,000) | $ (4,928,000) | (4,928,000) | |||||||||||||
Redemption of common units (shares) | (232) | ||||||||||||||||
Conversion of LTIP units to common units (shares) | 232 | (232) | |||||||||||||||
Distributions to non-controlling interests, net | (701,000) | (701,000) | (701,000) | (701,000) | |||||||||||||
Proceeds from offering (net of offering costs) | 411,101,000 | 411,101,000 | $ 4,111,000 | $ 21,000 | $ 406,990,000 | 411,080,000 | |||||||||||
Proceeds from offering (net of offering costs) (shares) | 209 | 21,004 | 20,795 | ||||||||||||||
Dividends (Distributions) declared | (577,474,000) | (577,474,000) | $ (5,776,000) | $ (571,698,000) | (577,474,000) | ||||||||||||
Ending balance at Dec. 31, 2020 | 7,343,857,000 | 7,344,247,000 | $ 73,977,000 | $ 541,000 | $ 7,316,269,000 | 7,460,726,000 | (71,411,000) | (51,324,000) | (51,324,000) | 5,325,000 | 5,325,000 | ||||||
Ending balance (Accounting Standards Update 2016-02) at Dec. 31, 2020 | $ (8,399,000) | $ (8,399,000) | |||||||||||||||
Ending balance (in shares) at Dec. 31, 2020 | 5,414 | 541,353 | 535,939 | ||||||||||||||
Net income | 656,940,000 | 656,940,000 | $ 6,560,000 | $ 649,461,000 | 656,021,000 | 919,000 | 919,000 | ||||||||||
Unrealized gain (loss) on interest rate swaps, net of tax | 52,288,000 | 52,288,000 | 52,288,000 | 52,288,000 | |||||||||||||
Foreign currency translation gain (loss) | (37,691,000) | (37,691,000) | (37,691,000) | (37,691,000) | |||||||||||||
Stock (Unit) vesting and amortization of stock-based compensation | 52,110,000 | 52,110,000 | $ 521,000 | $ 3,000 | $ 51,589,000 | 52,107,000 | |||||||||||
Stock (Unit) vesting and amortization of stock (unit)-based compensation (shares) | 23 | 2,332 | 2,309 | ||||||||||||||
Distributions to non-controlling interests, net | (761,000) | (761,000) | (761,000) | (761,000) | |||||||||||||
Proceeds from offering (net of offering costs) | 1,051,229,000 | 1,051,229,000 | $ 10,512,000 | $ 53,000 | $ 1,040,717,000 | 1,051,176,000 | |||||||||||
Proceeds from offering (net of offering costs) (shares) | 531 | 53,063 | 52,532 | ||||||||||||||
Dividends (Distributions) declared | (672,301,000) | (672,301,000) | $ (6,723,000) | $ (665,578,000) | (672,301,000) | ||||||||||||
Ending balance at Dec. 31, 2021 | 8,445,671,000 | 8,446,061,000 | $ 84,847,000 | $ 597,000 | $ 8,392,458,000 | 8,564,009,000 | (87,691,000) | (36,727,000) | (36,727,000) | 5,483,000 | 5,483,000 | ||||||
Ending balance (in shares) at Dec. 31, 2021 | 5,968 | 596,748 | 590,780 | ||||||||||||||
Net income | 903,819,000 | 903,819,000 | $ 9,026,000 | $ 893,571,000 | 902,597,000 | 1,222,000 | 1,222,000 | ||||||||||
Unrealized gain (loss) on interest rate swaps, net of tax | 100,550,000 | 100,550,000 | 100,550,000 | 100,550,000 | |||||||||||||
Foreign currency translation gain (loss) | (123,007,000) | (123,007,000) | (123,007,000) | (123,007,000) | |||||||||||||
Stock (Unit) vesting and amortization of stock-based compensation | 49,421,000 | 49,421,000 | $ 494,000 | $ 3,000 | $ 48,927,000 | 49,418,000 | |||||||||||
Stock (Unit) vesting and amortization of stock (unit)-based compensation (shares) | 37 | 3,675 | 3,638 | ||||||||||||||
Stock (Unit) vesting - satisfaction of tax withholding | (29,922,000) | (29,922,000) | $ (299,000) | $ (1,000) | $ (29,623,000) | (29,921,000) | |||||||||||
Stock (Unit) vesting - satisfaction of tax withholding (shares) | (13) | (1,302) | (1,289) | ||||||||||||||
Repurchase of units | (17,940,000) | (17,940,000) | $ (179,000) | $ (2,000) | $ (17,761,000) | (17,938,000) | |||||||||||
Repurchase of units (shares) | (16) | (1,645) | (1,629) | ||||||||||||||
Acquisition of non-controlling interest | (35,022,000) | (35,022,000) | $ (304,000) | $ (30,124,000) | (30,428,000) | (4,594,000) | (4,594,000) | ||||||||||
Redemption of MOP units | 0 | ||||||||||||||||
Issuance of non-controlling interest | 1,054,000 | 1,054,000 | 1,054,000 | 1,054,000 | |||||||||||||
Distributions to non-controlling interests, net | (1,596,000) | (1,596,000) | (1,596,000) | (1,596,000) | |||||||||||||
Dividends (Distributions) declared | (698,621,000) | (698,621,000) | (6,986,000) | (691,635,000) | (698,621,000) | ||||||||||||
Ending balance at Dec. 31, 2022 | $ 8,594,407,000 | $ 8,594,797,000 | $ 86,599,000 | $ 597,000 | $ 8,565,813,000 | $ 8,535,140,000 | $ 116,285,000 | $ (59,184,000) | $ (59,184,000) | $ 1,569,000 | $ 1,569,000 | ||||||
Ending balance (in shares) at Dec. 31, 2022 | 5,976 | 597,476 | 591,500 |
Consolidated Statements of Eq_2
Consolidated Statements of Equity / Capital (Parenthetical) - $ / shares | 12 Months Ended | |||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Dividends (Distributions) declared per common share / unit | $ 1.16 | $ 1.12 | $ 1.08 | |
MPT Operating Partnership, L.P. [Member] | ||||
Dividends (Distributions) declared per common share / unit | 1.16 | 1.12 | $ 1.08 | |
MPT Operating Partnership, L.P. [Member] | General Partner [Member] | ||||
Dividends (Distributions) declared per common share / unit | 1.16 | 1.12 | 1.08 | |
Common Par Value [Member] | MPT Operating Partnership, L.P. [Member] | Limited Partner [Member] | ||||
Dividends (Distributions) declared per common share / unit | $ 1.16 | $ 1.12 | $ 1.08 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Operating activities | |||
Net income | $ 903,819 | $ 656,940 | $ 432,272 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Depreciation and amortization | 345,577 | 333,781 | 275,953 |
Amortization of deferred financing costs and debt discount | 17,045 | 16,856 | 13,099 |
Straight-line rent revenue and other | (282,504) | (288,717) | (226,906) |
Stock / (Unit)-based compensation expense | 49,421 | 52,110 | 47,154 |
(Gain) loss from sale of real estate | (536,755) | (52,471) | 2,833 |
Real estate and other impairment charges | 268,375 | 39,411 | 19,006 |
Write-off of unbilled rent and other | 34,605 | 7,213 | 26,415 |
Debt refinancing and unutilized financing costs | 9,452 | 27,650 | 28,180 |
Gain on sale of equity investments | (40,945) | ||
Tax rate and other changes | 10,697 | 34,796 | 9,295 |
Pre-acquisition rent collected - Circle Transaction | (35,020) | ||
Other adjustments | 6,108 | 11,913 | 8,134 |
Changes in: | |||
Interest and rent receivables | (116,420) | (23,867) | (2,438) |
Other assets | (4,029) | (4,375) | 18,264 |
Accounts payable and accrued expenses | 33,576 | 54,058 | (18,424) |
Deferred revenue | 43 | (12,697) | 19,819 |
Net cash provided by operating activities | 739,010 | 811,656 | 617,636 |
Investing activities | |||
Cash paid for acquisitions and other related investments | (1,332,962) | (5,350,239) | (4,249,180) |
Net proceeds from sale of real estate | 2,185,574 | 246,468 | 94,177 |
Principal received on loans receivable | 53,322 | 1,595,708 | 1,306,187 |
Investment in loans receivable | (207,542) | (58,932) | (62,651) |
Construction in progress and other | (109,237) | (67,725) | (68,350) |
Proceeds from sale and return of equity investment | 14,295 | 65,546 | 69,224 |
Capital additions and other investments, net | (207,394) | (289,239) | (36,180) |
Net cash provided by (used for) investing activities | 396,056 | (3,858,413) | (2,946,773) |
Financing activities | |||
Proceeds from term debt, net of discount | 128,536 | 3,407,535 | 2,215,950 |
Payments of term debt | (869,606) | (1,390,994) | (800,000) |
Revolving credit facilities, net | 203,576 | 559,985 | 162,633 |
Dividends / Distribution paid | (698,535) | (643,473) | (567,969) |
Lease deposits and other obligations to tenants | (5,020) | 17,815 | 21,706 |
Proceeds from sale of common shares, net of offering costs | 1,051,229 | 411,101 | |
Repurchase of common stock / unit | (17,940) | ||
Stock / Unit vesting - satisfaction of tax withholdings | (29,922) | ||
Payment of debt refinancing, deferred financing costs and other financing activities | (53,612) | (54,489) | (42,347) |
Net cash (used for) provided by financing activities | (1,342,523) | 2,947,608 | 1,401,074 |
Decrease in cash, cash equivalents, and restricted cash for the year | (207,457) | (99,149) | (928,063) |
Effect of exchange rate changes | (12,887) | 4,662 | 16,441 |
Cash, cash equivalents, and restricted cash at beginning of year | 461,882 | 556,369 | 1,467,991 |
Cash, cash equivalents, and restricted cash at end of year | 241,538 | 461,882 | 556,369 |
Interest paid, including capitalized interest of $6,454 in 2022, $3,289 in 2021, and $3,030 in 2020 | 353,838 | 326,406 | 309,920 |
Supplemental schedule of non-cash financing activities: | |||
Dividends declared, unpaid | 176,580 | 176,494 | 147,666 |
Cash, cash equivalents, and restricted cash are comprised of the following: | |||
Cash and cash equivalents at beginning of period | 459,227 | 549,884 | 1,462,286 |
Restricted cash, included in Other assets at beginning of period | $ 2,655 | $ 6,485 | $ 5,705 |
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] | Other Assets | Other Assets | Other Assets |
Cash, cash equivalents, and restricted cash at beginning of year | $ 241,538 | $ 461,882 | $ 556,369 |
Cash and cash equivalents at end of period | 235,668 | 459,227 | 549,884 |
Restricted cash, included in Other assets at end of period | $ 5,870 | $ 2,655 | $ 6,485 |
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] | Other Assets | Other Assets | Other Assets |
Cash, cash equivalents, and restricted cash at end of year | $ 241,538 | $ 461,882 | $ 556,369 |
MPT Operating Partnership, L.P. [Member] | |||
Operating activities | |||
Net income | 903,819 | 656,940 | 432,272 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Depreciation and amortization | 345,577 | 333,781 | 275,953 |
Amortization of deferred financing costs and debt discount | 17,045 | 16,856 | 13,099 |
Straight-line rent revenue and other | (282,504) | (288,717) | (226,906) |
Stock / (Unit)-based compensation expense | 49,421 | 52,110 | 47,154 |
(Gain) loss from sale of real estate | (536,755) | (52,471) | 2,833 |
Real estate and other impairment charges | 268,375 | 39,411 | 19,006 |
Write-off of unbilled rent and other | 34,605 | 7,213 | 26,415 |
Debt refinancing and unutilized financing costs | 9,452 | 27,650 | 28,180 |
Gain on sale of equity investments | (40,945) | ||
Tax rate and other changes | 10,697 | 34,796 | 9,295 |
Pre-acquisition rent collected - Circle Transaction | (35,020) | ||
Other adjustments | 6,108 | 11,913 | 8,134 |
Changes in: | |||
Interest and rent receivables | (116,420) | (23,867) | (2,438) |
Other assets | (4,029) | (4,375) | 18,264 |
Accounts payable and accrued expenses | 33,576 | 54,058 | (18,424) |
Deferred revenue | 43 | (12,697) | 19,819 |
Net cash provided by operating activities | 739,010 | 811,656 | 617,636 |
Investing activities | |||
Cash paid for acquisitions and other related investments | (1,332,962) | (5,350,239) | (4,249,180) |
Net proceeds from sale of real estate | 2,185,574 | 246,468 | 94,177 |
Principal received on loans receivable | 53,322 | 1,595,708 | 1,306,187 |
Investment in loans receivable | (207,542) | (58,932) | (62,651) |
Construction in progress and other | (109,237) | (67,725) | (68,350) |
Proceeds from sale and return of equity investment | 14,295 | 65,546 | 69,224 |
Capital additions and other investments, net | (207,394) | (289,239) | (36,180) |
Net cash provided by (used for) investing activities | 396,056 | (3,858,413) | (2,946,773) |
Financing activities | |||
Proceeds from term debt, net of discount | 128,536 | 3,407,535 | 2,215,950 |
Payments of term debt | (869,606) | (1,390,994) | (800,000) |
Revolving credit facilities, net | 203,576 | 559,985 | 162,633 |
Dividends / Distribution paid | (698,535) | (643,473) | (567,969) |
Lease deposits and other obligations to tenants | (5,020) | 17,815 | 21,706 |
Proceeds from sale of units, net of offering costs | 1,051,229 | 411,101 | |
Repurchase of common stock / unit | (17,940) | ||
Stock / Unit vesting - satisfaction of tax withholdings | (29,922) | ||
Payment of debt refinancing, deferred financing costs and other financing activities | (53,612) | (54,489) | (42,347) |
Net cash (used for) provided by financing activities | (1,342,523) | 2,947,608 | 1,401,074 |
Decrease in cash, cash equivalents, and restricted cash for the year | (207,457) | (99,149) | (928,063) |
Effect of exchange rate changes | (12,887) | 4,662 | 16,441 |
Cash, cash equivalents, and restricted cash at beginning of year | 461,882 | 556,369 | 1,467,991 |
Cash, cash equivalents, and restricted cash at end of year | 241,538 | 461,882 | 556,369 |
Interest paid, including capitalized interest of $6,454 in 2022, $3,289 in 2021, and $3,030 in 2020 | 353,838 | 326,406 | 309,920 |
Supplemental schedule of non-cash financing activities: | |||
Dividends declared, unpaid | 176,580 | 176,494 | 147,666 |
Cash, cash equivalents, and restricted cash are comprised of the following: | |||
Cash and cash equivalents at beginning of period | 459,227 | 549,884 | 1,462,286 |
Restricted cash, included in Other assets at beginning of period | $ 2,655 | $ 6,485 | $ 5,705 |
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] | Other Assets | Other Assets | Other Assets |
Cash, cash equivalents, and restricted cash at beginning of year | $ 241,538 | $ 461,882 | $ 556,369 |
Cash and cash equivalents at end of period | 235,668 | 459,227 | 549,884 |
Restricted cash, included in Other assets at end of period | $ 5,870 | $ 2,655 | $ 6,485 |
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List] | Other Assets | Other Assets | Other Assets |
Cash, cash equivalents, and restricted cash at end of year | $ 241,538 | $ 461,882 | $ 556,369 |
Consolidated Statements of Ca_2
Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Interest paid, capitalized | $ 6,454 | $ 3,289 | $ 3,030 |
MPT Operating Partnership, L.P. [Member] | |||
Interest paid, capitalized | $ 6,454 | $ 3,289 | $ 3,030 |
Organization
Organization | 12 Months Ended |
Dec. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization | 1. Orga nization Medical Properties Trust, Inc., a Maryland corporation, was formed on August 27, 2003, under the Maryland General Corporation Law for the purpose of engaging in the business of investing in, owning, and leasing healthcare real estate. Our operating partnership subsidiary, MPT Operating Partnership, L.P. (the “Operating Partnership”), through which we conduct substantially all of our operations, was formed in September 2003. At present, we own all of the partnership interests in the Operating Partnership and have elected to report our required disclosures and that of the Operating Partnership on a combined basis, except where material differences exist. We operate as a real estate investment trust (“REIT”). Accordingly, we are generally not subject to United States (“U.S.”) federal income tax on our REIT taxable income, provided that we continue to qualify as a REIT and our distributions to our stockholders equal or exceed such taxable income. Certain non-real estate activities we undertake are conducted by entities which we elected to be treated as taxable REIT subsidiaries (“TRS”). Our TRS entities are subject to both U.S. federal and state income taxes. For our properties located outside the U.S., we are subject to the local taxes of the jurisdictions where our properties reside and/or legal entities are domiciled; however, we do not expect to incur additional taxes, of a significant nature, in the U.S. from foreign-based income as the majority of such income flows through our REIT. Our primary business strategy is to acquire and develop real estate and improvements, primarily for long-term lease to providers of healthcare services, such as operators of general acute care hospitals, behavioral health facilities, inpatient physical rehabilitation facilities, long-term acute care hospitals, and freestanding ER/urgent care facilities. We also make mortgage loans to healthcare operators collateralized by their real estate. In addition, we may make noncontrolling investments in our tenants, from time-to-time, typically in conjunction with larger real estate transactions with the tenant, which may enhance our overall return and provide for certain minority rights and protections. Our business model facilitates acquisitions and recapitalizations, and allows operators of healthcare facilities to unlock the value of their real estate to fund facility improvements, technology upgrades, and other investments in operations. At December 31, 2022 , we have investments in 444 facilities in 31 states in the U.S., in seven countries in Europe, one country in South America, and across Australia. We manage our business as a single business segment. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | 2. Summary of Signific ant Accounting Policies Use of Estimates: The preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We believe the estimates and assumptions underlying our consolidated financial statements at December 31, 2022 are reasonable and supportable based on the information available (particularly as it relates to our assessments of the recoverability of our real estate and the adequacy of our credit loss reserves on loans and financing receivables). Actual results could differ from those estimates. Principles of Consolidation: Property holding entities and other subsidiaries of which we own 100 % of the equity or have a controlling financial interest evidenced by ownership of a majority voting interest are consolidated. All inter-company balances and transactions are eliminated. For entities in which we own less than 100% of the equity interest, we consolidate the property if we have the direct or indirect ability to control the entities’ activities based upon the terms of the respective entities’ ownership agreements. For these entities, we record a non-controlling interest representing equity held by non-controlling interests. We continually evaluate all of our transactions and investments to determine if they represent variable interests in a variable interest entity. If we determine that we have a variable interest in a variable interest entity, we then evaluate if we are the primary beneficiary of the variable interest entity. The evaluation is a qualitative assessment as to whether we have the ability to direct the activities of a variable interest entity that most significantly impact the entity’s economic performance. We consolidate each variable interest entity in which we, by virtue of or transactions with our investments in the entity, are considered to be the primary beneficiary. At December 31, 2022, we had loans and/or equity investments in certain variable interest entities approximating $ 633 million, which represents our maximum exposure to loss as a result of our involvement in such entities. We have determined that we were not the primary beneficiary of any variable interest entity in which we hold a variable interest because we do not control the activities (such as the day-to-day operations) that most significantly impact the economic performance of these entities. Investments in Unconsolidated Entities: Investments in entities in which we have the ability to significantly influence (but not control) are accounted for by the equity method. This includes the five investments in unconsolidated real estate joint ventures at December 31, 2022. Under the equity method of accounting, our share of the investee’s earnings or losses are included in the “Earnings from equity interests” line of our consolidated statements of net income. Except for our joint ventures with Primotop Holdings S.à.r.l. ("Primotop") and Macquarie Asset Management ("MAM") (for which we handle the accounting of), we have elected to record our share of such investee’s earnings or losses on a lag basis (not to exceed three months). The initial carrying value of investments in unconsolidated entities is based on the amount paid to purchase the interest in the investee entity. Subsequently, our investments are increased/decreased by our share in the investees’ earnings/losses and decreased by cash distributions from our investees. To the extent that our cost basis is different from the basis reflected at the investee entity level, the basis difference is generally amortized over the lives of the related assets and liabilities, and such amortization is included in our share of equity in earnings of the investee. We evaluate our equity method investments for impairment based upon a comparison of the fair value of the equity method investment to its carrying value, when impairment indicators exist. If we determine a decline in the fair value of an investment in an unconsolidated investee entity below its carrying value is other-than-temporary, an impairment is recorded. Investments in entities in which we do not control nor do we have the ability to significantly influence and for which there is no readily determinable fair value (such as our investment in Steward Health Care System LLC (“Steward”)) are accounted for at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions involving the investee. Cash distributions on these types of investments are recorded to either income upon receipt (if a return on investment) or as a reduction of our investment (if the distributions received are in excess of our share of the investee’s earnings). For similar investments but for which there are readily determinable fair values, such investments are measured at fair value, with unrealized gains and losses recorded in income. Cash and Cash Equivalents: Certificates of deposit, short-term investments with original maturities of three months or less, and money-market mutual funds are considered cash equivalents. The majority of our cash and cash equivalents are held at major commercial banks, which at times may exceed the Federal Deposit Insurance Corporation limit. We have not experienced any losses to-date on our invested cash. Cash and cash equivalents which have been restricted as to its use are recorded in other assets. Revenue Recognition: Our revenues are primarily from leases and loans. For leases, we follow Accounting Standards Update (“ASU”) 2016-02, “Leases”, (“ASU 2016-02”). ASU 2016-02 sets out the principles for the recognition, measurement, presentation, and disclosure of leases for both parties to a contract (i.e. lessees and lessors). For lessors, we apply this standard as follows: Operating Lease Revenue We receive income from operating leases based on the fixed required rents (base rents) per the lease agreements. Rent revenue from base rents is recorded on the straight-line method, when collectability of the lease payments is deemed probable, over the terms of the related lease agreements for new leases and the remaining terms of existing leases for those acquired as part of a property acquisition. The straight-line method records the periodic average amount of base rents earned over the term of a lease, taking into account contractual rent increases over the lease term. The straight-line method typically has the effect of recording more rent revenue from a lease than a tenant is required to pay early in the term of the lease. During the later parts of a lease term, this effect reverses with less rent revenue recorded than a tenant is required to pay. Rent revenue, as recorded on the straight-line method, in our consolidated statements of net income is presented as two amounts: rent billed and straight-line rent. Rent billed revenue is the amount of base rent actually billed to our tenants each period as required by the lease. Straight-line rent revenue is the difference between rent revenue earned based on the straight-line method and the amount recorded as rent billed revenue. We record the difference between rent revenues earned and amounts due per the respective lease agreements, as applicable, as an increase or decrease to straight-line rent receivables. Rental payments received prior to their recognition as income are classified as deferred revenue. Financing Lease Revenue Under ASU 2016-02, if an acquisition and subsequent lease of a property back to the seller does not meet the definition of a sale, we must account for the transaction as a financing lease with income recognized using the imputed interest method. Another type of financing lease is a direct financing lease (“DFL”). For leases accounted for as DFLs, the future minimum lease payments are recorded as a receivable at lease inception, while, the difference between the future minimum lease payments and the estimated residual values less the cost of the properties is recorded as unearned income. Unearned income is deferred and amortized to income over the lease term to provide a constant yield when collectability of the lease payments is reasonably assured. Investments in DFLs are presented net of unearned income. Other Leasing Revenue We begin recording base rent income from our development projects when the lessee takes physical possession of the facility, which may be different from the stated start date of the lease. Also, during construction of our development projects, we may be entitled to accrue rent based on the cost paid during the construction period (construction period rent). We accrue construction period rent as a receivable with a corresponding offset to deferred revenue during the construction period. When the lessee takes physical possession of the facility, we begin recognizing the deferred construction period revenue on the straight-line method over the term of the lease. We also receive additional rent (contingent rent) under some leases based on increases in the consumer price index (“CPI”) (or similar index outside the U.S.) or when CPI exceeds the annual minimum percentage increase as stipulated in the lease. Contingent rents are recorded as rent billed revenue in the period earned. Tenant payments for ground leases along with other operating expenses, such as property taxes and insurance, that are paid directly by us and reimbursed by our tenants are presented on a gross basis with the related revenues recorded in “Interest and other income” and the related expenses in “Property-related” in our consolidated statements of net income. All payments of other operating expenses made directly by the tenant to the applicable government or appropriate third-party vendor are recorded on a net basis. Interest Revenue We receive interest income from our tenants/borrowers on mortgage loans, working capital loans, and other long-term loans. Interest income from these loans is recognized as earned based upon the principal outstanding and terms of the loans. Other Revenue Commitment fees received from lessees for development and leasing services are initially recorded as deferred revenue and recognized as income over the initial term of a lease to produce a constant effective yield on the lease (interest method). Commitment and origination fees from lending services are also recorded as deferred revenue initially and recognized as income over the life of the loan using the interest method. Acquired Real Estate Purchase Price Allocation: We account for acquisitions of real estate under asset acquisition accounting rules. Under this accounting standard, we allocate the purchase price (including any third-party transaction costs directly related to the acquisition) of acquired properties to tangible and identified intangible assets acquired and liabilities assumed (if any) based on their relative fair values. In making estimates of fair values for purposes of allocating purchase prices of acquired real estate, we may utilize a number of sources, from time-to-time, including available real estate broker data, independent appraisals that may be obtained in connection with the acquisition, internal data from previous acquisitions or developments, and other market data, including market comparables for significant assumptions such as market rental, capitalization, and discount rates. We also consider information obtained about each property as a result of our pre-acquisition due diligence, marketing, and leasing activities in estimating the fair value of the tangible and intangible assets acquired. We measure the aggregate value of lease intangible assets acquired based on the difference between (i) the property valued with new or in-place leases adjusted to market rental rates and (ii) the property valued as if vacant. Management’s estimates of value are made using methods similar to those used by independent appraisers (e.g., discounted cash flow analysis). Factors considered by management in our analysis include an estimate of carrying costs during hypothetical expected lease-up periods, considering current market conditions, and costs to execute similar leases. We also consider information obtained about each targeted facility as a result of our pre-acquisition due diligence, marketing, and leasing activities in estimating the fair value of the intangible assets acquired. In estimating carrying costs, management includes real estate taxes, insurance, and other operating expenses and estimates of lost rentals at market rates during the expected lease-up periods, which we expect to be about six months , but can be longer depending on specific local market conditions. Management also estimates costs to execute similar leases including leasing commissions, legal costs, and other related expenses to the extent that such costs are not already incurred in connection with a new lease origination as part of the transaction. Other intangible assets acquired may include customer relationship intangible values which are based on management’s evaluation of the specific characteristics of each prospective tenant’s lease and our overall relationship with that tenant. Characteristics to be considered by management in allocating these values include the nature and extent of our existing business relationships with the tenant, growth prospects for developing new business with the tenant, the tenant’s credit quality, and expectations of lease renewals, including those existing under the terms of the lease agreement, among other factors. We amortize the value of our lease intangible assets to expense over the term of the respective leases. If a lease is terminated early, the unamortized portion of the lease intangibles are charged to expense. We record above-market and below-market in-place lease values, if any, for our facilities, which are based on the present value of the difference between (i) the contractual amounts to be paid pursuant to the in-place leases and (ii) management’s estimate of fair market lease rates for the corresponding in-place leases, measured over a period equal to the remaining non-cancelable term of the lease. We amortize any resulting capitalized above-market lease values as a reduction of rental income over the lease term. We amortize any resulting capitalized below-market lease values as an increase to rental income over the lease term. If a lease is terminated early, the unamortized portion of the capitalized above/below market lease value is recognized in rental income at that time. Real Estate and Depreciation: Real estate, consisting of land, buildings and improvements, is maintained at cost. Although typically paid by our tenants, any expenditure for ordinary maintenance and repairs that we pay are expensed to operations as incurred. Significant renovations and improvements, which improve and/or extend the useful life of the asset, are capitalized and depreciated over their estimated useful lives. We record impairment losses on long-lived assets used in operations when events and circumstances indicate that the assets might be impaired and the undiscounted cash flows estimated to be generated by those assets, including an estimated liquidation amount, during the expected holding periods are less than the carrying amounts of those assets. Impairment losses are measured as the difference between carrying value and fair value of the assets. For assets held for sale, we cease recording depreciation expense and adjust the assets’ value to the lower of its carrying value or fair value, less cost of disposal. Fair value is based on estimated cash flows discounted at a risk-adjusted rate of interest. We classify real estate assets as held for sale when we have commenced an active program to sell the assets, and in the opinion of management, it is probable the asset will be sold within the next 12 months. Construction in progress includes the cost of land, the cost of construction of buildings, improvements, and fixed equipment, and costs for design and engineering. Other costs, such as interest, legal, property taxes, and corporate project supervision, which can be directly associated with the project during construction, are also included in construction in progress. We commence capitalization of costs associated with a development project when the development of the future asset is probable and activities necessary to get the underlying property ready for its intended use have been initiated. We stop the capitalization of costs when the property is substantially complete and ready for its intended use. Depreciation is calculated on the straight-line method over the estimated useful lives of the related real estate and other assets. Our weighted-average useful lives at December 31, 2022 are as follows: Buildings and improvements 39.0 years Lease intangibles 26.8 years Leasehold improvements 14.4 years Furniture, equipment, and other 9.8 years Credit Losses: Losses from Rent Receivables: For all leases, we continuously monitor the performance of our existing tenants including, but not limited to: admission levels and surgery/procedure volumes by type; current operating margins; ratio of our tenant's operating margins both to facility rent and to facility rent plus other fixed costs; trends in revenue, cash collections, patient mix; and the effect of evolving healthcare regulations, adverse economic and political conditions, such as rising inflation and interest rates, and other events ongoing on a tenant's profitability and liquidity. Losses from Operating Lease Receivables: We utilize the information above along with the tenant’s payment and default history in evaluating (on a property-by-property basis) whether or not a provision for losses on outstanding billed rent and/or straight-line rent receivables is needed. A provision for losses on rent receivables (including straight-line rent receivables) is ultimately recorded when it becomes probable that the receivable will not be collected in full. The provision is an amount which reduces the receivable to its estimated net realizable value based on a determination of the eventual amounts to be collected either from the debtor or from existing collateral, if any. Losses on Financing Lease Receivables: We apply a forward-looking “expected credit loss” model to all of our financing receivables, including financing leases and loans. To do this, we have grouped our financial instruments into two primary pools of similar credit risk: secured and unsecured. The secured instruments include our investments in financing receivables as all are secured by the underlying real estate, among other collateral. Within the two primary pools, we further grouped our instruments into sub-pools based on several tenant/borrower characteristics, including years of experience in the healthcare industry and in a particular market or region and overall capitalization. We then determined a credit loss percentage per pool based on our history over a period of time that closely matches the remaining terms of the financial instruments being analyzed and adjusted as needed for current trends or unusual circumstances. We have applied these credit loss percentages to the book value of the related instruments to establish a credit loss reserve on our financing lease receivables and such credit loss reserve (including the underlying assumptions) is reviewed and adjusted quarterly. If a financing receivable is under performing and is deemed uncollectible based on the lessee’s overall financial condition, we will adjust the credit loss reserve based on the fair value of the underlying collateral. We made the accounting policy election to exclude interest receivables from the credit loss reserve model. Instead, such receivables are impaired and an allowance recorded when it is deemed probable that we will be unable to collect all amounts due. Like operating lease receivables, the need for an allowance is based upon our assessment of the lessee’s overall financial condition, economic resources and payment record, the prospects for support from any financially responsible guarantors, and, if appropriate, the realizable value of any collateral. Financing leases are placed on non-accrual status when we determine that the collectability of contractual amounts is not reasonably assured. If on non-accrual status, we generally account for the financing lease on a cash basis, in which income is recognized only upon receipt of cash. Loans : Loans consist of mortgage loans, working capital loans, and other loans. Mortgage loans are collateralized by interests in real property. Working capital and other loans are typically collateralized by interests in receivables and corporate and individual guarantees. We record loans at cost. Like our financing lease receivables, we establish credit loss reserves on all outstanding loans based on historical credit losses of similar instruments. Such credit loss reserves, including the underlying assumptions, are reviewed and adjusted quarterly. If a loan’s performance worsens and foreclosure is deemed probable for our collateral-based loans (after considering the borrower’s overall financial condition as described above for leases), we will adjust the allowance for expected credit losses based on the current fair value of such collateral at the time the loan is deemed uncollectible. If the loan is not collateralized, the loan will be reserved for/written-off once it is determined that such loan is no longer collectible. Interest receivables on loans are excluded from the forward looking credit loss reserve model; however, we assess their collectability similar to how we assess collectability for interest receivables on financing leases described above. The following table summarizes our credit loss reserves (in thousands): December 31, 2022 December 31, 2021 Balance at beginning of the year $ 48,527 $ 8,726 Provision (recovery) for credit loss, net 99,009 41,710 Expected credit loss reserve related to financial instruments sold, ( 26,390 ) ( 1,909 ) Balance at end of year $ 121,146 $ 48,527 Earnings Per Share/Units: Basic earnings per common share/unit is computed by dividing net income by the weighted-average number of shares/units outstanding during the period. Diluted earnings per common share/unit is calculated by including the effect of dilutive securities. Our unvested restricted stock awards contain non-forfeitable rights to dividends, and accordingly, these awards are deemed to be participating securities. These participating securities are included in the earnings allocation in computing both basic and diluted earnings per common share/unit. Income Taxes: We conduct our business as a REIT under Sections 856 through 860 of the Internal Revenue Code of 1986, as amended (“the Code”). To qualify as a REIT, we must meet certain organizational and operational requirements, including a requirement to distribute to stockholders at least 90 % of our REIT’s ordinary taxable income. As a REIT, we generally pay little U.S. federal and state income tax because of the dividends paid deduction that we are allowed to take. If we fail to qualify as a REIT in any taxable year, we will then be subject to U.S. federal income taxes on our taxable income at regular corporate rates and will not be permitted to qualify for treatment as a REIT for federal income tax purposes for four years following the year during which qualification is lost, unless the Internal Revenue Service grants us relief under certain statutory provisions. Such an event could materially adversely affect our net income and net cash available for distribution to stockholders. However, we intend to operate in such a manner so that we will remain qualified as a REIT for U.S. federal income tax purposes. Our financial statements include the operations of TRS entities. None of our TRS entities are entitled to a dividends paid deduction and are subject to U.S. federal, state, and local income taxes. Our TRS entities are authorized to provide property development, leasing, and management services for third-party owned properties, and we will make non-mortgage loans to and/or investments in our lessees through these entities. With the property acquisitions and investments in Europe, Australia, and South America, we are subject to income taxes internationally. However, we do not expect to incur any additional income taxes, of a significant nature, in the U.S. as the majority such income from our international properties flows through our REIT income tax returns. For our TRS entities and international subsidiaries, we determine deferred tax assets and liabilities based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Any increase or decrease in our deferred tax assets/liabilities that results from a change in circumstances and that causes us to change our judgment about expected future tax consequences of events, is reflected in our tax provision when such changes occur. Deferred income taxes also reflect the impact of operating loss carryforwards. A valuation allowance is provided if we believe it is more likely than not that all or some portion of our deferred tax assets will not be realized. Any increase or decrease in the valuation allowance that results from a change in circumstances, and that causes us to change our judgment about our ability to realize the related deferred tax asset, is reflected in our tax provision when such changes occur. The calculation of our income taxes involves dealing with uncertainties in the application of complex tax laws and regulations in a multitude of jurisdictions across our global operations. An income tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, on the basis of technical merits. However, if a more likely than not position cannot be reached, we record a liability as an offset to the tax benefit and adjust the liabilities when our judgment changes as a result of the evaluation of new information not previously available. Because of the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from our current estimate of the uncertain tax position liabilities. These differences will be reflected as increases or decreases to income tax expense in the period in which new information is available. Stock-Based Compensation: We adopted the 2019 Equity Incentive Plan (the “Equity Incentive Plan”) during the second quarter of 2019, which was amended during the second quarter of 2022. Awards of restricted stock and other equity-based awards with service conditions are valued at the average stock price per share on the date of grant and are amortized to compensation expense over the service periods (typically three years ), using the straight-line method. Awards that contain market conditions are valued on the grant date using a Monte Carlo valuation model and are amortized to compensation expense over the derived service periods, which correspond to the periods over which we estimate the awards will be earned, which generally range from three to five years , using the straight-line method. Awards with performance conditions are valued at the average stock price per share on the date of grant and are amortized using the straight-line method over the service period, adjusted for the probability of achieving the performance conditions. Forfeitures of stock-based awards are recognized as they occur. Deferred Costs: Costs incurred that directly relate to the offerings of stock are deferred and netted against proceeds received from the offering. Leasing commissions and other third-party leasing costs that would not have been incurred if the lease was not obtained are capitalized as deferred leasing costs and amortized on the straight-line method over the terms of the related lease agreements. Costs identifiable with loans made to borrowers are capitalized and recognized as a reduction in interest income over the life of the loan. Deferred Financing Costs: We generally capitalize financing costs incurred in connection with new financings and refinancings of debt. These costs are amortized over the lives of the related debt as an addition to interest expense. For debt with defined principal re-payment terms, the deferred costs are amortized to produce a constant effective yield on the debt (interest method) and are included within “Debt, net” on our consolidated balance sheets. For debt without defined principal repayment terms, such as our revolving credit facility, the deferred costs are amortized on the straight-line method over the term of the debt and are included as a component of “Other assets” on our consolidated balance sheets. Foreign Currency Translation and Transactions: Certain of our international subsidiaries’ functional currencies are the local currencies of their respective countries. We translate the results of operations of our foreign subsidiaries into U.S. dollars using average rates of exchange in effect during the period, and we translate balance sheet accounts using exchange rates in effect at the end of the period. We record resulting currency translation adjustments in accumulated other comprehensive income (loss), a component of stockholders’ equity/partnership capital on our consolidated balance sheets. Certain of our U.S. subsidiaries will enter into short-term and long-term transactions denominated in a foreign currency from time-to-time. Gains or losses resulting from these foreign currency transactions are revalued into U.S. dollars at the rates of exchange prevailing at the dates of the transactions. The effects of revaluation gains or losses on our short-term transactions are included in other income (expense) in the consolidated statements of income, while the revaluation effects on our long-term investments are recorded in accumulated other comprehensive income (loss) on our consolidated balance sheets. Derivative Financial Investments and Hedging Activities: During our normal course of business, we may use certain types of derivative instruments for the purpose of managing interest rate and/or foreign currency risk. We record our derivative and hedging instruments at fair value on the balance sheet. Changes in the estimated fair value of derivative instruments that are not designated as hedges or that do not meet the criteria for hedge accounting are recognized in earnings. For derivatives designated as cash flow hedges, the change in the estimated fair value of the effective portion of the derivative is recognized in accumulated other comprehensive income (loss) on our consolidated balance sheets, whereas the change in the estimated fair value of the ineffective portion is recognized in earnings. For derivatives designated as fair value hedges, the change in the estimated fair value of the effective portion of the derivatives offsets the change in the estimated fair value of the hedged item, whereas the change in the estimated fair value of the ineffective portion is recognized in earnings. To qualify for hedge accounting, we formally document all relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking the hedge prior to entering into a derivative transaction. This process includes specific identification of the hedging instrument and the hedge transaction, the nature of the risk being hedged and how the hedging instrument’s effectiveness in hedging the exposure to the hedged transaction’s variability in cash flows attributable to the hedged risk will be assessed. Both at the inception of the hedge and on an ongoing basis, we assess whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in cash flows or fair values of hedged items. In addition, for cash flow hedges, we assess whether the underlying forecasted transaction will occur. We discontinue hedge accounting if a derivative is not determined to be highly effective as a hedge or that it is probable that the underlying forecasted transaction will not occur. F |
Real Estate and Other Activitie
Real Estate and Other Activities | 12 Months Ended |
Dec. 31, 2022 | |
Real Estate [Abstract] | |
Real Estate and Other Activities | 3. Real Esta te and Other Activities New Investments For the years ended December 31, 2022, 2021, and 2020, we acquired or invested in the following net assets (in thousands): 2022 2021 2020 Land and land improvements $ 135,301 $ 642,312 $ 365,281 Buildings 487,698 2,381,654 2,547,313 Intangible lease assets — subject to amortization 21.3 years in 2022, 34.5 years in 2021, and 27.5 years in 2020) 45,394 262,385 642,699 Investment in financing leases — — 114,797 Mortgage loans(1)(2) 159,735 1,113,300 176,840 Investments in unconsolidated real estate joint ventures 399,456 — 233,593 Investments in unconsolidated operating entities 131,105 1,033,096 205,000 Other loans — — 103,195 Other assets — — 1,328 Liabilities assumed ( 25,727 ) ( 82,508 ) ( 140,866 ) $ 1,332,962 $ 5,350,239 $ 4,249,180 Loans repaid(1) — ( 1,103,410 ) ( 834,743 ) Total net assets acquired $ 1,332,962 $ 4,246,829 $ 3,414,437 (1) The 2021 column includes an £ 800 million mortgage loan advanced to the Priory Group (“Priory”) in the first quarter of 2021 and converted to fee simple ownership of 35 properties in the second quarter of 2021 as described below. The 2020 column includes approximately $ 740 million of loans advanced to Steward in 2017 and exchanged for the fee simple real estate of two hospitals as described below, as well as approximately $ 100 million of loans advanced to Ernest Health, Inc. (“Ernest”) in 2012 and exchanged for the fee simple real estate of four hospitals as described below. (2) In the 2022 second quarter, we increased our mortgage loan to Prospect Medical Holdings, Inc. ("Prospect") that was originated in 2019 and that is secured by a first lien on a California hospital. The loan bears interest at a current market rate plus a component of additional interest upon repayment. 2022 Activity Macquarie Transaction On March 14, 2022, we completed a transaction with Macquarie Asset Management (“MAM”), an unrelated party, to form a partnership (the “Macquarie Transaction”), pursuant to which we contributed eight Massachusetts-based general acute care hospitals that are leased to Steward, and a fund managed by MAM acquired, for cash consideration, a 50 % interest in the partnership. The transaction valued the portfolio at approximately $ 1.7 billion, and we recognized a gain on sale of real estate of approximately $ 600 million from this transaction, partially offset by the write-off of unbilled straight-line rent receivables. The partnership raised nonrecourse secured debt of 55 % of asset value, and we received proceeds, including from the secured debt, of approximately $ 1.3 billion. We obtained a 50 % interest in the real estate partnership valued at approximately $ 400 million (included in the "Investments in unconsolidated real estate joint ventures" line of our consolidated balance sheets), which is being accounted for under the equity method of accounting. In connection with this transaction, we separated the eight Massachusetts-based facilities into a separate master lease with terms generally identical to the other master lease, and the initial fixed lease term of both master leases were extended to 2041 . Other Transactions On December 9, 2022, we acquired six behavioral health facilities in the United Kingdom for £ 233 million ($ 286 million), plus customary tax and other transaction costs. These hospitals are leased to Priory pursuant to separate long-term leases with inflation-based escalators. As part of this transaction, the third-party seller of the real estate provided £ 105 million of seller financing - see Note 4 for further details on this debt. On March 11, 2022, we acquired four general acute care hospitals in Finland for € 178 million ($ 194 million). These hospitals are leased to Pihlajalinna pursuant to a long-term lease with annual inflation-based escalators. We acquired these facilities by the share purchase of real estate holding entities that included deferred income tax and other liabilities of approximately $ 26 million. On February 16, 2022, we agreed to participate in an existing syndicated term loan with a term of six years originated on behalf of Priory. We funded £ 96.5 million towards a £ 100 million participation level, reflecting a 3.5 % discount. The loan carries a variable rate that was 8.3 % at December 31, 2022. Other investments in 2022 included the acquisition of six general acute care facilities and the origination of a CHF 60 million mortgage loan to Infracore SA ("Infracore"). Of the assets acquired, three were general acute care facilities located throughout Spain, acquired on April 29, 2022 for € 27 million, and leased to GenesisCare pursuant to a long-term lease with annual inflation-based escalators. In addition, two general acute care facilities, one in Arizona and the other in Florida, were acquired on April 18 and 25, 2022, respectively, for approximately $ 80 million and leased to Steward pursuant to an already existing master lease agreement with annual inflation-based escalators. The other general acute care facility, located in Colombia, was acquired on July 29, 2022 for $ 26 million and leased to Fundación Cardiovascular de Colombia pursuant to a long-term lease with inflation-based escalators. 2021 Activity Priory Group Transaction On January 19, 2021, we completed the first of two phases in the Priory transaction in which we funded an £ 800 million interim mortgage loan on an identified portfolio of Priory real estate assets in the United Kingdom. On June 25, 2021, we completed the second phase of the transaction in which we converted this mortgage loan to fee simple ownership in a portfolio of 35 select real estate assets from Priory (which is currently owned by Waterland Private Equity Fund VII C.V. (“Waterland VII”)) in individual sale-and-leaseback transactions. Therefore, the net aggregate purchase price for the real estate assets we acquired from Priory was approximately £ 800 million, plus customary stamp duty, tax, and other transaction costs. As part of the real estate acquisition (for which some of the assets were acquired by the share purchase of real estate holding entities), we incurred deferred income tax liabilities and other liabilities of approximately £ 47.1 million. In addition to the real estate investment, on January 19, 2021, we made a £ 250 million acquisition loan to Waterland VII, in connection with the closing of Waterland VII’s acquisition of Priory, which was repaid in full plus interest on October 22, 2021. Finally, we acquired a 9.9 % passive equity interest in the Waterland VII affiliate that indirectly owns Priory. Other Transactions On December 2, 2021, we acquired the remaining 50 % interest in a general acute hospital operated by IMED Hospitales ("IMED") in Valencia, Spain, which was formerly owned by our joint venture partner. We followed the asset acquisition cost accumulation model to account for this acquisition and included the carrying amount of our previously held equity interest, along with the approximately € 46 million consideration paid and direct transaction costs incurred, in determining the total cost allocated to the net assets acquired. On October 21, 2021, we acquired an acute care facility in Portugal for € 17.8 million. This facility is leased to Atrys Health pursuant to a long-term master lease with annual escalations. On October 19, 2021, we invested in 18 inpatient behavioral health facilities throughout the U.S. and an interest in the operations of Springstone for total consideration of $ 950 million (including an acquisition loan of approximately $ 185 million), plus closing and other transaction costs. We also incurred deferred income tax liabilities of approximately $ 8.0 million. These facilities are leased to Springstone pursuant to a long-term master lease with annual escalations and multiple extension options. On August 1, 2021, we completed the acquisition of five general acute care hospitals located in South Florida for approximately $ 900 million, plus closing and other transaction costs. These hospitals are leased to Steward pursuant to a master lease, with annual inflation-based escalators. On July 6, 2021, we acquired four acute care hospitals and two on-campus medical office buildings in Los Angeles, California for $ 215 million. These hospitals are leased to Pipeline Health System, LLC ("Pipeline") pursuant to a long-term lease with annual inflation-based escalators. On July 6, 2021, we also acquired an acute care hospital in Stirling, Scotland for £ 15.6 million. This hospital is leased to Circle Health Ltd. (“Circle”) pursuant to a long-term lease with annual inflation-based escalators. On April 16, 2021, we made a CHF 145 million investment in Swiss Medical Network, our tenant via our Infracore equity investment. On January 8, 2021, we made a $ 335 million loan to affiliates of Steward, all of the proceeds of which were used to redeem a similarly sized convertible loan held by Steward’s former private equity sponsor. 2020 Activity Circle Transaction On January 8, 2020, we acquired a portfolio of 30 acute care hospitals located throughout the United Kingdom for approximately £ 1.5 billion from affiliates of BMI Healthcare, Inc. (“BMI”), as part of a share purchase in which we also inherited certain net deferred income tax and other liabilities and £ 27.6 million of unearned rent revenue. In a related transaction, affiliates of Circle acquired BMI and assumed its operations in the United Kingdom. As part of our acquisition, we inherited 30 existing leases with the operator that had initial fixed terms ending in 2050 , with no renewal options but with annual inflation-based escalators. Effective June 16, 2020, these 30 leases were amended to include two five-year renewal options and improve the annual inflation-based escalators. These 30 leases are cross-defaulted and guaranteed by Circle. Other Transactions On December 31, 2020, we acquired an inpatient rehabilitation hospital in South Carolina for approximately $ 17 million. As part of the transaction, we acquired the fee simple real estate of three inpatient rehabilitation hospitals and one long-term acute care hospital in exchange for the reduction of the mortgage loans made to Ernest for such properties in 2012. These five facilities, with an approximate $ 115 million total investment, are leased to Ernest pursuant to an existing long-term master lease with multiple extension options and annual escalation provisions. On December 29, 2020, we increased our equity ownership and related investment in Infracore by investing an additional CHF 206.5 million. We are accounting for our total investment in this joint venture (this investment along with our initial investment in 2019 as noted below) under the equity method. On August 13, 2020, we acquired a general acute care hospital in Lynwood, California for a total investment of approximately $ 300 million. This property is leased to Prime Healthcare Services, Inc. (“Prime”) pursuant to a long-term master lease with annual escalations and multiple extension options. On July 8, 2020, we acquired the fee simple real estate of two general acute care hospitals located in the Salt Lake City, Utah area, Davis Hospital & Medical Center and Jordan Valley Medical Center, in exchange for the reduction of the mortgage loans made to Steward for such properties and additional cash consideration of $ 200 million based on their relative fair value. The approximate $ 950 million investment in these two facilities is subject to a Steward master lease. On June 24, 2020, we originated a CHF 45 million secured loan to Infracore, which was paid in full on December 2, 2020. On May 13, 2020, we formed a joint venture for the purpose of investing in the operations of international hospitals. As part of the formation, we originated a $ 205 million acquisition loan. We have a 49 % interest in this joint venture and are accounting for our investment using the fair value option election. The joint venture simultaneously purchased from Steward the rights and existing assets related to all present and future international opportunities previously owned by Steward for strategic, regulatory, and risk management purposes. Through this joint venture, we invested, on November 17, 2020, in the real estate of three general acute care hospitals in Colombia for approximately $ 135 million. These properties are operated by the international joint venture. Other acquisitions in 2020 included three inpatient rehabilitation hospitals, two general acute care hospitals, and one private acute care hospital totaling approximately $ 300 million. One inpatient rehabilitation facility, located in Dahlen, Germany, was acquired on August 5, 2020 for € 12.5 million and is leased to MEDIAN Kliniken S.á.r.l. (“MEDIAN”) pursuant to the existing master lease. One of the general acute care facilities, located in Darlington, United Kingdom, was acquired on August 7, 2020 for £ 29.4 million and is leased to Circle pursuant to a long-term lease. The other general acute care hospital, located in London, United Kingdom, was acquired on November 25, 2020 for £ 50 million via the purchase of a 999 -year ground lease and is leased to The Royal Marsden NHS Foundation Trust pursuant to a long-term lease. The inpatient rehabilitation hospitals, one in Texas and one in Indiana, were acquired on December 17, 2020 for approximately $ 58 million and are leased to Post Acute Medical, LLC pursuant to a long-term lease. The private acute care hospital, located in Reading, United Kingdom, was acquired on December 18, 2020 for £ 85.0 million and is leased to Circle pursuant to the existing long-term Circle master lease. Development Activities 2022 Activity During 2022, we agreed to finance the development of five new projects. One of these development projects is a behavioral health facility in McKinney, Texas with a total budget of approximately $ 35 million. This facility will be leased to Springstone pursuant to the existing long-term master lease. The second development project is an inpatient rehabilitation facility in Cayce, South Carolina with a total budget of approximately $ 22 million. This facility will be leased to Ernest pursuant to an existing long-term master lease. In addition, we agreed to finance the development of and lease three general acute care facilities located throughout Spain for a total commitment of approximately € 120 million. These facilities will be leased to our existing tenant, IMED, under a long-term master lease agreement. During the 2022 first quarter, we completed construction and began recording rental income on an inpatient rehabilitation facility located in Bakersfield, California. This facility commenced rent on March 1, 2022 and is being leased to Ernest pursuant to an existing long-term master lease. 2021 Activity In the fourth quarter of 2021, we agreed to finance the development of and lease an acute care facility in Texarkana, Texas for $ 169.4 million. After initial delays with a change in the general contractor, physical construction has begun with an updated expected completion date of the first quarter of 2026. This facility will be leased to Steward pursuant to an existing long-term master lease. 2020 Activity On November 23, 2020, we agreed to finance the development of and lease an inpatient rehabilitation facility in Stockton, California for $ 47.7 million. This facility will be leased to Ernest pursuant to an existing long-term master lease. During 2020, we completed construction on two general acute care facilities and one inpatient rehabilitation facility and began recognizing revenue on these properties immediately thereafter. See table below for a status summary of our current development projects (in thousands): Property Commitment Costs Estimated Rent Ernest (Stockton, California) $ 47,700 $ 45,739 1Q 2023 IMED (Spain) 50,411 13,037 2Q 2023 Ernest (South Carolina) 22,400 7,541 2Q 2023 IMED (Spain) 45,408 33,801 3Q 2023 Springstone (Texas) 34,600 1,962 1Q 2024 IMED (Spain) 36,734 8,320 3Q 2024 Steward (Texas) 169,408 57,020 1Q 2026 $ 406,661 $ 167,420 Disposals 2022 Activity On March 14, 2022, we completed the previously described partnership with MAM, in which we sold the real estate of eight Massachusetts-based general acute care hospitals, with a fair value of approximately $ 1.7 billion. See "New Investments" in this Note 3 for further details on this transaction. During 2022, we also completed the sale of 15 other facilities (including 11 properties sold on September 1, 2022 related to the Prime repurchase option for proceeds of $ 366 million) and five ancillary properties for total proceeds of approximately $ 522 million and recognized a gain on real estate of approximately $ 100 million, along with a $ 42 million write-off of straight-line rent receivables due to the early termination of certain properties' expected lease terms. Summary of Operations for Disposed Assets in 2022 The properties sold during 2022 do not meet the definition of discontinued operations. However, the following represents the operating results from these properties for the periods presented (in thousands): For the Year Ended December 31, 2022 2021 2020 Revenues(1) $ 17,831 $ 180,549 $ 174,362 Real estate depreciation and amortization(2) ( 4,683 ) ( 28,579 ) ( 38,059 ) Property-related expenses ( 1,588 ) ( 5,065 ) ( 12,509 ) Other income(3) 536,813 181 1,228 Income from real estate dispositions, net $ 548,373 $ 147,086 $ 125,022 (1) Includes approximately $ 42 million of straight-line rent and other write-offs associated with the non-Macquarie disposal transactions for the year ended December 31, 2022. (2) Lower in 2022 as we stopped depreciating the properties making up the Macquarie Transaction once deemed held for sale in September 2021. (3) Includes $ 536.8 million of gains (net of $ 125 million write-off of straight-line rent receivables related to the Macquarie Transaction) for the year ended December 31, 2022. 2021 Activity During the 2021 fourth quarter, we sold our interest in the operations of three operators (two of which were in Germany) for proceeds of approximately $ 54.5 million, resulting in a net gain of approximately $ 40 million. During 2021, we also completed the sale of 16 facilities and an ancillary property for approximately $ 246 million, resulting in a net gain on real estate of approximately $ 52.5 million. 2020 Activity During 2020, we completed the sale of nine facilities and six ancillary properties for approximately $ 94 million, resulting in a net loss of $ 2.8 million. Intangible Assets At December 31, 2022 and 2021 , our intangible lease assets were $ 1.4 billion ($ 1.2 billion, net of accumulated amortization) and $ 1.4 billion ($ 1.3 billion, net of accumulated amortization), respectively. We recorded amortization expense related to intangible lease assets of $ 55.9 million, $ 56.0 million, and $ 42.4 million in 2022, 2021, and 2020, respectively, and expect to recognize amortization expense from existing lease intangible assets as follows (amounts in thousands): For the Year Ended December 31: 2023 $ 56,740 2024 56,683 2025 56,535 2026 56,266 2027 55,932 As of December 31, 2022 , capitalized lease intangibles have a weighted-average remaining life of 23.7 years. Leasing Operations (Lessor) We acquire and develop healthcare facilities and lease the facilities to healthcare operating companies. The initial fixed lease terms of these infrastructure-type assets are typically at least 15 years, and most include renewal options at the election of our tenants, generally in five year increments. Over 99 % of our leases provide annual rent escalations based on increases in the CPI (or similar indices outside the U.S.) and/or fixed minimum annual rent escalations. Many of our domestic leases contain purchase options with pricing set at various terms but in no case less than our total initial investment. For three properties with a carrying value of approximately $ 110 million at December 31, 2022, our leases require a residual value guarantee from the tenant. Our leases typically require the tenant to handle and bear most of the costs associated with our properties including repair/maintenance, property taxes, and insurance. We routinely inspect our properties to ensure our assets are being maintained properly and in compliance with the terms of our leases. The following table summarizes total future minimum lease payments to be received, excluding operating expense reimbursements, from tenants under noncancelable leases as of December 31, 2022 (amounts in thousands): Total Under Total Under Total 2023 $ 984,353 $ 161,079 $ 1,145,432 2024 1,001,456 164,357 1,165,813 2025 1,016,367 167,701 1,184,068 2026 1,031,717 171,112 1,202,829 2027 1,048,409 174,591 1,223,000 Thereafter 25,851,987 4,376,304 30,228,291 $ 30,934,289 $ 5,215,144 $ 36,149,433 For all of our properties subject to lease, we are the legal owner of the property and the tenant's right to use and possess such property is guided by the terms of a lease. At December 31, 2022 , we account for all of these leases as operating leases, except where GAAP requires alternative classification, including leases on 13 Ernest facilities and three Prime facilities that are accounted for as DFLs and leases on 13 of our Prospect facilities and five of our Ernest facilities that are accounted for as a financing. The components of our total investment in financing leases consisted of the following (in thousands): As of December 31, 2022 As of December 31, 2021 Minimum lease payments receivable $ 880,253 $ 1,183,855 Estimated unguaranteed residual values 203,818 203,818 Less: Unearned income and allowance for credit loss ( 731,915 ) ( 918,584 ) Net investment in direct financing leases 352,156 469,089 Other financing leases (net of allowance for credit loss) 1,339,167 1,584,238 Total investment in financing leases $ 1,691,323 $ 2,053,327 The decrease in total investment in financing leases during 2022 is primarily related to financing leases associated with two properties sold on September 1, 2022 associated with the Prime repurchase transaction, along with the impairment associated with our Prospect properties, as discussed further below. COVID-19 Rent Deferrals Due to the COVID-19 pandemic and its impact on our tenants’ business, we agreed to defer collection of a certain amount of rent for a few tenants. Pursuant to our agreements with these tenants, we expect repayments of previously deferred rent to continue, with the remaining outstanding deferred rent balance of approximately $ 14.6 million as of December 31, 2022, to be paid over specified periods in the future with interest. Prospect Medical Holdings In August 2019, we invested in a portfolio of 14 acute care hospitals in three states (California, Pennsylvania, and Connecticut) operated by Prospect for a combined purchase price of approximately $ 1.5 billion. In addition, we originated a $ 112.9 million term loan secured by a parent guaranty. In the 2022 second quarter, we funded an additional $ 100 million towards the existing mortgage loan that is secured by a first lien on a California hospital. Prospect (like other healthcare systems around the world) struggled through the COVID-19 pandemic, starting in early 2020 and continuing through much of the 2022 first quarter with the impact from the Omicron variant. Although admissions, surgeries, and ER visits are back above pre-COVID levels at their California and Connecticut properties, Prospect’s four Pennsylvania facilities are still trailing. Now with the impact of higher labor and other costs due to inflation, Prospect has experienced a decline in cash flows during 2022. Prospect has been working through various restructuring plans to manage their cash flow. Some of these plans have made it to the binding commitment stage, including the expected sale of their Connecticut properties to Yale New Haven Health ("Yale") announced in October 2022, while others have not. Until the 2022 fourth quarter, Prospect was current on its rent and interest obligations under the various agreements. However, with rent and interest now past due and certain of Prospect’s restructuring plans yet to be finalized, we recorded an approximate $ 280 million impairment charge in the 2022 fourth quarter, as shown in "Real estate and other impairment charges, net" on the consolidated statements of net income. As part of this charge, we reduced the carrying value of the underperforming Pennsylvania properties by approximately $ 170 million (to approximately $ 250 million) and reserved all non-cash rent for a total of $ 112 million. We expect to record rent on our Prospect leases on a cash basis for the foreseeable future. At December 31, 2022, we believe our remaining investment in the Prospect real estate and other assets are fully recoverable, but no assurances can be given that we will not have any further impairments in future periods. Pipeline Health System On October 2, 2022, Pipeline filed for reorganization relief under Chapter 11 protection of the United States Bankruptcy Code in the Southern District of Texas, while keeping its hospitals open to continue providing care to the communities served. On February 6, 2023, Pipeline emerged from bankruptcy. Per the bankruptcy settlement, Pipeline's current lease of our California assets remains in place, and we were repaid on February 7, 2023 for all rent that was outstanding at December 31, 2022, along with what was due for January and February 2023. We have agreed to defer $ 5.6 million, or approximately 30 %, of rent in 2023 to be paid in 2024 with interest. We also agreed to provide approximately $ 11 million in capital funding for Pipeline to complete their behavioral facility addition to the Coast Plaza Hospital, which will result in increased rent to us upon completion. As of December 31, 2022, assets leased to Pipeline represent 1 % of our total assets, which we believe are fully recoverable at this time. However, no assurances can be given that we will not have any write-offs or impairments in future periods. Watsonville Community Hospital On September 30, 2019, we acquired the real estate of Watsonville Community Hospital in Watsonville, California for $ 40 million, which was then leased to Halsen Healthcare. In addition, we made a working capital loan to Halsen Healthcare. The hospital operator faced significant financial challenges over a two-year period that were worsened by the COVID-19 pandemic. During this time, we increased the loan in an effort to support the operator of this facility, allowing it to continue to serve the community's needs. On December 5, 2021, Halsen Healthcare filed Chapter 11 bankruptcy in order to reorganize, while keeping the hospital open. As such, we recorded a credit loss reserve of approximately $ 40 million against the estimated uncollectible portion of the loan and wrote off approximately $ 2.5 million of billed and straight-line rent receivables. On February 23, 2022, the bankruptcy court approved the bid by Pajaro Valley Healthcare District Corporation ("Pajaro") to purchase the operations of the Watsonville Community Hospital and lease the real estate from us. On August 31, 2022, Pajaro completed this purchase of the operations of the Watsonville Community Hospital. As a result of this transaction, we were repaid approximately $ 32 million of the loans previously provided to the hospital. This loan repayment resulted in a net credit loss recovery of approximately $ 15 million in 2022 and reflected in the "Real estate and other impairment charges, net" line of the consolidated statements of net income. To date, Pajaro has been current on its monthly rental payments to us. Other Leasing Activities 2022 Activity At September 30, 2022 , 99 % of our properties are occupied by tenants, leaving five properties as vacant, representing less than 0.3 % of total assets. We are in various stages of either releasing or selling these vacant properties, for one of which we received and recorded a significant termination fee in 2019. 2021 Activity On December 23, 2021, Lifepoint Health, Inc. ("Lifepoint") announced the completion of the transaction with Kindred Healthcare (“Kindred”), in which Lifepoint acquired Kindred, and announced the related launch of ScionHealth, a new healthcare company made up of a combination of former Kindred and Lifepoint hospitals. With this transaction, we have eight properties leased to ScionHealth and nine properties leased to Lifepoint. 2020 Activity On July 24, 2020, we re-leased our five San Antonio, Texas free standing emergency facilities (with a total investment of approximately $ 30 million) to Methodist Healthcare System of San Antonio, a joint venture between HCA and Methodist Healthcare Ministries of South Texas, pursuant to a long-term master lease. As a result, we recorded an approximate $ 1.5 million write-off of straight-line rent in the 2020 third quarter. Investments in Unconsolidated Entities Investments in Unconsolidated Real Estate Joint Ventures Our primary business strategy is to acquire real estate and lease to providers of healthcare services. Typically, we directly own 100 % of such investment. However, from time-to-time, we will co-invest with other investors that share a similar view that hospital real estate is a necessary infrastructure-type asset in communities. In these types of investments, we will own undivided interests of less than 100 % of the real estate and share control over the assets through unconsolidated real estate joint ventures. The underlying real estate and leases in these unconsolidated real estate joint ventures are structured similarly and carry a similar risk profile to the rest of our real estate portfolio. The following is a summary of our investments in unconsolidated real estate joint ventures by operator (amounts in thousands): Operator Ownership Percentage As of December 31, 2022 As of December 31, 2021 MEDIAN 50 % $ 482,735 $ 517,648 Swiss Medical Network 70 % 454,083 476,193 Steward (Macquarie Transaction) 50 % 417,701 — Policlinico di Monza 50 % 86,245 95,468 HM Hospitales 45 % 57,139 63,618 Total $ 1,497,903 $ 1,152,927 For the increase in our investments in unconsolidated real estate joint ventures since December 31, 2021, see "New Investments" section in this same Note 3 for a discussion of the Macquarie Transaction. Investments in Unconsolidated Operating Entities Our investments in unconsolidated operating entities are noncontrolling investments that are typically made in conjunction with larger real estate transactions in which the operators are vetted as part of our overall underwriting process. In many cases, we would not be able to acquire the larger real estate portfolio without such investments in operators. These investments also offer the opportunity to enhance our overall return and provide for certain minority rights and protections. The following is a summary of our investments in unconsolidated operating entities (amounts in thousands): Operator As of December 31, As of December 31, Steward (loan investment) $ 362,831 $ 360,164 International joint venture 231,402 219,387 Springstone 200,827 187,450 Priory 156,575 42,315 Swiss Medical Network 157,145 159,208 Steward (equity investment) 125,862 139,000 Prospect 112,777 112,283 Aevis Victoria SA ("Aevis") 72,904 61,271 Aspris Children's Services ("Aspris") 16,023 8,356 Caremax 8,526 — Total $ 1,444,872 $ 1,289,434 The increase during 2022 is primarily due to our investment in the Priory syndicated term loan as described under "New Investments" in this Note 3 . In the 2022 fourth quarter, Steward sold its managed care business to Caremax and received shares of Caremax plus cash, along with the potential for additional stock contingent on performance. As part of this transaction, we received a dividend of Caremax shares that are marked to fair value each period. Pursuant to our approximate 5 % stake in Aevis and other investments marked to fair value, we recorded a $ 2.3 million favorable non-cash fair value adjustment during 2022 as shown in the "Other (including fair value adjustments on securities)" line of the consolidated statements of net income; whereas, this was an $ 8.2 million favorable non-cash fair value adjustment in 2021. We also earned approximately $ 4 million of dividend income from our Switzerland investments during 2022. Pursuant to our existing 9.9 % equity interest in Steward, we received an $ 11 million cash distribution during 2021, which was accounted for as a return of capital. Other Investment Activities In the 2022 second quarter, we l |
Debt
Debt | 12 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Debt | 4. Debt The following is a summary of debt (dollar amounts in thousands): As of December 31, As of December 31, Revolving credit facility(A) $ 929,584 $ 730,000 Interim credit facility — 869,606 Term loan 200,000 200,000 British pound sterling term loan due 2024(B) 126,690 — British pound sterling term loan due 2025(B) 845,810 947,240 Australian term loan facility(B) 817,560 871,560 2.550 % Senior Unsecured Notes due 2023(B) 483,320 541,280 3.325 % Senior Unsecured Notes due 2025(B) 535,250 568,500 0.993 % Senior Unsecured Notes due 2026(B) 535,250 568,500 2.500 % Senior Unsecured Notes due 2026(B) 604,150 676,600 5.250 % Senior Unsecured Notes due 2026 500,000 500,000 5.000 % Senior Unsecured Notes due 2027 1,400,000 1,400,000 3.692 % Senior Unsecured Notes due 2028(B) 724,980 811,920 4.625 % Senior Unsecured Notes due 2029 900,000 900,000 3.375 % Senior Unsecured Notes due 2030(B) 422,905 473,620 3.500 % Senior Unsecured Notes due 2031 1,300,000 1,300,000 $ 10,325,499 $ 11,358,826 Debt issue costs and discount, net ( 57,087 ) ( 76,056 ) $ 10,268,412 $ 11,282,770 (a) Includes £ 90 million of GBP-denominated borrowings and € 253 million of Euro-denominated borrowings that reflect the exchange rate at December 31, 2022 . (b) Non-U.S. dollar denominated debt that reflects the exchange rate at period-end. As of December 31, 2022, principal payments due on our debt (which exclude the effects of any discounts, premiums, or debt issue costs recorded) are as follows (amounts in thousands): 2023 $ 483,320 2024 944,250 2025 1,381,060 2026 2,568,984 2027 1,600,000 Thereafter 3,347,885 Total $ 10,325,499 Credit Facility On May 6, 2022, we increased the amount of our unsecured credit facility ("Credit Facility") by $ 500 million by exercising the accordion feature. In addition, our revolver and U.S. dollar term loan were modified with Secured Overnight Financing Rate as a replacement reference rate to U.S. dollar LIBOR. Currently, our Credit Facility includes a $ 1.8 billion unsecured revolving loan facility and a $ 200 million unsecured term loan facility. On June 29, 2022, we amended our Credit Facility. The amendment extended the maturity date of our revolving facility to June 30, 2026 with our option to extend for an additional 12 months. The maturity date of our $ 200 million unsecured term loan facility was extended to June 30, 2027 . Additionally, we may request incremental term loan and/or revolving loan commitments in an aggregate amount not to exceed $ 1 billion. In addition, the amendment improved interest rate spreads for both facilities. Under the amended Credit Facility and at our election, loans may be made as either ABR Loans or Term Benchmark Loans. The applicable margin for term loans that are ABR Loans is adjustable on a sliding scale from 0.00 % to 0.70 % based on current credit rating. The applicable margin for term loans that are Term Benchmark Loans is adjustable on a sliding scale from 0.875 % to 1.70 % based on current credit rating. The applicable margin for revolving loans that are ABR Loans is adjustable on a sliding scale from 0.00 % to 0.50 % based on current credit rating. The applicable margin for revolving loans that are Term Benchmark Loans or RFR Loans, as defined in the Credit Facility agreement, is adjustable on a sliding scale from 0.80 % to 1.50 % based on current credit rating. The facility fee is adjustable on a sliding scale from 0.125 % to 0.30 % (currently 0.25 %) based on current credit rating and is payable on the revolving loan facility. At December 31, 2022 , we had $ 929.6 million outstanding on the revolving credit facility, whereas, we had $ 730.0 million outstanding on our revolving credit facility at December 31, 2021. At December 31, 2022 and 2021, our availability under our revolving credit facility was $ 0.9 billion and $ 0.6 billion, respectively. The weighted-average interest rate on the revolving facility was 3.8 % and 1.3 % during 2022 and 2021, respectively. At December 31, 2022 and 2021 , the interest rate in effect on our term loan was 5.70 % and 1.56 %, respectively. Interim Credit Facilities January 2021 Interim Credit Facility On January 15, 2021, we entered into a $ 900 million interim credit facility (“January 2021 Interim Credit Facility”), of which we borrowed £ 500 million to partially fund the Priory Group Transaction. We paid off and terminated this facility on March 26, 2021 with proceeds from the issuance of the 2.500 % Senior Unsecured Notes due 2026 and the 3.375 % Senior Unsecured Notes due 2030. July 2021 Interim Credit Facility On July 27, 2021, we entered into a $ 1 billion interim credit facility with Barclays Bank PLC as administrative agent ("July 2021 Interim Credit Facility"), and several lenders from time-to-time are parties thereto. We used this facility to partially fund the acquisition of five South Florida facilities in August 2021 and the Springstone investments in October 2021. At December 31, 2021, the outstanding balance under this facility was $ 869.6 million. On March 15, 2022 , we paid off and terminated the July 2021 Interim Credit Facility with proceeds from the Macquarie Transaction as more fully described in Note 3 to the consolidated financial statements. Non-U.S. Term Loans British Pound Sterling Term Loan due 2024 On December 9, 2022, we entered into a £ 105 million unsecured sterling-denominated term loan, of which we used to partially fund the Priory acquisition on the same date. This term loan matures on December 9, 2024 , and has a fixed interest rate of 5.250 %. British Pound Sterling Term Loan due 2025 On January 6, 2020, we entered into a £ 700 million unsecured sterling-denominated term loan with Bank of America, N.A., as administrative agent, and several lenders from time-to-time are parties thereto. The term loan matures on January 15, 2025 . The applicable margin under the term loan is adjustable based on a pricing grid from 0.85 % to 1.65 % dependent on our current credit rating. On March 4, 2020, we entered into an interest rate swap transaction (effective March 6, 2020 ) to fix the interest rate to approximately 0.70 % for the duration of the loan. The current applicable margin for the pricing grid (which can vary based on our credit rating) is 1.25 % for an all-in fixed rate of 1.95 %. Australian Term Loan On May 23, 2019, we entered into an A$ 1.2 billion term loan with Bank of America, N.A., as administrative agent, and several lenders from time-to-time are parties thereto. The term loan matures on May 23, 2024 . The interest rate under the term loan is adjustable based on a pricing grid from 0.85 % to 1.65 %, dependent on our current senior unsecured credit rating. On June 27, 2019, we entered into an interest rate swap transaction (effective July 3, 2019 ) to fix the interest rate to approximately 1.20 % for the duration of the loan as long as the reference rate stays above 0.00 %. The current applicable margin for the pricing grid (which can vary based on our credit rating) is 1.25 % for an all-in fixed rate of 2.45 %. Interest Rate Swaps At December 31, 2022, we had a derivative asset of approximately $ 93.2 million related to the combination of the sterling-denominated term loan interest rate swap and the Australian dollar term loan interest rate swap. At December 31, 2021, we had a derivative asset of approximately $ 12.4 million related to the sterling-denominated term loan interest rate swap and a derivative liability of approximately $ 4.2 million related to the Australian dollar term loan interest rate swap. Derivative assets are included in “Other assets” while, the derivative liabilities are included in "Accounts payable and accrued expenses" on our consolidated balance sheets. Senior Unsecured Notes The following are the basic terms of our senior unsecured notes at December 31, 2022 (par value amounts in thousands): Offering Maturity Date Par Value % of Par Interest Payment Frequency 2.550% Senior Unsecured Notes due 2023 December 5, 2019 December 5, 2023 £ 400,000 100.000 % Annually 3.325% Senior Unsecured Notes due 2025 March 24, 2017 March 24, 2025 € 500,000 100.000 % Annually 0.993% Senior Unsecured Notes due 2026 October 6, 2021 October 15, 2026 € 500,000 100.000 % Annually 2.500% Senior Unsecured Notes due 2026 March 24, 2021 March 24, 2026 £ 500,000 99.937 % Annually 5.250% Senior Unsecured Notes due 2026 July 22, 2016 August 1, 2026 $ 500,000 100.000 % Semi-annually 5.000% Senior Unsecured Notes due 2027 September 7, 2017 October 15, 2027 $ 1,400,000 100.000 % Semi-annually 3.692% Senior Unsecured Notes due 2028 December 5, 2019 June 5, 2028 £ 600,000 99.998 % Annually 4.625% Senior Unsecured Notes due 2029 July 26, 2019 August 1, 2029 $ 900,000 99.500 % Semi-annually 3.375% Senior Unsecured Notes due 2030 March 24, 2021 April 24, 2030 £ 350,000 99.448 % Annually 3.500% Senior Unsecured Notes due 2031 December 4, 2020 March 15, 2031 $ 1,300,000 100.000 % Semi-annually We may repurchase, redeem, or refinance senior unsecured notes from time-to-time. We may purchase senior notes for cash through open market purchases, privately negotiated transactions, or a tender offer. In some cases, we may redeem some or all of the notes at any time, but may require a redemption premium that will decrease over time. In the event of a change of control, each holder of the notes may require us to repurchase some or all of our notes at a repurchase price equal to 101 % of the aggregate principal amount of the notes plus accrued and unpaid interest to the date of purchase. Redemptions and repurchases of debt, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions, and other factors. Debt Refinancing and Unutilized Financing Costs 2022 In 2022, we incurred approximately $ 9.5 million of debt refinancing costs. These costs were incurred as a result of the payoff of our July 2021 Interim Credit Facility with proceeds from the Macquarie Transaction on March 14, 2022, along with the amendment of our Credit Facility on June 29, 2022 . 2021 With the termination of our January 2021 Interim Credit Facility and other debt activity, we incurred approximately $ 7.3 million of debt refinancing costs in 2021. With proceeds from our 0.993 % Senior Unsecured Notes due 2026 offering, on October 22, 2021, we redeemed all of our outstanding € 500 million aggregate principal amount of 4.000 % senior unsecured notes that were due in 2022 , including accrued and unpaid interest. As a result of this redemption, we incurred a charge of approximately $ 20 million (including redemption premiums and accelerated amortization of deferred debt issuance costs). 2020 With proceeds from our 3.500 % Senior Unsecured Notes due 2031 offering in 2020, we redeemed all of our outstanding $ 500.0 million aggregate principal amount of 6.375 % senior unsecured notes that were due in 2024 and $ 300.0 million aggregate principal amount of 5.500 % senior unsecured notes that were due in 2024 , including accrued and unpaid interest. As a result of these redemptions, we incurred a charge of approximately $ 28 million (including redemption premiums and accelerated amortization of deferred debt issuance costs). Covenants Our debt facilities impose certain restrictions on us, including restrictions on our ability to: incur debts; create or incur liens; provide guarantees in respect of obligations of any other entity; make redemptions and repurchases of our capital stock; prepay, redeem, or repurchase debt; engage in mergers or consolidations; enter into affiliated transactions; dispose of real estate or other assets; and change our business. In addition, the credit agreements governing our Credit Facility limit the amount of dividends we can pay as a percentage of normalized adjusted funds from operations (“NAFFO”), as defined in the agreements, on a rolling four quarter basis. At December 31, 2022 , the dividend restriction was 95 % of NAFFO. The indentures governing our senior unsecured notes also limit the amount of dividends we can pay based on the sum of 95 % of NAFFO, proceeds of equity issuances, and certain other net cash proceeds. Finally, our senior unsecured notes require us to maintain total unencumbered assets (as defined in the related indenture) of not less than 150 % of our unsecured indebtedness. In addition to these restrictions, the Credit Facility contains customary financial and operating covenants, including covenants relating to our total leverage ratio, fixed charge coverage ratio, secured leverage ratio, consolidated adjusted net worth, unsecured leverage ratio, and unsecured interest coverage ratio. The Credit Facility also contains customary events of default, including among others, nonpayment of principal or interest, material inaccuracy of representations, and failure to comply with our covenants. If an event of default occurs and is continuing under the Credit Facility, the entire outstanding balance may become immediately due and payable. At December 31, 2022 , we were in compliance with all such financial and operating covenants. |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | 5. Inco me Taxes Medical Properties Trust, Inc. We have maintained and intend to maintain our election as a REIT under the Code. To qualify as a REIT, we must meet a number of organizational and operational requirements, including a requirement to distribute at least 90 % of our REIT taxable income to our stockholders. As a REIT, we generally will not be subject to U.S. federal income tax if we distribute 100 % of our REIT taxable income to our stockholders and satisfy certain other requirements; instead, income tax is paid directly by our stockholders on the dividends distributed to them. If our REIT taxable income exceeds our dividends in a tax year, REIT tax rules allow us to designate dividends from the subsequent tax year in order to avoid current taxation on undistributed income. If we fail to qualify as a REIT in any taxable year, we will be subject to federal income taxes at regular corporate rates. Taxable income from non-REIT activities managed through our TRS entities is subject to applicable U.S. federal, state, and local income taxes. Our international subsidiaries are also subject to income taxes in the jurisdictions in which they operate. From our TRS entities and our foreign operations, income tax (expense) benefit were as follows (in thousands): For the Years Ended December 31, 2022 2021 2020 Current income tax (expense) benefit: Domestic $ 1,111 $ ( 1,559 ) $ 63 Foreign ( 27,751 ) ( 18,964 ) ( 10,203 ) ( 26,640 ) ( 20,523 ) ( 10,140 ) Deferred income tax (expense) benefit: Domestic ( 15,628 ) 6,915 ( 10,680 ) Foreign ( 13,632 ) ( 60,340 ) ( 10,236 ) ( 29,260 ) ( 53,425 ) ( 20,916 ) Income tax (expense) $ ( 55,900 ) $ ( 73,948 ) $ ( 31,056 ) A reconciliation of income tax (expense) benefit from the statutory income tax rate to the effective tax rate based on income before income taxes for the years ended December 31, 2022, 2021, and 2020 is as follows (in thousands): For the Years Ended December 31, 2022 2021 2020 Income before income tax $ 959,719 $ 730,888 $ 463,328 Income tax (expense) at the U.S. statutory federal rate ( 21 % in 2022, 2021, and 2020) ( 201,541 ) ( 153,486 ) ( 97,299 ) Decrease (increase) in income tax resulting from: Foreign rate differential 1,826 2,742 2,160 State income taxes, net of federal benefit ( 1,886 ) — 970 U.S. earnings not subject to federal income tax 165,705 132,266 82,921 Equity investments — — 380 Change in valuation allowance ( 11,281 ) ( 10,040 ) ( 8,514 ) Statutory tax rate change ( 941 ) ( 43,924 ) ( 9,471 ) Interest disallowance ( 1,737 ) ( 646 ) — Other items, net ( 6,045 ) ( 860 ) ( 2,203 ) Total income tax (expense) $ ( 55,900 ) $ ( 73,948 ) $ ( 31,056 ) In 2022, we incurred approximately $ 5 million of income tax expense from the credit loss recovery on loans made to the Watsonville Community Hospital; whereas, in 2021, we recorded an approximate $ 10 million income tax benefit related to the initial loan impairment, as more fully described in Note 3 to Item 8 of this Annual Report on Form 10-K. During the 2021 second quarter, the United Kingdom enacted an increase in its corporate income tax rates from 19 % to 25 % effective April 1, 2023, which resulted in a one-time adjustment to our net deferred tax liabilities of approximately $ 43 million. The foreign provision for income taxes is based on foreign profit before income taxes of $ 159.6 million, $ 164.0 million, and $ 62.1 million in 2022, 2021, and 2020, respectively. The domestic provision for income taxes is based on income (loss) before income taxes of $ 10.8 million in 2022 , $( 29.7 ) million in 2021 , and $ 6.4 million in 2020 from our TRS entities. At December 31, 2022 and 2021, components of our deferred tax assets and liabilities were as follows (in thousands): 2022 2021 Deferred tax assets: Operating loss and interest deduction carry forwards $ 175,922 $ 197,876 Other 15,218 1,815 Total deferred tax assets 191,140 199,691 Valuation allowance ( 71,499 ) ( 61,747 ) Total net deferred tax assets $ 119,641 $ 137,944 Deferred tax liabilities: Property and equipment $ ( 294,181 ) $ ( 320,546 ) Net unbilled revenue ( 63,324 ) ( 43,366 ) Partnership investments ( 26,268 ) ( 15,963 ) Other ( 27,153 ) ( 3,836 ) Total deferred tax liabilities ( 410,926 ) ( 383,711 ) Net deferred tax asset (liability) $ ( 291,285 ) $ ( 245,767 ) At December 31, 2022, we had net NOL and other tax attribute carryforwards as follows (in thousands): U.S. Foreign Gross NOL carryforwards $ 148,900 $ 633,682 Tax-effected NOL carryforwards $ 24,013 $ 151,909 Valuation allowance ( 13,864 ) ( 57,635 ) Net deferred tax asset - NOL carryforwards $ 10,149 $ 94,274 Expiration periods 2024 - indefinite indefinite Valuation Allowance A valuation allowance has been recorded on certain foreign and domestic net operating loss carryforwards and other net deferred tax assets that may not be realized. As of each reporting date, we consider all new evidence that could impact the future realization of our deferred tax assets. In the evaluation of the need for a valuation allowance on our deferred income tax assets, we consider all available positive and negative evidence, including scheduled reversals of deferred income tax liabilities, carryback of future period losses to prior periods, projected future taxable income, tax planning strategies, and recent financial performance. During 2022, a valuation allowance of $ 9.8 million has been recorded against a portion of our deferred tax assets to recognize only the components of the deferred tax assets that is more likely than not to be realized. The valuation allowance was primarily recorded against deferred tax assets for NOLs, non-depreciable basis of real property, and other tax attributes that we believe will not be realized. Valuation allowance activity recorded generally follows the activity of the associated deferred tax asset that is not expected to be recognized. From time-to-time, we may acquire deferred tax assets as part of real estate transactions and will assess the need for a valuation allowance as part of the opening balance sheet. Additionally, valuation allowances will be remeasured for foreign currency translation fluctuations through other comprehensive income. We have no material uncertain tax position liabilities and related interest or penalties. REIT Status We have met the annual REIT distribution requirements by payment of at least 90 % of our REIT taxable income in 2022, 2021, and 2020. Earnings and profits, which determine the taxability of such distributions, will differ from net income reported for financial reporting purposes due primarily to differences in cost basis, differences in the estimated useful lives used to compute depreciation, and differences between the allocation of our net income and loss for financial reporting purposes and for tax reporting purposes. A schedule of per share distributions we paid and reported to our stockholders is set forth in the following: For the Years Ended December 31, Per share: 2022 2021 2020 Ordinary dividend (1) $ 0.4703 $ 0.7646 $ 0.6030 Long-term capital gain (2) 0.6797 0.1654 — Return of capital — 0.1800 0.4670 Total $ 1.1500 $ 1.1100 $ 1.0700 (1) For the years ended December 31, 2022, 2021, and 2020, includes Section 199A dividends of 0.4703 , 0.7646 , and 0.6030 , respectively. (2) For the years ended December 31, 2022, 2021, and 2020, includes Unrecaptured Section 1250 gains of 0.2574 , 0.0583 , and 0.0000 , respectively. MPT Operating Partnership, L.P. As a partnership, the allocated share of income of the Operating Partnership is included in the income tax returns of the general and limited partners. Accordingly, no accounting for income taxes is generally required for such income of the Operating Partnership. However, the Operating Partnership has formed TRS entities on behalf of Medical Properties Trust, Inc., which are subject to U.S. federal, state, and local income taxes at regular corporate rates, and its international subsidiaries are subject to income taxes in the jurisdictions in which they operate. See discussion above under Medical Properties Trust, Inc. for more details of income taxes associated with our TRS entities and international operations. |
Earnings Per Share_Unit
Earnings Per Share/Unit | 12 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Earnings Per Share/Unit | 6. Earnings P er Share/Unit Medical Properties Trust, Inc. Our earnings per share were calculated based on the following (amounts in thousands): For the Years Ended December 31, 2022 2021 2020 Numerator: Net income $ 903,819 $ 656,940 $ 432,272 Non-controlling interests’ share in earnings ( 1,222 ) ( 919 ) ( 822 ) Participating securities’ share in earnings ( 1,602 ) ( 2,161 ) ( 2,105 ) Net income, less participating securities’ share in $ 900,995 $ 653,860 $ 429,345 Denominator: Basic weighted-average common shares 598,634 588,817 529,239 Dilutive potential common shares 203 1,322 1,222 Diluted weighted-average common shares 598,837 590,139 530,461 MPT Operating Partnership, L.P. Our earnings per unit were calculated based on the following (amounts in thousands): For the Years Ended December 31, 2022 2021 2020 Numerator: Net income $ 903,819 $ 656,940 $ 432,272 Non-controlling interests’ share in earnings ( 1,222 ) ( 919 ) ( 822 ) Participating securities’ share in earnings ( 1,602 ) ( 2,161 ) ( 2,105 ) Net income, less participating securities’ share in $ 900,995 $ 653,860 $ 429,345 Denominator: Basic weighted-average units 598,634 588,817 529,239 Dilutive potential units 203 1,322 1,222 Diluted weighted-average units 598,837 590,139 530,461 |
Stock Awards
Stock Awards | 12 Months Ended |
Dec. 31, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Stock Awards | 7. Stoc k Awards Stock Awards During the second quarter of 2022, we amended the 2019 Equity Incentive Plan (the "Equity Incentive Plan"), which authorizes the issuance of common stock options, restricted stock, restricted stock units, deferred stock units, stock appreciation rights, performance units, and awards of interests in our Operating Partnership. Our Equity Incentive Plan is administered by the Compensation Committee of the Board of Directors. Among other things, the recent amendment increased the number of shares of common stock registered and reserved for stock awards by 16 million to 28.9 million. As of December 31, 2022 , 19.3 million shares remain available for future stock awards. The Equity Incentive Plan contains a limit of 5 million shares as the maximum number of shares of common stock that may be awarded to an individual in any fiscal year. Awards under the Equity Incentive Plan are subject to forfeiture due to termination of employment prior to vesting and/or from not achieving the respective performance/market conditions. In the event of a change in control, outstanding and unvested options will immediately vest, unless otherwise provided in the participant’s award or employment agreement, and restricted stock, restricted stock units, deferred stock units, and other stock-based awards will vest if so provided in the participant’s award agreement. The term of the awards is set by the Compensation Committee, though Incentive Stock Options may not have terms of more than ten years . Forfeited awards (along with shares withheld for payroll tax withholding purposes) are returned to the Equity Incentive Plan and are then available to be re-issued as future awards. For each share of common stock issued by Medical Properties Trust, Inc. pursuant to its Equity Incentive Plan, the Operating Partnership issues a corresponding number of Operating Partnership units. For the past three years, we have only granted restricted stock and restricted stock units pursuant to our Equity Incentive Plan. These stock-based awards have been granted in the form of service-based awards and performance awards based on company-specific performance hurdles. See below for further details on each of these stock-based awards: Service-Based Awards In 2022, 2021, and 2020 , the Compensation Committee granted service-based awards to employees and non-employee directors. Service-based awards vest as the employee/director provides the required service (typically over three years ). Dividends are generally paid on these awards prior to vesting. Performance-Based Awards In 2022, 2021, and 2020, the Compensation Committee granted performance-based awards to employees. Generally, dividends are not paid on performance awards until the award is earned. See below for details of such performance-based award grants: In 2022, 2021, and 2020 , a target number of stock awards were granted to employees that could be earned based on the achievement of specific performance thresholds as set by our Compensation Committee. The performance thresholds were based on a three-year period with the opportunity to earn a portion of the award earlier. More or less shares than the target number of shares are available to be earned based on our performance compared to the set thresholds. At the end of each of the performance periods, any earned shares during such period will vest on January 1 of the following calendar year. The performance thresholds for 2022, 2021, and 2020 awards were based on funds from operations growth, EBITDA, and acquisitions. Certain performance awards granted were subject to a modifier which increases or decreases the actual shares earned in each performance period. The modifier for the 2022, 2021, and 2020 awards was based on two components: 1) how our total shareholder return (“TSR”) compared to the SNL U.S. REIT Healthcare Index (“SNL Index”) and 2) how our TSR compared to a threshold set by the Compensation Committee. The following summarizes stock-based award activity in 2022 and 2021 (which includes awards granted in 2022, 2021, 2020, and any applicable prior years), respectively: For the Year Ended December 31, 2022: Vesting Based Vesting Based on Shares Weighted-Average Shares Weighted-Average Nonvested awards at beginning of the year 922,954 $ 20.26 5,477,536 $ 15.86 Awarded 659,393 $ 21.18 1,828,971 $ 18.45 Vested ( 750,854 ) $ 20.25 ( 2,924,722 ) $ 13.87 Forfeited ( 21,010 ) $ 20.06 ( 32,704 ) $ 19.17 Nonvested awards at end of year 810,483 $ 21.02 4,349,081 $ 18.26 For the Year Ended December 31, 2021: Vesting Based Vesting Based on Shares Weighted-Average Shares Weighted-Average Nonvested awards at beginning of the year 1,057,054 $ 18.79 5,086,983 $ 14.41 Awarded 651,113 $ 20.83 1,957,802 $ 17.94 Vested ( 781,076 ) $ 18.77 ( 1,551,482 ) $ 13.73 Forfeited ( 4,137 ) $ 18.69 ( 15,767 ) $ 16.72 Nonvested awards at end of year 922,954 $ 20.26 5,477,536 $ 15.86 The value of stock-based awards is charged to compensation expense over the service periods. For the years ended December 31, 2022, 2021, and 2020 , we recorded $ 49.4 million, $ 52.1 million, and $ 47.2 million, respectively, of non-cash compensation expense. The remaining unrecognized cost from stock-based awards at December 31, 2022 , is $ 47.1 million, which will be recognized over a weighted-average period of 1.2 years. Stock-based awards that vested in 2022, 2021, and 2020 , had a value of $ 82.6 million, $ 49.9 million, and $ 58.9 million, respectively. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | 8. Commitments and Contingencies Commitments On October 5, 2022, we entered into definitive agreements to sell three Prospect facilities located in Connecticut to Yale for approximately $ 457 million. This transaction is expected to close in 2023 subject to certain regulatory approvals and the completion of Yale's acquisition of the hospital operations from Prospect. No assurances can be given that this transaction will be consummated as described or at all. Contingencies We are a party to various legal proceedings incidental to our business. In the opinion of management, after consultation with legal counsel, the ultimate liability, if any, with respect to those proceedings is not presently expected to materially affect our financial position, results of operations, or cash flows. |
Common Stock_Partner's Capital
Common Stock/Partner's Capital | 12 Months Ended |
Dec. 31, 2022 | |
Equity [Abstract] | |
Common Stock/Partner's Capital | 9. Common Stock/ Partner’s Capital Medical Properties Trust, Inc. 2022 Activity On October 9, 2022, the board of directors of the Company authorized a stock repurchase program (the "Stock Repurchase Program") for up to $ 500 million of common stock, par value $ 0.001 per share. In 2022, we repurchased 1.6 million shares for a total of $ 17.9 million. The Stock Repurchase Program expires on October 10, 2023 . 2021 Activity On January 11, 2021, we completed an underwritten public offering of 36.8 million shares of our common stock, resulting in net proceeds of approximately $ 711 million, after deducting underwriting discounts and commissions and offering expenses. In addition, we sold 16.3 million shares of common stock under our at-the-market equity offering program during 2021, resulting in net proceeds of approximately $ 340 million. 2020 Activity In 2020, we sold 21.0 million shares of common stock under our at-the-market equity offering program, resulting in net proceeds of approximately $ 411 million. MPT Operating Partnership, L.P. At December 31, 2022 , the Operating Partnership is made up of a general partner, Medical Properties Trust, LLC (“General Partner”) and limited partners, including the Company (which owns 100 % of the General Partner) and MPT TRS, Inc. (which is 100 % owned by the General Partner). By virtue of its ownership of the General Partner, the Company has a 100 % ownership interest in the Operating Partnership. In regards to distributions, the Operating Partnership shall distribute cash at such times and in such amounts as are determined by the General Partner in its sole and absolute discretion, to common unit holders who are common unit holders on the record date. However, per the Second Amended and Restated Agreement of Limited Partnership of MPT Operating Partnership, L.P. (“Operating Partnership Agreement”), the General Partner shall use its reasonable efforts to cause the Operating Partnership to distribute amounts sufficient to enable the Company to pay stockholder dividends that will allow the Company to (i) meet its distribution requirement for qualification as a REIT and (ii) avoid any U.S. federal income or excise tax liability imposed by the Code, other than to the extent the Company elects to retain and pay income tax on its net capital gain. In accordance with the Operating Partnership Agreement, LTIP units are treated as common units for distribution purposes. The Operating Partnership’s net income will generally be allocated first to the General Partner to the extent of any cumulative losses and then to the limited partners in accordance with their respective percentage interests in the common units issued by the Operating Partnership. Any losses of the Operating Partnership will generally be allocated first to the limited partners until their capital account is zero and then to the General Partner. In accordance with the Operating Partnership Agreement, LTIP units are treated as common units for purposes of income and loss allocations. Limited partners have the right to require the Operating Partnership to redeem part or all of their common units. It is at the Operating Partnership’s discretion to redeem such common units for cash based on the fair market value of an equivalent number of shares of the Company’s common stock at the time of redemption or, alternatively, redeem the common units for shares of the Company’s common stock on a one-for-one basis, subject to adjustment in the event of stock splits, stock dividends, or similar events. LTIP units must wait two years from the issuance of the LTIP units to be redeemed, and then converted to common units. On December 28, 2020, approximately 232 thousand LTIP units were converted to common units and then redeemed for approximately $ 4.9 million of cash. No LTIP units exist at December 31, 2022. For each share of common stock issued/repurchased by Medical Properties Trust, Inc., the Operating Partnership issues/repurchases a corresponding number of operating partnership units. |
Fair Value of Financial Instrum
Fair Value of Financial Instruments | 12 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value of Financial Instruments | 10. Fair Value of F inancial Instruments We have various assets and liabilities that are considered financial instruments. We estimate that the carrying value of cash and cash equivalents and accounts payable and accrued expenses approximate their fair values. We estimate the fair value of our interest and rent receivables using Level 2 inputs such as discounting the estimated future cash flows using the current rates at which similar receivables would be made to others with similar credit ratings and for the same remaining maturities. The fair value of our mortgage loans and other loans are estimated by using Level 2 inputs such as discounting the estimated future cash flows using the current rates which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities. We determine the fair value of our senior unsecured notes using Level 2 inputs such as quotes from securities dealers and market makers. We estimate the fair value of our revolving credit facility and term loans using Level 2 inputs based on the present value of future payments, discounted at a rate which we consider appropriate for such debt. Fair value estimates are made at a specific point in time, are subjective in nature, and involve uncertainties and matters of significant judgment. Settlement of such fair value amounts may not be a prudent management decision. The following table summarizes fair value estimates for our financial instruments (in thousands): December 31, 2022 December 31, 2021 Asset (Liability) Book Fair Book Fair Interest and rent receivables $ 167,035 $ 163,101 $ 56,229 $ 56,564 Loans(1) 1,405,615 (2) 1,360,113 991,609 (2) 991,954 Debt, net ( 10,268,412 ) ( 8,697,042 ) ( 11,282,770 ) ( 11,526,388 ) (1) Excludes the acquisition loan and mortgage loan made in October 2021 for our Springstone investment and the acquisition loan made in May 2020 related to our investment in the international joint venture, along with the related subsequent investment in the real estate of three hospitals in Colombia, as these assets are accounted for under the fair value option method, as noted below. (2) Includes $ 223.8 million and $ 70.1 million of mortgage loans, a $ 315.9 million and $ 335.6 million shareholder loan included in investments in unconsolidated real estate joint ventures, $ 640.4 million and $ 521.4 million of loans that are part of our investments in unconsolidated operating entities, and $ 225.5 million and $ 64.5 million of other loans at December 31, 2022 and 2021, respectively. Items Measured at Fair Value on a Recurring Basis Our equity investment and related loan to the international joint venture, our loan investment in the real estate of three hospitals operated by subsidiaries of the international joint venture in Colombia, and our equity investment and related loans in Springstone are measured at fair value on a recurring basis as we elected to account for these investments using the fair value option at the point of initial investment. We elected to account for these investments at fair value due to the size of the investments and because we believe this method was more reflective of current values. At December 31, 2022 and 2021, the amounts recorded under the fair value option method were as follows (in thousands): As of December 31, 2022 As of December 31, 2021 Asset (Liability) Fair Value Original Fair Value Original Asset Type Classification Mortgage loans $ 140,260 $ 140,260 $ 143,068 $ 143,068 Mortgage loans Equity investment and other loans 434,609 441,943 409,638 409,638 Investments in unconsolidated Our loans to Springstone and the international joint venture and its subsidiaries are recorded at fair value based on Level 2 inputs by discounting the estimated cash flows using the market rates at which similar loans would be made to borrowers with similar credit ratings and the same remaining maturities, while also considering the value of the underlying collateral of each loan. Our equity investment in Springstone and the international joint venture is recorded at fair value based on Level 3 inputs, by using a discounted cash flow model, which requires significant estimates of our investee such as projected revenue and expenses and appropriate consideration of the underlying risk profile of the forecasted assumptions associated with the investee. We classify our valuations of equity investments as Level 3, as we use certain unobservable inputs to the valuation methodology that are significant to the fair value measurement, and the valuations require management judgment due to absence of quoted market prices. For the cash flow models, our observable inputs include use of a capitalization rate and discount rate (which is based on a weighted-average cost of capital) and our unobservable input includes an adjustment for a marketability discount (“DLOM”). In regards to the underlying projections used in the discounted cash flow model, such projections are provided by the investees. However, we will modify such projections as needed based on our review and analysis of historical results, meetings with key members of management, and our understanding of trends and developments within the healthcare industry. In 2022, we recorded an unfavorable fair value adjustment of approximately $ 7 million to our investments, as shown in "Other (including fair value adjustments on securities)" in our consolidated statements of net income. No fair value adjustment was recorded in 2021. The DLOM on our Springstone investment was 40 % at December 31, 2022. In arriving at the DLOM, we started with a DLOM range based on the results of studies supporting valuation discounts for other transactions or structures without a public market. To select the appropriate DLOM within the range, we then considered many qualitative factors, including the percent of control, the nature of the underlying investee’s business along with our rights as an investor pursuant to the operating agreement, the size of investment, expected holding period, number of shareholders, access to capital marketplace, etc. To illustrate the effect of movements in the DLOM, we performed a sensitivity analysis below by using basis point variations (dollars in thousands): Basis Point Change in Marketability Discount Estimated Increase + 100 basis points $ ( 43 ) - 100 basis points 43 Items Measured at Fair Value on a Nonrecurring Basis In addition to items that are measured at fair value on a recurring basis, we have assets and liabilities that are measured, from time-to-time, at fair value on a nonrecurring basis, such as for long-lived asset impairment purposes. In these cases, fair value may be based on estimated cash flows discounted at a risk-adjusted rate of interest by using Level 2 inputs as more fully described in Note 2 , or for our real estate, including for the impairment analysis on our Prospect Pennsylvania real estate in 2022, we may use a market approach using level 2 inputs, whereby we will divide the expected net operating income (i.e. rent revenue less expenses, if any) of the facility by a market capitalization rate. |
Leases (Lessee)
Leases (Lessee) | 12 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Leases (Lessee) | 11. Lease s (Lessee) We lease the land underlying certain of our facilities (for which we sublease to our tenants), along with corporate offices and equipment. Our leases have remaining lease terms that vary in years, and some of the leases have initial fixed terms (or renewal options available) that extend the leases up to, or just beyond, the depreciable life of the properties that occupy the leased land. Renewal options that we are reasonably certain to exercise are recognized in our right-of-use assets and lease liabilities. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at lease commencement date in determining the present value of future payments. The following is a summary of our lease expense (in thousands): Income Statement For the Years Ended December 31, Classification 2022 2021 Operating lease cost (1) (2) $ 12,175 $ 10,694 Finance lease cost: Amortization of right-of-use assets Real estate depreciation and amortization 51 51 Interest on lease liabilities Interest 128 128 Sublease income Other ( 4,485 ) ( 4,466 ) Total lease cost $ 7,869 $ 6,407 (1) Includes short-term leases. (2) $ 5.7 million and $ 6.3 million included in “Property-related”, with the remainder reflected in the “General and administrative” line of our consolidated statements of net income for 2022 and 2021, respectively. Fixed minimum payments due over the remaining lease term under non-cancelable leases of more than one year and amounts to be received in the future from non-cancelable subleases over their remaining lease term at December 31, 2022 are as follows (amounts in thousands): Operating Leases Finance Leases Amounts To Net 2023 $ 8,742 $ 129 $ ( 4,416 ) $ 4,455 2024 8,880 130 ( 4,272 ) 4,738 2025 8,289 131 ( 4,328 ) 4,092 2026 7,884 133 ( 4,021 ) 3,996 2027 7,873 134 ( 3,730 ) 4,277 Thereafter 235,940 4,516 ( 65,320 ) 175,136 (1) Total undiscounted minimum lease payments $ 277,608 $ 5,173 $ ( 86,087 ) $ 196,694 Less: interest ( 176,016 ) ( 3,235 ) Present value of lease liabilities $ 101,592 $ 1,938 (1) Reflects certain ground leases, in which we are the lessee, that have longer initial fixed terms than our existing sublease to our tenants. However, we would expect to either renew the related sublease, enter into a lease with a new tenant, or early terminate the ground lease to reduce or avoid any significant impact from such ground leases . Supplemental balance sheet information is as follows (in thousands, except lease terms and discount rate): Balance Sheet December 31, December 31, Right of use assets: Operating leases - real estate Land $ 63,553 $ 68,616 Finance leases - real estate Land 1,734 1,785 Total real estate right of use assets $ 65,287 $ 70,401 Operating leases - corporate Other assets 26,225 7,458 Total right of use assets $ 91,512 $ 77,859 Lease liabilities: Operating leases Obligations to tenants and $ 101,592 $ 85,217 Financing leases Obligations to tenants and 1,938 1,937 Total lease liabilities $ 103,530 $ 87,154 Weighted-average remaining lease term: Operating leases 33.2 40.6 Finance leases 33.9 34.9 Weighted-average discount rate: Operating leases 6.1 % 6.4 % Finance leases 6.6 % 6.6 % The following is supplemental cash flow information (in thousands): For the Years Ended December 31, 2022 2021 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows used for operating leases $ 7,169 $ 7,330 Operating cash flows used for finance leases 128 126 Non-cash activities - Right-of-use assets obtained in exchange for lease Operating leases 23,066 1,120 |
Other Assets
Other Assets | 12 Months Ended |
Dec. 31, 2022 | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
Other Assets | 12. Othe r Assets The following is a summary of our other assets on our consolidated balance sheets (in thousands): As of December 31, 2022 2021 Debt issue costs, net(1) $ 12,036 $ 5,488 Other corporate assets 256,438 231,731 Prepaids and other assets 304,516 96,261 Total other assets $ 572,990 $ 333,480 (1) Relates to our revolving credit facility Other corporate assets include land and land improvements associated with our corporate offices, furniture and fixtures, equipment, corporate vehicles, aircraft, enterprise and other software, deposits, and right-of-use assets associated with corporate leases. Included in prepaids and other assets is prepaid insurance, prepaid taxes, deferred income tax assets (net of valuation allowances, if any), non-tenant receivables, derivative assets, and lease inducements made to tenants, among other items. Prepaids and other assets are higher in 2022 due to an approximate $ 80 million increase in derivative assets (associated with our interest rate swaps) and recovery receivables associated with flood damage of our Norwood facility, among other things. |
Subsequent Events
Subsequent Events | 12 Months Ended |
Dec. 31, 2022 | |
Subsequent Events [Abstract] | |
Subsequent Events | 13. Subsequent Events On February 7, 2023, a subsidiary of Lifepoint acquired a majority interest in Springstone (the "Lifepoint Transaction") based on an enterprise value of $ 250 million. We received approximately $ 205 million in full satisfaction of our initial acquisition loan to Springstone, including accrued interest. We also retained our minority equity interest in the operations of Springstone and will continue to own and lease Springstone's behavioral hospitals. As part of the Lifepoint Transaction, Lifepoint agreed to extend its current lease with us on eight existing general acute care hospitals by five years to 2041 . On February 15, 2023, we agreed to lease five general acute care facilities located in Utah currently leased to Steward to Catholic Health Initiatives Colorado ("CHIC"), a wholly owned subsidiary of CommonSpirit Health, subsequent to CHIC's pending acquisition of the Utah hospital business currently operated by Steward. Centura Health will manage the facilities for CHIC. The consummation of this transaction, which is subject to regulatory approval, is expected in 2023. The initial 15 year lease with CHIC for these Utah assets (approximately 5.5 % of our total assets at December 31, 2022) will generate an initial cash yield of 7.8 %, bump annually by 3 %, and include repurchase options at the greater of fair value or our gross investment. |
Schedule II_ Valuation and Qual
Schedule II: Valuation and Qualifying Accounts | 12 Months Ended |
Dec. 31, 2022 | |
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] | |
Schedule II: Valuation and Qualifying Accounts | Schedule II: Valuation and Qualifying Accounts Medical Properties Trust, Inc. and MPT Operating Partnership, L.P. December 31, 2022 Additions Deductions Year Ended December 31, Balance at Charged Charged to Net Balance at (In thousands) 2022 $ 154,161 $ 294,861 (2) $ — $ ( 55,965 ) (3) $ 393,057 2021 $ 146,637 $ 69,131 (4) $ 7,340 (5) $ ( 68,947 ) (6) $ 154,161 2020 $ 109,803 $ 58,044 (7) $ 22,944 (8) $ ( 44,154 ) (9) $ 146,637 (1) Includes real estate impairment reserves, allowance for doubtful accounts, straight-line rent reserves, credit loss reserves, tax valuation allowances, and other reserves. (2) Represents a $ 170.6 million increase to real estate impairment reserves, $ 0.5 million increase in accounts receivable and other reserves, $ 114.0 million increase in credit loss reserves on financing-type receivables, and a $ 9.8 million increase in valuation allowance to reserve against our net deferred tax assets in 2022. (3) Includes a $ 2.9 million decrease in real estate impairment reserves related to disposals in 2022, a $ 11.7 million decrease in accounts receivable and other reserves, a net credit loss recovery of approximately $ 15 million on the Watsonville loans, and a $ 26.4 million decrease of credit loss reserves related to financial instruments sold, repaid, or satisfied in 2022. (4) Represents a $ 41.7 million increase in credit loss reserves on financing-type receivables, $ 8 million increase in accounts receivable and other reserves, and an approximately $ 20 million increase in valuation allowances to reserve against our net deferred tax assets in 2021. (5) Represents $ 7.3 million of tax valuation allowances recorded as part of the purchase price allocation of the Priory Transaction as disclosed in Note 3 to Item 8 of this Annual Report on Form 10-K. (6) Includes a $ 22.4 million decrease in real estate impairment reserves related to disposals in 2021, a $ 38.7 million decrease in accounts receivable and other reserves, $ 6.0 million decrease of equity investment impairment reserve related to disposals in 2021, and $ 1.9 million of credit loss recovery related to loan paydowns in 2021. (7) Represents a $ 19.0 million increase to real estate impairment reserves, $ 23.9 million increase in accounts receivable and other reserves, $ 3.3 million increase in credit loss reserves on financing-type receivables, and a $ 11.9 million increase in valuation allowances to reserve against our net deferred tax assets in 2020. (8) Reflects $ 8.4 million of a credit loss reserve recorded on January 1, 2020 to equity as the cumulative effect of a change in accounting principle adjustment upon adoption of ASU No. 2016-13, “Measurement of Credit Losses on Financial Instruments” along with $ 14.5 million of tax valuation allowances recorded as part of the purchase price allocation of the Circle Transaction as disclosed in Note 3 to Item 8 of this Annual Report on Form 10-K. (9) Includes a $ 40.5 million decrease in real estate impairment reserves related to disposals in 2020, $ 2.9 million of credit loss recovery related to loan paydowns in 2020, and a $ 0.8 million decrease in tax valuation allowances. |
SCHEDULE III - REAL ESTATE INVE
SCHEDULE III - REAL ESTATE INVESTMENTS AND ACCUMULATED DEPRECIATION | 12 Months Ended |
Dec. 31, 2022 | |
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Abstract] | |
SCHEDULE III - REAL ESTATE INVESTMENTS AND ACCUMULATED DEPRECIATION | SCHEDULE III — REAL ESTATE INVEST MENTS AND ACCUMULATED DEPRECIATION December 31, 2022 Initial Costs Additions Subsequent Cost at December 31, 2022(1) Accumulated Life on Location Type of Property Land Buildings Improve- Carrying Land Buildings Total Depreciation Encum- Date of Date computed (Dollar amounts in thousands) Aberdeen, UK Acute care general hospital $ 4,036 $ 95,595 $ — $ — $ 4,036 $ 95,595 $ 99,631 $ 7,194 $ — 1985 January 9, 2020 40 Algeciras, Spain Acute care general hospital 505 7,973 — — 505 7,973 8,478 146 — 1997 April 29, 2022 40 Altoona, WI Acute care general hospital — 29,062 — — — 29,062 29,062 6,055 — 2014 August 31, 2014 40 Altrincham, UK Behavioral health facility 13,899 23,895 — — 13,899 23,895 37,794 61 — 1890 , 2014 December 9, 2022 40 Alvin, TX Freestanding ER 105 4,087 — — 105 4,087 4,192 871 — 2014 March 19, 2014 40 Arnold, UK Behavioral health facility 453 9,412 — — 453 9,412 9,865 387 — 2008 June 25, 2021 40 Ashtead, UK Acute care general hospital 35,840 67,195 — — 35,840 67,195 103,035 5,852 — 1981 August 16, 2019 40 Aurora, CO Freestanding ER 2,845 4,812 — — 2,845 4,812 7,657 872 — 2015 September 17, 2015 40 Austin, TX Freestanding ER 3,665 4,200 — — 3,665 4,200 7,865 642 — 2017 March 2, 2017 40 Avondale, AZ Behavioral health facility 5,383 64,650 — — 5,383 64,650 70,033 2,050 — 2016 October 19, 2021 40 Ayr, UK Behavioral health facility 16,125 46,178 — — 16,125 46,178 62,303 1,768 — 2004 June 25, 2021 40 Bad Salzuflen, Germany Rehabilitation hospital 10,186 25,777 — — 10,186 25,777 35,963 3,573 — 1974 , 2016 November 30, 2017 40 Bad Salzuflen, Germany Rehabilitation hospital 6,922 22,669 — — 6,922 22,669 29,591 2,992 — 1989 , 2016 November 30, 2017 40 Bad Oeynhausen, Germany Rehabilitation hospital 1,092 2,669 — — 1,092 2,669 3,761 379 — 1973 , 2010 November 30, 2017 40 Bakersfield, CA Rehabilitation hospital 2,178 45,253 — — 2,178 45,253 47,431 930 — 2022 May 15, 2020 40 Basingstoke, UK Acute care general hospital 12,264 47,635 — — 12,264 47,635 59,899 3,609 — 1984 January 9, 2020 40 Bassenheim, Germany Rehabilitation hospital 1,095 5,129 — — 1,095 5,129 6,224 557 — 1887 , 1983 February 9, 2019 39 Bath, UK Acute care general hospital 1,432 29,685 — — 1,432 29,685 31,117 6,308 — 2008 , 2009 July 1, 2014 40 Bath, UK Acute care general hospital 6,827 12,389 — — 6,827 12,389 19,216 965 — 1992 January 9, 2020 40 Beckenham, UK Acute care general hospital 5,184 19,882 — — 5,184 19,882 25,066 1,501 — 1981 January 9, 2020 40 Bedford, UK Acute care general hospital 1,462 7,122 — — 1,462 7,122 8,584 544 — 1982 January 9, 2020 40 Bellflower, CA Behavioral health facility 2,563 — — — 2,563 — 2,563 — — 1972 August 23, 2019 — Bennettsville, SC Acute care general hospital 794 15,773 — — 794 15,773 16,567 9,999 — 1984 April 1, 2008 42 Big Spring, TX Acute care general hospital 1,655 21,254 815 — 1,655 22,069 23,724 2,296 — 1973 April 12, 2019 41 Birmingham, UK Acute care general hospital 7,952 40,068 — — 7,952 40,068 48,020 2,504 — 2017 April 3, 2017 40 Birmingham, UK Acute care general hospital 9,360 89,090 — — 9,360 89,090 98,450 6,751 — 1982 January 9, 2020 40 Birmingham, UK Rehabilitation hospital — 16,477 — — — 16,477 16,477 1,030 — 2018 June 29, 2020 40 Birmingham, UK Behavioral health facility 391 18,188 — — 391 18,188 18,579 731 — 1900 , 1984 , 2016 June 25, 2021 40 Blackburn, UK Acute care general hospital 2,526 48,405 — — 2,526 48,405 50,931 3,652 — 1957 January 9, 2020 40 Blackburn, UK Behavioral health facility 19,010 51,573 — — 19,010 51,573 70,583 2,120 — 1930 June 25, 2021 40 Blue Springs, MO Acute care general hospital 4,347 23,494 — — 4,347 23,494 27,841 4,886 — 1980 February 13, 2015 40 Boardman, OH Long term acute care hospital 79 275 — — 79 275 354 26 — 2008 August 30, 2019 40 Boise, ID Long term acute care hospital 1,558 11,027 — — 1,558 11,027 12,585 1,094 — 2008 February 29, 2012 50 Bolton, UK Acute care general hospital 1,504 42,267 — — 1,504 42,267 43,771 3,181 — 1989 January 9, 2020 40 Boonton Township, NJ Behavioral health facility 6,712 17,031 — — 6,712 17,031 23,743 1,033 — 1952 , 1971 - 1978 September 30, 2015 40 Initial Costs Additions Subsequent Cost at December 31, 2022(1) Accumulated Life on Location Type of Property Land Buildings Improve- Carrying Land Buildings Total Depreciation Encum- Date of Date computed (Dollar amounts in thousands) Bossier City, LA Long term acute care hospital 900 17,818 944 — 900 18,762 19,662 6,692 — 1982 April 1, 2008 40 Bowling Green, KY Rehabilitation hospital 3,486 56,296 3,550 — 3,486 59,846 63,332 5,255 — 1992 August 30, 2019 40 Braunfels, Germany Acute care general hospital 2,109 13,138 — — 2,109 13,138 15,247 2,490 — 1977 June 30, 2015 40 Bristol, UK Behavioral health facility 4,466 35,485 — — 4,466 35,485 39,951 79 — 1790 , 2014 December 9, 2022 40 Bromley, UK Behavioral health facility 6,856 14,731 — — 6,856 14,731 21,587 614 — 1714 , 1830 , 2021 June 25, 2021 40 Broomfield, CO Freestanding ER 825 3,895 — — 825 3,895 4,720 828 — 2014 July 3, 2014 40 Bundoora, Australia Acute care general hospital 6,510 60,125 3,935 — 6,510 64,060 70,570 6,090 — 1979 June 7, 2019 37 Bury, UK Behavioral health facility 8,076 18,404 — — 8,076 18,404 26,480 796 — 2003 June 25, 2021 40 Bussage, UK Behavioral health facility 8,058 3,562 — — 8,058 3,562 11,620 149 — 1970 June 25, 2021 40 Cadiz, Spain Acute care general hospital 290 6,593 — — 290 6,593 6,883 118 — 2000 April 29, 2022 40 Campbelltown, Australia Acute care general hospital 1,037 51,364 312 — 1,037 51,676 52,713 4,621 — 2007 June 7, 2019 40 Canterbury, UK Acute care general hospital 8,718 26,185 — — 8,718 26,185 34,903 1,980 — 1982 January 9, 2020 40 Carmarthen, UK Acute care general hospital 864 24,274 — — 864 24,274 25,138 1,839 — 1990 January 9, 2020 40 Carrollton, TX Behavioral health facility 4,941 52,227 — — 4,941 52,227 57,168 1,663 — 2012 October 19, 2021 40 Casper, WY Rehabilitation hospital 1,734 — — — 1,734 — 1,734 — — 2012 February 29, 2012 — Caterham, UK Acute care general hospital 10,015 19,785 — — 10,015 19,785 29,800 1,748 — 1982 August 16, 2019 40 Chandler, AZ Freestanding ER 3,567 4,783 — — 3,567 4,783 8,350 917 — 2015 April 24, 2015 40 Chandler, AZ Freestanding ER 750 3,853 — — 750 3,853 4,603 698 — 2015 October 7, 2015 40 Cheadle, UK Acute care general hospital 29,362 154,668 — — 29,362 154,668 184,030 11,673 — 1981 January 9, 2020 40 Cheadle, UK Behavioral health facility 28,297 89,982 — — 28,297 89,982 118,279 3,652 — 1994 July 8, 2020 40 Cheraw, SC Acute care general hospital 657 19,576 — — 657 19,576 20,233 12,409 — 1982 April 1, 2008 42 Clarksville, TX Rehabilitation hospital 2,460 25,540 — — 2,460 25,540 28,000 1,420 — 2019 December 17, 2020 39 Cologne, Germany Acute care general hospital 4,292 14,512 — — 4,292 14,512 18,804 2,031 — 2001 August 7, 2020 40 Colorado Springs, CO Freestanding ER 600 4,231 — — 600 4,231 4,831 908 — 2014 June 5, 2014 40 Columbus, OH Behavioral health facility 2,101 44,218 — — 2,101 44,218 46,319 1,422 — 2017 October 19, 2021 40 Commerce City, TX Freestanding ER 707 4,248 — — 707 4,248 4,955 858 — 2014 December 11, 2014 40 Conroe, TX Behavioral health facility 3,855 38,892 — — 3,855 38,892 42,747 1,278 — 2018 October 19, 2021 40 Converse, TX Freestanding ER 750 4,423 — — 750 4,423 5,173 857 — 2015 April 10, 2015 40 Coral Gables, FL Acute care general hospital 26,215 84,584 — — 26,215 84,584 110,799 3,104 — 1959 August 1, 2021 40 Crown Point, IN Long term acute care hospital 302 528 — — 302 528 830 56 — 2008 August 30, 2019 40 Croydon, UK Acute care general hospital 9,437 39,583 — — 9,437 39,583 49,020 3,007 — 1981 January 9, 2020 40 Dahlen, Germany Rehabilitation hospital 1,303 10,996 — — 1,303 10,996 12,299 730 — 1993 , 2006 August 28, 2018 40 Dallas, TX Long term acute care hospital 1,421 13,536 — — 1,421 13,536 14,957 5,527 — 2006 September 5, 2006 40 Darlington, UK Acute care general hospital 1,981 33,995 — — 1,981 33,995 35,976 2,106 — 2001 August 7, 2020 40 Darlington, UK Behavioral health facility 20,165 45,806 — — 20,165 45,806 65,971 2,012 — 1935 , 2018 , 2020 June 25, 2021 40 Darlington, UK Behavioral health facility 4,962 25,007 — — 4,962 25,007 29,969 988 — 1960 , 1990 June 25, 2021 40 Denver, CO Freestanding ER 1,257 4,276 — — 1,257 4,276 5,533 811 — 2015 June 8, 2015 40 Denville, NJ Acute care general hospital 15,709 55,772 — — 15,709 55,772 71,481 3,308 — 1953 , 1969 - 2008 September 30, 2015 40 Detroit, MI Long term acute care hospital 1,220 8,323 — — 1,220 8,323 9,543 3,099 — 1956 May 22, 2008 40 Diss, UK Behavioral health facility 2,762 9,849 — — 2,762 9,849 12,611 453 — 1840 (2) June 25, 2021 40 Dorchester, UK Acute care general hospital 512 29,746 — — 512 29,746 30,258 2,242 — 1981 January 9, 2020 40 Dormagen, Germany Rehabilitation hospital 1,852 5,477 — — 1,852 5,477 7,329 631 — 1993 , 2006 August 28, 2018 40 Dover, NJ Acute care general hospital 3,865 8,693 — — 3,865 8,693 12,558 549 — 1925 , 1927 - 2008 September 30, 2015 40 Initial Costs Additions Subsequent Cost at December 31, 2022(1) Accumulated Life on Location Type of Property Land Buildings Improve- Carrying Land Buildings Total Depreciation Encum- Date of Date computed (Dollar amounts in thousands) Droitwich, UK Acute care general hospital 72 14,520 — — 72 14,520 14,592 1,103 — 1984 January 9, 2020 40 Dublin, OH Behavioral health facility 5,118 69,346 — — 5,118 69,346 74,464 2,185 — 2012 October 19, 2021 40 El Paso, TX Rehabilitation hospital 4,268 21,345 — — 4,268 21,345 25,613 1,240 — 2018 December 17, 2020 38 Englewood, CO Behavioral health facility 3,369 65,480 — — 3,369 65,480 68,849 2,081 — 2017 October 19, 2021 40 Essex, UK Behavioral health facility 4,406 41,011 — — 4,406 41,011 45,417 91 — 1790 , 1992 , 2014 December 9, 2022 40 Euxton, UK Acute care general hospital 4,382 33,750 — — 4,382 33,750 38,132 3,026 — 1981 August 16, 2019 40 Firestone, TX Freestanding ER 495 3,963 — — 495 3,963 4,458 850 — 2014 June 6, 2014 40 Flagstaff, AZ Rehabilitation hospital 3,049 22,464 — — 3,049 22,464 25,513 2,714 — 2016 August 23, 2016 40 Florence, AZ Acute care general hospital 900 28,462 105 — 900 28,567 29,467 7,674 — 2012 February 7, 2012 40 Floridablanca, Colombia Acute care general hospital 651 20,392 — — 651 20,392 21,043 214 — 1997 July 29, 2022 40 Folsom, CA Long term acute care hospital 3,291 21,293 — — 3,291 21,293 24,584 2,106 — 2009 August 30, 2019 40 Fort Worth, TX Behavioral health facility 3,406 34,627 — — 3,406 34,627 38,033 1,131 — 2014 October 19, 2021 40 Fountain, CO Freestanding ER 1,508 4,131 — — 1,508 4,131 5,639 869 — 2014 July 31, 2014 40 Fresno, CA Rehabilitation hospital 5,507 70,473 — — 5,507 70,473 75,980 6,329 — 1991 August 30, 2019 40 Frome, UK Behavioral health facility 2,748 16,652 — — 2,748 16,652 19,400 705 — 1980 June 25, 2021 40 Frome, UK Behavioral health facility 10,340 10,166 — — 10,340 10,166 20,506 567 — 1700 , 2015 , 2017 June 25, 2021 40 Gardena, CA Acute care general hospital 14,010 65,282 — — 14,010 65,282 79,292 2,646 — 1966 July 6, 2021 40 Georgetown, TX Behavioral health facility 4,569 22,858 1,062 — 4,569 23,920 28,489 741 — 2014 October 19, 2021 40 Gilbert, AZ Freestanding ER 1,517 4,661 — — 1,517 4,661 6,178 864 — 2015 July 22, 2015 40 Gilbert, AZ Behavioral health facility 4,790 45,076 — — 4,790 45,076 49,866 1,408 — 2020 October 19, 2021 40 Glasgow, UK Acute care general hospital 6,114 124,874 — — 6,114 124,874 130,988 9,392 — 1983 January 9, 2020 40 Glasgow, UK Behavioral health facility 1,355 14,824 — — 1,355 14,824 16,179 603 — 1900 , 1980 June 25, 2021 40 Glen Waverly, Australia Rehabilitation hospital 29,641 22,296 — — 29,641 22,296 51,937 2,848 — 1972 June 7, 2019 32 Glendale, AZ Freestanding ER 1,144 6,087 — — 1,144 6,087 7,231 938 — 2016 October 21, 2016 40 Glendale, AZ Freestanding ER 1,193 4,046 — — 1,193 4,046 5,239 767 — 2015 June 5, 2015 40 Gloucester, UK Acute care general hospital 5,296 58,249 — — 5,296 58,249 63,545 5,142 — 1990 August 16, 2019 40 Godalming, UK Behavioral health facility 8,880 18,014 — — 8,880 18,014 26,894 783 — 1796 , 2007 June 25, 2021 40 Goodyear, AZ Freestanding ER 1,800 4,713 — — 1,800 4,713 6,513 795 — 2016 April 4, 2016 40 Great Missenden, UK Acute care general hospital 11,171 99,814 — — 11,171 99,814 110,985 7,545 — 1981 January 9, 2020 40 Grefath, Germany Rehabilitation hospital 1,164 2,937 — — 1,164 2,937 4,101 346 — 1886 , 1983 August 28, 2018 40 Guildford, UK Acute care general hospital 6,531 34,573 — — 6,531 34,573 41,104 2,616 — 1989 January 9, 2020 40 Halsall, UK Acute care general hospital 1,912 29,573 — — 1,912 29,573 31,485 2,618 — 1986 August 16, 2019 40 Harrow, UK Acute care general hospital 36,448 38,358 — — 36,448 38,358 74,806 2,917 — 1980 January 9, 2020 40 Hartsville, SC Acute care general hospital 2,050 43,970 — — 2,050 43,970 46,020 9,332 — 1999 August 31, 2015 34 Hassocks, UK Behavioral health facility 5,205 27,215 — — 5,205 27,215 32,420 1,255 — 1998 June 25, 2021 40 Hastings, PA Acute care general hospital 603 8,834 — — 603 8,834 9,437 1,090 — 1924 December 17, 2019 30 Hausman, TX Acute care general hospital 1,500 8,957 — — 1,500 8,957 10,457 2,183 — 2013 March 1, 2013 40 Heidelberg, Germany Rehabilitation hospital 6,049 34,547 — — 6,049 34,547 40,596 5,644 — 1885 , 1991 June 22, 2016 40 Helotes, TX Freestanding ER 1,900 5,115 — — 1,900 5,115 7,015 874 — 2016 March 10, 2016 40 Helsinki, Finland Acute care general hospital 3,962 65,927 — — 3,962 65,927 69,889 1,384 — 1992 , 2013 March 11, 2022 40 Hemel Hempstead, UK Behavioral health facility 11,854 5,983 — — 11,854 5,983 17,837 313 — 1901 , 1990 June 25, 2021 40 Hialeah, FL Acute care general hospital 18,802 107,783 — — 18,802 107,783 126,585 4,043 — 1950 August 1, 2021 40 Hialeah, FL Acute care general hospital 75,339 222,271 75,494 — 75,339 297,765 373,104 8,995 — 1969 August 1, 2021 40 Highland Hills, OH Behavioral health facility 3,148 43,891 — — 3,148 43,891 47,039 1,412 — 2015 October 19, 2021 40 Initial Costs Additions Subsequent Cost at December 31, 2022(1) Accumulated Life on Location Type of Property Land Buildings Improve- Carrying Land Buildings Total Depreciation Encum- Date of Date computed (Dollar amounts in thousands) Highland Village, TX Freestanding ER 3,218 1,551 — — 3,218 1,551 4,769 445 — 2015 September 22, 2015 40 Highlands Ranch, CO Freestanding ER 4,200 4,779 — — 4,200 4,779 8,979 767 — 2016 July 25, 2016 40 Hill County, TX Acute care general hospital 1,120 17,882 503 — 1,120 18,385 19,505 14,833 — 1980 September 17, 2010 15 Hinckley, UK Behavioral health facility 2,340 15,949 — — 2,340 15,949 18,289 648 — 1892 , 2007 June 25, 2021 40 Hook, UK Behavioral health facility 5,140 9,790 — — 5,140 9,790 14,930 432 — 1980 June 25, 2021 40 Hoover, AL Freestanding ER — 7,581 — — — 7,581 7,581 1,697 — 2015 May 1, 2015 34 Hoover, AL Freestanding ER — 1,034 296 — — 1,330 1,330 268 — 2015 May 1, 2015 34 Hope, AR Acute care general hospital 1,651 3,359 2,733 — 1,651 6,092 7,743 1,146 — 1984 - 2001 September 29, 2017 41 Hot Springs, AR Acute care general hospital 5,622 59,432 21,221 — 5,622 80,653 86,275 15,232 — 1985 August 31, 2015 40 Houston, TX Acute care general hospital 28,687 104,028 78,415 — 28,687 182,443 211,130 12,756 — 1940 - 1950 September 29, 2017 41 Houston, TX Freestanding ER 950 3,996 — — 950 3,996 4,946 624 — 2016 September 26, 2016 40 Houston, TX Behavioral health facility 6,063 19,881 2,565 — 6,063 22,446 28,509 1,122 — 2020 October 25, 2019 40 Houston, TX Acute care general hospital 3,274 27,324 32,499 — 3,274 59,823 63,097 19,503 — 1960 August 10, 2007 40 Huntington Park, CA Acute care general hospital 3,132 5,002 — — 3,132 5,002 8,134 231 — 1967 July 6, 2021 40 Huntington Park, CA Acute care general hospital 3,935 6,103 — — 3,935 6,103 10,038 276 — 1960 - 1969 July 6, 2021 40 Idaho Falls, ID Acute care general hospital 1,822 37,467 15,921 — 1,822 53,388 55,210 16,455 — 2002 April 1, 2008 40 Idaho Falls, ID Acute care general hospital 1,880 107,608 — — 1,880 107,608 109,488 7,835 — 2020 December 19, 2017 40 Johnstown, PA Acute care general hospital 8,877 247,158 — — 8,877 247,158 256,035 25,076 — 1924 December 17, 2019 30 Kansas City, KS Acute care general hospital 2,351 13,665 — — 2,351 13,665 16,016 1,059 — 2017 June 10, 2019 50 Kansas City, MO Acute care general hospital 10,497 64,419 — — 10,497 64,419 74,916 12,996 — 1978 February 13, 2015 40 Katy, TX Freestanding ER 1,556 4,174 — — 1,556 4,174 5,730 652 — 2016 October 10, 2016 40 Katy, TX Freestanding ER 2,147 3,873 — — 2,147 3,873 6,020 694 — 2015 October 21, 2015 40 Kingswood, Australia Acute care general hospital 23,216 75,501 11,829 — 23,216 87,330 110,546 6,888 — 2000 June 7, 2019 40 Kuopio, Finland Acute care general hospital 1,269 42,401 — — 1,269 42,401 43,670 920 — 2017 March 11, 2022 29 Lafayette, IN Rehabilitation hospital 800 14,968 ( 25 ) — 800 14,943 15,743 3,694 — 2013 February 1, 2013 40 Lafayette, IN Behavioral health facility 2,829 10,795 — — 2,829 10,795 13,624 421 — 2012 October 19, 2021 40 Lander, WY Acute care general hospital 761 42,849 — — 761 42,849 43,610 3,434 — 1983 December 17, 2019 40 Lauderdale Lakes, FL Acute care general hospital 10,657 150,313 — — 10,657 150,313 160,970 6,038 — 1975 August 1, 2021 40 Lawton, OK Acute care general hospital 3,944 63,031 — — 3,944 63,031 66,975 5,077 — 1985 December 17, 2019 40 Layton, UT Acute care general hospital 14,360 370,154 5,481 — 14,360 375,635 389,995 22,737 — 1976 - 2010 September 29, 2017 40 League City, TX Freestanding ER 1,297 3,901 — — 1,297 3,901 5,198 731 — 2015 June 19, 2015 40 Leawood, KS Acute care general hospital 2,513 13,938 — — 2,513 13,938 16,451 1,073 — 2017 June 10, 2019 50 Leeds, UK Behavioral health facility 2,163 9,037 — — 2,163 9,037 11,200 379 — 1990 June 25, 2021 40 Lehi, UT Acute care general hospital 13,368 29,950 1,676 — 13,368 31,626 44,994 4,738 — 2015 September 29, 2017 45 Lewiston, ID Acute care general hospital 5,389 75,435 — — 5,389 75,435 80,824 14,455 — 1922 May 1, 2017 40 Little Elm, TX Freestanding ER 1,241 3,491 — — 1,241 3,491 4,732 790 — 2013 December 1, 2013 40 Liverpool, Australia Acute care general hospital 13,022 40,532 196 — 13,022 40,728 53,750 4,879 — 1975 June 7, 2019 30 London, UK Acute care general hospital 8,772 57,899 — — 8,772 57,899 66,671 4,357 — 1984 January 9, 2020 40 London, UK Behavioral health facility 34,421 49,182 — — 34,421 49,182 83,603 110 — 1811 , 2014 December 9, 2022 40 London, UK Acute care general hospital 3,117 3,937 — — 3,117 3,937 7,054 300 — 1987 January 9, 2020 40 London, UK Behavioral health facility 27,463 14,237 — — 27,463 14,237 41,700 36 — 1790 , 1992 , 2014 December 9, 2022 40 London, UK Acute care general hospital 11,817 77,130 — — 11,817 77,130 88,947 5,790 — 1977 January 9, 2020 40 London, UK Behavioral health facility 5,848 14,858 — — 5,848 14,858 20,706 613 — 1900 , 1960 June 25, 2021 40 Initial Costs Additions Subsequent Cost at December 31, 2022(1) Accumulated Life on Location Type of Property Land Buildings Improve- Carrying Land Buildings Total Depreciation Encum- Date of Date computed (Dollar amounts in thousands) London, UK Behavioral health facility 13,107 6,464 — — 13,107 6,464 19,571 277 — 1992 June 25, 2021 40 Longmont, CO Freestanding ER 1,773 4,181 — — 1,773 4,181 5,954 723 — 2016 February 10, 2016 40 Los Angeles, CA Acute care general hospital 12,562 40,164 — — 12,562 40,164 52,726 1,556 — 1972 July 6, 2021 40 Lubbock, TX Rehabilitation hospital 1,376 28,292 3,648 — 1,376 31,940 33,316 5,906 — 2008 June 16, 2015 40 Lynwood, CA Acute care general hospital 30,116 148,527 — — 30,116 148,527 178,643 9,018 — 1940 , 1989 - 2000 August 13, 2020 40 Malaga, SP Acute care general hospital 726 11,364 — — 726 11,364 12,090 193 — 2018 April 29, 2022 40 Mandeville, LA Freestanding ER 2,800 5,370 — — 2,800 5,370 8,170 828 — 2016 October 28, 2016 40 Marrero, LA Freestanding ER 1,584 5,801 — — 1,584 5,801 7,385 943 — 2016 July 15, 2016 40 McKinney, TX Freestanding ER 2,614 4,060 — — 2,614 4,060 6,674 1,012 — 2015 July 31, 2015 30 McKinney, TX Behavioral health facility 2,934 — — — 2,934 — 2,934 — — 2021 October 19, 2021 - McMinnville, OR Acute care general hospital 5,000 97,900 — — 5,000 97,900 102,900 16,630 — 1996 August 31, 2015 41 Melbourne, FL Acute care general hospital 5,642 17,087 21,818 — 5,642 38,905 44,547 4,054 — 2002 May 1, 2017 42 Melton Mowbray, UK Behavioral health facility 5,411 15,169 — — 5,411 15,169 20,580 651 — 1990 June 25, 2021 40 Mesa, AZ Acute care general hospital 6,534 100,042 4,135 — 6,534 104,177 110,711 24,726 — 2007 September 26, 2013 40 Mesa, AZ Acute care general hospital 2,604 16,400 — — 2,604 16,400 19,004 283 — 2019 April 18, 2022 40 Meyersdale, PA Acute care general hospital 390 4,280 — — 390 4,280 4,670 548 — 1960 December 17, 2019 30 Miami, FL Acute care general hospital 44,400 107,203 — — 44,400 107,203 151,603 4,744 — 1955 August 1, 2021 40 Miami, FL Acute care general hospital 20,430 33,881 10,364 — 20,430 44,245 64,675 593 — 1958 , 1962 , 1988 , 2016 April 25, 2022 40 Milton Keynes, UK Acute care general hospital 4,979 34,035 — — 4,979 34,035 39,014 2,570 — 1983 January 9, 2020 40 Monmouth, UK Behavioral health facility 14,717 10,964 — — 14,717 10,964 25,681 556 — 2017 June 25, 2021 40 Montclair, NJ Acute care general hospital 7,900 99,640 577 — 8,477 99,640 108,117 22,329 — 1920 - 2000 April 1, 2014 40 Mount Pleasant, SC Long term acute care hospital 597 2,198 — — 597 2,198 2,795 213 — 2012 August 30, 2019 40 New Braunfels, TX Rehabilitation hospital 1,853 10,622 — — 1,853 10,622 12,475 574 — 2011 February 29, 2012 40 New Orleans, LA Freestanding ER 2,850 6,125 — — 2,850 6,125 8,975 957 — 2016 September 23, 2016 40 Newark, NJ Acute care general hospital 32,957 24,553 — — 32,957 24,553 57,510 1,381 — 1919 , 1920 - 2003 May 2, 2016 40 Newburgh, IN Behavioral health facility 1,215 7,212 — — 1,215 7,212 8,427 254 — 2010 October 19, 2021 40 Northland, MO Long term acute care hospital 834 17,182 — — 834 17,182 18,016 5,119 — 2007 February 14, 2011 40 Norwalk, CA Acute care general hospital 2,811 5,940 — — 2,811 5,940 8,751 278 — 1959 , 1995 July 6, 2021 40 Norwalk, CA Acute care general hospital 7,946 30,465 — — 7,946 30,465 38,411 1,221 — 1958 - 1978 July 6, 2021 40 Norwood, MA Acute care general hospital 6,373 — 69,916 — 6,373 69,916 76,289 — — 1926 - 2001 June 27, 2018 46 Nottingham, UK Acute care general hospital 4,700 43,612 — — 4,700 43,612 48,312 3,317 — 1983 January 9, 2020 40 Nottingham, UK Behavioral health facility 9,502 8,504 — — 9,502 8,504 18,006 419 — 2000 June 25, 2021 40 Nottingham, UK Behavioral health facility 9,643 3,081 — — 9,643 3,081 12,724 129 — 1980 June 25, 2021 40 Odessa, TX Acute care general hospital 6,217 123,518 16,600 — 6,217 140,118 146,335 16,927 — 1973 - 2004 September 29, 2017 41 Ogden, UT Rehabilitation hospital 1,759 16,414 — — 1,759 16,414 18,173 3,614 — 2014 March 1, 2014 40 Oklahoma City, OK Behavioral health facility 3,641 3,047 — — 3,641 3,047 6,688 181 — 2017 October 19, 2021 40 Olathe, KS Behavioral health facility 5,966 55,745 — — 5,966 55,745 61,711 1,818 — 2015 October 19, 2021 40 Olathe, KS Acute care general hospital 3,485 14,484 — — 3,485 14,484 17,969 1,127 — 2018 June 10, 2019 50 Orpington, UK Acute care general hospital 9,811 40,540 — — 9,811 40,540 50,351 3,069 — 1987 January 9, 2020 40 Ottumwa, IA Acute care general hospital 2,377 48,697 — — 2,377 48,697 51,074 5,434 — 1950 December 17, 2019 30 Oulu, Finland Acute care general hospital 3,076 43,939 — — 3,076 43,939 47,015 965 — 2017 March 11, 2022 40 Overland Park, KS Acute care general hospital 2,974 14,405 — — 2,974 14,405 17,379 1,127 — 2017 June 10, 2019 50 Overland Park, KS Acute care general hospital 3,191 14,263 — — 3,191 14,263 17,454 1,172 — 2019 June 10, 2019 50 Overlook, TX Acute care general hospital 2,452 9,666 7 — 2,452 9,673 12,125 2,383 — 2012 February 1, 2013 40 Palestine, TX Acute care general hospital 1,848 95,257 — — 1,848 95,257 97,105 7,489 — 1988 December 17, 2019 40 Parker, CO Freestanding ER 1,300 4,448 — — 1,300 4,448 5,748 797 — 2015 November 6, 2015 40 Initial Costs Additions Subsequent Cost at December 31, 2022(1) Accumulated Life on Location Type of Property Land Buildings Improve- Carrying Land Buildings Total Depreciation Encum- Date of Date computed (Dollar amounts in thousands) Pasco, WA Acute care general hospital 2,594 13,195 — — 2,594 13,195 15,789 1,953 — 1920 August 31, 2018 30 Pearland, TX Freestanding ER 1,075 3,577 — — 1,075 3,577 4,652 745 — 2014 September 8, 2014 40 Perth, Australia Acute care general hospital 99,659 35,321 2,165 — 99,659 37,486 137,145 4,456 — 1965 June 7, 2019 30 Petersburg, VA Rehabilitation hospital 1,302 9,121 — — 1,302 9,121 10,423 3,306 — 2006 July 1, 2008 40 Phoenix, AZ Behavioral health facility 2,396 26,521 2,985 — 2,396 29,506 31,902 4,062 — 1979 September 29, 2017 42 Phoenix, AZ Acute care general hospital 12,695 73,773 4,499 — 12,695 78,272 90,967 10,931 — 1968 - 1976 September 29, 2017 43 Phoenix, AZ Acute care general hospital 5,576 45,782 — — 5,576 45,782 51,358 6,772 — 2017 February 10, 2017 40 Phoenix, AZ Freestanding ER 1,132 5,052 — — 1,132 5,052 6,184 726 — 2017 April 13, 2017 40 Plano, TX Freestanding ER 4,204 2,492 — — 4,204 2,492 6,696 494 — 2016 September 30, 2016 40 Poole, UK Acute care general hospital 2,206 36,429 — — 2,206 36,429 38,635 3,538 — 1996 April 3, 2019 40 Poplar Bluff, MO Acute care general hospital 2,659 38,694 — — 2,659 38,694 41,353 14,217 — 1980 April 22, 2008 40 Port Arthur, TX Acute care general hospital 12,972 78,051 6,877 — 12,972 84,928 97,900 18,823 — 2005 September 26, 2013 40 Port Huron, MI Acute care general hospital 2,531 14,252 — — 2,531 14,252 16,783 3,408 — 1953 , 1973 - 1983 December 31, 2015 30 Post Falls, ID Rehabilitation hospital 417 12,175 1,905 — 767 13,730 14,497 3,099 — 2013 December 31, 2013 40 Preston, UK Behavioral health facility 8,296 24,677 — — 8,296 24,677 32,973 991 — 1850 , 2018 , 2021 June 25, 2021 40 Princes Risborough, UK Acute care general hospital 4,425 — — — 4,425 — 4,425 — — N/A January 9, 2020 40 Raleigh, NC Behavioral health facility 3,469 27,514 — — 3,469 27,514 30,983 952 — 2018 October 19, 2021 40 Reading, UK Acute care general hospital 33,024 43,823 — — 33,024 43,823 76,847 3,816 — 1990 August 16, 2019 40 Reading, UK Acute care general hospital 24,672 79,057 — — 24,672 79,057 103,729 4,028 — 2012 December 18, 2020 40 Remscheid, Germany Rehabilitation hospital 1,017 2,451 — — 1,017 2,451 3,468 282 — 1951 , 1983 August 28, 2018 40 Richmond, TX Behavioral health facility 5,380 6,155 736 — 5,380 6,891 12,271 254 — 2014 October 19, 2021 40 Richmond, VA Long term acute care hospital 1,299 10,071 — — 1,299 10,071 11,370 1,087 — 1989 August 30, 2019 40 Ringwood, Australia Acute care general hospital 4,038 18,125 — — 4,038 18,125 22,163 1,912 — 1973 June 7, 2019 35 Riverton, WY Acute care general hospital 1,163 29,647 — — 1,163 29,647 30,810 2,756 — 1983 December 17, 2019 36 Roaring Springs, PA Acute care general hospital 1,446 9,549 — — 1,446 9,549 10,995 1,216 — 1924 December 17, 2019 30 Rochdale, MA Long term acute care hospital 654 3,368 — — 654 3,368 4,022 329 — 1989 August 30, 2019 40 Rochdale, MA Acute care general hospital 67 344 — — 67 344 411 34 — 1989 August 30, 2019 40 Rochdale, UK Acute care general hospital 3,395 38,679 — — 3,395 38,679 42,074 2,927 — 1965 January 9, 2020 40 Rockledge, FL Acute care general hospital 13,919 23,282 8,338 — 13,919 31,620 45,539 5,521 — 1950 , 1970 May 1, 2017 42 Roeland Park, KS Acute care general hospital 1,569 15,103 — — 1,569 15,103 16,672 1,152 — 2018 June 10, 2019 50 Romford, UK Behavioral health facility 5,082 8,319 — — 5,082 8,319 13,401 394 — 1980 June 25, 2021 40 Rosenberg, TX Freestanding ER 1,270 4,505 — — 1,270 4,505 5,775 788 — 2016 January 15, 2016 40 Rowley, UK Acute care general hospital 2,760 17,370 — — 2,760 17,370 20,130 1,585 — 1986 August 16, 2019 40 Royston, UK Behavioral health facility 6,391 19,028 — — 6,391 19,028 25,419 899 — 1906 , 1970 June 25, 2021 40 Salt Lake City, UT Acute care general hospital 13,590 101,915 15,268 — 13,590 117,183 130,773 14,618 — 1906 - 1987 September 29, 2017 41 San Antonio, TX Acute care general hospital 8,053 29,333 7,981 — 8,053 37,314 45,367 4,701 — 1978 - 2002 September 29, 2017 41 San Antonio, TX Freestanding ER 3,120 4,801 — — 3,120 4,801 7,921 730 — 2016 December 9, 2016 40 San Antonio, TX Freestanding ER 351 3,952 — — 351 3,952 4,303 863 — 2014 January 1, 2014 40 San Antonio, TX Acute care general hospital 2,248 5,880 — — 2,248 5,880 8,128 1,494 — 2012 October 2, 2012 40 San Antonio, TX Freestanding ER 2,412 4,253 — — 2,412 4,253 6,665 656 — 2016 October 27, 2016 40 San Bernardino, CA Acute care general hospital 2,209 37,498 — — 2,209 37,498 39,707 3,415 — 1993 August 30, 2019 40 Initial Costs Additions Subsequent Cost at December 31, 2022(1) Accumulated Life on which Location Type of Property Land Buildings Improve- Carrying Land Buildings Total Depreciation Encum- Date of Date Acquired computed (Dollar amounts in thousands) Santa Maria de Feira, PT Acute care general hospital 1,804 17,299 — — 1,804 17,299 19,103 531 — 2015 October 21, 2021 40 Sebastian, FL Acute care general hospital 5,733 49,136 56,430 — 5,733 105,566 111,299 11,126 — 1974 May 1, 2017 41 Sharon, PA Acute care general hospital 6,179 9,066 5,428 — 6,179 14,494 20,673 3,091 — 1950 - 1980 May 1, 2017 41 Shawnee, KS Acute care general hospital 3,076 14,945 — — 3,076 14,945 18,021 1,328 — 2018 June 10, 2019 50 Sheffield, UK Acute care general hospital 6,277 42,344 — — 6,277 42,344 48,621 3,223 — 2008 January 9, 2020 40 Sherman, TX Acute care general hospital 3,363 10,932 — — 3,363 10,932 14,295 3,940 — 1913 , 1960 - 2010 October 31, 2014 40 Southampton, UK Behavioral health facility 6,116 17,961 — — 6,116 17,961 24,077 835 — 1820 , 1985 June 25, 2021 40 Spartanburg, SC Rehabilitation hospital 1,135 15,717 — — 1,135 15,717 16,852 3,685 — 2013 August 1, 2013 40 St. Albans Park, Australia Acute care general hospital 2,562 20,786 10,700 — 2,562 31,486 34,048 2,420 — 1985 June 7, 2019 40 Stirling, UK Acute care general hospital 1,001 18,517 — — 1,001 18,517 19,518 726 — 1992 July 6, 2021 40 Stockton, CA Rehabilitation hospital 2,841 — — — 2,841 — 2,841 — — 2021 November 23, 2020 40 Strathpine, Australia Acute care general hospital 2,755 34,489 — — 2,755 34,489 37,244 3,177 — 1985 June 7, 2019 40 Sunnybank, Australia Acute care general hospital 5,982 42,915 — — 5,982 42,915 48,897 4,580 — 1979 June 7, 2019 34 Surrey, UK Behavioral health facility 14,280 8,741 — — 14,280 8,741 23,021 25 — 1950 , 2014 December 9, 2022 40 Sussex, NJ Acute care general hospital 477 2,097 — — 477 2,097 2,574 130 — 1920 September 30, 2015 40 Swindon, UK Acute care general hospital 5,056 56,730 — — 5,056 56,730 61,786 4,280 — 1984 January 9, 2020 40 Tadley, UK Behavioral health facility 19,853 18,090 — — 19,853 18,090 37,943 891 — 2020 June 25, 2021 40 Tempe, AZ Acute care general hospital 6,050 10,986 5,084 — 6,050 16,070 22,120 2,410 — 1940 September 29, 2017 41 Texarkana, TX Acute care general hospital 14,562 — — — 14,562 — 14,562 — — 2017 September 29, 2017 - The Woodlands, TX Freestanding ER 2,005 4,524 — — 2,005 4,524 6,529 764 — 2016 March 28, 2016 40 Thornton, CO Freestanding ER 1,350 4,259 — — 1,350 4,259 5,609 887 — 2014 August 29, 2014 40 Toledo, OH Rehabilitation hospital 1,150 17,740 — — 1,150 17,740 18,890 2,994 — 2016 April 1, 2016 40 Tomball, TX Long term acute care hospital 1,299 23,982 — — 1,299 23,982 25,281 7,195 — 2005 December 21, 2010 40 Torquay, UK Acute care general hospital 2,829 33,923 — — 2,829 33,923 36,752 2,915 — 1981 August 16, 2019 40 Turku, Finland Acute care general hospital 1,171 57,048 — — 1,171 57,048 58,219 1,206 — 2018 March 11, 2022 40 Usk, UK Behavioral health facility 1,641 21,072 — — 1,641 21,072 22,713 838 — 1770 , 1850 , 1980 June 25, 2021 40 Valencia, SP Acute care general hospital 10,791 67,447 — — 10,791 67,447 78,238 2,106 — 2017 December 2, 2021 40 Viseu, Portugal Acute care general hospital 2,458 28,010 — — 2,458 28,010 30,468 2,422 — 2016 November 28, 2019 37 Wantirna, Australia Acute care general hospital 25,595 202,892 24,129 — 25,595 227,021 252,616 18,529 — 1984 June 7, 2019 40 Warren, OH Acute care general hospital 5,385 47,588 10,486 — 5,385 58,074 63,459 9,460 — 1982 May 1, 2017 41 Warren, OH Rehabilitation hospital 2,417 15,857 1,737 — 2,417 17,594 20,011 3,150 — 1922 - 2000 May 1, 2017 46 Watsonville, CA Acute care general hospital 16,488 17,800 — — 16,488 17,800 34,288 2,126 — 1983 September 30, 2019 39 Webster, TX Long term acute care hospital 663 33,751 — — 663 33,751 34,414 10,126 — 2 |
SCHEDULE IV - MORTGAGE LOANS ON
SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE | 12 Months Ended |
Dec. 31, 2022 | |
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract] | |
SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE | SCHEDULE IV — MORTGAGE LOANS ON REAL ESTATE MEDICAL PROPERTIES TRUST, INC. AND MPT OPERATING PARTNERSHIP, L.P. December 31, 2022 Column A Column B Column C Column D Column E Column F Column G(1) Column H Description Interest Final Periodic Payment Prior Face Carrying Principal (Dollar amounts in thousands) Long-term first mortgage loan: Payable in monthly Colombia(4) 8.95 % 2035 (2 ) $ 117,360 $ 117,360 (3 ) Vibra 11.50 % 2024 (2 ) 7,986 7,986 (3 ) Prospect 7.96 % 2034 (2 ) 151,267 151,267 (3 ) Springstone 7.00 % 2041 (2 ) 22,900 22,900 (3 ) Infracore 4.20 % 2023 (2 ) 64,907 64,907 (3 ) $ 364,420 $ 364,420 (5 ) (1) The aggregate cost for federal income tax purposes is $ 364.4 million. (2) There were no prior liens on loans as of December 31, 2022. (3) Mortgage loans were not delinquent with respect to principal or interest, other than for two months of interest on the Prospect loan. (4) Mortgage loans covering three properties. (5) Excludes allowance for credit loss of $ 0.3 million at December 31, 2022. Changes in mortgage loans (excluding allowance for credit loss) for the years ended December 31, 2022, 2021, and 2020 are summarized as follows: Year Ended December 31, 2022 2021 2020 (Dollar amounts in thousands) Balance at beginning of year $ 213,320 $ 248,335 $ 1,274,995 Additions during year: New mortgage loans and additional advances on 177,924 1,128,695 (6) 193,590 Exchange rate fluctuations ( 15,824 ) ( 3,640 ) 9,785 375,420 1,373,390 1,478,370 Deductions during year: Collection of principal ( 11,000 ) ( 1,160,070 ) (6) ( 1,230,035 ) (7) ( 11,000 ) ( 1,160,070 ) ( 1,230,035 ) Balance at end of year $ 364,420 $ 213,320 $ 248,335 (6) Includes an £ 800 million mortgage loan advanced to Priory in the first quarter of 2021 that was redeemed as part of the acquisition of the underlying fee simple real estate in the second quarter of 2021 as more fully described in Note 3 to Item 8 of this Annual Report on Form 10-K. (7) Includes $ 835 million of mortgage loans that were used to acquire the underlying fee simple real estate as more fully described in Note 3 to Item 8 of this Annual Report on Form 10-K. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Use of Estimates | Use of Estimates: The preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We believe the estimates and assumptions underlying our consolidated financial statements at December 31, 2022 are reasonable and supportable based on the information available (particularly as it relates to our assessments of the recoverability of our real estate and the adequacy of our credit loss reserves on loans and financing receivables). Actual results could differ from those estimates. |
Principles of Consolidation | Principles of Consolidation: Property holding entities and other subsidiaries of which we own 100 % of the equity or have a controlling financial interest evidenced by ownership of a majority voting interest are consolidated. All inter-company balances and transactions are eliminated. For entities in which we own less than 100% of the equity interest, we consolidate the property if we have the direct or indirect ability to control the entities’ activities based upon the terms of the respective entities’ ownership agreements. For these entities, we record a non-controlling interest representing equity held by non-controlling interests. We continually evaluate all of our transactions and investments to determine if they represent variable interests in a variable interest entity. If we determine that we have a variable interest in a variable interest entity, we then evaluate if we are the primary beneficiary of the variable interest entity. The evaluation is a qualitative assessment as to whether we have the ability to direct the activities of a variable interest entity that most significantly impact the entity’s economic performance. We consolidate each variable interest entity in which we, by virtue of or transactions with our investments in the entity, are considered to be the primary beneficiary. At December 31, 2022, we had loans and/or equity investments in certain variable interest entities approximating $ 633 million, which represents our maximum exposure to loss as a result of our involvement in such entities. We have determined that we were not the primary beneficiary of any variable interest entity in which we hold a variable interest because we do not control the activities (such as the day-to-day operations) that most significantly impact the economic performance of these entities. |
Investments in Unconsolidated Entities | Investments in Unconsolidated Entities: Investments in entities in which we have the ability to significantly influence (but not control) are accounted for by the equity method. This includes the five investments in unconsolidated real estate joint ventures at December 31, 2022. Under the equity method of accounting, our share of the investee’s earnings or losses are included in the “Earnings from equity interests” line of our consolidated statements of net income. Except for our joint ventures with Primotop Holdings S.à.r.l. ("Primotop") and Macquarie Asset Management ("MAM") (for which we handle the accounting of), we have elected to record our share of such investee’s earnings or losses on a lag basis (not to exceed three months). The initial carrying value of investments in unconsolidated entities is based on the amount paid to purchase the interest in the investee entity. Subsequently, our investments are increased/decreased by our share in the investees’ earnings/losses and decreased by cash distributions from our investees. To the extent that our cost basis is different from the basis reflected at the investee entity level, the basis difference is generally amortized over the lives of the related assets and liabilities, and such amortization is included in our share of equity in earnings of the investee. We evaluate our equity method investments for impairment based upon a comparison of the fair value of the equity method investment to its carrying value, when impairment indicators exist. If we determine a decline in the fair value of an investment in an unconsolidated investee entity below its carrying value is other-than-temporary, an impairment is recorded. Investments in entities in which we do not control nor do we have the ability to significantly influence and for which there is no readily determinable fair value (such as our investment in Steward Health Care System LLC (“Steward”)) are accounted for at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions involving the investee. Cash distributions on these types of investments are recorded to either income upon receipt (if a return on investment) or as a reduction of our investment (if the distributions received are in excess of our share of the investee’s earnings). For similar investments but for which there are readily determinable fair values, such investments are measured at fair value, with unrealized gains and losses recorded in income. |
Cash and Cash Equivalents | Cash and Cash Equivalents: Certificates of deposit, short-term investments with original maturities of three months or less, and money-market mutual funds are considered cash equivalents. The majority of our cash and cash equivalents are held at major commercial banks, which at times may exceed the Federal Deposit Insurance Corporation limit. We have not experienced any losses to-date on our invested cash. Cash and cash equivalents which have been restricted as to its use are recorded in other assets. |
Revenue Recognition | Revenue Recognition: Our revenues are primarily from leases and loans. For leases, we follow Accounting Standards Update (“ASU”) 2016-02, “Leases”, (“ASU 2016-02”). ASU 2016-02 sets out the principles for the recognition, measurement, presentation, and disclosure of leases for both parties to a contract (i.e. lessees and lessors). For lessors, we apply this standard as follows: Operating Lease Revenue We receive income from operating leases based on the fixed required rents (base rents) per the lease agreements. Rent revenue from base rents is recorded on the straight-line method, when collectability of the lease payments is deemed probable, over the terms of the related lease agreements for new leases and the remaining terms of existing leases for those acquired as part of a property acquisition. The straight-line method records the periodic average amount of base rents earned over the term of a lease, taking into account contractual rent increases over the lease term. The straight-line method typically has the effect of recording more rent revenue from a lease than a tenant is required to pay early in the term of the lease. During the later parts of a lease term, this effect reverses with less rent revenue recorded than a tenant is required to pay. Rent revenue, as recorded on the straight-line method, in our consolidated statements of net income is presented as two amounts: rent billed and straight-line rent. Rent billed revenue is the amount of base rent actually billed to our tenants each period as required by the lease. Straight-line rent revenue is the difference between rent revenue earned based on the straight-line method and the amount recorded as rent billed revenue. We record the difference between rent revenues earned and amounts due per the respective lease agreements, as applicable, as an increase or decrease to straight-line rent receivables. Rental payments received prior to their recognition as income are classified as deferred revenue. Financing Lease Revenue Under ASU 2016-02, if an acquisition and subsequent lease of a property back to the seller does not meet the definition of a sale, we must account for the transaction as a financing lease with income recognized using the imputed interest method. Another type of financing lease is a direct financing lease (“DFL”). For leases accounted for as DFLs, the future minimum lease payments are recorded as a receivable at lease inception, while, the difference between the future minimum lease payments and the estimated residual values less the cost of the properties is recorded as unearned income. Unearned income is deferred and amortized to income over the lease term to provide a constant yield when collectability of the lease payments is reasonably assured. Investments in DFLs are presented net of unearned income. Other Leasing Revenue We begin recording base rent income from our development projects when the lessee takes physical possession of the facility, which may be different from the stated start date of the lease. Also, during construction of our development projects, we may be entitled to accrue rent based on the cost paid during the construction period (construction period rent). We accrue construction period rent as a receivable with a corresponding offset to deferred revenue during the construction period. When the lessee takes physical possession of the facility, we begin recognizing the deferred construction period revenue on the straight-line method over the term of the lease. We also receive additional rent (contingent rent) under some leases based on increases in the consumer price index (“CPI”) (or similar index outside the U.S.) or when CPI exceeds the annual minimum percentage increase as stipulated in the lease. Contingent rents are recorded as rent billed revenue in the period earned. Tenant payments for ground leases along with other operating expenses, such as property taxes and insurance, that are paid directly by us and reimbursed by our tenants are presented on a gross basis with the related revenues recorded in “Interest and other income” and the related expenses in “Property-related” in our consolidated statements of net income. All payments of other operating expenses made directly by the tenant to the applicable government or appropriate third-party vendor are recorded on a net basis. Interest Revenue We receive interest income from our tenants/borrowers on mortgage loans, working capital loans, and other long-term loans. Interest income from these loans is recognized as earned based upon the principal outstanding and terms of the loans. Other Revenue Commitment fees received from lessees for development and leasing services are initially recorded as deferred revenue and recognized as income over the initial term of a lease to produce a constant effective yield on the lease (interest method). Commitment and origination fees from lending services are also recorded as deferred revenue initially and recognized as income over the life of the loan using the interest method. |
Acquired Real Estate Purchase Price Allocation | Acquired Real Estate Purchase Price Allocation: We account for acquisitions of real estate under asset acquisition accounting rules. Under this accounting standard, we allocate the purchase price (including any third-party transaction costs directly related to the acquisition) of acquired properties to tangible and identified intangible assets acquired and liabilities assumed (if any) based on their relative fair values. In making estimates of fair values for purposes of allocating purchase prices of acquired real estate, we may utilize a number of sources, from time-to-time, including available real estate broker data, independent appraisals that may be obtained in connection with the acquisition, internal data from previous acquisitions or developments, and other market data, including market comparables for significant assumptions such as market rental, capitalization, and discount rates. We also consider information obtained about each property as a result of our pre-acquisition due diligence, marketing, and leasing activities in estimating the fair value of the tangible and intangible assets acquired. We measure the aggregate value of lease intangible assets acquired based on the difference between (i) the property valued with new or in-place leases adjusted to market rental rates and (ii) the property valued as if vacant. Management’s estimates of value are made using methods similar to those used by independent appraisers (e.g., discounted cash flow analysis). Factors considered by management in our analysis include an estimate of carrying costs during hypothetical expected lease-up periods, considering current market conditions, and costs to execute similar leases. We also consider information obtained about each targeted facility as a result of our pre-acquisition due diligence, marketing, and leasing activities in estimating the fair value of the intangible assets acquired. In estimating carrying costs, management includes real estate taxes, insurance, and other operating expenses and estimates of lost rentals at market rates during the expected lease-up periods, which we expect to be about six months , but can be longer depending on specific local market conditions. Management also estimates costs to execute similar leases including leasing commissions, legal costs, and other related expenses to the extent that such costs are not already incurred in connection with a new lease origination as part of the transaction. Other intangible assets acquired may include customer relationship intangible values which are based on management’s evaluation of the specific characteristics of each prospective tenant’s lease and our overall relationship with that tenant. Characteristics to be considered by management in allocating these values include the nature and extent of our existing business relationships with the tenant, growth prospects for developing new business with the tenant, the tenant’s credit quality, and expectations of lease renewals, including those existing under the terms of the lease agreement, among other factors. We amortize the value of our lease intangible assets to expense over the term of the respective leases. If a lease is terminated early, the unamortized portion of the lease intangibles are charged to expense. We record above-market and below-market in-place lease values, if any, for our facilities, which are based on the present value of the difference between (i) the contractual amounts to be paid pursuant to the in-place leases and (ii) management’s estimate of fair market lease rates for the corresponding in-place leases, measured over a period equal to the remaining non-cancelable term of the lease. We amortize any resulting capitalized above-market lease values as a reduction of rental income over the lease term. We amortize any resulting capitalized below-market lease values as an increase to rental income over the lease term. If a lease is terminated early, the unamortized portion of the capitalized above/below market lease value is recognized in rental income at that time. |
Real Estate and Depreciation | Real Estate and Depreciation: Real estate, consisting of land, buildings and improvements, is maintained at cost. Although typically paid by our tenants, any expenditure for ordinary maintenance and repairs that we pay are expensed to operations as incurred. Significant renovations and improvements, which improve and/or extend the useful life of the asset, are capitalized and depreciated over their estimated useful lives. We record impairment losses on long-lived assets used in operations when events and circumstances indicate that the assets might be impaired and the undiscounted cash flows estimated to be generated by those assets, including an estimated liquidation amount, during the expected holding periods are less than the carrying amounts of those assets. Impairment losses are measured as the difference between carrying value and fair value of the assets. For assets held for sale, we cease recording depreciation expense and adjust the assets’ value to the lower of its carrying value or fair value, less cost of disposal. Fair value is based on estimated cash flows discounted at a risk-adjusted rate of interest. We classify real estate assets as held for sale when we have commenced an active program to sell the assets, and in the opinion of management, it is probable the asset will be sold within the next 12 months. Construction in progress includes the cost of land, the cost of construction of buildings, improvements, and fixed equipment, and costs for design and engineering. Other costs, such as interest, legal, property taxes, and corporate project supervision, which can be directly associated with the project during construction, are also included in construction in progress. We commence capitalization of costs associated with a development project when the development of the future asset is probable and activities necessary to get the underlying property ready for its intended use have been initiated. We stop the capitalization of costs when the property is substantially complete and ready for its intended use. Depreciation is calculated on the straight-line method over the estimated useful lives of the related real estate and other assets. Our weighted-average useful lives at December 31, 2022 are as follows: Buildings and improvements 39.0 years Lease intangibles 26.8 years Leasehold improvements 14.4 years Furniture, equipment, and other 9.8 years |
Losses from Rent Receivables | Credit Losses: Losses from Rent Receivables: For all leases, we continuously monitor the performance of our existing tenants including, but not limited to: admission levels and surgery/procedure volumes by type; current operating margins; ratio of our tenant's operating margins both to facility rent and to facility rent plus other fixed costs; trends in revenue, cash collections, patient mix; and the effect of evolving healthcare regulations, adverse economic and political conditions, such as rising inflation and interest rates, and other events ongoing on a tenant's profitability and liquidity. Losses from Operating Lease Receivables: We utilize the information above along with the tenant’s payment and default history in evaluating (on a property-by-property basis) whether or not a provision for losses on outstanding billed rent and/or straight-line rent receivables is needed. A provision for losses on rent receivables (including straight-line rent receivables) is ultimately recorded when it becomes probable that the receivable will not be collected in full. The provision is an amount which reduces the receivable to its estimated net realizable value based on a determination of the eventual amounts to be collected either from the debtor or from existing collateral, if any. Losses on Financing Lease Receivables: We apply a forward-looking “expected credit loss” model to all of our financing receivables, including financing leases and loans. To do this, we have grouped our financial instruments into two primary pools of similar credit risk: secured and unsecured. The secured instruments include our investments in financing receivables as all are secured by the underlying real estate, among other collateral. Within the two primary pools, we further grouped our instruments into sub-pools based on several tenant/borrower characteristics, including years of experience in the healthcare industry and in a particular market or region and overall capitalization. We then determined a credit loss percentage per pool based on our history over a period of time that closely matches the remaining terms of the financial instruments being analyzed and adjusted as needed for current trends or unusual circumstances. We have applied these credit loss percentages to the book value of the related instruments to establish a credit loss reserve on our financing lease receivables and such credit loss reserve (including the underlying assumptions) is reviewed and adjusted quarterly. If a financing receivable is under performing and is deemed uncollectible based on the lessee’s overall financial condition, we will adjust the credit loss reserve based on the fair value of the underlying collateral. We made the accounting policy election to exclude interest receivables from the credit loss reserve model. Instead, such receivables are impaired and an allowance recorded when it is deemed probable that we will be unable to collect all amounts due. Like operating lease receivables, the need for an allowance is based upon our assessment of the lessee’s overall financial condition, economic resources and payment record, the prospects for support from any financially responsible guarantors, and, if appropriate, the realizable value of any collateral. Financing leases are placed on non-accrual status when we determine that the collectability of contractual amounts is not reasonably assured. If on non-accrual status, we generally account for the financing lease on a cash basis, in which income is recognized only upon receipt of cash. |
Loans | Loans : Loans consist of mortgage loans, working capital loans, and other loans. Mortgage loans are collateralized by interests in real property. Working capital and other loans are typically collateralized by interests in receivables and corporate and individual guarantees. We record loans at cost. Like our financing lease receivables, we establish credit loss reserves on all outstanding loans based on historical credit losses of similar instruments. Such credit loss reserves, including the underlying assumptions, are reviewed and adjusted quarterly. If a loan’s performance worsens and foreclosure is deemed probable for our collateral-based loans (after considering the borrower’s overall financial condition as described above for leases), we will adjust the allowance for expected credit losses based on the current fair value of such collateral at the time the loan is deemed uncollectible. If the loan is not collateralized, the loan will be reserved for/written-off once it is determined that such loan is no longer collectible. Interest receivables on loans are excluded from the forward looking credit loss reserve model; however, we assess their collectability similar to how we assess collectability for interest receivables on financing leases described above. The following table summarizes our credit loss reserves (in thousands): December 31, 2022 December 31, 2021 Balance at beginning of the year $ 48,527 $ 8,726 Provision (recovery) for credit loss, net 99,009 41,710 Expected credit loss reserve related to financial instruments sold, ( 26,390 ) ( 1,909 ) Balance at end of year $ 121,146 $ 48,527 |
Earnings Per Share/Units | Earnings Per Share/Units: Basic earnings per common share/unit is computed by dividing net income by the weighted-average number of shares/units outstanding during the period. Diluted earnings per common share/unit is calculated by including the effect of dilutive securities. Our unvested restricted stock awards contain non-forfeitable rights to dividends, and accordingly, these awards are deemed to be participating securities. These participating securities are included in the earnings allocation in computing both basic and diluted earnings per common share/unit. |
Income Taxes | Income Taxes: We conduct our business as a REIT under Sections 856 through 860 of the Internal Revenue Code of 1986, as amended (“the Code”). To qualify as a REIT, we must meet certain organizational and operational requirements, including a requirement to distribute to stockholders at least 90 % of our REIT’s ordinary taxable income. As a REIT, we generally pay little U.S. federal and state income tax because of the dividends paid deduction that we are allowed to take. If we fail to qualify as a REIT in any taxable year, we will then be subject to U.S. federal income taxes on our taxable income at regular corporate rates and will not be permitted to qualify for treatment as a REIT for federal income tax purposes for four years following the year during which qualification is lost, unless the Internal Revenue Service grants us relief under certain statutory provisions. Such an event could materially adversely affect our net income and net cash available for distribution to stockholders. However, we intend to operate in such a manner so that we will remain qualified as a REIT for U.S. federal income tax purposes. Our financial statements include the operations of TRS entities. None of our TRS entities are entitled to a dividends paid deduction and are subject to U.S. federal, state, and local income taxes. Our TRS entities are authorized to provide property development, leasing, and management services for third-party owned properties, and we will make non-mortgage loans to and/or investments in our lessees through these entities. With the property acquisitions and investments in Europe, Australia, and South America, we are subject to income taxes internationally. However, we do not expect to incur any additional income taxes, of a significant nature, in the U.S. as the majority such income from our international properties flows through our REIT income tax returns. For our TRS entities and international subsidiaries, we determine deferred tax assets and liabilities based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Any increase or decrease in our deferred tax assets/liabilities that results from a change in circumstances and that causes us to change our judgment about expected future tax consequences of events, is reflected in our tax provision when such changes occur. Deferred income taxes also reflect the impact of operating loss carryforwards. A valuation allowance is provided if we believe it is more likely than not that all or some portion of our deferred tax assets will not be realized. Any increase or decrease in the valuation allowance that results from a change in circumstances, and that causes us to change our judgment about our ability to realize the related deferred tax asset, is reflected in our tax provision when such changes occur. The calculation of our income taxes involves dealing with uncertainties in the application of complex tax laws and regulations in a multitude of jurisdictions across our global operations. An income tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, on the basis of technical merits. However, if a more likely than not position cannot be reached, we record a liability as an offset to the tax benefit and adjust the liabilities when our judgment changes as a result of the evaluation of new information not previously available. Because of the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from our current estimate of the uncertain tax position liabilities. These differences will be reflected as increases or decreases to income tax expense in the period in which new information is available. |
Stock-Based Compensation | Stock-Based Compensation: We adopted the 2019 Equity Incentive Plan (the “Equity Incentive Plan”) during the second quarter of 2019, which was amended during the second quarter of 2022. Awards of restricted stock and other equity-based awards with service conditions are valued at the average stock price per share on the date of grant and are amortized to compensation expense over the service periods (typically three years ), using the straight-line method. Awards that contain market conditions are valued on the grant date using a Monte Carlo valuation model and are amortized to compensation expense over the derived service periods, which correspond to the periods over which we estimate the awards will be earned, which generally range from three to five years , using the straight-line method. Awards with performance conditions are valued at the average stock price per share on the date of grant and are amortized using the straight-line method over the service period, adjusted for the probability of achieving the performance conditions. Forfeitures of stock-based awards are recognized as they occur. |
Deferred Costs | Deferred Costs: Costs incurred that directly relate to the offerings of stock are deferred and netted against proceeds received from the offering. Leasing commissions and other third-party leasing costs that would not have been incurred if the lease was not obtained are capitalized as deferred leasing costs and amortized on the straight-line method over the terms of the related lease agreements. Costs identifiable with loans made to borrowers are capitalized and recognized as a reduction in interest income over the life of the loan. |
Deferred Financing Costs | Deferred Financing Costs: We generally capitalize financing costs incurred in connection with new financings and refinancings of debt. These costs are amortized over the lives of the related debt as an addition to interest expense. For debt with defined principal re-payment terms, the deferred costs are amortized to produce a constant effective yield on the debt (interest method) and are included within “Debt, net” on our consolidated balance sheets. For debt without defined principal repayment terms, such as our revolving credit facility, the deferred costs are amortized on the straight-line method over the term of the debt and are included as a component of “Other assets” on our consolidated balance sheets. |
Foreign Currency Translation and Transactions | Foreign Currency Translation and Transactions: Certain of our international subsidiaries’ functional currencies are the local currencies of their respective countries. We translate the results of operations of our foreign subsidiaries into U.S. dollars using average rates of exchange in effect during the period, and we translate balance sheet accounts using exchange rates in effect at the end of the period. We record resulting currency translation adjustments in accumulated other comprehensive income (loss), a component of stockholders’ equity/partnership capital on our consolidated balance sheets. Certain of our U.S. subsidiaries will enter into short-term and long-term transactions denominated in a foreign currency from time-to-time. Gains or losses resulting from these foreign currency transactions are revalued into U.S. dollars at the rates of exchange prevailing at the dates of the transactions. The effects of revaluation gains or losses on our short-term transactions are included in other income (expense) in the consolidated statements of income, while the revaluation effects on our long-term investments are recorded in accumulated other comprehensive income (loss) on our consolidated balance sheets. |
Derivative Financial Investments and Hedging Activities | Derivative Financial Investments and Hedging Activities: During our normal course of business, we may use certain types of derivative instruments for the purpose of managing interest rate and/or foreign currency risk. We record our derivative and hedging instruments at fair value on the balance sheet. Changes in the estimated fair value of derivative instruments that are not designated as hedges or that do not meet the criteria for hedge accounting are recognized in earnings. For derivatives designated as cash flow hedges, the change in the estimated fair value of the effective portion of the derivative is recognized in accumulated other comprehensive income (loss) on our consolidated balance sheets, whereas the change in the estimated fair value of the ineffective portion is recognized in earnings. For derivatives designated as fair value hedges, the change in the estimated fair value of the effective portion of the derivatives offsets the change in the estimated fair value of the hedged item, whereas the change in the estimated fair value of the ineffective portion is recognized in earnings. To qualify for hedge accounting, we formally document all relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking the hedge prior to entering into a derivative transaction. This process includes specific identification of the hedging instrument and the hedge transaction, the nature of the risk being hedged and how the hedging instrument’s effectiveness in hedging the exposure to the hedged transaction’s variability in cash flows attributable to the hedged risk will be assessed. Both at the inception of the hedge and on an ongoing basis, we assess whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in cash flows or fair values of hedged items. In addition, for cash flow hedges, we assess whether the underlying forecasted transaction will occur. We discontinue hedge accounting if a derivative is not determined to be highly effective as a hedge or that it is probable that the underlying forecasted transaction will not occur. |
Fair Value Measurement | Fair Value Measurement: We measure and disclose the estimated fair value of financial assets and liabilities utilizing a hierarchy of valuation techniques based on whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy: • Level 1 — quoted prices for identical instruments in active markets; • Level 2 — quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and • Level 3 — fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable . We measure fair value using a set of standardized procedures that are outlined herein for all assets and liabilities which are required to be measured at their estimated fair value on either a recurring or non-recurring basis. When available, we utilize quoted market prices from an independent third party source to determine fair value and classify such items in Level 1. In some instances where a market price is available, but the instrument is in an inactive or over-the-counter market, we apply the dealer (market maker) pricing estimate and classify the asset or liability in Level 2. If quoted market prices or inputs are not available, fair value measurements are based upon valuation models that utilize current market or independently sourced market inputs, such as interest rates, option volatilities, credit spreads, market capitalization rates, etc. Items valued using such internally-generated valuation techniques are classified according to the lowest level input that is significant to the fair value measurement. As a result, the asset or liability could be classified in either Level 2 or 3 even though there may be some significant inputs that are readily observable. Internal fair value models and techniques that have been used by us include discounted cash flow and Monte Carlo valuation models. We also consider counterparty’s and our own credit risk on derivatives and other liabilities measured at their estimated fair value. Fair Value Option Election: For our equity investment in the international joint venture and equity interest in Springstone Health Opco, LLC (“Springstone”), along with any related investments such as loans (see Note 3 for more details), we have elected to account for these investments at fair value due to the size of the investments and because we believe this method is more reflective of current values. We have not made a similar election for other investments that exist at December 31, 2022 . |
Leases (Lessee) | Leases (Lessee) Pursuant to ASU 2016-02, we are required to apply a dual approach, classifying leases (in which we are the lessee) as either financing or operating leases based on the principle of whether or not the lease is effectively a financed purchase. This classification determines whether lease expense is recognized based on an effective interest method (for finance leases) or on a straight-line basis (for operating leases) over the term of the lease. We record a right-of-use asset and a lease liability for all material leases with a term greater than 12 months regardless of their classification. Leases with a term of 12 months or less are off balance sheet with lease expense recognized on a straight-line basis over the lease term. |
Reclassification | Reclassifications: Certain amounts in the consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. For the year ended December 31, 2021, $ 39.4 million has been reclassified from "Other (including fair value adjustments on securities)" to "Real estate and other impairment charges, net" in our consolidated statements of Net Income. There is no impact to net income. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Accounting Policies [Abstract] | |
Estimated Useful Lives of Related Real Estate and Other Assets | Depreciation is calculated on the straight-line method over the estimated useful lives of the related real estate and other assets. Our weighted-average useful lives at December 31, 2022 are as follows: Buildings and improvements 39.0 years Lease intangibles 26.8 years Leasehold improvements 14.4 years Furniture, equipment, and other 9.8 years |
Summary of Credit Loss Reserves | The following table summarizes our credit loss reserves (in thousands): December 31, 2022 December 31, 2021 Balance at beginning of the year $ 48,527 $ 8,726 Provision (recovery) for credit loss, net 99,009 41,710 Expected credit loss reserve related to financial instruments sold, ( 26,390 ) ( 1,909 ) Balance at end of year $ 121,146 $ 48,527 |
Real Estate and Other Activit_2
Real Estate and Other Activities (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Real Estate [Abstract] | |
Net Assets Acquired | For the years ended December 31, 2022, 2021, and 2020, we acquired or invested in the following net assets (in thousands): 2022 2021 2020 Land and land improvements $ 135,301 $ 642,312 $ 365,281 Buildings 487,698 2,381,654 2,547,313 Intangible lease assets — subject to amortization 21.3 years in 2022, 34.5 years in 2021, and 27.5 years in 2020) 45,394 262,385 642,699 Investment in financing leases — — 114,797 Mortgage loans(1)(2) 159,735 1,113,300 176,840 Investments in unconsolidated real estate joint ventures 399,456 — 233,593 Investments in unconsolidated operating entities 131,105 1,033,096 205,000 Other loans — — 103,195 Other assets — — 1,328 Liabilities assumed ( 25,727 ) ( 82,508 ) ( 140,866 ) $ 1,332,962 $ 5,350,239 $ 4,249,180 Loans repaid(1) — ( 1,103,410 ) ( 834,743 ) Total net assets acquired $ 1,332,962 $ 4,246,829 $ 3,414,437 (1) The 2021 column includes an £ 800 million mortgage loan advanced to the Priory Group (“Priory”) in the first quarter of 2021 and converted to fee simple ownership of 35 properties in the second quarter of 2021 as described below. The 2020 column includes approximately $ 740 million of loans advanced to Steward in 2017 and exchanged for the fee simple real estate of two hospitals as described below, as well as approximately $ 100 million of loans advanced to Ernest Health, Inc. (“Ernest”) in 2012 and exchanged for the fee simple real estate of four hospitals as described below. (2) In the 2022 second quarter, we increased our mortgage loan to Prospect Medical Holdings, Inc. ("Prospect") that was originated in 2019 and that is secured by a first lien on a California hospital. The loan bears interest at a current market rate plus a component of additional interest upon repayment. |
Summary of Status on Current Development Projects | See table below for a status summary of our current development projects (in thousands): Property Commitment Costs Estimated Rent Ernest (Stockton, California) $ 47,700 $ 45,739 1Q 2023 IMED (Spain) 50,411 13,037 2Q 2023 Ernest (South Carolina) 22,400 7,541 2Q 2023 IMED (Spain) 45,408 33,801 3Q 2023 Springstone (Texas) 34,600 1,962 1Q 2024 IMED (Spain) 36,734 8,320 3Q 2024 Steward (Texas) 169,408 57,020 1Q 2026 $ 406,661 $ 167,420 |
Summary of Operating Results from Properties | The properties sold during 2022 do not meet the definition of discontinued operations. However, the following represents the operating results from these properties for the periods presented (in thousands): For the Year Ended December 31, 2022 2021 2020 Revenues(1) $ 17,831 $ 180,549 $ 174,362 Real estate depreciation and amortization(2) ( 4,683 ) ( 28,579 ) ( 38,059 ) Property-related expenses ( 1,588 ) ( 5,065 ) ( 12,509 ) Other income(3) 536,813 181 1,228 Income from real estate dispositions, net $ 548,373 $ 147,086 $ 125,022 (1) Includes approximately $ 42 million of straight-line rent and other write-offs associated with the non-Macquarie disposal transactions for the year ended December 31, 2022. (2) Lower in 2022 as we stopped depreciating the properties making up the Macquarie Transaction once deemed held for sale in September 2021. (3) Includes $ 536.8 million of gains (net of $ 125 million write-off of straight-line rent receivables related to the Macquarie Transaction) for the year ended December 31, 2022. |
Amortization Expense from Existing Lease Intangible Assets | We recorded amortization expense related to intangible lease assets of $ 55.9 million, $ 56.0 million, and $ 42.4 million in 2022, 2021, and 2020, respectively, and expect to recognize amortization expense from existing lease intangible assets as follows (amounts in thousands): For the Year Ended December 31: 2023 $ 56,740 2024 56,683 2025 56,535 2026 56,266 2027 55,932 |
Summary of Total Future Minimum Lease Payments to be Received | The following table summarizes total future minimum lease payments to be received, excluding operating expense reimbursements, from tenants under noncancelable leases as of December 31, 2022 (amounts in thousands): Total Under Total Under Total 2023 $ 984,353 $ 161,079 $ 1,145,432 2024 1,001,456 164,357 1,165,813 2025 1,016,367 167,701 1,184,068 2026 1,031,717 171,112 1,202,829 2027 1,048,409 174,591 1,223,000 Thereafter 25,851,987 4,376,304 30,228,291 $ 30,934,289 $ 5,215,144 $ 36,149,433 |
Components of Total Investment in Financing Leases | The components of our total investment in financing leases consisted of the following (in thousands): As of December 31, 2022 As of December 31, 2021 Minimum lease payments receivable $ 880,253 $ 1,183,855 Estimated unguaranteed residual values 203,818 203,818 Less: Unearned income and allowance for credit loss ( 731,915 ) ( 918,584 ) Net investment in direct financing leases 352,156 469,089 Other financing leases (net of allowance for credit loss) 1,339,167 1,584,238 Total investment in financing leases $ 1,691,323 $ 2,053,327 |
Summary of Investments in Unconsolidated Operating Entities | The following is a summary of our investments in unconsolidated real estate joint ventures by operator (amounts in thousands): Operator Ownership Percentage As of December 31, 2022 As of December 31, 2021 MEDIAN 50 % $ 482,735 $ 517,648 Swiss Medical Network 70 % 454,083 476,193 Steward (Macquarie Transaction) 50 % 417,701 — Policlinico di Monza 50 % 86,245 95,468 HM Hospitales 45 % 57,139 63,618 Total $ 1,497,903 $ 1,152,927 The following is a summary of our investments in unconsolidated operating entities (amounts in thousands): Operator As of December 31, As of December 31, Steward (loan investment) $ 362,831 $ 360,164 International joint venture 231,402 219,387 Springstone 200,827 187,450 Priory 156,575 42,315 Swiss Medical Network 157,145 159,208 Steward (equity investment) 125,862 139,000 Prospect 112,777 112,283 Aevis Victoria SA ("Aevis") 72,904 61,271 Aspris Children's Services ("Aspris") 16,023 8,356 Caremax 8,526 — Total $ 1,444,872 $ 1,289,434 |
Debt (Tables)
Debt (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Summary of Debt | The following is a summary of debt (dollar amounts in thousands): As of December 31, As of December 31, Revolving credit facility(A) $ 929,584 $ 730,000 Interim credit facility — 869,606 Term loan 200,000 200,000 British pound sterling term loan due 2024(B) 126,690 — British pound sterling term loan due 2025(B) 845,810 947,240 Australian term loan facility(B) 817,560 871,560 2.550 % Senior Unsecured Notes due 2023(B) 483,320 541,280 3.325 % Senior Unsecured Notes due 2025(B) 535,250 568,500 0.993 % Senior Unsecured Notes due 2026(B) 535,250 568,500 2.500 % Senior Unsecured Notes due 2026(B) 604,150 676,600 5.250 % Senior Unsecured Notes due 2026 500,000 500,000 5.000 % Senior Unsecured Notes due 2027 1,400,000 1,400,000 3.692 % Senior Unsecured Notes due 2028(B) 724,980 811,920 4.625 % Senior Unsecured Notes due 2029 900,000 900,000 3.375 % Senior Unsecured Notes due 2030(B) 422,905 473,620 3.500 % Senior Unsecured Notes due 2031 1,300,000 1,300,000 $ 10,325,499 $ 11,358,826 Debt issue costs and discount, net ( 57,087 ) ( 76,056 ) $ 10,268,412 $ 11,282,770 (a) Includes £ 90 million of GBP-denominated borrowings and € 253 million of Euro-denominated borrowings that reflect the exchange rate at December 31, 2022 . (b) Non-U.S. dollar denominated debt that reflects the exchange rate at period-end. |
Principal Payments Due on Debt | As of December 31, 2022, principal payments due on our debt (which exclude the effects of any discounts, premiums, or debt issue costs recorded) are as follows (amounts in thousands): 2023 $ 483,320 2024 944,250 2025 1,381,060 2026 2,568,984 2027 1,600,000 Thereafter 3,347,885 Total $ 10,325,499 |
Basic Terms of Senior Unsecured Notes | The following are the basic terms of our senior unsecured notes at December 31, 2022 (par value amounts in thousands): Offering Maturity Date Par Value % of Par Interest Payment Frequency 2.550% Senior Unsecured Notes due 2023 December 5, 2019 December 5, 2023 £ 400,000 100.000 % Annually 3.325% Senior Unsecured Notes due 2025 March 24, 2017 March 24, 2025 € 500,000 100.000 % Annually 0.993% Senior Unsecured Notes due 2026 October 6, 2021 October 15, 2026 € 500,000 100.000 % Annually 2.500% Senior Unsecured Notes due 2026 March 24, 2021 March 24, 2026 £ 500,000 99.937 % Annually 5.250% Senior Unsecured Notes due 2026 July 22, 2016 August 1, 2026 $ 500,000 100.000 % Semi-annually 5.000% Senior Unsecured Notes due 2027 September 7, 2017 October 15, 2027 $ 1,400,000 100.000 % Semi-annually 3.692% Senior Unsecured Notes due 2028 December 5, 2019 June 5, 2028 £ 600,000 99.998 % Annually 4.625% Senior Unsecured Notes due 2029 July 26, 2019 August 1, 2029 $ 900,000 99.500 % Semi-annually 3.375% Senior Unsecured Notes due 2030 March 24, 2021 April 24, 2030 £ 350,000 99.448 % Annually 3.500% Senior Unsecured Notes due 2031 December 4, 2020 March 15, 2031 $ 1,300,000 100.000 % Semi-annually |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Schedule of Income Tax Benefit (Expense) | From our TRS entities and our foreign operations, income tax (expense) benefit were as follows (in thousands): For the Years Ended December 31, 2022 2021 2020 Current income tax (expense) benefit: Domestic $ 1,111 $ ( 1,559 ) $ 63 Foreign ( 27,751 ) ( 18,964 ) ( 10,203 ) ( 26,640 ) ( 20,523 ) ( 10,140 ) Deferred income tax (expense) benefit: Domestic ( 15,628 ) 6,915 ( 10,680 ) Foreign ( 13,632 ) ( 60,340 ) ( 10,236 ) ( 29,260 ) ( 53,425 ) ( 20,916 ) Income tax (expense) $ ( 55,900 ) $ ( 73,948 ) $ ( 31,056 ) |
Summary of Reconciliation of Income Tax Benefit (Expense) from the Statutory Income Tax Rate to the Effective Tax Rate Based on Income before Income Taxes | A reconciliation of income tax (expense) benefit from the statutory income tax rate to the effective tax rate based on income before income taxes for the years ended December 31, 2022, 2021, and 2020 is as follows (in thousands): For the Years Ended December 31, 2022 2021 2020 Income before income tax $ 959,719 $ 730,888 $ 463,328 Income tax (expense) at the U.S. statutory federal rate ( 21 % in 2022, 2021, and 2020) ( 201,541 ) ( 153,486 ) ( 97,299 ) Decrease (increase) in income tax resulting from: Foreign rate differential 1,826 2,742 2,160 State income taxes, net of federal benefit ( 1,886 ) — 970 U.S. earnings not subject to federal income tax 165,705 132,266 82,921 Equity investments — — 380 Change in valuation allowance ( 11,281 ) ( 10,040 ) ( 8,514 ) Statutory tax rate change ( 941 ) ( 43,924 ) ( 9,471 ) Interest disallowance ( 1,737 ) ( 646 ) — Other items, net ( 6,045 ) ( 860 ) ( 2,203 ) Total income tax (expense) $ ( 55,900 ) $ ( 73,948 ) $ ( 31,056 ) |
Schedule of Deferred Tax Assets and Liabilities | At December 31, 2022 and 2021, components of our deferred tax assets and liabilities were as follows (in thousands): 2022 2021 Deferred tax assets: Operating loss and interest deduction carry forwards $ 175,922 $ 197,876 Other 15,218 1,815 Total deferred tax assets 191,140 199,691 Valuation allowance ( 71,499 ) ( 61,747 ) Total net deferred tax assets $ 119,641 $ 137,944 Deferred tax liabilities: Property and equipment $ ( 294,181 ) $ ( 320,546 ) Net unbilled revenue ( 63,324 ) ( 43,366 ) Partnership investments ( 26,268 ) ( 15,963 ) Other ( 27,153 ) ( 3,836 ) Total deferred tax liabilities ( 410,926 ) ( 383,711 ) Net deferred tax asset (liability) $ ( 291,285 ) $ ( 245,767 ) |
Schedule of Net NOL and Other Tax Attribute Carryforwards | At December 31, 2022, we had net NOL and other tax attribute carryforwards as follows (in thousands): U.S. Foreign Gross NOL carryforwards $ 148,900 $ 633,682 Tax-effected NOL carryforwards $ 24,013 $ 151,909 Valuation allowance ( 13,864 ) ( 57,635 ) Net deferred tax asset - NOL carryforwards $ 10,149 $ 94,274 Expiration periods 2024 - indefinite indefinite |
Schedule of Per Share Distributions to Stockholders | A schedule of per share distributions we paid and reported to our stockholders is set forth in the following: For the Years Ended December 31, Per share: 2022 2021 2020 Ordinary dividend (1) $ 0.4703 $ 0.7646 $ 0.6030 Long-term capital gain (2) 0.6797 0.1654 — Return of capital — 0.1800 0.4670 Total $ 1.1500 $ 1.1100 $ 1.0700 (1) For the years ended December 31, 2022, 2021, and 2020, includes Section 199A dividends of 0.4703 , 0.7646 , and 0.6030 , respectively. (2) For the years ended December 31, 2022, 2021, and 2020, includes Unrecaptured Section 1250 gains of 0.2574 , 0.0583 , and 0.0000 , respectively. |
Earnings Per Share_Unit (Tables
Earnings Per Share/Unit (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Earnings Per Share [Abstract] | |
Calculation of Earnings Per Share | Medical Properties Trust, Inc. Our earnings per share were calculated based on the following (amounts in thousands): For the Years Ended December 31, 2022 2021 2020 Numerator: Net income $ 903,819 $ 656,940 $ 432,272 Non-controlling interests’ share in earnings ( 1,222 ) ( 919 ) ( 822 ) Participating securities’ share in earnings ( 1,602 ) ( 2,161 ) ( 2,105 ) Net income, less participating securities’ share in $ 900,995 $ 653,860 $ 429,345 Denominator: Basic weighted-average common shares 598,634 588,817 529,239 Dilutive potential common shares 203 1,322 1,222 Diluted weighted-average common shares 598,837 590,139 530,461 MPT Operating Partnership, L.P. Our earnings per unit were calculated based on the following (amounts in thousands): For the Years Ended December 31, 2022 2021 2020 Numerator: Net income $ 903,819 $ 656,940 $ 432,272 Non-controlling interests’ share in earnings ( 1,222 ) ( 919 ) ( 822 ) Participating securities’ share in earnings ( 1,602 ) ( 2,161 ) ( 2,105 ) Net income, less participating securities’ share in $ 900,995 $ 653,860 $ 429,345 Denominator: Basic weighted-average units 598,634 588,817 529,239 Dilutive potential units 203 1,322 1,222 Diluted weighted-average units 598,837 590,139 530,461 |
Stock Awards (Tables)
Stock Awards (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Share-Based Payment Arrangement [Abstract] | |
Stock-based Award Activity | The following summarizes stock-based award activity in 2022 and 2021 (which includes awards granted in 2022, 2021, 2020, and any applicable prior years), respectively: For the Year Ended December 31, 2022: Vesting Based Vesting Based on Shares Weighted-Average Shares Weighted-Average Nonvested awards at beginning of the year 922,954 $ 20.26 5,477,536 $ 15.86 Awarded 659,393 $ 21.18 1,828,971 $ 18.45 Vested ( 750,854 ) $ 20.25 ( 2,924,722 ) $ 13.87 Forfeited ( 21,010 ) $ 20.06 ( 32,704 ) $ 19.17 Nonvested awards at end of year 810,483 $ 21.02 4,349,081 $ 18.26 For the Year Ended December 31, 2021: Vesting Based Vesting Based on Shares Weighted-Average Shares Weighted-Average Nonvested awards at beginning of the year 1,057,054 $ 18.79 5,086,983 $ 14.41 Awarded 651,113 $ 20.83 1,957,802 $ 17.94 Vested ( 781,076 ) $ 18.77 ( 1,551,482 ) $ 13.73 Forfeited ( 4,137 ) $ 18.69 ( 15,767 ) $ 16.72 Nonvested awards at end of year 922,954 $ 20.26 5,477,536 $ 15.86 |
Fair Value of Financial Instr_2
Fair Value of Financial Instruments (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Summary of Fair Value Information of Financial Instruments | The following table summarizes fair value estimates for our financial instruments (in thousands): December 31, 2022 December 31, 2021 Asset (Liability) Book Fair Book Fair Interest and rent receivables $ 167,035 $ 163,101 $ 56,229 $ 56,564 Loans(1) 1,405,615 (2) 1,360,113 991,609 (2) 991,954 Debt, net ( 10,268,412 ) ( 8,697,042 ) ( 11,282,770 ) ( 11,526,388 ) (1) Excludes the acquisition loan and mortgage loan made in October 2021 for our Springstone investment and the acquisition loan made in May 2020 related to our investment in the international joint venture, along with the related subsequent investment in the real estate of three hospitals in Colombia, as these assets are accounted for under the fair value option method, as noted below. (2) Includes $ 223.8 million and $ 70.1 million of mortgage loans, a $ 315.9 million and $ 335.6 million shareholder loan included in investments in unconsolidated real estate joint ventures, $ 640.4 million and $ 521.4 million of loans that are part of our investments in unconsolidated operating entities, and $ 225.5 million and $ 64.5 million of other loans at December 31, 2022 and 2021, respectively. |
Equity Interest in Related Party and Related Loans Measured at Fair Value on Recurring Basis | At December 31, 2022 and 2021, the amounts recorded under the fair value option method were as follows (in thousands): As of December 31, 2022 As of December 31, 2021 Asset (Liability) Fair Value Original Fair Value Original Asset Type Classification Mortgage loans $ 140,260 $ 140,260 $ 143,068 $ 143,068 Mortgage loans Equity investment and other loans 434,609 441,943 409,638 409,638 Investments in unconsolidated |
Schedule of Effects of Movement in DLOM by Sensitivity Analysis by Using Basis Point Variations | The DLOM on our Springstone investment was 40 % at December 31, 2022. In arriving at the DLOM, we started with a DLOM range based on the results of studies supporting valuation discounts for other transactions or structures without a public market. To select the appropriate DLOM within the range, we then considered many qualitative factors, including the percent of control, the nature of the underlying investee’s business along with our rights as an investor pursuant to the operating agreement, the size of investment, expected holding period, number of shareholders, access to capital marketplace, etc. To illustrate the effect of movements in the DLOM, we performed a sensitivity analysis below by using basis point variations (dollars in thousands): Basis Point Change in Marketability Discount Estimated Increase + 100 basis points $ ( 43 ) - 100 basis points 43 |
Leases (Lessee) (Tables)
Leases (Lessee) (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Leases [Abstract] | |
Summary of Lease Expense | The following is a summary of our lease expense (in thousands): Income Statement For the Years Ended December 31, Classification 2022 2021 Operating lease cost (1) (2) $ 12,175 $ 10,694 Finance lease cost: Amortization of right-of-use assets Real estate depreciation and amortization 51 51 Interest on lease liabilities Interest 128 128 Sublease income Other ( 4,485 ) ( 4,466 ) Total lease cost $ 7,869 $ 6,407 (1) Includes short-term leases. (2) $ 5.7 million and $ 6.3 million included in “Property-related”, with the remainder reflected in the “General and administrative” line of our consolidated statements of net income for 2022 and 2021, respectively. |
Schedule Of Future Minimum Rental Payments For Leases Sublease Receivable And Net Payments | Fixed minimum payments due over the remaining lease term under non-cancelable leases of more than one year and amounts to be received in the future from non-cancelable subleases over their remaining lease term at December 31, 2022 are as follows (amounts in thousands): Operating Leases Finance Leases Amounts To Net 2023 $ 8,742 $ 129 $ ( 4,416 ) $ 4,455 2024 8,880 130 ( 4,272 ) 4,738 2025 8,289 131 ( 4,328 ) 4,092 2026 7,884 133 ( 4,021 ) 3,996 2027 7,873 134 ( 3,730 ) 4,277 Thereafter 235,940 4,516 ( 65,320 ) 175,136 (1) Total undiscounted minimum lease payments $ 277,608 $ 5,173 $ ( 86,087 ) $ 196,694 Less: interest ( 176,016 ) ( 3,235 ) Present value of lease liabilities $ 101,592 $ 1,938 (1) Reflects certain ground leases, in which we are the lessee, that have longer initial fixed terms than our existing sublease to our tenants. However, we would expect to either renew the related sublease, enter into a lease with a new tenant, or early terminate the ground lease to reduce or avoid any significant impact from such ground leases . |
Summary of Supplemental Balance Sheet Information | Supplemental balance sheet information is as follows (in thousands, except lease terms and discount rate): Balance Sheet December 31, December 31, Right of use assets: Operating leases - real estate Land $ 63,553 $ 68,616 Finance leases - real estate Land 1,734 1,785 Total real estate right of use assets $ 65,287 $ 70,401 Operating leases - corporate Other assets 26,225 7,458 Total right of use assets $ 91,512 $ 77,859 Lease liabilities: Operating leases Obligations to tenants and $ 101,592 $ 85,217 Financing leases Obligations to tenants and 1,938 1,937 Total lease liabilities $ 103,530 $ 87,154 Weighted-average remaining lease term: Operating leases 33.2 40.6 Finance leases 33.9 34.9 Weighted-average discount rate: Operating leases 6.1 % 6.4 % Finance leases 6.6 % 6.6 % |
Summary of Supplemental Cash Flow Information | The following is supplemental cash flow information (in thousands): For the Years Ended December 31, 2022 2021 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows used for operating leases $ 7,169 $ 7,330 Operating cash flows used for finance leases 128 126 Non-cash activities - Right-of-use assets obtained in exchange for lease Operating leases 23,066 1,120 |
Other Assets (Tables)
Other Assets (Tables) | 12 Months Ended |
Dec. 31, 2022 | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
Summary of Other Assets | The following is a summary of our other assets on our consolidated balance sheets (in thousands): As of December 31, 2022 2021 Debt issue costs, net(1) $ 12,036 $ 5,488 Other corporate assets 256,438 231,731 Prepaids and other assets 304,516 96,261 Total other assets $ 572,990 $ 333,480 (1) Relates to our revolving credit facility |
Organization - Additional Infor
Organization - Additional Information (Detail) | Dec. 31, 2022 Facility State Country |
Business Acquisition [Line Items] | |
Number of facilities | Facility | 444 |
Number of states | State | 31 |
Europe [Member] | |
Business Acquisition [Line Items] | |
Number of countries | 7 |
South America [Member] | |
Business Acquisition [Line Items] | |
Number of countries | 1 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Significant Accounting Policies [Line Items] | |||
Threshold ownership percentage for inter company balances and transactions elimination | 100% | ||
Loans and/or equity investments in variable interest entities | $ 633,000 | ||
Expected lease-up periods for estimating lost rentals, in months | 6 months | ||
Percentage of ordinary taxable income to be distributed for real estate investment trust qualification | 90% | 90% | 90% |
Number of years of federal income tax at corporate rates on failure to qualify as REIT | 4 years | ||
Real estate and other impairment charges | $ 268,375 | $ 39,411 | $ 19,006 |
Net income | $ 903,819 | $ 656,940 | $ 432,272 |
Time-Based Awards [Member] | |||
Significant Accounting Policies [Line Items] | |||
Stock award service period in years | 3 years | ||
Market Conditions Based Awards [Member] | Minimum [Member] | |||
Significant Accounting Policies [Line Items] | |||
Stock award service period in years | 3 years | ||
Market Conditions Based Awards [Member] | Maximum [Member] | |||
Significant Accounting Policies [Line Items] | |||
Stock award service period in years | 5 years |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies - Estimated Useful Lives of Related Real Estate and Other Assets (Detail) | 12 Months Ended |
Dec. 31, 2022 | |
Buildings and improvements [Member] | |
Property, Plant and Equipment [Line Items] | |
Weighted average useful lives of related real estate and other assets | 39 years |
Lease Intangibles [Member] | |
Property, Plant and Equipment [Line Items] | |
Weighted average useful lives of related real estate and other assets | 26 years 9 months 18 days |
Leasehold improvements [Member] | |
Property, Plant and Equipment [Line Items] | |
Weighted average useful lives of related real estate and other assets | 14 years 4 months 24 days |
Furniture, equipment and other [Member] | |
Property, Plant and Equipment [Line Items] | |
Weighted average useful lives of related real estate and other assets | 9 years 9 months 18 days |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies - Summary of Credit Loss Reserves (Detail) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Accounting Policies [Abstract] | ||
Balance at beginning of the year | $ 48,527 | $ 8,726 |
Provision (recovery) for credit loss, net | 99,009 | 41,710 |
Expected credit loss reserve related to financial instruments sold, repaid, or satisfied | (26,390) | (1,909) |
Balance at end of year | $ 121,146 | $ 48,527 |
Real Estate and Other Activit_3
Real Estate and Other Activities - Net Assets Acquired (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Business Acquisition [Line Items] | ||||
Total assets acquired | $ 1,332,962 | $ 5,350,239 | $ 4,249,180 | |
Liabilities assumed | (25,727) | (82,508) | (140,866) | |
Loans repaid | [1] | (1,103,410) | (834,743) | |
Total net assets acquired | 1,332,962 | 4,246,829 | 3,414,437 | |
Land and Land Improvements [Member] | ||||
Business Acquisition [Line Items] | ||||
Total assets acquired | 135,301 | 642,312 | 365,281 | |
Building [Member] | ||||
Business Acquisition [Line Items] | ||||
Total assets acquired | 487,698 | 2,381,654 | 2,547,313 | |
Intangible Lease Assets [Member] | ||||
Business Acquisition [Line Items] | ||||
Total assets acquired | 45,394 | 262,385 | 642,699 | |
Mortgage Loans [Member] | ||||
Business Acquisition [Line Items] | ||||
Total assets acquired | [1],[2] | 159,735 | 1,113,300 | 176,840 |
Investments in Financing Leases [Member] | ||||
Business Acquisition [Line Items] | ||||
Total assets acquired | 114,797 | |||
Equity Investments [Member] | ||||
Business Acquisition [Line Items] | ||||
Total assets acquired | 1,328 | |||
Other Loans and Assets [Member] | ||||
Business Acquisition [Line Items] | ||||
Total assets acquired | 103,195 | |||
Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures [Member] | ||||
Business Acquisition [Line Items] | ||||
Total assets acquired | 399,456 | 233,593 | ||
Investments In Unconsolidated Operating Entities [Member] | ||||
Business Acquisition [Line Items] | ||||
Total assets acquired | $ 131,105 | $ 1,033,096 | $ 205,000 | |
[1] The 2021 column includes an £ 800 million mortgage loan advanced to the Priory Group (“Priory”) in the first quarter of 2021 and converted to fee simple ownership of 35 properties in the second quarter of 2021 as described below. The 2020 column includes approximately $ 740 million of loans advanced to Steward in 2017 and exchanged for the fee simple real estate of two hospitals as described below, as well as approximately $ 100 million of loans advanced to Ernest Health, Inc. (“Ernest”) in 2012 and exchanged for the fee simple real estate of four hospitals as described below. In the 2022 second quarter, we increased our mortgage loan to Prospect Medical Holdings, Inc. ("Prospect") that was originated in 2019 and that is secured by a first lien on a California hospital. The loan bears interest at a current market rate plus a component of additional interest upon repayment. |
Real Estate and Other Activit_4
Real Estate and Other Activities - Net Assets Acquired (Parenthetical) (Detail) $ in Thousands, £ in Millions | 12 Months Ended | ||||||
Dec. 31, 2022 | Dec. 31, 2021 USD ($) | Dec. 31, 2020 USD ($) Hospital | Dec. 31, 2019 USD ($) Hospital | Jun. 30, 2021 Property | Mar. 31, 2021 GBP (£) | ||
Business Acquisition [Line Items] | |||||||
Weighted-average useful life of acquired intangible lease assets (in years) | 23 years 8 months 12 days | ||||||
Loans repaid | [1] | $ 1,103,410 | $ 834,743 | ||||
Ernest [Member] | |||||||
Business Acquisition [Line Items] | |||||||
Number of facilities acquired | Hospital | 4 | ||||||
Priory Group [Member] | |||||||
Business Acquisition [Line Items] | |||||||
Number of real estate assets acquired | Property | 35 | ||||||
Steward Health Care System LLC [Member] | |||||||
Business Acquisition [Line Items] | |||||||
Number of facilities acquired | Hospital | 2 | ||||||
Mortgage Loans [Member] | Ernest [Member] | |||||||
Business Acquisition [Line Items] | |||||||
Loans repaid | $ 100,000 | ||||||
Mortgage Loans [Member] | Priory Group [Member] | |||||||
Business Acquisition [Line Items] | |||||||
Loans repaid | £ | £ 800 | ||||||
Mortgage Loans [Member] | Steward Health Care System LLC [Member] | |||||||
Business Acquisition [Line Items] | |||||||
Loans repaid | $ 740,000 | ||||||
Intangible Lease Assets [Member] | |||||||
Business Acquisition [Line Items] | |||||||
Weighted-average useful life of acquired intangible lease assets (in years) | 21 years 3 months 18 days | 34 years 6 months | 27 years 6 months | ||||
[1] The 2021 column includes an £ 800 million mortgage loan advanced to the Priory Group (“Priory”) in the first quarter of 2021 and converted to fee simple ownership of 35 properties in the second quarter of 2021 as described below. The 2020 column includes approximately $ 740 million of loans advanced to Steward in 2017 and exchanged for the fee simple real estate of two hospitals as described below, as well as approximately $ 100 million of loans advanced to Ernest Health, Inc. (“Ernest”) in 2012 and exchanged for the fee simple real estate of four hospitals as described below. |
Real Estate and Other Activit_5
Real Estate and Other Activities - 2022 Activity - Additional Information) (Detail) $ in Thousands, € in Millions, £ in Millions, SFr in Millions | 3 Months Ended | 12 Months Ended | ||||||||||||||
Dec. 09, 2022 USD ($) Facility | Dec. 09, 2022 GBP (£) Facility | Jul. 29, 2022 USD ($) | Apr. 29, 2022 EUR (€) Facility | Apr. 25, 2022 USD ($) Facility | Apr. 18, 2022 Facility | Mar. 14, 2022 USD ($) Facility | Mar. 11, 2022 USD ($) Facility | Mar. 11, 2022 EUR (€) Facility | Feb. 16, 2022 GBP (£) | Dec. 29, 2020 CHF (SFr) | Dec. 31, 2021 USD ($) | Dec. 31, 2022 USD ($) Facility | Dec. 31, 2022 CHF (SFr) Facility | Dec. 31, 2021 USD ($) | Dec. 31, 2020 USD ($) | |
Business Acquisition [Line Items] | ||||||||||||||||
Investments in unconsolidated real estate joint ventures | $ 1,152,927 | $ 1,497,903 | $ 1,152,927 | |||||||||||||
Gain (loss) on real estate dispositions | (40,000) | 52,500 | $ (2,800) | |||||||||||||
Mortgage loan | 177,924 | 1,128,695 | 193,590 | |||||||||||||
Deferred income tax liabilities and other liabilities, incurred | $ 26,000 | |||||||||||||||
Acquisition loan | $ 5,350,239 | $ 1,332,962 | $ 5,350,239 | $ 4,249,180 | ||||||||||||
Syndicated Term Loan [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Purchase price of acquisition | £ | £ 96.5 | |||||||||||||||
Acquisition loan | £ | £ 100 | |||||||||||||||
Loan term | 6 years | |||||||||||||||
Percentage of discount on investment | 3.50% | |||||||||||||||
Variable interest rate | 8.30% | |||||||||||||||
General Acute Care Hospitals [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Number of facilities acquired | Facility | 2 | 6 | 6 | |||||||||||||
Purchase price of acquisition | $ 80,000 | |||||||||||||||
Infracore [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Purchase price of acquisition | SFr | SFr 206.5 | |||||||||||||||
Mortgage loan | SFr | SFr 60 | |||||||||||||||
Massachusetts-based General Acute Care Hospitals [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Proceeds from expected secured debt | $ 1,300,000 | |||||||||||||||
Gain (loss) on real estate dispositions | $ 600,000 | |||||||||||||||
Nonrecourse secured debt percentage of asset value | 55% | |||||||||||||||
Number of facilities acquired | Facility | 8 | |||||||||||||||
Purchase price of acquisition | $ 1,700,000 | |||||||||||||||
Lease extension expiration year | 2041 | |||||||||||||||
United Kingdom [Member] | Behavioral Health Facilities [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Number of facilities acquired | Facility | 6 | 6 | ||||||||||||||
Purchase price of acquisition | $ 286,000 | £ 233 | ||||||||||||||
Real estate financing by third party seller | £ | £ 105 | |||||||||||||||
Finland [Member] | General Acute Care Hospitals [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Number of facilities acquired | Facility | 4 | 4 | ||||||||||||||
Purchase price of acquisition | $ 194,000 | € 178 | ||||||||||||||
Spain [Member] | General Acute Care Hospitals [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Number of facilities acquired | Facility | 3 | 3 | 3 | |||||||||||||
Purchase price of acquisition | € | € 27 | |||||||||||||||
Arizona [Member] | General Acute Care Hospitals [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Number of facilities acquired | Facility | 1 | |||||||||||||||
Colombia [Member] | General Acute Care Hospitals [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Purchase price of acquisition | $ 26,000 | |||||||||||||||
Corporate Joint Venture [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Investments in unconsolidated real estate joint ventures | $ 400,000 | |||||||||||||||
Real Estate Partnership [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Percentage of equity investment | 50% | |||||||||||||||
Macquarie Asset Management [Member] | Massachusetts-based General Acute Care Hospitals [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Percentage of equity investment | 50% |
Real Estate and Other Activit_6
Real Estate and Other Activities - 2021 Activity - Additional Information (Detail) € in Millions, £ in Millions, SFr in Millions, $ in Millions | 12 Months Ended | |||||||||||||||||
Apr. 25, 2022 USD ($) Facility | Mar. 14, 2022 USD ($) Facility | Dec. 02, 2021 EUR (€) | Oct. 21, 2021 EUR (€) | Oct. 19, 2021 USD ($) | Aug. 01, 2021 USD ($) Hospital | Jul. 06, 2021 USD ($) Hospital | Jul. 06, 2021 GBP (£) Hospital | Jun. 25, 2021 GBP (£) Property | Jan. 19, 2021 GBP (£) | Nov. 25, 2020 GBP (£) | Dec. 31, 2022 Facility | Dec. 31, 2021 Hospital | Dec. 31, 2020 Hospital | Mar. 11, 2022 USD ($) | Jun. 30, 2021 Property | Apr. 16, 2021 CHF (SFr) | Jan. 08, 2021 USD ($) | |
Business Acquisition [Line Items] | ||||||||||||||||||
Deferred income tax liabilities and other liabilities, incurred | $ 26 | |||||||||||||||||
General Acute Care Hospitals [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | $ 80 | |||||||||||||||||
Number of facilities acquired | Facility | 2 | 6 | ||||||||||||||||
Swiss Medical Network [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Equity investment | SFr | SFr 145 | |||||||||||||||||
Massachusetts Based General Acute Care Hospitals [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | $ 1,700 | |||||||||||||||||
Nonrecourse Secured Debt Percentage Of Asset Value | 55% | |||||||||||||||||
Number of facilities acquired | Facility | 8 | |||||||||||||||||
Lease extension expiration year | 2041 | |||||||||||||||||
Acute Care Hospital [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | Hospital | 2 | |||||||||||||||||
United Kingdom [Member] | Acute Care Hospital [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | £ | £ 50 | |||||||||||||||||
Portugal [Member] | Acute Care Hospital [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | € | € 17.8 | |||||||||||||||||
Florida [Member] | General Acute Care Hospitals [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | $ 900 | |||||||||||||||||
Number of facilities acquired | Hospital | 5 | |||||||||||||||||
Los Angeles, California [Member] | Acute Care Hospital [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | Hospital | 4 | 4 | ||||||||||||||||
Los Angeles, California [Member] | On Campus Medical Office Buildings [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | Hospital | 2 | 2 | ||||||||||||||||
Los Angeles, California [Member] | Acute Care Hospital and On Campus Medical Office Buildings [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | $ 215 | |||||||||||||||||
Stirling, Scotland [Member] | Acute Care Hospital [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | £ | £ 15.6 | |||||||||||||||||
General Acute Hospital [Member] | Valencia, Spain [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | € | € 46 | |||||||||||||||||
Ownership interest | 50% | |||||||||||||||||
Priory Group [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of real estate assets acquired | Property | 35 | |||||||||||||||||
Deferred income tax liabilities and other liabilities, incurred | £ | £ 47.1 | |||||||||||||||||
Waterland Private Equity Fund VII C.V. [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of real estate assets acquired | Property | 35 | |||||||||||||||||
Payment for acquisition | £ | £ 800 | |||||||||||||||||
Purchase price of acquisition loan | £ | £ 250 | |||||||||||||||||
Waterland Private Equity Fund VII C.V. [Member] | United Kingdom [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | £ | £ 800 | |||||||||||||||||
Waterland Private Equity Fund VII C.V. [Member] | Waterland Private Equity Fund VII C.V. Affiliate [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Ownership interest | 9.90% | |||||||||||||||||
Springstone Inc. [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Purchase price of acquisition | $ 185 | |||||||||||||||||
Consideration of other transaction costs | 950 | |||||||||||||||||
Incurred deferred income tax liabilities | $ 8 | |||||||||||||||||
Steward Health Care System LLC [Member] | ||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||
Number of facilities acquired | Hospital | 2 | |||||||||||||||||
Other loan to affiliates | $ 335 |
Real Estate and Other Activit_7
Real Estate and Other Activities - 2020 Activity - Additional Information (Detail) $ in Thousands, € in Millions, £ in Millions, SFr in Millions | 12 Months Ended | |||||||||||||||
Dec. 29, 2020 CHF (SFr) | Dec. 18, 2020 GBP (£) Hospital | Dec. 17, 2020 USD ($) Hospital | Nov. 25, 2020 GBP (£) | Nov. 17, 2020 USD ($) Hospital | Aug. 13, 2020 USD ($) | Aug. 07, 2020 GBP (£) Hospital | Aug. 05, 2020 EUR (€) | Jul. 08, 2020 USD ($) Hospital | Jun. 16, 2020 RenewalOption | Jan. 08, 2020 GBP (£) Hospital | Dec. 31, 2022 USD ($) Hospital | Dec. 31, 2021 USD ($) Hospital | Dec. 31, 2020 USD ($) Hospital Facility | Jun. 24, 2020 CHF (SFr) | May 13, 2020 USD ($) | |
Business Acquisition [Line Items] | ||||||||||||||||
Term of lease extension, years | 5 years | |||||||||||||||
Acquisition loan | $ | $ 1,332,962 | $ 5,350,239 | $ 4,249,180 | |||||||||||||
Joint Venture Partner [Member] | Other Loans [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Acquisition loan | $ | $ 205,000 | |||||||||||||||
Steward [Member] | Joint Venture Partner [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Ownership interest | 49% | |||||||||||||||
Infracore [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Purchase price of acquisition | SFr | SFr 206.5 | |||||||||||||||
Secured loan | SFr | SFr 45 | |||||||||||||||
South Carolina [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Purchase price of acquisition | $ | 17,000 | |||||||||||||||
Net investment in lease | $ | $ 115,000 | |||||||||||||||
Investment in number of facilities | Facility | 5 | |||||||||||||||
Utah [Member] | Steward [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Number of facilities acquired | 2 | |||||||||||||||
Purchase price of acquisition | $ | $ 200,000 | |||||||||||||||
Utah [Member] | Steward [Member] | Davis and Jordan Valley Facilities [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Net investment in lease | $ | $ 950,000 | |||||||||||||||
Acute Care Hospital [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Number of facilities acquired | 2 | |||||||||||||||
Acute Care Hospital [Member] | United Kingdom [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Purchase price of acquisition | £ | £ 50 | |||||||||||||||
Lessor operating lease ground lease term | 999 years | |||||||||||||||
Acute Care Hospital [Member] | United Kingdom [Member] | BMI [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Number of facilities acquired | 30 | |||||||||||||||
Purchase price of acquisition | £ | £ 1,500 | |||||||||||||||
Unearned rent revenue | £ | £ 27.6 | |||||||||||||||
Initial fixed term of lease | 2050 | |||||||||||||||
Existence of option to extend | true | false | ||||||||||||||
Number of lease extension options | RenewalOption | 2 | |||||||||||||||
Term of lease extension, years | 5 years | |||||||||||||||
Lease extension options, description | two five-year renewal options | |||||||||||||||
Acute Care Hospital [Member] | South Carolina [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Number of facilities acquired | 1 | |||||||||||||||
Acute Care Hospital [Member] | California [Member] | Prime [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Purchase price of acquisition | $ | $ 300,000 | |||||||||||||||
Acute Care Hospital [Member] | Colombia [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Number of facilities acquired | 3 | |||||||||||||||
Purchase price of acquisition | $ | $ 135,000 | |||||||||||||||
Acute Care Hospital [Member] | Darlington, United Kingdom [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Number of facilities acquired | 1 | |||||||||||||||
Purchase price of acquisition | £ | £ 29.4 | |||||||||||||||
Inpatient Rehabilitation Hospital [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Purchase price of acquisition | $ | $ 58,000 | |||||||||||||||
Inpatient Rehabilitation Hospital [Member] | South Carolina [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Number of facilities acquired | 3 | |||||||||||||||
Inpatient Rehabilitation Hospital [Member] | Dahlen, Germany [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Number of facilities acquired | 3 | |||||||||||||||
Purchase price of acquisition | € | € 12.5 | |||||||||||||||
Inpatient Rehabilitation Hospital [Member] | Texas [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Number of facilities acquired | 1 | |||||||||||||||
Inpatient Rehabilitation Hospital [Member] | Indiana [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Number of facilities acquired | 1 | |||||||||||||||
Private Acute Care Hospital [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Number of facilities acquired | 1 | |||||||||||||||
Private Acute Care Hospital [Member] | Reading, United Kingdom [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Purchase price of acquisition | £ | £ 85 | |||||||||||||||
Inpatient Rehabilitation Hospital, Acute Care Hospital and Private Acute Care Hospital [Member] | ||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||
Purchase price of acquisition | $ | $ 300,000 |
Real Estate and Other Activit_8
Real Estate and Other Activities - Development Activities - Additional Information (Detail) $ in Thousands, € in Millions | 3 Months Ended | 12 Months Ended | |||||||
Apr. 29, 2022 Facility | Apr. 25, 2022 Facility | Jun. 30, 2020 Hospital | Dec. 31, 2022 USD ($) NewProject Facility | Dec. 31, 2021 USD ($) Hospital | Dec. 31, 2020 Hospital | Dec. 31, 2019 Hospital | Dec. 31, 2022 EUR (€) | Nov. 23, 2020 USD ($) | |
Business Acquisition [Line Items] | |||||||||
Number of development of new projects | NewProject | 5 | ||||||||
Total commitment | $ | $ 406,661 | ||||||||
Acute Care Hospital [Member] | |||||||||
Business Acquisition [Line Items] | |||||||||
Number of facilities acquired | 2 | ||||||||
Acute Care Hospital [Member] | Cayce, South Carolina [member] | |||||||||
Business Acquisition [Line Items] | |||||||||
Number of facilities acquired | 1 | ||||||||
Inpatient Rehabilitation Hospital [Member] | Cayce, South Carolina [member] | |||||||||
Business Acquisition [Line Items] | |||||||||
Number of facilities acquired | 3 | ||||||||
Ernest [Member] | |||||||||
Business Acquisition [Line Items] | |||||||||
Number of facilities acquired | 4 | ||||||||
Ernest [Member] | Cayce, South Carolina [member] | |||||||||
Business Acquisition [Line Items] | |||||||||
Total commitment | $ | $ 22,400 | ||||||||
General Acute Care Hospitals [Member] | |||||||||
Business Acquisition [Line Items] | |||||||||
Number of facilities acquired | Facility | 2 | 6 | |||||||
General Acute Care Hospitals [Member] | Spain [Member] | |||||||||
Business Acquisition [Line Items] | |||||||||
Number of facilities acquired | Facility | 3 | 3 | |||||||
Total commitment | € | € 120 | ||||||||
Springstone [Member] | McKinney, Texas [Member] | |||||||||
Business Acquisition [Line Items] | |||||||||
Total commitment | $ | $ 35,000 | ||||||||
Development Activities [Member] | Acute Care Hospital [Member] | |||||||||
Business Acquisition [Line Items] | |||||||||
Number of facilities acquired | 2 | ||||||||
Development Activities [Member] | Inpatient Rehabilitation Hospital [Member] | |||||||||
Business Acquisition [Line Items] | |||||||||
Number of facilities acquired | 1 | ||||||||
Development Activities [Member] | Ernest [Member] | |||||||||
Business Acquisition [Line Items] | |||||||||
Total commitment | $ | $ 47,700 | ||||||||
Development Activities [Member] | Steward [Member] | |||||||||
Business Acquisition [Line Items] | |||||||||
Total commitment | $ | $ 169,400 |
Real Estate and Other Activit_9
Real Estate and Other Activities - Development Activities - Summary of Status on Current Development Projects (Detail) $ in Thousands | 12 Months Ended |
Dec. 31, 2022 USD ($) | |
Business Acquisition [Line Items] | |
Commitment | $ 406,661 |
Costs Incurred as of December 31, 2022 | 167,420 |
Steward [Member] | Texas [Member] | |
Business Acquisition [Line Items] | |
Commitment | 169,408 |
Costs Incurred as of December 31, 2022 | $ 57,020 |
Estimated Rent Commencement Date | 1Q 2026 |
Ernest [Member] | California [Member] | |
Business Acquisition [Line Items] | |
Commitment | $ 47,700 |
Costs Incurred as of December 31, 2022 | $ 45,739 |
Estimated Rent Commencement Date | 1Q 2023 |
Ernest [Member] | South Carolina [Member] | |
Business Acquisition [Line Items] | |
Commitment | $ 22,400 |
Costs Incurred as of December 31, 2022 | $ 7,541 |
Estimated Rent Commencement Date | 2Q 2023 |
IMED [Member] | Spain [Member] | |
Business Acquisition [Line Items] | |
Commitment | $ 50,411 |
Costs Incurred as of December 31, 2022 | $ 13,037 |
Estimated Rent Commencement Date | 2Q 2023 |
IMED [Member] | Spain [Member] | |
Business Acquisition [Line Items] | |
Commitment | $ 45,408 |
Costs Incurred as of December 31, 2022 | $ 33,801 |
Estimated Rent Commencement Date | 3Q 2023 |
IMED [Member] | Spain [Member] | |
Business Acquisition [Line Items] | |
Commitment | $ 36,734 |
Costs Incurred as of December 31, 2022 | $ 8,320 |
Estimated Rent Commencement Date | 3Q 2024 |
Springstone [Member] | Texas [Member] | |
Business Acquisition [Line Items] | |
Commitment | $ 34,600 |
Costs Incurred as of December 31, 2022 | $ 1,962 |
Estimated Rent Commencement Date | 1Q 2024 |
Real Estate and Other Activi_10
Real Estate and Other Activities - Disposals - Additional Information (Detail) $ in Thousands | 3 Months Ended | 12 Months Ended | |||
Mar. 14, 2022 USD ($) Facility | Dec. 31, 2021 USD ($) | Dec. 31, 2022 USD ($) Property Facility | Dec. 31, 2021 USD ($) Facility | Dec. 31, 2020 USD ($) Facility Hospital Property | |
Business Acquisition [Line Items] | |||||
Number of facilities sold | Facility | 15 | 16 | 9 | ||
Number of properties sold | Property | 6 | ||||
Proceeds from sale of facilities | $ 54,500 | $ 522,000 | $ 246,000 | $ 94 | |
Number of ancillary properties sold | Facility | 5 | ||||
Gain (loss) on real estate dispositions | $ (40,000) | $ 52,500 | $ (2,800) | ||
Straight-line rent write-offs | $ 42 | ||||
Steward Health Care System LLC [Member] | |||||
Business Acquisition [Line Items] | |||||
Number of facilities acquired | Hospital | 2 | ||||
Massachusetts-based General Acute Care Hospitals [Member] | |||||
Business Acquisition [Line Items] | |||||
Number of facilities acquired | Facility | 8 | ||||
Purchase price of acquisition | $ 1,700,000 | ||||
Gain (loss) on real estate dispositions | $ 600,000 | ||||
Proceeds from expected secured debt | $ 1,300,000 | ||||
Prime Healthcare Services, Inc. Facilities [Member] | |||||
Business Acquisition [Line Items] | |||||
Number of properties sold | Property | 11 | ||||
Proceeds from sale of facilities | $ 366,000 | ||||
Prime [Member] | |||||
Business Acquisition [Line Items] | |||||
Gain (loss) on real estate dispositions | $ 100,000 |
Real Estate and Other Activi_11
Real Estate and Other Activities - Summary of Operating Results from Properties Sold (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Business Acquisition [Line Items] | |||
Revenues | $ 1,542,851 | $ 1,544,669 | $ 1,249,238 |
Real estate depreciation and amortization | (332,977) | (321,249) | (264,245) |
Other income | 15,344 | 45,699 | (6,782) |
Disposal Group, Not Discontinued Operations [Member] | |||
Business Acquisition [Line Items] | |||
Revenues | 17,831 | 180,549 | 174,362 |
Real estate depreciation and amortization | (4,683) | (28,579) | (38,059) |
Property-related expenses | (1,588) | (5,065) | (12,509) |
Other income | 536,813 | 181 | 1,228 |
Income from real estate dispositions, net | $ 548,373 | $ 147,086 | $ 125,022 |
Real Estate and Other Activi_12
Real Estate and Other Activities - Summary of Operating Results from Properties Sold (Parenthetical) (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Business Acquisition [Line Items] | ||
Straight-line rent write-offs | $ 42 | |
Gains | $ 40,945 | |
Disposal Group, Not Discontinued Operations [Member] | ||
Business Acquisition [Line Items] | ||
Straight-line rent write-offs | 42,000 | |
Massachusetts-based General Acute Care Hospitals [Member] | ||
Business Acquisition [Line Items] | ||
Straight-line rent write-offs | 125,000 | |
Massachusetts-based General Acute Care Hospitals [Member] | Disposal Group, Not Discontinued Operations [Member] | ||
Business Acquisition [Line Items] | ||
Gains | $ 536,800 |
Real Estate and Other Activi_13
Real Estate and Other Activities - Other Disposal Transactions - Additional Information (Detail) $ in Thousands | 3 Months Ended | 12 Months Ended | ||
Dec. 31, 2021 USD ($) Operator | Dec. 31, 2022 USD ($) Facility | Dec. 31, 2021 USD ($) Operator Facility | Dec. 31, 2020 USD ($) Facility Property | |
Business Acquisition [Line Items] | ||||
Number of operations sold | Operator | 3 | 3 | ||
Proceeds from sale of facilities | $ 54,500 | $ 522,000 | $ 246,000 | $ 94 |
Gain (loss) on real estate dispositions | $ (40,000) | $ 52,500 | $ (2,800) | |
Number of facilities sold | Facility | 15 | 16 | 9 | |
Number of properties sold | Property | 6 |
Real Estate and Other Activi_14
Real Estate and Other Activities - Intangible Assets - Additional Information (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Business Combinations [Abstract] | |||
Intangible lease assets | $ 1,394,471 | $ 1,417,813 | |
Accumulated amortization, net | 1,200,000 | 1,300,000 | |
Amortization expense related to intangible lease assets | $ 55,900 | $ 56,000 | $ 42,400 |
Capitalized lease intangibles, weighted average life (in years) | 23 years 8 months 12 days |
Real Estate and Other Activi_15
Real Estate and Other Activities - Amortization Expense from Existing Lease Intangible Assets (Detail) $ in Thousands | Dec. 31, 2022 USD ($) |
Business Combinations [Abstract] | |
2023 | $ 56,740 |
2024 | 56,683 |
2025 | 56,535 |
2026 | 56,266 |
2027 | $ 55,932 |
Real Estate and Other Activi_16
Real Estate and Other Activities - Leasing Operations (Lessor) - Additional Information (Detail) $ in Millions | 12 Months Ended | |
Sep. 01, 2022 Property | Dec. 31, 2022 USD ($) Property Lease | |
Lessor Lease Description [Line Items] | ||
Lease renewal term | 5 years | |
Annual rent escalations | 99% | |
Carrying value of lease requiring residual value guarantee | $ | $ 110 | |
Number of properties | Property | 3 | |
Number of properties sold associated with financing leases | Property | 2 | |
Minimum [Member] | ||
Lessor Lease Description [Line Items] | ||
Term of lease | 15 years | |
Ernest [Member] | ||
Lessor Lease Description [Line Items] | ||
Number of direct financing leases | 13 | |
Number of financing leases | 5 | |
Prime Healthcare Services, Inc. Facilities [Member] | ||
Lessor Lease Description [Line Items] | ||
Number of direct financing leases | 3 | |
Prospect [Member] | ||
Lessor Lease Description [Line Items] | ||
Number of financing leases | 13 |
Real Estate and Other Activi_17
Real Estate and Other Activities - Summary of Total Future Minimum Lease Payments to be Received (Detail) $ in Thousands | Dec. 31, 2022 USD ($) |
Lessor Lease Description [Line Items] | |
2023 | $ 1,145,432 |
2024 | 1,165,813 |
2025 | 1,184,068 |
2026 | 1,202,829 |
2027 | 1,223,000 |
Thereafter | 30,228,291 |
Future minimum lease payments to be received | 36,149,433 |
Operating Leases [Member] | |
Lessor Lease Description [Line Items] | |
2023 | 984,353 |
2024 | 1,001,456 |
2025 | 1,016,367 |
2026 | 1,031,717 |
2027 | 1,048,409 |
Thereafter | 25,851,987 |
Future minimum lease payments to be received | 30,934,289 |
Financing Leases [Member] | |
Lessor Lease Description [Line Items] | |
2023 | 161,079 |
2024 | 164,357 |
2025 | 167,701 |
2026 | 171,112 |
2027 | 174,591 |
Thereafter | 4,376,304 |
Future minimum lease payments to be received | $ 5,215,144 |
Real Estate and Other Activi_18
Real Estate and Other Activities - Components of Total Investment in Financing Leases (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Direct Financing Lease Net Investment In Leases [Abstract] | ||
Minimum lease payments receivable | $ 880,253 | $ 1,183,855 |
Estimated unguaranteed residual values | 203,818 | 203,818 |
Less: Unearned income and allowance for credit loss | (731,915) | (918,584) |
Net investment in direct financing leases | 352,156 | 469,089 |
Other financing leases (net of allowance for credit loss) | 1,339,167 | 1,584,238 |
Total investment in financing leases | $ 1,691,323 | $ 2,053,327 |
Real Estate and Other Activi_19
Real Estate and Other Activities - Rent Deferrals - Additional Information (Detail) $ in Millions | Dec. 31, 2022 USD ($) |
Business Acquisition [Line Items] | |
Remaining outstanding deferred rent to be received | $ 14.6 |
Real Estate and Other Activi_20
Real Estate and Other Activities - Prospect Medical Holdings Additional Information (Detail) $ in Thousands | 1 Months Ended | 3 Months Ended | ||||
Aug. 31, 2019 USD ($) Hospital | Dec. 31, 2022 USD ($) | Jun. 30, 2022 USD ($) | Dec. 31, 2021 USD ($) | Dec. 31, 2020 USD ($) | ||
Business Acquisition [Line Items] | ||||||
Additional mortgage loan | $ 1,332,962 | $ 5,350,239 | $ 4,249,180 | |||
Carrying value of lease requiring residual value guarantee | 110,000 | |||||
Mortgage Loans [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Additional mortgage loan | [1],[2] | 159,735 | $ 1,113,300 | $ 176,840 | ||
Prospect [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Purchase price of acquisition | $ 1,500,000 | |||||
Term loan | $ 112,900 | |||||
Impairment charge | 280,000 | |||||
Prospect [Member] | Pennsylvania | ||||||
Business Acquisition [Line Items] | ||||||
Carrying value of lease requiring residual value guarantee | 170,000 | |||||
Non-cash rent | 112,000 | |||||
Prospect [Member] | Pennsylvania | Maximum [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Carrying value of lease requiring residual value guarantee | $ 250,000 | |||||
Prospect [Member] | Mortgage Loans [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Additional mortgage loan | $ 100,000 | |||||
Acute Care Campus [Member] | Prospect [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Number of facilities acquired | Hospital | 14 | |||||
[1] In the 2022 second quarter, we increased our mortgage loan to Prospect Medical Holdings, Inc. ("Prospect") that was originated in 2019 and that is secured by a first lien on a California hospital. The loan bears interest at a current market rate plus a component of additional interest upon repayment. The 2021 column includes an £ 800 million mortgage loan advanced to the Priory Group (“Priory”) in the first quarter of 2021 and converted to fee simple ownership of 35 properties in the second quarter of 2021 as described below. The 2020 column includes approximately $ 740 million of loans advanced to Steward in 2017 and exchanged for the fee simple real estate of two hospitals as described below, as well as approximately $ 100 million of loans advanced to Ernest Health, Inc. (“Ernest”) in 2012 and exchanged for the fee simple real estate of four hospitals as described below. |
Real Estate and Other Activi_21
Real Estate and Other Activities - Pipeline Health System - Additional Information (Detail) - Pipeline Health System [Member] - USD ($) $ in Millions | 12 Months Ended | |
Feb. 07, 2023 | Dec. 31, 2022 | |
Subsequent Event [Member] | ||
Business Acquisition [Line Items] | ||
Cash rent | $ 5.6 | |
Percentage of defered rent | 30% | |
Capital funding | $ 11 | |
Customer Concentration Risk [Member] | Total Gross Assets [Member] | ||
Business Acquisition [Line Items] | ||
Percentage of total assets | 1% |
Real Estate and Other Activi_22
Real Estate and Other Activities - Watsonville Community Hospital - Additional Information (Detail) - USD ($) $ in Thousands | 12 Months Ended | |||||
Sep. 30, 2019 | Dec. 31, 2022 | Aug. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | ||
Business Acquisition [Line Items] | ||||||
Loans repaid | [1] | $ 1,103,410 | $ 834,743 | |||
Halsen Healthcare [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Credit loss reserve | $ 40,000 | |||||
Halsen Healthcare [Member] | Maximum [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Write off of billed and straight-line rent receivables | 2,500 | |||||
Watsonville, California [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Provision (recovery) for credit loss | 15,000 | |||||
Watsonville, California [Member] | Halsen Healthcare [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Loans repaid | $ 32,000 | |||||
Provision (recovery) for credit loss | $ 15,000 | |||||
Acute Care Hospital [Member] | Watsonville, California [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Funded for interim mortgage loan | $ 40,000 | |||||
[1] The 2021 column includes an £ 800 million mortgage loan advanced to the Priory Group (“Priory”) in the first quarter of 2021 and converted to fee simple ownership of 35 properties in the second quarter of 2021 as described below. The 2020 column includes approximately $ 740 million of loans advanced to Steward in 2017 and exchanged for the fee simple real estate of two hospitals as described below, as well as approximately $ 100 million of loans advanced to Ernest Health, Inc. (“Ernest”) in 2012 and exchanged for the fee simple real estate of four hospitals as described below. |
Real Estate and Other Activi_23
Real Estate and Other Activities - Other Leasing Activities - Additional Information (Detail) $ in Millions | 3 Months Ended | 9 Months Ended | ||
Jul. 24, 2020 USD ($) Property | Sep. 30, 2020 USD ($) | Sep. 30, 2022 Property | Dec. 23, 2021 Property | |
Business Acquisition [Line Items] | ||||
Percentage of properties occupied by tenants | 99% | |||
Number of properties vacant | 5 | |||
Minimum [Member] | ||||
Business Acquisition [Line Items] | ||||
Percentage of vacant on leased property | 0.30% | |||
ScionHealth Master Lease [Member] | ||||
Business Acquisition [Line Items] | ||||
Number of properties | 8 | |||
LifePoint Master Lease [Member] | ||||
Business Acquisition [Line Items] | ||||
Number of properties | 9 | |||
Methodist [Member] | Texas [Member] | ||||
Business Acquisition [Line Items] | ||||
Total investments | $ | $ 30 | |||
Number of re-leased properties | 5 | |||
Straight-line rent and other write-off, net of tax | $ | $ 1.5 |
Real Estate and Other Activi_24
Real Estate and Other Activities - Investments in Unconsolidated Real Estate Joint Ventures - Additional Information (Details) - Investments in Unconsolidated Real Estate Joint Ventures [Member] | Dec. 31, 2022 |
Business Acquisition [Line Items] | |
Percentage of equity investment | 100% |
Maximum [Member] | |
Business Acquisition [Line Items] | |
Percentage of equity investment | 100% |
Real Estate and Other Activi_25
Real Estate and Other Activities - Summary of Investments in Unconsolidated Real Estate Joint Ventures by Operator (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Schedule of Equity Method Investments [Line Items] | ||
Investments in unconsolidated real estate joint ventures | $ 1,497,903 | $ 1,152,927 |
Median [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Ownership interest | 50% | |
Investments in unconsolidated real estate joint ventures | $ 482,735 | 517,648 |
Swiss Medical Network [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Ownership interest | 70% | |
Investments in unconsolidated real estate joint ventures | $ 454,083 | 476,193 |
Steward (Macquarie Transaction) [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Ownership interest | 50% | |
Investments in unconsolidated real estate joint ventures | $ 417,701 | |
Policlinico di Monza [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Ownership interest | 50% | |
Investments in unconsolidated real estate joint ventures | $ 86,245 | 95,468 |
HM Hospital [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Ownership interest | 45% | |
Investments in unconsolidated real estate joint ventures | $ 57,139 | $ 63,618 |
Real Estate and Other Activi_26
Real Estate and Other Activities - Summary of Investments in Unconsolidated Operating Entities (Details) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Schedule of Equity Method Investments [Line Items] | ||
Investments in unconsolidated operating entities | $ 1,444,872 | $ 1,289,434 |
Steward Loan Investment [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Investments in unconsolidated operating entities | 362,831 | 360,164 |
International Joint Venture [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Investments in unconsolidated operating entities | 231,402 | 219,387 |
Springstone [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Investments in unconsolidated operating entities | 200,827 | 187,450 |
Priory [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Investments in unconsolidated operating entities | 156,575 | 42,315 |
Swiss Medical Network [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Investments in unconsolidated operating entities | 157,145 | 159,208 |
Steward Equity Investment [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Investments in unconsolidated operating entities | 125,862 | 139,000 |
Prospect [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Investments in unconsolidated operating entities | 112,777 | 112,283 |
Aevis Victoria SA [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Investments in unconsolidated operating entities | 72,904 | 61,271 |
Aspris Children's Services [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Investments in unconsolidated operating entities | 16,023 | $ 8,356 |
Caremax [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Investments in unconsolidated operating entities | $ 8,526 |
Real Estate and Other Activi_27
Real Estate and Other Activities - Investments in Unconsolidated Operating Entities - Additional Information (Details) - USD ($) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Jan. 08, 2021 | |
Business Acquisition [Line Items] | |||
Distribution on equity investment | $ 11,000,000 | ||
Steward Health Care System LLC [Member] | Affiliates of Steward Health Care System L L C [Member] | |||
Business Acquisition [Line Items] | |||
Passive equity interest | 9.90% | ||
Aevis Victoria SA [Member] | |||
Business Acquisition [Line Items] | |||
Ownership interest in joint venture under the cost method | 5% | ||
COVID-19 Pandemic [Member] | |||
Business Acquisition [Line Items] | |||
Favorable non-cash fair value adjustment on investment | $ 8,200,000 | ||
Dividend income | $ 4,000,000 | ||
COVID-19 Pandemic [Member] | Other [Member] | |||
Business Acquisition [Line Items] | |||
Favorable non-cash fair value adjustment on investment | $ 2,300 |
Real Estate and Other Activi_28
Real Estate and Other Activities - Other Investment Activities - Additional Information (Detail) - Steward Health Care System LLC [Member] $ in Millions | 3 Months Ended |
Jun. 30, 2022 USD ($) | |
Business Acquisition [Line Items] | |
Secured loan amount | $ 150 |
Secured loan period | 5 years |
Real Estate and Other Activi_29
Real Estate and Other Activities - Concentration of Credit Risks and Related Party Transactions - Additional Information (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Related Party Transactions [Member] | |||
Business Acquisition [Line Items] | |||
Lease and interest revenue earned from tenants | $ 135.5 | $ 63.9 | $ 29.8 |
Total Gross Assets [Member] | Geographic Concentration [Member] | U.S. [Member] | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 61% | 64% | |
Total Gross Assets [Member] | Geographic Concentration [Member] | Europe [Member] | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 33% | 30% | |
Total Gross Assets [Member] | Geographic Concentration [Member] | Australia [Member] | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 5% | 5% | |
Total Gross Assets [Member] | Geographic Concentration [Member] | South America [Member] | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 1% | 1% | |
Revenue [Member] | Customer Concentration Risk [Member] | General Acute Care Hospital And Healthcare System | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 76% | 81% | |
Revenue [Member] | Customer Concentration Risk [Member] | Behavioral health facilities | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 8% | ||
Revenue [Member] | Customer Concentration Risk [Member] | Rehabilitation Hospital | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 13% | 7% | |
Revenue [Member] | Customer Concentration Risk [Member] | Freestanding ER/Urgent Care Facilities and Behavioral Health Facilities [Member] | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 4% | ||
Revenue [Member] | Customer Concentration Risk [Member] | Long Term Acute Care Hospital | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 7% | ||
Revenue [Member] | Customer Concentration Risk [Member] | Maximum [Member] | Freestanding ER/Urgent Care and Long-Term Acute Care Facilities [Member] | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 4% | ||
Revenue [Member] | Operator Concentration Risk [Member] | Steward Health Care System LLC [Member] | Minimum [Member] | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 10% | ||
Revenue [Member] | Operator Concentration Risk [Member] | Circle [Member] | Minimum [Member] | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 10% | ||
Revenue [Member] | Operator Concentration Risk [Member] | Prospect [Member] | Minimum [Member] | |||
Business Acquisition [Line Items] | |||
Percentage of concentration risk | 10% | ||
Pro Forma [Member] | Total Gross Assets [Member] | Customer Concentration Risk [Member] | |||
Business Acquisition [Line Items] | |||
Maximum percentage of entity's assets invested on single property | 2.70% | 2.70% |
Debt - Summary of Debt (Detail)
Debt - Summary of Debt (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | |
Debt Instrument [Line Items] | |||
Debt | $ 10,325,499 | $ 11,358,826 | |
Debt issue costs and discount, net | (57,087) | (76,056) | |
Debt, net | 10,268,412 | 11,282,770 | |
Revolving Credit Facility [Member] | |||
Debt Instrument [Line Items] | |||
Debt | [1] | 929,584 | 730,000 |
Interim Credit Facility [Member] | |||
Debt Instrument [Line Items] | |||
Debt | 869,606 | ||
Term Loan [Member] | |||
Debt Instrument [Line Items] | |||
Debt | 200,000 | 200,000 | |
Term Loan [Member] | Australia [Member] | |||
Debt Instrument [Line Items] | |||
Debt | [2] | 817,560 | 871,560 |
Term loan due 2024 | British Pound Sterling [Member] | |||
Debt Instrument [Line Items] | |||
Debt | [2] | 126,690 | |
Term loan due 2025 | British Pound Sterling [Member] | |||
Debt Instrument [Line Items] | |||
Debt | [2] | 845,810 | 947,240 |
2.550% Senior Unsecured Notes due 2023 [Member] | |||
Debt Instrument [Line Items] | |||
Debt | [2] | 483,320 | 541,280 |
3.325% Senior Unsecured Notes Due 2025 [Member] | |||
Debt Instrument [Line Items] | |||
Debt | [2] | 535,250 | 568,500 |
0.993% Senior Unsecured Notes due 2026 [Member] | |||
Debt Instrument [Line Items] | |||
Debt | [2] | 535,250 | 568,500 |
2.500% Senior Unsecured Notes due 2026 [Member] | |||
Debt Instrument [Line Items] | |||
Debt | [2] | 604,150 | 676,600 |
5.250% Senior Unsecured Notes Due 2026 [Member] | |||
Debt Instrument [Line Items] | |||
Debt | 500,000 | 500,000 | |
5.000% Senior Unsecured Notes Due 2027 [Member] | |||
Debt Instrument [Line Items] | |||
Debt | 1,400,000 | 1,400,000 | |
3.692% Senior Unsecured Notes due 2028 [Member] | |||
Debt Instrument [Line Items] | |||
Debt | [2] | 724,980 | 811,920 |
4.625% Senior Unsecured Notes Due 2029 [Member] | |||
Debt Instrument [Line Items] | |||
Debt | 900,000 | 900,000 | |
3.375% Senior Unsecured Notes Due 2030 [Member] | |||
Debt Instrument [Line Items] | |||
Debt | [2] | 422,905 | 473,620 |
3.500% Senior Unsecured Notes Due 2031 [Member] | |||
Debt Instrument [Line Items] | |||
Debt | $ 1,300,000 | $ 1,300,000 | |
[1] Includes £ 90 million of GBP-denominated borrowings and € 253 million of Euro-denominated borrowings that reflect the exchange rate at December 31, 2022 . Non-U.S. dollar denominated debt that reflects the exchange rate at period-end. |
Debt - Summary of Debt (Parenth
Debt - Summary of Debt (Parenthetical) (Detail) $ in Thousands, € in Millions, £ in Millions | Dec. 31, 2022 USD ($) | Dec. 31, 2022 GBP (£) | Dec. 31, 2022 EUR (€) | Dec. 31, 2021 USD ($) | Dec. 31, 2020 | |
Debt Instrument [Line Items] | ||||||
Debt | $ 10,325,499 | $ 11,358,826 | ||||
GBP-denominated Borrowings [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Debt | £ | £ 90 | |||||
EURO-denominated Borrowings [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Debt | € | € 253 | |||||
2.550% Senior Unsecured Notes due 2023 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Senior unsecured notes, interest rate | 2.55% | 2.55% | 2.55% | 2.55% | ||
Debt | [1] | $ 483,320 | $ 541,280 | |||
3.325% Senior Unsecured Notes Due 2025 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Senior unsecured notes, interest rate | 3.325% | 3.325% | 3.325% | 3.325% | ||
Debt | [1] | $ 535,250 | $ 568,500 | |||
0.993% Senior Unsecured Notes due 2026 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Senior unsecured notes, interest rate | 0.993% | 0.993% | 0.993% | 0.993% | ||
Debt | [1] | $ 535,250 | $ 568,500 | |||
2.500% Senior Unsecured Notes due 2026 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Senior unsecured notes, interest rate | 2.50% | 2.50% | 2.50% | 2.50% | ||
Debt | [1] | $ 604,150 | $ 676,600 | |||
5.250% Senior Unsecured Notes Due 2026 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Senior unsecured notes, interest rate | 5.25% | 5.25% | 5.25% | 5.25% | ||
Debt | $ 500,000 | $ 500,000 | ||||
5.000% Senior Unsecured Notes Due 2027 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Senior unsecured notes, interest rate | 5% | 5% | 5% | 5% | ||
Debt | $ 1,400,000 | $ 1,400,000 | ||||
3.692% Senior Unsecured Notes due 2028 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Senior unsecured notes, interest rate | 3.692% | 3.692% | 3.692% | 3.692% | ||
Debt | [1] | $ 724,980 | $ 811,920 | |||
4.625% Senior Unsecured Notes Due 2029 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Senior unsecured notes, interest rate | 4.625% | 4.625% | 4.625% | 4.625% | ||
Debt | $ 900,000 | $ 900,000 | ||||
3.375% Senior Unsecured Notes Due 2030 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Senior unsecured notes, interest rate | 3.375% | 3.375% | 3.375% | 3.375% | ||
Debt | [1] | $ 422,905 | $ 473,620 | |||
3.500% Senior Unsecured Notes Due 2031 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Senior unsecured notes, interest rate | 3.50% | 3.50% | 3.50% | 3.50% | 3.50% | |
Debt | $ 1,300,000 | $ 1,300,000 | ||||
[1] Non-U.S. dollar denominated debt that reflects the exchange rate at period-end. |
Debt - Principal Payments Due f
Debt - Principal Payments Due for Debt (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Debt Disclosure [Abstract] | ||
2023 | $ 483,320 | |
2024 | 944,250 | |
2025 | 1,381,060 | |
2026 | 2,568,984 | |
2027 | 1,600,000 | |
Thereafter | 3,347,885 | |
Total | $ 10,325,499 | $ 11,358,826 |
Debt - Credit Facility - Additi
Debt - Credit Facility - Additional Information (Detail) - USD ($) $ in Millions | 12 Months Ended | |||
Jun. 29, 2022 | May 06, 2022 | Dec. 31, 2022 | Dec. 31, 2021 | |
Debt Instrument [Line Items] | ||||
Commitment fee | 0.25% | |||
Minimum [Member] | ||||
Debt Instrument [Line Items] | ||||
Commitment fee | 0.125% | |||
Maximum [Member] | ||||
Debt Instrument [Line Items] | ||||
Commitment fee | 0.30% | |||
Alternate Base Rate [Member] | Minimum [Member] | ||||
Debt Instrument [Line Items] | ||||
Applicable margin for term loan | 0% | |||
Applicable margin for revolving loans | 0% | |||
Alternate Base Rate [Member] | Maximum [Member] | ||||
Debt Instrument [Line Items] | ||||
Applicable margin for term loan | 0.70% | |||
Applicable margin for revolving loans | 0.50% | |||
Term Benchmark Loans or RFR Loans [Member] | Minimum [Member] | ||||
Debt Instrument [Line Items] | ||||
Applicable margin for revolving loans | 0.80% | |||
Term Benchmark Loans or RFR Loans [Member] | Maximum [Member] | ||||
Debt Instrument [Line Items] | ||||
Applicable margin for revolving loans | 1.50% | |||
Revolving Credit Facility [Member] | ||||
Debt Instrument [Line Items] | ||||
Increase in revolving credit facility | $ 500 | |||
Debt instrument amendment extended maturity date description | The amendment extended the maturity date of our revolving facility to June 30, 2026 with our option to extend for an additional 12 months. | |||
Unsecured Revolving Credit Facility [Member] | ||||
Debt Instrument [Line Items] | ||||
Amount of senior unsecured debt | 1,800 | |||
Debt instrument maturity date | Jun. 30, 2026 | |||
Credit facilities, amount outstanding | $ 929.6 | $ 730 | ||
Line of credit facility, Borrowing capacity | $ 900 | $ 600 | ||
Maximum incremental credit facility | $ 1,000 | |||
Credit facilities, weighted average interest rate | 3.80% | 1.30% | ||
Term Loan [Member] | ||||
Debt Instrument [Line Items] | ||||
Amount of senior unsecured debt | $ 200 | $ 200 | ||
Debt instrument maturity date | Jun. 30, 2027 | |||
Interest rate at end of period | 5.70% | 1.56% | ||
Term Loan [Member] | Term Benchmark Loans [Member] | Minimum [Member] | ||||
Debt Instrument [Line Items] | ||||
Applicable margin for term loan | 0.875% | |||
Term Loan [Member] | Term Benchmark Loans [Member] | Maximum [Member] | ||||
Debt Instrument [Line Items] | ||||
Applicable margin for term loan | 1.70% |
Debt - Interim Credit Facility
Debt - Interim Credit Facility - Additional Information (Detail) £ in Millions | Jan. 15, 2021 USD ($) | Dec. 31, 2022 | Dec. 31, 2021 | Jan. 15, 2021 GBP (£) |
2.500% Senior Unsecured Notes due 2026 [Member] | ||||
Debt Instrument [Line Items] | ||||
Senior unsecured notes, interest rate | 2.50% | 2.50% | ||
3.375% Senior Unsecured Notes Due 2030 [Member] | ||||
Debt Instrument [Line Items] | ||||
Senior unsecured notes, interest rate | 3.375% | 3.375% | ||
Interim Credit Facility [Member] | ||||
Debt Instrument [Line Items] | ||||
Line of credit facility, Borrowing capacity | $ | $ 900,000,000 | |||
Line of credit | £ | £ 500 | |||
Line of credit, terminated date | Mar. 26, 2021 | |||
Interim Credit Facility [Member] | 2.500% Senior Unsecured Notes due 2026 [Member] | ||||
Debt Instrument [Line Items] | ||||
Senior unsecured notes, interest rate | 2.50% | 2.50% | ||
Interim Credit Facility [Member] | 3.375% Senior Unsecured Notes Due 2030 [Member] | ||||
Debt Instrument [Line Items] | ||||
Senior unsecured notes, interest rate | 3.375% | 3.375% |
Debt - July 2021 Interim Credit
Debt - July 2021 Interim Credit Facility - Additional Information (Detail) - Interim Credit Facility [Member] £ in Millions | 12 Months Ended | ||||
Jan. 15, 2021 USD ($) | Dec. 31, 2022 | Dec. 31, 2021 USD ($) | Jul. 27, 2021 USD ($) | Jan. 15, 2021 GBP (£) | |
Debt Instrument [Line Items] | |||||
Line of credit facility, Borrowing capacity | $ 900,000,000 | ||||
Line of credit | £ | £ 500 | ||||
Line of credit, terminated date | Mar. 26, 2021 | ||||
Barclays Bank PLC [Member] | |||||
Debt Instrument [Line Items] | |||||
Line of credit facility, Borrowing capacity | $ 1,000,000,000 | ||||
Line of credit | $ 869,600,000 | ||||
Line of credit, terminated date | Mar. 15, 2022 |
Debt - British Pound Sterling T
Debt - British Pound Sterling Term Loan - Additional Information (Detail) - British Pound Sterling [Member] - GBP (£) | Dec. 09, 2022 | Mar. 04, 2020 | Jan. 06, 2020 | Dec. 31, 2022 |
Term loan due 2024 | ||||
Debt Instrument [Line Items] | ||||
Line of Credit Facility, Maximum Borrowing Capacity | £ 105,000,000 | |||
Debt instrument maturity date | Dec. 09, 2024 | |||
Senior unsecured notes, interest rate | 5.25% | |||
Term loan due 2025 | Bank of America, N.A | ||||
Debt Instrument [Line Items] | ||||
Line of Credit Facility, Maximum Borrowing Capacity | £ 700,000,000 | |||
Debt instrument maturity date | Jan. 15, 2025 | |||
Debt instrument effective date | Mar. 06, 2020 | |||
Effective interest rate | 0.70% | |||
Senior unsecured notes, interest rate | 1.95% | |||
Term loan due 2025 | Bank of America, N.A | Minimum [Member] | ||||
Debt Instrument [Line Items] | ||||
Applicable margin adjustable based on pricing grid, percentage | 0.85% | |||
Term loan due 2025 | Bank of America, N.A | Maximum [Member] | ||||
Debt Instrument [Line Items] | ||||
Applicable margin adjustable based on pricing grid, percentage | 1.65% | |||
Term loan due 2025 | Bank of America, N.A | Credit Rating | ||||
Debt Instrument [Line Items] | ||||
Variable interest rate | 1.25% |
Debt - Australian Term Loan - A
Debt - Australian Term Loan - Additional Information (Detail) - Term Loan [Member] - Bank of America, N.A - Australia [Member] - USD ($) | Jun. 27, 2019 | May 23, 2019 |
Debt Instrument [Line Items] | ||
Line of credit facility, Borrowing capacity | $ 1,200,000,000 | |
Debt instrument maturity date | May 23, 2024 | |
Debt instrument effective date | Jul. 03, 2019 | |
Effective interest rate | 1.20% | |
Reference rate | 0% | |
Senior unsecured notes, interest rate | 2.45% | |
Credit Rating | ||
Debt Instrument [Line Items] | ||
Variable interest rate | 1.25% | |
Minimum [Member] | ||
Debt Instrument [Line Items] | ||
Applicable margin adjustable based on pricing grid, percentage | 0.85% | |
Maximum [Member] | ||
Debt Instrument [Line Items] | ||
Applicable margin adjustable based on pricing grid, percentage | 1.65% |
Debt - Interest Rate Swaps - Ad
Debt - Interest Rate Swaps - Additional Information (Detail) - USD ($) $ in Millions | Dec. 31, 2022 | Dec. 31, 2021 |
Debt Instrument [Line Items] | ||
Derivative asset | $ 93.2 | $ 12.4 |
Derivative Asset, Statement of Financial Position [Extensible Enumeration] | Other Assets | Other Assets |
Derivative liability | $ 4.2 | |
Derivative Liability, Statement of Financial Position [Extensible Enumeration] | Accounts Payable and Accrued Liabilities |
Debt - Basic Terms of Senior Un
Debt - Basic Terms of Senior Unsecured Notes (Details) - 12 months ended Dec. 31, 2022 | GBP (£) | EUR (€) | USD ($) |
2.550% Senior Unsecured Notes due 2023 [Member] | |||
Debt Instrument [Line Items] | |||
Offering Completion Date | Dec. 05, 2019 | ||
Debt instrument maturity date | Dec. 05, 2023 | ||
Par Value | £ | £ 400,000,000 | ||
% of Par Value | 100% | ||
Interest Payment Frequency | Annually | ||
3.325% Senior Unsecured Notes Due 2025 [Member] | |||
Debt Instrument [Line Items] | |||
Offering Completion Date | Mar. 24, 2017 | ||
Debt instrument maturity date | Mar. 24, 2025 | ||
Par Value | € | € 500,000,000 | ||
% of Par Value | 100% | ||
Interest Payment Frequency | Annually | ||
0.993% Senior Unsecured Notes due 2026 [Member] | |||
Debt Instrument [Line Items] | |||
Offering Completion Date | Oct. 06, 2021 | ||
Debt instrument maturity date | Oct. 15, 2026 | ||
Par Value | € | € 500,000,000 | ||
% of Par Value | 100% | ||
Interest Payment Frequency | Annually | ||
2.500% Senior Unsecured Notes due 2026 [Member] | |||
Debt Instrument [Line Items] | |||
Offering Completion Date | Mar. 24, 2021 | ||
Debt instrument maturity date | Mar. 24, 2026 | ||
Par Value | £ | £ 500,000,000 | ||
% of Par Value | 99.937% | ||
Interest Payment Frequency | Annually | ||
5.250% Senior Unsecured Notes Due 2026 [Member] | |||
Debt Instrument [Line Items] | |||
Offering Completion Date | Jul. 22, 2016 | ||
Debt instrument maturity date | Aug. 01, 2026 | ||
Par Value | $ | $ 500,000,000 | ||
% of Par Value | 100% | ||
Interest Payment Frequency | Semi-annually | ||
5.000% Senior Unsecured Notes Due 2027 [Member] | |||
Debt Instrument [Line Items] | |||
Offering Completion Date | Sep. 07, 2017 | ||
Debt instrument maturity date | Oct. 15, 2027 | ||
Par Value | $ | 1,400,000,000 | ||
% of Par Value | 100% | ||
Interest Payment Frequency | Semi-annually | ||
3.692% Senior Unsecured Notes due 2028 [Member] | |||
Debt Instrument [Line Items] | |||
Offering Completion Date | Dec. 05, 2019 | ||
Debt instrument maturity date | Jun. 05, 2028 | ||
Par Value | £ | £ 600,000,000 | ||
% of Par Value | 99.998% | ||
Interest Payment Frequency | Annually | ||
4.625% Senior Unsecured Notes Due 2029 [Member] | |||
Debt Instrument [Line Items] | |||
Offering Completion Date | Jul. 26, 2019 | ||
Debt instrument maturity date | Aug. 01, 2029 | ||
Par Value | $ | 900,000,000 | ||
% of Par Value | 99.50% | ||
Interest Payment Frequency | Semi-annually | ||
3.375% Senior Unsecured Notes Due 2030 [Member] | |||
Debt Instrument [Line Items] | |||
Offering Completion Date | Mar. 24, 2021 | ||
Debt instrument maturity date | Apr. 24, 2030 | ||
Par Value | £ | £ 350,000,000 | ||
% of Par Value | 99.448% | ||
Interest Payment Frequency | Annually | ||
3.500% Senior Unsecured Notes Due 2031 [Member] | |||
Debt Instrument [Line Items] | |||
Offering Completion Date | Dec. 04, 2020 | ||
Debt instrument maturity date | Mar. 15, 2031 | ||
Par Value | $ | $ 1,300,000,000 | ||
% of Par Value | 100% | ||
Interest Payment Frequency | Semi-annually |
Debt - Senior Unsecured Notes -
Debt - Senior Unsecured Notes - Additional Information (Detail) | 12 Months Ended |
Dec. 31, 2022 | |
Senior Unsecured Notes [Member] | |
Debt Instrument [Line Items] | |
Senior notes, repurchased price percentage on principal amount plus accrued and unpaid interest | 101% |
Debt - Additional Information (
Debt - Additional Information (Detail) € in Millions, $ in Millions | 12 Months Ended | |||
Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | Dec. 31, 2021 EUR (€) | Dec. 31, 2020 USD ($) | |
0.993% Senior Unsecured Notes due 2026 [Member] | ||||
Debt Instrument [Line Items] | ||||
Senior unsecured notes, interest rate | 0.993% | 0.993% | 0.993% | |
Senior unsecured notes, maturity year | 2026 | 2026 | ||
Debt instrument maturity date | Oct. 15, 2026 | |||
4.000% Senior Unsecured Notes Due 2022 [Member] | ||||
Debt Instrument [Line Items] | ||||
Senior unsecured notes, interest rate | 4% | 4% | ||
Senior unsecured notes, maturity year | 2022 | 2022 | ||
Senior unsecured notes redemption amount including accrued and unpaid interest | € | € 500 | |||
Term Loans [Member] | ||||
Debt Instrument [Line Items] | ||||
Debt refinancing costs | € 20 | $ 28 | ||
3.500% Senior Unsecured Notes Due 2031 [Member] | ||||
Debt Instrument [Line Items] | ||||
Senior unsecured notes, interest rate | 3.50% | 3.50% | 3.50% | 3.50% |
Senior unsecured notes, maturity year | 2031 | |||
Debt instrument maturity date | Mar. 15, 2031 | |||
6.375% Senior Unsecured Notes due 2024 [Member] | ||||
Debt Instrument [Line Items] | ||||
Senior unsecured notes, interest rate | 6.375% | |||
Senior unsecured notes, maturity year | 2024 | |||
Senior unsecured notes redemption amount including accrued and unpaid interest | $ 500 | |||
5.500% Senior Unsecured Notes due 2024 [Member] | ||||
Debt Instrument [Line Items] | ||||
Senior unsecured notes, interest rate | 5.50% | |||
Senior unsecured notes, maturity year | 2024 | |||
Senior unsecured notes redemption amount including accrued and unpaid interest | $ 300 | |||
Waterland Private Equity Fund VII C.V. [Member] | Interim Credit Facility [Member] | ||||
Debt Instrument [Line Items] | ||||
Debt refinancing costs | $ 9.5 | $ 7.3 | ||
Debt instrument maturity date | Jun. 29, 2022 |
Debt - Covenants - Additional I
Debt - Covenants - Additional Information (Detail) | 12 Months Ended |
Dec. 31, 2022 | |
Debt Disclosure [Abstract] | |
Percentage of dividends which could be paid from adjusted operating funds | 95% |
Percentage of dividends which could be paid from operation funds | 95% |
Maximum percentage of total unencumbered assets | 150% |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Detail) - USD ($) | 3 Months Ended | 12 Months Ended | ||||
Apr. 01, 2023 | Sep. 30, 2022 | Jun. 30, 2021 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Taxes [Line Items] | ||||||
Percentage of ordinary taxable income to be distributed for real estate investment trust qualification | 90% | 90% | 90% | |||
Percentage of taxable income to be distributed for federal income tax assumption | 100% | |||||
Amount of foreign income (loss) before income taxes | $ 159,600,000 | $ 164,000,000 | $ 62,100,000 | |||
Amount of domestic income (loss) before income taxes | 10,800,000 | (29,700,000) | 6,400,000 | |||
Income tax expense (benefit) | $ 5,000,000 | $ 55,900,000 | 73,948,000 | $ 31,056,000 | ||
Income tax benefit related to the initial loan impairment | $ 10,000,000 | |||||
Income tax at the US statutory federal rate | 21% | 21% | 21% | |||
Valuation allowance not expected to be realized | $ 9,800,000 | |||||
Uncertain tax position liabilities and related interest or penalties | $ 0 | |||||
United Kingdom [Member] | ||||||
Income Taxes [Line Items] | ||||||
Income tax at the US statutory federal rate | 19% | |||||
Deferred tax liabilities, one time adjustment | $ 43,000,000 | |||||
United Kingdom [Member] | Forecast [Member] | ||||||
Income Taxes [Line Items] | ||||||
Income tax at the US statutory federal rate | 25% |
Income Taxes - Schedule of Inco
Income Taxes - Schedule of Income Tax (Expense) Benefit (Detail) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | ||
Sep. 30, 2022 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Current income tax (expense) benefit: | ||||
Domestic | $ 1,111 | $ (1,559) | $ 63 | |
Foreign | (27,751) | (18,964) | (10,203) | |
Total income tax expense | (26,640) | (20,523) | (10,140) | |
Deferred income tax (expense) benefit: | ||||
Domestic | (15,628) | 6,915 | (10,680) | |
Foreign | (13,632) | (60,340) | (10,236) | |
Total income tax expense | (29,260) | (53,425) | (20,916) | |
Income tax (expense) | $ (5,000) | $ (55,900) | $ (73,948) | $ (31,056) |
Income Taxes - Summary of Recon
Income Taxes - Summary of Reconciliation of Income Tax (Expense) Benefit from the Statutory Income Tax Rate to the Effective Tax Rate Based on Income before Income Taxes (Detail) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | ||
Sep. 30, 2022 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | ||||
Income before income tax | $ 959,719 | $ 730,888 | $ 463,328 | |
Income tax (expense) at the U.S. statutory federal rate (21% in 2022, 2021, and 2020) | (201,541) | (153,486) | (97,299) | |
Decrease (increase) in income tax resulting from: | ||||
Foreign rate differential | 1,826 | 2,742 | 2,160 | |
State income taxes, net of federal benefit | (1,886) | 970 | ||
U.S. earnings not subject to federal income tax | 165,705 | 132,266 | 82,921 | |
Equity investments | 380 | |||
Change in valuation allowance | (11,281) | (10,040) | (8,514) | |
Statutory tax rate change | (941) | (43,924) | (9,471) | |
Interest disallowance | (1,737) | (646) | ||
Other items, net | (6,045) | (860) | (2,203) | |
Income tax (expense) | $ (5,000) | $ (55,900) | $ (73,948) | $ (31,056) |
Income Taxes - Summary of Rec_2
Income Taxes - Summary of Reconciliation of Income Tax Benefit (Expense) from the Statutory Income Tax Rate to the Effective Tax Rate Based on Income before Income Taxes (Parenthetical) (Detail) | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | |||
Income tax at the US statutory federal rate | 21% | 21% | 21% |
Income Taxes - Schedule of Defe
Income Taxes - Schedule of Deferred Tax Assets and liabilities (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Income Tax Disclosure [Abstract] | ||
Operating loss and interest deduction carry forwards | $ 175,922 | $ 197,876 |
Other | 15,218 | 1,815 |
Total deferred tax assets | 191,140 | 199,691 |
Valuation allowance | (71,499) | (61,747) |
Total net deferred tax assets | 119,641 | 137,944 |
Property and equipment | (294,181) | (320,546) |
Net unbilled revenue | (63,324) | (43,366) |
Partnership investments | (26,268) | (15,963) |
Other | (27,153) | (3,836) |
Total deferred tax liabilities | (410,926) | (383,711) |
Net deferred tax asset (liability) | $ (291,285) | $ (245,767) |
Income Taxes - Schedule of Net
Income Taxes - Schedule of Net NOL and Other Tax Attribute Carryforwards (Detail) $ in Thousands | 12 Months Ended |
Dec. 31, 2022 USD ($) | |
U.S. [Member] | |
Income Taxes [Line Items] | |
Gross NOL carryforwards | $ 148,900 |
Tax-effected NOL carryforwards | 24,013 |
Valuation allowance | (13,864) |
Net deferred tax asset - NOL carryforwards | $ 10,149 |
Expiration periods | 2024 |
Expiration periods | indefinite |
Foreign [Member] | |
Income Taxes [Line Items] | |
Gross NOL carryforwards | $ 633,682 |
Tax-effected NOL carryforwards | 151,909 |
Valuation allowance | (57,635) |
Net deferred tax asset - NOL carryforwards | $ 94,274 |
Expiration periods | indefinite |
Income Taxes - Schedule of Per
Income Taxes - Schedule of Per Share Distributions to Stockholders (Detail) - $ / shares | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | |||
Common share distribution | $ 1.1500 | $ 1.1100 | $ 1.0700 |
Ordinary dividend | 0.4703 | 0.7646 | 0.6030 |
Long-term capital gain | 0.6797 | 0.1654 | |
Return of capital | 0.1800 | 0.4670 | |
Total | $ 1.1500 | $ 1.1100 | $ 1.0700 |
Income Taxes - Schedule of Pe_2
Income Taxes - Schedule of Per Share Distributions to Stockholders (Parenthetical) (Details) - $ / shares | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | |||
Section 199A Dividends | $ 0.4703 | $ 0.7646 | $ 0.6030 |
Unrecaptured Sec. 1250 gain | $ 0.2574 | $ 0.0583 | $ 0 |
Earnings Per Share_Unit - Calcu
Earnings Per Share/Unit - Calculation of Earnings Per Share (Detail) - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] | |||
Net income | $ 903,819 | $ 656,940 | $ 432,272 |
Non-controlling interests’ share in earnings | (1,222) | (919) | (822) |
Participating securities’ share in earnings | (1,602) | (2,161) | (2,105) |
Net income, less participating securities’ share in earnings | $ 900,995 | $ 653,860 | $ 429,345 |
Basic weighted-average common shares | 598,634 | 588,817 | 529,239 |
Dilutive potential common shares | 203 | 1,322 | 1,222 |
Diluted weighted-average common shares | 598,837 | 590,139 | 530,461 |
MPT Operating Partnership, L.P. [Member] | |||
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] | |||
Net income | $ 903,819 | $ 656,940 | $ 432,272 |
Non-controlling interests’ share in earnings | (1,222) | (919) | (822) |
Participating securities’ share in earnings | (1,602) | (2,161) | (2,105) |
Net income, less participating securities’ share in earnings | $ 900,995 | $ 653,860 | $ 429,345 |
Basic weighted-average common shares | 598,634 | 588,817 | 529,239 |
Dilutive potential common shares | 203 | 1,322 | 1,222 |
Diluted weighted-average common shares | 598,837 | 590,139 | 530,461 |
Stock Awards - Additional Infor
Stock Awards - Additional Information (Detail) - USD ($) $ in Thousands | 12 Months Ended | |||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Jun. 30, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Stock / (Unit)-based compensation expense | $ 49,421 | $ 52,110 | $ 47,154 | |
Stock-based compensation expense, unrecognized cost | $ 47,100 | |||
Stock-based compensation expense, unrecognized cost, reorganization period (in years) | 1 year 2 months 12 days | |||
Stock-based awards, fair value | $ 82,600 | $ 49,900 | $ 58,900 | |
Maximum [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Stock awards vesting period in years | 10 years | |||
Equity Incentive Plan [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Reserved shares of new common stock for awards under the Equity Incentive Plan | 28,900,000 | 16,000,000 | ||
Common stock remaining for future stock awards transferred to the equity incentive plan | 19,300,000 | |||
Maximum number of shares of common stock that may be awarded | 5,000,000 | |||
Service-Based Awards [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based compensation arrangement by share based payment award, expected service period (in years) | 3 years | |||
Performance-Based Awards [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based compensation arrangement by share based payment award, expected service period (in years) | 3 years |
Stock Awards - Stock-based Awar
Stock Awards - Stock-based Award Activity (Detail) - $ / shares | 12 Months Ended | |
Dec. 31, 2022 | Dec. 31, 2021 | |
Vesting Based on Service [Member] | ||
Employee Restricted Equity Awards Vesting Activity [Line Items] | ||
Nonvested awards at beginning of the year, Shares | 922,954 | 1,057,054 |
Awarded, Shares | 659,393 | 651,113 |
Vested, Shares | (750,854) | (781,076) |
Forfeited, Shares | (21,010) | (4,137) |
Nonvested awards at end of year, Shares | 810,483 | 922,954 |
Nonvested awards at beginning of the year, Weighted Average Value at Award Date | $ 20.26 | $ 18.79 |
Awarded, Weighted Average Value at Award Date | 21.18 | 20.83 |
Vested, Weighted Average Value at Award Date | 20.25 | 18.77 |
Forfeited, Weighted Average Value at Award Date | 20.06 | 18.69 |
Nonvested awards at end of year, Weighted Average Value at Award Date | $ 21.02 | $ 20.26 |
Vesting Based on Market/Performance Conditions [Member] | ||
Employee Restricted Equity Awards Vesting Activity [Line Items] | ||
Nonvested awards at beginning of the year, Shares | 5,477,536 | 5,086,983 |
Awarded, Shares | 1,828,971 | 1,957,802 |
Vested, Shares | (2,924,722) | (1,551,482) |
Forfeited, Shares | (32,704) | (15,767) |
Nonvested awards at end of year, Shares | 4,349,081 | 5,477,536 |
Nonvested awards at beginning of the year, Weighted Average Value at Award Date | $ 15.86 | $ 14.41 |
Awarded, Weighted Average Value at Award Date | 18.45 | 17.94 |
Vested, Weighted Average Value at Award Date | 13.87 | 13.73 |
Forfeited, Weighted Average Value at Award Date | 19.17 | 16.72 |
Nonvested awards at end of year, Weighted Average Value at Award Date | $ 18.26 | $ 15.86 |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Detail) $ in Thousands | 3 Months Ended | 12 Months Ended | |||
Oct. 05, 2022 USD ($) Facility | Dec. 31, 2021 USD ($) | Dec. 31, 2022 USD ($) Facility | Dec. 31, 2021 USD ($) Facility | Dec. 31, 2020 USD ($) Facility | |
Commitment And Contingencies [Line Items] | |||||
Number of facilities sold | Facility | 15 | 16 | 9 | ||
Expected cash proceeds on transaction close | $ | $ 54,500 | $ 522,000 | $ 246,000 | $ 94 | |
Prospect [Member] | Connecticut [Member] | |||||
Commitment And Contingencies [Line Items] | |||||
Number of facilities sold | Facility | 3 | ||||
Expected cash proceeds on transaction close | $ | $ 457,000 |
Common Stock_Partners' Capital
Common Stock/Partners' Capital - Additional Information (Detail) - USD ($) | 12 Months Ended | |||||
Oct. 09, 2022 | Jan. 11, 2021 | Dec. 28, 2020 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Class Of Stock [Line Items] | ||||||
Common stock, shares issued | 597,476,000 | 596,748,000 | ||||
Proceeds from sale of common shares / units, net of offering costs | $ 1,051,229,000 | $ 411,101,000 | ||||
Shares issued price per share | $ 0.001 | |||||
Stock repurchase, Value | $ 17,940,000 | |||||
Stock repurchase program expiration date | Oct. 10, 2023 | |||||
Redemption of common units | 4,928,000 | |||||
Maximum [Member] | ||||||
Class Of Stock [Line Items] | ||||||
Stock repurchase program, authorized amount | $ 500,000,000 | |||||
MPT Operating Partnership, L.P. [Member] | ||||||
Class Of Stock [Line Items] | ||||||
Stock repurchase, Value | 17,940,000 | |||||
Redemption of common units | $ 4,900,000 | $ 0 | $ 4,928,000 | |||
MPT Operating Partnership, L.P. [Member] | Medical Properties Trust, LLC. [Member] | ||||||
Class Of Stock [Line Items] | ||||||
Percentage of ownership of general partner | 100% | |||||
MPT Operating Partnership, L.P. [Member] | MPT TRS, Inc [Member] | ||||||
Class Of Stock [Line Items] | ||||||
Percentage of ownership of general partner | 100% | |||||
MPT Operating Partnership, L.P. [Member] | Operating Partnership [Member] | ||||||
Class Of Stock [Line Items] | ||||||
Percentage of ownership limited partner | 100% | |||||
Common Units [Member] | ||||||
Class Of Stock [Line Items] | ||||||
Number of share sold | 53,063,000 | 21,004,000 | ||||
Stock repurchase, Shares | 1,645,000 | |||||
Stock repurchase, Value | $ 2,000 | |||||
Common Units [Member] | MPT Operating Partnership, L.P. [Member] | Limited Partner [Member] | ||||||
Class Of Stock [Line Items] | ||||||
Number of share sold | 52,532,000 | 20,795,000 | ||||
Stock repurchase, Shares | 1,629,000 | |||||
Stock repurchase, Value | $ 17,761,000 | |||||
Conversion of LTIP units to common units | 232,000 | 232,000 | ||||
Redemption of common units | $ 4,928,000 | |||||
Public Offering [Member] | ||||||
Class Of Stock [Line Items] | ||||||
Common stock, shares issued | 36,800,000 | |||||
Proceeds from sale of common shares / units, net of offering costs | $ 711,000,000 | |||||
At-the-Market Equity Offering Program [Member] | ||||||
Class Of Stock [Line Items] | ||||||
Proceeds from sale of common shares / units, net of offering costs | $ 340,000,000 | |||||
At-the-Market Equity Offering Program [Member] | Common Units [Member] | ||||||
Class Of Stock [Line Items] | ||||||
Number of share sold | 16,300,000 | 21,000,000 |
Fair Value of Financial Instr_3
Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Fair Value Disclosures [Abstract] | ||
Interest and rent receivables, Book value | $ 167,035 | $ 56,229 |
Loans, Book value | 1,405,615 | 991,609 |
Debt, net Book value | (10,268,412) | (11,282,770) |
Interest and rent receivables, Fair value | 163,101 | 56,564 |
Loans, Fair value | 1,360,113 | 991,954 |
Debt, net Fair value | $ (8,697,042) | $ (11,526,388) |
Fair Value of Financial Instr_4
Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Parenthetical) (Detail) $ in Thousands | 12 Months Ended | |
Dec. 31, 2022 USD ($) Health_Center | Dec. 31, 2021 USD ($) | |
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items] | ||
Mortgage loans | $ 364,101 | $ 213,211 |
Investments in unconsolidated real estate joint ventures | 1,497,903 | 1,152,927 |
Investments in unconsolidated operating entities | 1,444,872 | 1,289,434 |
Shareholder Loan [Member] | ||
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items] | ||
Mortgage loans | 223,800 | 70,100 |
Investments in unconsolidated real estate joint ventures | 315,900 | 335,600 |
Loans [Member] | ||
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items] | ||
Investments in unconsolidated operating entities | 640,400 | 521,400 |
Other loans | $ 225,500 | $ 64,500 |
Fair Value, Recurring | Colombia [Member] | ||
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items] | ||
Number of facilities acquired | Health_Center | 3 | |
Fair Value, Recurring | Acquisition Loans [Member] | Colombia [Member] | ||
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items] | ||
Number of facilities acquired | Health_Center | 3 |
Fair Value of Financial Instr_5
Fair Value of Financial Instruments - Additional Information (Detail) | 12 Months Ended | |
Dec. 31, 2022 USD ($) Health_Center | Dec. 31, 2021 USD ($) | |
Springstone Inc. and International Joint Venture [Member] | ||
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items] | ||
Discount for lack of marketability percentage on Springstone equity investment | 40% | |
Equity investments unrealized gain/loss | $ | $ 7,000,000 | $ 0 |
Fair Value, Recurring | Colombia [Member] | ||
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items] | ||
Number of facilities acquired | Health_Center | 3 |
Fair Value of Financial Instr_6
Fair Value of Financial Instruments - Equity Interest in Related Party and Related Loans Measured at Fair Value on Recurring Basis (Detail) - Fair Value, Recurring - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Mortgage Loans [Member] | ||
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items] | ||
Fair Value | $ 140,260 | $ 143,068 |
Original Cost | 140,260 | 143,068 |
Equity Method Investment and Other Loans [Member] | ||
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items] | ||
Fair Value | 434,609 | 409,638 |
Original Cost | $ 441,943 | $ 409,638 |
Fair Value of Financial Instr_7
Fair Value of Financial Instruments - Schedule of Effects of Movement in DLOM by Sensitivity Analysis by Using Basis Point Variations (Detail) - Springstone Inc. and International Joint Venture [Member] $ in Thousands | 12 Months Ended |
Dec. 31, 2022 USD ($) | |
+ 100 Basis Points [Member] | |
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items] | |
Estimated Increase (Decrease) in Fair Value | $ (43) |
- 100 Basis Points [Member] | |
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items] | |
Estimated Increase (Decrease) in Fair Value | $ 43 |
Leases (Lessee) - Summary of Le
Leases (Lessee) - Summary of Lease Expense (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | ||
Lessee Lease Description [Line Items] | |||
Operating lease cost | [1],[2] | $ 12,175 | $ 10,694 |
Finance lease cost: | |||
Total lease cost | 7,869 | 6,407 | |
Real Estate Depreciation and Amortization [Member] | |||
Finance lease cost: | |||
Amortization of right-of-use assets | 51 | 51 | |
Interest [Member] | |||
Finance lease cost: | |||
Interest on lease liabilities | 128 | 128 | |
Other [Member] | |||
Finance lease cost: | |||
Sublease income | $ (4,485) | $ (4,466) | |
[1] $ 5.7 million and $ 6.3 million included in “Property-related”, with the remainder reflected in the “General and administrative” line of our consolidated statements of net income for 2022 and 2021, respectively. Includes short-term leases. |
Leases (Lessee) - Summary of _2
Leases (Lessee) - Summary of Lease Expense (Parenthetical) (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | ||
Lessee Lease Description [Line Items] | |||
Operating lease cost | [1],[2] | $ 12,175 | $ 10,694 |
Property-related [Member] | |||
Lessee Lease Description [Line Items] | |||
Operating lease cost | $ 5,700 | $ 6,300 | |
[1] $ 5.7 million and $ 6.3 million included in “Property-related”, with the remainder reflected in the “General and administrative” line of our consolidated statements of net income for 2022 and 2021, respectively. Includes short-term leases. |
Leases (Lessee) - Schedule of F
Leases (Lessee) - Schedule of Fixed Minimum Rental Payments Due under Leases with Non-Cancelable Terms (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | |
Leases [Abstract] | |||
Operating Leases, 2023 | $ 8,742 | ||
Operating Leases, 2024 | 8,880 | ||
Operating Leases, 2025 | 8,289 | ||
Operating Leases, 2026 | 7,884 | ||
Operating Leases, 2027 | 7,873 | ||
Operating Leases, Thereafter | 235,940 | ||
Operating Leases, Total undiscounted minimum lease payments | 277,608 | ||
Operating Leases, Less: interest | (176,016) | ||
Operating Leases, Present value of lease liabilities | 101,592 | $ 85,217 | |
Finance Leases, 2023 | 129 | ||
Finance Leases, 2024 | 130 | ||
Finance Leases, 2025 | 131 | ||
Finance Leases, 2026 | 133 | ||
Finance Leases, 2027 | 134 | ||
Finance Leases, Thereafter | 4,516 | ||
Finance Leases, Total undiscounted minimum lease payments | 5,173 | ||
Finance Leases, Less: interest | (3,235) | ||
Finance Leases, Present value of lease liabilities | 1,938 | $ 1,937 | |
Amounts To Be Received From Subleases, 2023 | (4,416) | ||
Amounts To Be Received From Subleases, 2024 | (4,272) | ||
Amounts To Be Received From Subleases, 2025 | (4,328) | ||
Amounts To Be Received From Subleases, 2026 | (4,021) | ||
Amounts To Be Received From Subleases, 2027 | (3,730) | ||
Amounts To Be Received From Subleases, Thereafter | (65,320) | ||
Amounts To Be Received From Subleases, Total undiscounted minimum lease payments | (86,087) | ||
Net Payments, 2023 | 4,455 | ||
Net Payments, 2024 | 4,738 | ||
Net Payments, 2025 | 4,092 | ||
Net Payments, 2026 | 3,996 | ||
Net Payments, 2027 | 4,277 | ||
Net Payments, Thereafter | [1] | 175,136 | |
Net Payments, Total undiscounted minimum lease payments | $ 196,694 | ||
[1] Reflects certain ground leases, in which we are the lessee, that have longer initial fixed terms than our existing sublease to our tenants. However, we would expect to either renew the related sublease, enter into a lease with a new tenant, or early terminate the ground lease to reduce or avoid any significant impact from such ground leases |
Leases (Lessee) - Summary of Su
Leases (Lessee) - Summary of Supplemental Balance Sheet Information (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
Right of use assets: | ||
Finance leases | $ 1,734 | $ 1,785 |
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] | Land | Land |
Total real estate right of use assets | $ 65,287 | $ 70,401 |
Total right of use assets | 91,512 | 77,859 |
Lease liabilities: | ||
Operating leases | $ 101,592 | $ 85,217 |
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] | us-gaap:OtherLiabilities | us-gaap:OtherLiabilities |
Financing leases | $ 1,938 | $ 1,937 |
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration] | us-gaap:OtherLiabilities | us-gaap:OtherLiabilities |
Total lease liabilities | $ 103,530 | $ 87,154 |
Weighted-average remaining lease term: | ||
Operating leases | 33 years 2 months 12 days | 40 years 7 months 6 days |
Finance leases | 33 years 10 months 24 days | 34 years 10 months 24 days |
Weighted-average discount rate: | ||
Operating leases | 6.10% | 6.40% |
Finance leases | 6.60% | 6.60% |
Corporate [Member] | ||
Right of use assets: | ||
Operating leases | $ 26,225 | $ 7,458 |
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] | Other Assets | Other Assets |
Real Estate [Member] | ||
Right of use assets: | ||
Operating leases | $ 63,553 | $ 68,616 |
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] | Land | Land |
Leases (Lessee) - Summary of _3
Leases (Lessee) - Summary of Supplemental Cash Flow Information (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Cash paid for amounts included in the measurement of lease liabilities: | |||
Operating cash flows used for operating leases | $ 7,169 | $ 7,330 | |
Operating cash flows used for finance leases | 128 | 126 | |
Non-cash activities - Right-of-use assets obtained in exchange for lease obligations: | |||
Operating leases | $ 23,066 | $ 1,120 | $ 13,800 |
Other Assets - Summary of Other
Other Assets - Summary of Other Assets on our Condensed Consolidated Balance Sheets (Detail) - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 | |
Other Assets [Abstract] | |||
Debt issue costs, net | [1] | $ 12,036 | $ 5,488 |
Other corporate assets | 256,438 | 231,731 | |
Prepaids and other assets | 304,516 | 96,261 | |
Total other assets | $ 572,990 | $ 333,480 | |
[1] Relates to our revolving credit facility |
Other Assets - Additional Infor
Other Assets - Additional Information (Detail) $ in Millions | 12 Months Ended |
Dec. 31, 2022 USD ($) | |
Other Assets [Abstract] | |
Increase in derivative assets | $ 80 |
Subsequent Events - Additional
Subsequent Events - Additional Information (Detail) $ in Thousands | 12 Months Ended | |||||
Feb. 15, 2023 Facility | Feb. 07, 2023 USD ($) Facility | Apr. 25, 2022 USD ($) Facility | Dec. 31, 2022 USD ($) Facility | Dec. 31, 2021 USD ($) | Dec. 31, 2020 USD ($) | |
Subsequent Event [Line Items] | ||||||
Acquisition loan | $ 1,332,962 | $ 5,350,239 | $ 4,249,180 | |||
Catholic Health Initiatives Colorado [Member] | Utah [Member] | ||||||
Subsequent Event [Line Items] | ||||||
Percentage of total assets | 5.50% | |||||
General Acute Care Hospitals [Member] | ||||||
Subsequent Event [Line Items] | ||||||
Number of facilities acquired | Facility | 2 | 6 | ||||
Purchase price of acquisition | $ 80,000 | |||||
Subsequent Event [Member] | Catholic Health Initiatives Colorado [Member] | Utah [Member] | ||||||
Subsequent Event [Line Items] | ||||||
Initial lease term | 15 years | |||||
Percentage of initial cash yield | 7.80% | |||||
Percentage of annually operating lease | 3% | |||||
Subsequent Event [Member] | General Acute Care Hospitals [Member] | Catholic Health Initiatives Colorado [Member] | Utah [Member] | ||||||
Subsequent Event [Line Items] | ||||||
Number of leased facilities | Facility | 5 | |||||
Subsequent Event [Member] | Springstone Health Opco, LLC [Member] | ||||||
Subsequent Event [Line Items] | ||||||
Acquisition loan | $ 205,000 | |||||
Purchase price of acquisition | $ 250,000 | |||||
Subsequent Event [Member] | Springstone Health Opco, LLC [Member] | General Acute Care Hospitals [Member] | ||||||
Subsequent Event [Line Items] | ||||||
Number of facilities acquired | Facility | 8 | |||||
Lease extension expiration term | 5 years | |||||
Lease extension expiration year | 2041 |
Schedule II - Schedule of Valua
Schedule II - Schedule of Valuation and Qualifying Accounts (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] | |||
Balance at Beginning of Year | $ 154,161 | $ 146,637 | $ 109,803 |
Additions, Charged Against Operations | 294,861 | 69,131 | 58,044 |
Addition, Charged to Other Accounts | 7,340 | 22,944 | |
Deductions, Net Recoveries/Write-offs | (55,965) | (68,947) | (44,154) |
Balance at End of Year | $ 393,057 | $ 154,161 | $ 146,637 |
Schedule II - Schedule of Val_2
Schedule II - Schedule of Valuation and Qualifying Accounts (Parenthetical) (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||||
Jan. 08, 2020 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Jan. 01, 2020 | |
Increase in real estate impairment reserves | $ 170,600 | $ 19,000 | |||
Equity investment impairments reserve related to disposals | $ 6,000 | ||||
Increase in accounts receivable and other reserves | 500 | 8,000 | 23,900 | ||
Decrease in accounts receivable and other reserves | 11,700 | 38,700 | |||
Increase (decrease) in valuation allowances | 800 | ||||
Tax valuation allowances recorded as part of purchase price allocation | 7,340 | 22,944 | |||
Valuation allowances recorded as part of the purchase price allocation of the Circle Transaction | $ 14,500 | ||||
Increase (decrease) in real estate impairment reserves related to disposals | (2,900) | (22,400) | (40,500) | ||
Credit loss recovery related to loan paydowns | 1,900 | 2,900 | |||
Increase in credit loss reserves on financing-type receivables | 114,000 | 41,700 | 3,300 | ||
Decrease in credit loss reserves on financing-type receivables | 26,400 | ||||
Watsonville, California [Member] | |||||
Provision (recovery) for credit loss | 15,000 | ||||
Priory Group [Member] | |||||
Tax valuation allowances recorded as part of purchase price allocation | 7,300 | ||||
Accounting Standards Update 2016-13 | |||||
Cumulative effect of change in accounting principle | $ 8,400 | ||||
Valuation Allowance, Deferred Tax Asset [Member] | |||||
Increase (decrease) in valuation allowances | $ 9,800 | $ 20,000 | $ 11,900 |
Schedule III - Real Estate In_2
Schedule III - Real Estate Investments and Accumulated Depreciation (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | ||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Initial costs, land | $ 1,946,737 | ||||
Initial costs, buildings | 9,772,121 | ||||
Additions subsequent to acquisition, Improvements | 581,666 | ||||
Land at cost | 1,948,216 | ||||
Buildings at cost | 10,352,308 | ||||
Total at cost | 12,300,524 | $ 13,628,749 | [1] | $ 10,749,707 | $ 7,312,486 |
Accumulated Depreciation | $ 1,008,340 | $ 853,879 | |||
Princes Risborough, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 4,425 | ||||
Land at cost | 4,425 | ||||
Total at cost | 4,425 | ||||
Encumbrances | $ 0 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1981 [Member] | Ashtead, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 35,840 | ||||
Initial costs, buildings | 67,195 | ||||
Land at cost | 35,840 | ||||
Buildings at cost | 67,195 | ||||
Total at cost | 103,035 | ||||
Accumulated Depreciation | 5,852 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1981 | ||||
Date Acquired | Aug. 16, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1981 [Member] | Beckenham, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 5,184 | ||||
Initial costs, buildings | 19,882 | ||||
Land at cost | 5,184 | ||||
Buildings at cost | 19,882 | ||||
Total at cost | 25,066 | ||||
Accumulated Depreciation | 1,501 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1981 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1981 [Member] | Cheadle, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 29,362 | ||||
Initial costs, buildings | 154,668 | ||||
Land at cost | 29,362 | ||||
Buildings at cost | 154,668 | ||||
Total at cost | 184,030 | ||||
Accumulated Depreciation | 11,673 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1981 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1981 [Member] | Croydon, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 9,437 | ||||
Initial costs, buildings | 39,583 | ||||
Land at cost | 9,437 | ||||
Buildings at cost | 39,583 | ||||
Total at cost | 49,020 | ||||
Accumulated Depreciation | 3,007 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1981 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1981 [Member] | Dorchester, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 512 | ||||
Initial costs, buildings | 29,746 | ||||
Land at cost | 512 | ||||
Buildings at cost | 29,746 | ||||
Total at cost | 30,258 | ||||
Accumulated Depreciation | 2,242 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1981 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1981 [Member] | Euxton, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 4,382 | ||||
Initial costs, buildings | 33,750 | ||||
Land at cost | 4,382 | ||||
Buildings at cost | 33,750 | ||||
Total at cost | 38,132 | ||||
Accumulated Depreciation | 3,026 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1981 | ||||
Date Acquired | Aug. 16, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1981 [Member] | Great Missenden, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 11,171 | ||||
Initial costs, buildings | 99,814 | ||||
Land at cost | 11,171 | ||||
Buildings at cost | 99,814 | ||||
Total at cost | 110,985 | ||||
Accumulated Depreciation | 7,545 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1981 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1981 [Member] | Torquay, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,829 | ||||
Initial costs, buildings | 33,923 | ||||
Land at cost | 2,829 | ||||
Buildings at cost | 33,923 | ||||
Total at cost | 36,752 | ||||
Accumulated Depreciation | 2,915 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1981 | ||||
Date Acquired | Aug. 16, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2008 [Member] | Arnold, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 453 | ||||
Initial costs, buildings | 9,412 | ||||
Land at cost | 453 | ||||
Buildings at cost | 9,412 | ||||
Total at cost | 9,865 | ||||
Accumulated Depreciation | 387 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2008 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2008 [Member] | Bath, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,432 | ||||
Initial costs, buildings | 29,685 | ||||
Land at cost | 1,432 | ||||
Buildings at cost | 29,685 | ||||
Total at cost | 31,117 | ||||
Accumulated Depreciation | 6,308 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2008 | ||||
Date Acquired | Jul. 01, 2014 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2008 [Member] | Boardman, OH [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Long term acute care hospital | ||||
Initial costs, land | $ 79 | ||||
Initial costs, buildings | 275 | ||||
Land at cost | 79 | ||||
Buildings at cost | 275 | ||||
Total at cost | 354 | ||||
Accumulated Depreciation | 26 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2008 | ||||
Date Acquired | Aug. 30, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2008 [Member] | Boise, ID [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Long term acute care hospital | ||||
Initial costs, land | $ 1,558 | ||||
Initial costs, buildings | 11,027 | ||||
Land at cost | 1,558 | ||||
Buildings at cost | 11,027 | ||||
Total at cost | 12,585 | ||||
Accumulated Depreciation | 1,094 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2008 | ||||
Date Acquired | Feb. 29, 2012 | ||||
Life on which depreciation in latest income statements is computed (Years) | 50 years | ||||
2008 [Member] | Crown Point, IN [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Long term acute care hospital | ||||
Initial costs, land | $ 302 | ||||
Initial costs, buildings | 528 | ||||
Land at cost | 302 | ||||
Buildings at cost | 528 | ||||
Total at cost | 830 | ||||
Accumulated Depreciation | 56 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2008 | ||||
Date Acquired | Aug. 30, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2008 [Member] | Denville, NJ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 15,709 | ||||
Initial costs, buildings | 55,772 | ||||
Land at cost | 15,709 | ||||
Buildings at cost | 55,772 | ||||
Total at cost | 71,481 | ||||
Accumulated Depreciation | 3,308 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2008 | ||||
Date Acquired | Sep. 30, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2008 [Member] | Dover NJ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 3,865 | ||||
Initial costs, buildings | 8,693 | ||||
Land at cost | 3,865 | ||||
Buildings at cost | 8,693 | ||||
Total at cost | 12,558 | ||||
Accumulated Depreciation | 549 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2008 | ||||
Date Acquired | Sep. 30, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2008 [Member] | Lubbock, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 1,376 | ||||
Initial costs, buildings | 28,292 | ||||
Additions subsequent to acquisition, Improvements | 3,648 | ||||
Land at cost | 1,376 | ||||
Buildings at cost | 31,940 | ||||
Total at cost | 33,316 | ||||
Accumulated Depreciation | 5,906 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2008 | ||||
Date Acquired | Jun. 16, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2008 [Member] | Sheffield, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 6,277 | ||||
Initial costs, buildings | 42,344 | ||||
Land at cost | 6,277 | ||||
Buildings at cost | 42,344 | ||||
Total at cost | 48,621 | ||||
Accumulated Depreciation | 3,223 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2008 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1811 [Member] | London, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 34,421 | ||||
Initial costs, buildings | 49,182 | ||||
Land at cost | 34,421 | ||||
Buildings at cost | 49,182 | ||||
Total at cost | 83,603 | ||||
Accumulated Depreciation | 110 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1811 | ||||
Date Acquired | Dec. 09, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1890 [Member] | Altrincham, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 13,899 | ||||
Initial costs, buildings | 23,895 | ||||
Land at cost | 13,899 | ||||
Buildings at cost | 23,895 | ||||
Total at cost | 37,794 | ||||
Accumulated Depreciation | 61 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1890 | ||||
Date Acquired | Dec. 09, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1790 [Member] | Bristol, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 4,466 | ||||
Initial costs, buildings | 35,485 | ||||
Land at cost | 4,466 | ||||
Buildings at cost | 35,485 | ||||
Total at cost | 39,951 | ||||
Accumulated Depreciation | 79 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1790 | ||||
Date Acquired | Dec. 09, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1790 [Member] | Essex, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 4,406 | ||||
Initial costs, buildings | 41,011 | ||||
Land at cost | 4,406 | ||||
Buildings at cost | 41,011 | ||||
Total at cost | 45,417 | ||||
Accumulated Depreciation | 91 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1790 | ||||
Date Acquired | Dec. 09, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1790 [Member] | London, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 27,463 | ||||
Initial costs, buildings | 14,237 | ||||
Land at cost | 27,463 | ||||
Buildings at cost | 14,237 | ||||
Total at cost | 41,700 | ||||
Accumulated Depreciation | 36 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1790 | ||||
Date Acquired | Dec. 09, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2014 [Member] | Altoona, WI [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, buildings | $ 29,062 | ||||
Buildings at cost | 29,062 | ||||
Total at cost | 29,062 | ||||
Accumulated Depreciation | 6,055 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2014 | ||||
Date Acquired | Aug. 31, 2014 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2014 [Member] | Altrincham, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 13,899 | ||||
Initial costs, buildings | 23,895 | ||||
Land at cost | 13,899 | ||||
Buildings at cost | 23,895 | ||||
Total at cost | 37,794 | ||||
Accumulated Depreciation | 61 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2014 | ||||
Date Acquired | Dec. 09, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2014 [Member] | Alvin, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 105 | ||||
Initial costs, buildings | 4,087 | ||||
Land at cost | 105 | ||||
Buildings at cost | 4,087 | ||||
Total at cost | 4,192 | ||||
Accumulated Depreciation | 871 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2014 | ||||
Date Acquired | Mar. 19, 2014 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2014 [Member] | Bristol, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 4,466 | ||||
Initial costs, buildings | 35,485 | ||||
Land at cost | 4,466 | ||||
Buildings at cost | 35,485 | ||||
Total at cost | 39,951 | ||||
Accumulated Depreciation | 79 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2014 | ||||
Date Acquired | Dec. 09, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2014 [Member] | Broomfield, CO [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 825 | ||||
Initial costs, buildings | 3,895 | ||||
Land at cost | 825 | ||||
Buildings at cost | 3,895 | ||||
Total at cost | 4,720 | ||||
Accumulated Depreciation | 828 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2014 | ||||
Date Acquired | Jul. 03, 2014 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2014 [Member] | Commerce City, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 707 | ||||
Initial costs, buildings | 4,248 | ||||
Land at cost | 707 | ||||
Buildings at cost | 4,248 | ||||
Total at cost | 4,955 | ||||
Accumulated Depreciation | 858 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2014 | ||||
Date Acquired | Dec. 11, 2014 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2014 [Member] | Colorado Springs CO [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 600 | ||||
Initial costs, buildings | 4,231 | ||||
Land at cost | 600 | ||||
Buildings at cost | 4,231 | ||||
Total at cost | 4,831 | ||||
Accumulated Depreciation | 908 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2014 | ||||
Date Acquired | Jun. 05, 2014 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2014 [Member] | Essex, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 4,406 | ||||
Initial costs, buildings | 41,011 | ||||
Land at cost | 4,406 | ||||
Buildings at cost | 41,011 | ||||
Total at cost | 45,417 | ||||
Accumulated Depreciation | 91 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2014 | ||||
Date Acquired | Dec. 09, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2014 [Member] | Firestone, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 495 | ||||
Initial costs, buildings | 3,963 | ||||
Land at cost | 495 | ||||
Buildings at cost | 3,963 | ||||
Total at cost | 4,458 | ||||
Accumulated Depreciation | 850 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2014 | ||||
Date Acquired | Jun. 06, 2014 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2014 [Member] | Fort Worth, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 3,406 | ||||
Initial costs, buildings | 34,627 | ||||
Land at cost | 3,406 | ||||
Buildings at cost | 34,627 | ||||
Total at cost | 38,033 | ||||
Accumulated Depreciation | 1,131 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2014 | ||||
Date Acquired | Oct. 19, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2014 [Member] | Fountain, CO [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 1,508 | ||||
Initial costs, buildings | 4,131 | ||||
Land at cost | 1,508 | ||||
Buildings at cost | 4,131 | ||||
Total at cost | 5,639 | ||||
Accumulated Depreciation | 869 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2014 | ||||
Date Acquired | Jul. 31, 2014 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2014 [Member] | Georgetown, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 4,569 | ||||
Initial costs, buildings | 22,858 | ||||
Additions subsequent to acquisition, Improvements | 1,062 | ||||
Land at cost | 4,569 | ||||
Buildings at cost | 23,920 | ||||
Total at cost | 28,489 | ||||
Accumulated Depreciation | 741 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2014 | ||||
Date Acquired | Oct. 19, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2014 [Member] | London, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 27,463 | ||||
Initial costs, buildings | 14,237 | ||||
Land at cost | 27,463 | ||||
Buildings at cost | 14,237 | ||||
Total at cost | 41,700 | ||||
Accumulated Depreciation | 36 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2014 | ||||
Date Acquired | Dec. 09, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2014 [Member] | London, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 34,421 | ||||
Initial costs, buildings | 49,182 | ||||
Land at cost | 34,421 | ||||
Buildings at cost | 49,182 | ||||
Total at cost | 83,603 | ||||
Accumulated Depreciation | 110 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2014 | ||||
Date Acquired | Dec. 09, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2014 [Member] | Ogden, UT [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 1,759 | ||||
Initial costs, buildings | 16,414 | ||||
Land at cost | 1,759 | ||||
Buildings at cost | 16,414 | ||||
Total at cost | 18,173 | ||||
Accumulated Depreciation | 3,614 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2014 | ||||
Date Acquired | Mar. 01, 2014 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2014 [Member] | Pearland, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 1,075 | ||||
Initial costs, buildings | 3,577 | ||||
Land at cost | 1,075 | ||||
Buildings at cost | 3,577 | ||||
Total at cost | 4,652 | ||||
Accumulated Depreciation | 745 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2014 | ||||
Date Acquired | Sep. 08, 2014 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2014 [Member] | San Antonio, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 351 | ||||
Initial costs, buildings | 3,952 | ||||
Land at cost | 351 | ||||
Buildings at cost | 3,952 | ||||
Total at cost | 4,303 | ||||
Accumulated Depreciation | 863 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2014 | ||||
Date Acquired | Jan. 01, 2014 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2014 [Member] | Richmond, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 5,380 | ||||
Initial costs, buildings | 6,155 | ||||
Additions subsequent to acquisition, Improvements | 736 | ||||
Land at cost | 5,380 | ||||
Buildings at cost | 6,891 | ||||
Total at cost | 12,271 | ||||
Accumulated Depreciation | 254 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2014 | ||||
Date Acquired | Oct. 19, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2014 [Member] | Surrey, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 14,280 | ||||
Initial costs, buildings | 8,741 | ||||
Land at cost | 14,280 | ||||
Buildings at cost | 8,741 | ||||
Total at cost | 23,021 | ||||
Accumulated Depreciation | 25 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2014 | ||||
Date Acquired | Dec. 09, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2014 [Member] | Thornton, CO [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 1,350 | ||||
Initial costs, buildings | 4,259 | ||||
Land at cost | 1,350 | ||||
Buildings at cost | 4,259 | ||||
Total at cost | 5,609 | ||||
Accumulated Depreciation | 887 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2014 | ||||
Date Acquired | Aug. 29, 2014 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1887 [Member} | Bassenheim, Germany [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 1,095 | ||||
Initial costs, buildings | 5,129 | ||||
Land at cost | 1,095 | ||||
Buildings at cost | 5,129 | ||||
Total at cost | 6,224 | ||||
Accumulated Depreciation | 557 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1887 | ||||
Date Acquired | Feb. 09, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 39 years | ||||
1974 [Member] | Bad Salzuflen, Germany [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 10,186 | ||||
Initial costs, buildings | 25,777 | ||||
Land at cost | 10,186 | ||||
Buildings at cost | 25,777 | ||||
Total at cost | 35,963 | ||||
Accumulated Depreciation | 3,573 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1974 | ||||
Date Acquired | Nov. 30, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1974 [Member] | Sebastian Fl | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 5,733 | ||||
Initial costs, buildings | 49,136 | ||||
Additions subsequent to acquisition, Improvements | 56,430 | ||||
Land at cost | 5,733 | ||||
Buildings at cost | 105,566 | ||||
Total at cost | 111,299 | ||||
Accumulated Depreciation | 11,126 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1974 | ||||
Date Acquired | May 01, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 41 years | ||||
2017 [Member] | Austin, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 3,665 | ||||
Initial costs, buildings | 4,200 | ||||
Land at cost | 3,665 | ||||
Buildings at cost | 4,200 | ||||
Total at cost | 7,865 | ||||
Accumulated Depreciation | 642 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2017 | ||||
Date Acquired | Mar. 02, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2017 [Member] | Birmingham, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 7,952 | ||||
Initial costs, buildings | 40,068 | ||||
Land at cost | 7,952 | ||||
Buildings at cost | 40,068 | ||||
Total at cost | 48,020 | ||||
Accumulated Depreciation | 2,504 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2017 | ||||
Date Acquired | Apr. 03, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2017 [Member] | Columbus OH [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 2,101 | ||||
Initial costs, buildings | 44,218 | ||||
Land at cost | 2,101 | ||||
Buildings at cost | 44,218 | ||||
Total at cost | 46,319 | ||||
Accumulated Depreciation | 1,422 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2017 | ||||
Date Acquired | Oct. 19, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2017 [Member] | Englewood, CO [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 3,369 | ||||
Initial costs, buildings | 65,480 | ||||
Land at cost | 3,369 | ||||
Buildings at cost | 65,480 | ||||
Total at cost | 68,849 | ||||
Accumulated Depreciation | 2,081 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2017 | ||||
Date Acquired | Oct. 19, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2017 [Member] | Frome, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 10,340 | ||||
Initial costs, buildings | 10,166 | ||||
Land at cost | 10,340 | ||||
Buildings at cost | 10,166 | ||||
Total at cost | 20,506 | ||||
Accumulated Depreciation | 567 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2017 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2017 [Member] | Kansas City, KS [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,351 | ||||
Initial costs, buildings | 13,665 | ||||
Land at cost | 2,351 | ||||
Buildings at cost | 13,665 | ||||
Total at cost | 16,016 | ||||
Accumulated Depreciation | 1,059 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2017 | ||||
Date Acquired | Jun. 10, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 50 years | ||||
2017 [Member] | Kuopio, Finland [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,269 | ||||
Initial costs, buildings | 42,401 | ||||
Land at cost | 1,269 | ||||
Buildings at cost | 42,401 | ||||
Total at cost | 43,670 | ||||
Accumulated Depreciation | 920 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2017 | ||||
Date Acquired | Mar. 11, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 29 years | ||||
2017 [Member] | Leawood, KS [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,513 | ||||
Initial costs, buildings | 13,938 | ||||
Land at cost | 2,513 | ||||
Buildings at cost | 13,938 | ||||
Total at cost | 16,451 | ||||
Accumulated Depreciation | 1,073 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2017 | ||||
Date Acquired | Jun. 10, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 50 years | ||||
2017 [Member] | Oulu, Finland [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 3,076 | ||||
Initial costs, buildings | 43,939 | ||||
Land at cost | 3,076 | ||||
Buildings at cost | 43,939 | ||||
Total at cost | 47,015 | ||||
Accumulated Depreciation | 965 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2017 | ||||
Date Acquired | Mar. 11, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2017 [Member] | Overland Park, KS [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,974 | ||||
Initial costs, buildings | 14,405 | ||||
Land at cost | 2,974 | ||||
Buildings at cost | 14,405 | ||||
Total at cost | 17,379 | ||||
Accumulated Depreciation | 1,127 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2017 | ||||
Date Acquired | Jun. 10, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 50 years | ||||
2017 [Member] | Monmouth, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 14,717 | ||||
Initial costs, buildings | 10,964 | ||||
Land at cost | 14,717 | ||||
Buildings at cost | 10,964 | ||||
Total at cost | 25,681 | ||||
Accumulated Depreciation | 556 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2017 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2017 [Member] | Oklahoma City, OK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 3,641 | ||||
Initial costs, buildings | 3,047 | ||||
Land at cost | 3,641 | ||||
Buildings at cost | 3,047 | ||||
Total at cost | 6,688 | ||||
Accumulated Depreciation | 181 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2017 | ||||
Date Acquired | Oct. 19, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2017 [Member] | Phoenix, AZ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 5,576 | ||||
Initial costs, buildings | 45,782 | ||||
Land at cost | 5,576 | ||||
Buildings at cost | 45,782 | ||||
Total at cost | 51,358 | ||||
Accumulated Depreciation | 6,772 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2017 | ||||
Date Acquired | Feb. 10, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2017 [Member] | Phoenix, AZ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 1,132 | ||||
Initial costs, buildings | 5,052 | ||||
Land at cost | 1,132 | ||||
Buildings at cost | 5,052 | ||||
Total at cost | 6,184 | ||||
Accumulated Depreciation | 726 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2017 | ||||
Date Acquired | Apr. 13, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2017 [Member] | Texarkana, Texas [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 14,562 | ||||
Land at cost | 14,562 | ||||
Total at cost | 14,562 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2017 | ||||
Date Acquired | Sep. 29, 2017 | ||||
2017 [Member] | Valencia, Spain [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 10,791 | ||||
Initial costs, buildings | 67,447 | ||||
Land at cost | 10,791 | ||||
Buildings at cost | 67,447 | ||||
Total at cost | 78,238 | ||||
Accumulated Depreciation | 2,106 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2017 | ||||
Date Acquired | Dec. 02, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | Avondale, AZ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 5,383 | ||||
Initial costs, buildings | 64,650 | ||||
Land at cost | 5,383 | ||||
Buildings at cost | 64,650 | ||||
Total at cost | 70,033 | ||||
Accumulated Depreciation | 2,050 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Oct. 19, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | Bad Salzuflen, Germany [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 10,186 | ||||
Initial costs, buildings | 25,777 | ||||
Land at cost | 10,186 | ||||
Buildings at cost | 25,777 | ||||
Total at cost | 35,963 | ||||
Accumulated Depreciation | 3,573 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Nov. 30, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | Birmingham, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 391 | ||||
Initial costs, buildings | 18,188 | ||||
Land at cost | 391 | ||||
Buildings at cost | 18,188 | ||||
Total at cost | 18,579 | ||||
Accumulated Depreciation | 731 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | Goodyear, AZ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 1,800 | ||||
Initial costs, buildings | 4,713 | ||||
Land at cost | 1,800 | ||||
Buildings at cost | 4,713 | ||||
Total at cost | 6,513 | ||||
Accumulated Depreciation | 795 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Apr. 04, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | Flagstaff, AZ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 3,049 | ||||
Initial costs, buildings | 22,464 | ||||
Land at cost | 3,049 | ||||
Buildings at cost | 22,464 | ||||
Total at cost | 25,513 | ||||
Accumulated Depreciation | 2,714 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Aug. 23, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | Helotes, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 1,900 | ||||
Initial costs, buildings | 5,115 | ||||
Land at cost | 1,900 | ||||
Buildings at cost | 5,115 | ||||
Total at cost | 7,015 | ||||
Accumulated Depreciation | 874 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Mar. 10, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | Glendale,AZ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 1,144 | ||||
Initial costs, buildings | 6,087 | ||||
Land at cost | 1,144 | ||||
Buildings at cost | 6,087 | ||||
Total at cost | 7,231 | ||||
Accumulated Depreciation | 938 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Oct. 21, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | Houston, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 950 | ||||
Initial costs, buildings | 3,996 | ||||
Land at cost | 950 | ||||
Buildings at cost | 3,996 | ||||
Total at cost | 4,946 | ||||
Accumulated Depreciation | 624 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Sep. 26, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | Highlands Ranch, CO [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 4,200 | ||||
Initial costs, buildings | 4,779 | ||||
Land at cost | 4,200 | ||||
Buildings at cost | 4,779 | ||||
Total at cost | 8,979 | ||||
Accumulated Depreciation | 767 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Jul. 25, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | Katy, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 1,556 | ||||
Initial costs, buildings | 4,174 | ||||
Land at cost | 1,556 | ||||
Buildings at cost | 4,174 | ||||
Total at cost | 5,730 | ||||
Accumulated Depreciation | 652 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Oct. 10, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | Longmont, CO [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 1,773 | ||||
Initial costs, buildings | 4,181 | ||||
Land at cost | 1,773 | ||||
Buildings at cost | 4,181 | ||||
Total at cost | 5,954 | ||||
Accumulated Depreciation | 723 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Feb. 10, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | Mandeville, LA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 2,800 | ||||
Initial costs, buildings | 5,370 | ||||
Land at cost | 2,800 | ||||
Buildings at cost | 5,370 | ||||
Total at cost | 8,170 | ||||
Accumulated Depreciation | 828 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Oct. 28, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | Marrero, LA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 1,584 | ||||
Initial costs, buildings | 5,801 | ||||
Land at cost | 1,584 | ||||
Buildings at cost | 5,801 | ||||
Total at cost | 7,385 | ||||
Accumulated Depreciation | 943 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Jul. 15, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | Miami, FL [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 20,430 | ||||
Initial costs, buildings | 33,881 | ||||
Additions subsequent to acquisition, Improvements | 10,364 | ||||
Land at cost | 20,430 | ||||
Buildings at cost | 44,245 | ||||
Total at cost | 64,675 | ||||
Accumulated Depreciation | 593 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Apr. 25, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | New Orleans, LA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 2,850 | ||||
Initial costs, buildings | 6,125 | ||||
Land at cost | 2,850 | ||||
Buildings at cost | 6,125 | ||||
Total at cost | 8,975 | ||||
Accumulated Depreciation | 957 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Sep. 23, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | San Antonio, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 3,120 | ||||
Initial costs, buildings | 4,801 | ||||
Land at cost | 3,120 | ||||
Buildings at cost | 4,801 | ||||
Total at cost | 7,921 | ||||
Accumulated Depreciation | 730 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Dec. 09, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | Plano, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 4,204 | ||||
Initial costs, buildings | 2,492 | ||||
Land at cost | 4,204 | ||||
Buildings at cost | 2,492 | ||||
Total at cost | 6,696 | ||||
Accumulated Depreciation | 494 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Sep. 30, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | Rosenberg, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 1,270 | ||||
Initial costs, buildings | 4,505 | ||||
Land at cost | 1,270 | ||||
Buildings at cost | 4,505 | ||||
Total at cost | 5,775 | ||||
Accumulated Depreciation | 788 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Jan. 15, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | San Antonio, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 2,412 | ||||
Initial costs, buildings | 4,253 | ||||
Land at cost | 2,412 | ||||
Buildings at cost | 4,253 | ||||
Total at cost | 6,665 | ||||
Accumulated Depreciation | 656 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Oct. 27, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | The Woodlands, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 2,005 | ||||
Initial costs, buildings | 4,524 | ||||
Land at cost | 2,005 | ||||
Buildings at cost | 4,524 | ||||
Total at cost | 6,529 | ||||
Accumulated Depreciation | 764 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Mar. 28, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | Toledo, OH [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 1,150 | ||||
Initial costs, buildings | 17,740 | ||||
Land at cost | 1,150 | ||||
Buildings at cost | 17,740 | ||||
Total at cost | 18,890 | ||||
Accumulated Depreciation | 2,994 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Apr. 01, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | Viseu, Portugal [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,458 | ||||
Initial costs, buildings | 28,010 | ||||
Land at cost | 2,458 | ||||
Buildings at cost | 28,010 | ||||
Total at cost | 30,468 | ||||
Accumulated Depreciation | 2,422 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Nov. 28, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 37 years | ||||
1989 [Member] | Bad Salzuflen, Germany [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 6,922 | ||||
Initial costs, buildings | 22,669 | ||||
Land at cost | 6,922 | ||||
Buildings at cost | 22,669 | ||||
Total at cost | 29,591 | ||||
Accumulated Depreciation | 2,992 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1989 | ||||
Date Acquired | Nov. 30, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1989 [Member] | Bolton, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,504 | ||||
Initial costs, buildings | 42,267 | ||||
Land at cost | 1,504 | ||||
Buildings at cost | 42,267 | ||||
Total at cost | 43,771 | ||||
Accumulated Depreciation | 3,181 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1989 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1989 [Member] | Guildford, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 6,531 | ||||
Initial costs, buildings | 34,573 | ||||
Land at cost | 6,531 | ||||
Buildings at cost | 34,573 | ||||
Total at cost | 41,104 | ||||
Accumulated Depreciation | 2,616 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1989 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1989 [Member] | Lynwood, CA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 30,116 | ||||
Initial costs, buildings | 148,527 | ||||
Land at cost | 30,116 | ||||
Buildings at cost | 148,527 | ||||
Total at cost | 178,643 | ||||
Accumulated Depreciation | 9,018 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1989 | ||||
Date Acquired | Aug. 13, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1989 [Member] | Richmond, VA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Long term acute care hospital | ||||
Initial costs, land | $ 1,299 | ||||
Initial costs, buildings | 10,071 | ||||
Land at cost | 1,299 | ||||
Buildings at cost | 10,071 | ||||
Total at cost | 11,370 | ||||
Accumulated Depreciation | 1,087 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1989 | ||||
Date Acquired | Aug. 30, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1989 [Member] | Rochdale, MA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Long term acute care hospital | ||||
Initial costs, land | $ 654 | ||||
Initial costs, buildings | 3,368 | ||||
Land at cost | 654 | ||||
Buildings at cost | 3,368 | ||||
Total at cost | 4,022 | ||||
Accumulated Depreciation | 329 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1989 | ||||
Date Acquired | Aug. 30, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1989 [Member] | Rochdale, MA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 67 | ||||
Initial costs, buildings | 344 | ||||
Land at cost | 67 | ||||
Buildings at cost | 344 | ||||
Total at cost | 411 | ||||
Accumulated Depreciation | 34 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1989 | ||||
Date Acquired | Aug. 30, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2004 [Member] | Ayr, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 16,125 | ||||
Initial costs, buildings | 46,178 | ||||
Land at cost | 16,125 | ||||
Buildings at cost | 46,178 | ||||
Total at cost | 62,303 | ||||
Accumulated Depreciation | 1,768 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2004 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2004 [Member] | Odessa, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 6,217 | ||||
Initial costs, buildings | 123,518 | ||||
Additions subsequent to acquisition, Improvements | 16,600 | ||||
Land at cost | 6,217 | ||||
Buildings at cost | 140,118 | ||||
Total at cost | 146,335 | ||||
Accumulated Depreciation | 16,927 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2004 | ||||
Date Acquired | Sep. 29, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 41 years | ||||
2004 [Member] | Webster, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Long term acute care hospital | ||||
Initial costs, land | $ 663 | ||||
Initial costs, buildings | 33,751 | ||||
Land at cost | 663 | ||||
Buildings at cost | 33,751 | ||||
Total at cost | 34,414 | ||||
Accumulated Depreciation | 10,126 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2004 | ||||
Date Acquired | Dec. 21, 2010 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1973 [Member] | Bad Oeynhausen, Germany [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 1,092 | ||||
Initial costs, buildings | 2,669 | ||||
Land at cost | 1,092 | ||||
Buildings at cost | 2,669 | ||||
Total at cost | 3,761 | ||||
Accumulated Depreciation | 379 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1973 | ||||
Date Acquired | Nov. 30, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1973 [Member] | Big Spring, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,655 | ||||
Initial costs, buildings | 21,254 | ||||
Additions subsequent to acquisition, Improvements | 815 | ||||
Land at cost | 1,655 | ||||
Buildings at cost | 22,069 | ||||
Total at cost | 23,724 | ||||
Accumulated Depreciation | 2,296 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1973 | ||||
Date Acquired | Apr. 12, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 41 years | ||||
1973 [Member] | Odessa, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 6,217 | ||||
Initial costs, buildings | 123,518 | ||||
Additions subsequent to acquisition, Improvements | 16,600 | ||||
Land at cost | 6,217 | ||||
Buildings at cost | 140,118 | ||||
Total at cost | 146,335 | ||||
Accumulated Depreciation | 16,927 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1973 | ||||
Date Acquired | Sep. 29, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 41 years | ||||
1973 [Member] | Port Huron, MI | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,531 | ||||
Initial costs, buildings | 14,252 | ||||
Land at cost | 2,531 | ||||
Buildings at cost | 14,252 | ||||
Total at cost | 16,783 | ||||
Accumulated Depreciation | 3,408 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1973 | ||||
Date Acquired | Dec. 31, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 30 years | ||||
1973 [Member] | Ringwood, Australia [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 4,038 | ||||
Initial costs, buildings | 18,125 | ||||
Land at cost | 4,038 | ||||
Buildings at cost | 18,125 | ||||
Total at cost | 22,163 | ||||
Accumulated Depreciation | 1,912 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1973 | ||||
Date Acquired | Jun. 07, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 35 years | ||||
2015 [Member] | Aurora, CO [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 2,845 | ||||
Initial costs, buildings | 4,812 | ||||
Land at cost | 2,845 | ||||
Buildings at cost | 4,812 | ||||
Total at cost | 7,657 | ||||
Accumulated Depreciation | 872 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2015 | ||||
Date Acquired | Sep. 17, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2015 [Member] | Chandler, AZ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 3,567 | ||||
Initial costs, buildings | 4,783 | ||||
Land at cost | 3,567 | ||||
Buildings at cost | 4,783 | ||||
Total at cost | 8,350 | ||||
Accumulated Depreciation | 917 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2015 | ||||
Date Acquired | Apr. 24, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2015 [Member] | Converse, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 750 | ||||
Initial costs, buildings | 4,423 | ||||
Land at cost | 750 | ||||
Buildings at cost | 4,423 | ||||
Total at cost | 5,173 | ||||
Accumulated Depreciation | 857 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2015 | ||||
Date Acquired | Apr. 10, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2015 [Member] | Denver, CO [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 1,257 | ||||
Initial costs, buildings | 4,276 | ||||
Land at cost | 1,257 | ||||
Buildings at cost | 4,276 | ||||
Total at cost | 5,533 | ||||
Accumulated Depreciation | 811 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2015 | ||||
Date Acquired | Jun. 08, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2015 [Member] | Frome, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 10,340 | ||||
Initial costs, buildings | 10,166 | ||||
Land at cost | 10,340 | ||||
Buildings at cost | 10,166 | ||||
Total at cost | 20,506 | ||||
Accumulated Depreciation | 567 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2015 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2015 [Member] | Gilbert, AZ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 1,517 | ||||
Initial costs, buildings | 4,661 | ||||
Land at cost | 1,517 | ||||
Buildings at cost | 4,661 | ||||
Total at cost | 6,178 | ||||
Accumulated Depreciation | 864 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2015 | ||||
Date Acquired | Jul. 22, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2015 [Member] | Glendale,AZ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 1,193 | ||||
Initial costs, buildings | 4,046 | ||||
Land at cost | 1,193 | ||||
Buildings at cost | 4,046 | ||||
Total at cost | 5,239 | ||||
Accumulated Depreciation | 767 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2015 | ||||
Date Acquired | Jun. 05, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2015 [Member] | Highland Hills, OH [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 3,148 | ||||
Initial costs, buildings | 43,891 | ||||
Land at cost | 3,148 | ||||
Buildings at cost | 43,891 | ||||
Total at cost | 47,039 | ||||
Accumulated Depreciation | 1,412 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2015 | ||||
Date Acquired | Oct. 19, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2015 [Member] | Highland Village TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 3,218 | ||||
Initial costs, buildings | 1,551 | ||||
Land at cost | 3,218 | ||||
Buildings at cost | 1,551 | ||||
Total at cost | 4,769 | ||||
Accumulated Depreciation | 445 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2015 | ||||
Date Acquired | Sep. 22, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2015 [Member] | Hoover, AL [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, buildings | $ 7,581 | ||||
Buildings at cost | 7,581 | ||||
Total at cost | 7,581 | ||||
Accumulated Depreciation | 1,697 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2015 | ||||
Date Acquired | May 01, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 34 years | ||||
2015 [Member] | Katy, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 2,147 | ||||
Initial costs, buildings | 3,873 | ||||
Land at cost | 2,147 | ||||
Buildings at cost | 3,873 | ||||
Total at cost | 6,020 | ||||
Accumulated Depreciation | 694 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2015 | ||||
Date Acquired | Oct. 21, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2015 [Member] | Lehi, UT [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 13,368 | ||||
Initial costs, buildings | 29,950 | ||||
Additions subsequent to acquisition, Improvements | 1,676 | ||||
Land at cost | 13,368 | ||||
Buildings at cost | 31,626 | ||||
Total at cost | 44,994 | ||||
Accumulated Depreciation | 4,738 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2015 | ||||
Date Acquired | Sep. 29, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 45 years | ||||
2015 [Member] | League City, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 1,297 | ||||
Initial costs, buildings | 3,901 | ||||
Land at cost | 1,297 | ||||
Buildings at cost | 3,901 | ||||
Total at cost | 5,198 | ||||
Accumulated Depreciation | 731 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2015 | ||||
Date Acquired | Jun. 19, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2015 [Member] | McKinney, Texas [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 2,614 | ||||
Initial costs, buildings | 4,060 | ||||
Land at cost | 2,614 | ||||
Buildings at cost | 4,060 | ||||
Total at cost | 6,674 | ||||
Accumulated Depreciation | 1,012 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2015 | ||||
Date Acquired | Jul. 31, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 30 years | ||||
2015 [Member] | Olathe, KS [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 5,966 | ||||
Initial costs, buildings | 55,745 | ||||
Land at cost | 5,966 | ||||
Buildings at cost | 55,745 | ||||
Total at cost | 61,711 | ||||
Accumulated Depreciation | 1,818 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2015 | ||||
Date Acquired | Oct. 19, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2015 [Member] | Parker, CO [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 1,300 | ||||
Initial costs, buildings | 4,448 | ||||
Land at cost | 1,300 | ||||
Buildings at cost | 4,448 | ||||
Total at cost | 5,748 | ||||
Accumulated Depreciation | 797 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2015 | ||||
Date Acquired | Nov. 06, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2015 [Member] | Santa Maria de Feira, PT [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,804 | ||||
Initial costs, buildings | 17,299 | ||||
Land at cost | 1,804 | ||||
Buildings at cost | 17,299 | ||||
Total at cost | 19,103 | ||||
Accumulated Depreciation | 531 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2015 | ||||
Date Acquired | Oct. 21, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1970 [Member] | Bussage, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 8,058 | ||||
Initial costs, buildings | 3,562 | ||||
Land at cost | 8,058 | ||||
Buildings at cost | 3,562 | ||||
Total at cost | 11,620 | ||||
Accumulated Depreciation | 149 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1970 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1970 [Member] | Rockledge, FL [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 13,919 | ||||
Initial costs, buildings | 23,282 | ||||
Additions subsequent to acquisition, Improvements | 8,338 | ||||
Land at cost | 13,919 | ||||
Buildings at cost | 31,620 | ||||
Total at cost | 45,539 | ||||
Accumulated Depreciation | 5,521 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1970 | ||||
Date Acquired | May 01, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 42 years | ||||
1970 [Member] | Royston, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 6,391 | ||||
Initial costs, buildings | 19,028 | ||||
Land at cost | 6,391 | ||||
Buildings at cost | 19,028 | ||||
Total at cost | 25,419 | ||||
Accumulated Depreciation | 899 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1970 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1992 [Member] | Bath, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 6,827 | ||||
Initial costs, buildings | 12,389 | ||||
Land at cost | 6,827 | ||||
Buildings at cost | 12,389 | ||||
Total at cost | 19,216 | ||||
Accumulated Depreciation | 965 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1992 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1992 [Member] | Bowling Green, KY [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 3,486 | ||||
Initial costs, buildings | 56,296 | ||||
Additions subsequent to acquisition, Improvements | 3,550 | ||||
Land at cost | 3,486 | ||||
Buildings at cost | 59,846 | ||||
Total at cost | 63,332 | ||||
Accumulated Depreciation | 5,255 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1992 | ||||
Date Acquired | Aug. 30, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1992 [Member] | Essex, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 4,406 | ||||
Initial costs, buildings | 41,011 | ||||
Land at cost | 4,406 | ||||
Buildings at cost | 41,011 | ||||
Total at cost | 45,417 | ||||
Accumulated Depreciation | 91 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1992 | ||||
Date Acquired | Dec. 09, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1992 [Member] | Helsinki, Finland [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 3,962 | ||||
Initial costs, buildings | 65,927 | ||||
Land at cost | 3,962 | ||||
Buildings at cost | 65,927 | ||||
Total at cost | 69,889 | ||||
Accumulated Depreciation | 1,384 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1992 | ||||
Date Acquired | Mar. 11, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1992 [Member] | London, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 27,463 | ||||
Initial costs, buildings | 14,237 | ||||
Land at cost | 27,463 | ||||
Buildings at cost | 14,237 | ||||
Total at cost | 41,700 | ||||
Accumulated Depreciation | 36 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1992 | ||||
Date Acquired | Dec. 09, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1992 [Member] | Stirling, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,001 | ||||
Initial costs, buildings | 18,517 | ||||
Land at cost | 1,001 | ||||
Buildings at cost | 18,517 | ||||
Total at cost | 19,518 | ||||
Accumulated Depreciation | 726 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1992 | ||||
Date Acquired | Jul. 06, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1992 [Member] | Wichita, KS [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 1,019 | ||||
Initial costs, buildings | 18,374 | ||||
Land at cost | 1,019 | ||||
Buildings at cost | 18,374 | ||||
Total at cost | 19,393 | ||||
Accumulated Depreciation | 6,774 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1992 | ||||
Date Acquired | Apr. 04, 2008 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1992 [Member] | London, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 13,107 | ||||
Initial costs, buildings | 6,464 | ||||
Land at cost | 13,107 | ||||
Buildings at cost | 6,464 | ||||
Total at cost | 19,571 | ||||
Accumulated Depreciation | 277 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1992 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1984 [Member] | Basingstoke, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 12,264 | ||||
Initial costs, buildings | 47,635 | ||||
Land at cost | 12,264 | ||||
Buildings at cost | 47,635 | ||||
Total at cost | 59,899 | ||||
Accumulated Depreciation | 3,609 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1984 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1984 [Member] | Bennettsville, SC [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 794 | ||||
Initial costs, buildings | 15,773 | ||||
Land at cost | 794 | ||||
Buildings at cost | 15,773 | ||||
Total at cost | 16,567 | ||||
Accumulated Depreciation | 9,999 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1984 | ||||
Date Acquired | Apr. 01, 2008 | ||||
Life on which depreciation in latest income statements is computed (Years) | 42 years | ||||
1984 [Member] | Birmingham, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 391 | ||||
Initial costs, buildings | 18,188 | ||||
Land at cost | 391 | ||||
Buildings at cost | 18,188 | ||||
Total at cost | 18,579 | ||||
Accumulated Depreciation | 731 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1984 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1984 [Member] | Droitwich, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 72 | ||||
Initial costs, buildings | 14,520 | ||||
Land at cost | 72 | ||||
Buildings at cost | 14,520 | ||||
Total at cost | 14,592 | ||||
Accumulated Depreciation | 1,103 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1984 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1984 [Member] | Hope, AR [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,651 | ||||
Initial costs, buildings | 3,359 | ||||
Additions subsequent to acquisition, Improvements | 2,733 | ||||
Land at cost | 1,651 | ||||
Buildings at cost | 6,092 | ||||
Total at cost | 7,743 | ||||
Accumulated Depreciation | 1,146 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1984 | ||||
Date Acquired | Sep. 29, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 41 years | ||||
1984 [Member] | London, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 8,772 | ||||
Initial costs, buildings | 57,899 | ||||
Land at cost | 8,772 | ||||
Buildings at cost | 57,899 | ||||
Total at cost | 66,671 | ||||
Accumulated Depreciation | 4,357 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1984 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1984 [Member] | Swindon, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 5,056 | ||||
Initial costs, buildings | 56,730 | ||||
Land at cost | 5,056 | ||||
Buildings at cost | 56,730 | ||||
Total at cost | 61,786 | ||||
Accumulated Depreciation | 4,280 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1984 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1984 [Member] | Wantirna, Australia [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 25,595 | ||||
Initial costs, buildings | 202,892 | ||||
Additions subsequent to acquisition, Improvements | 24,129 | ||||
Land at cost | 25,595 | ||||
Buildings at cost | 227,021 | ||||
Total at cost | 252,616 | ||||
Accumulated Depreciation | 18,529 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1984 | ||||
Date Acquired | Jun. 07, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1980 [Member] | Blue Springs, MO [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 4,347 | ||||
Initial costs, buildings | 23,494 | ||||
Land at cost | 4,347 | ||||
Buildings at cost | 23,494 | ||||
Total at cost | 27,841 | ||||
Accumulated Depreciation | 4,886 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1980 | ||||
Date Acquired | Feb. 13, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1980 [Member] | Frome, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 2,748 | ||||
Initial costs, buildings | 16,652 | ||||
Land at cost | 2,748 | ||||
Buildings at cost | 16,652 | ||||
Total at cost | 19,400 | ||||
Accumulated Depreciation | 705 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1980 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1980 [Member] | Glasgow, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 1,355 | ||||
Initial costs, buildings | 14,824 | ||||
Land at cost | 1,355 | ||||
Buildings at cost | 14,824 | ||||
Total at cost | 16,179 | ||||
Accumulated Depreciation | 603 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1980 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1980 [Member] | Harrow, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 36,448 | ||||
Initial costs, buildings | 38,358 | ||||
Land at cost | 36,448 | ||||
Buildings at cost | 38,358 | ||||
Total at cost | 74,806 | ||||
Accumulated Depreciation | 2,917 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1980 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1980 [Member] | Hill County, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,120 | ||||
Initial costs, buildings | 17,882 | ||||
Additions subsequent to acquisition, Improvements | 503 | ||||
Land at cost | 1,120 | ||||
Buildings at cost | 18,385 | ||||
Total at cost | 19,505 | ||||
Accumulated Depreciation | 14,833 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1980 | ||||
Date Acquired | Sep. 17, 2010 | ||||
Life on which depreciation in latest income statements is computed (Years) | 15 years | ||||
1980 [Member] | Hook, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 5,140 | ||||
Initial costs, buildings | 9,790 | ||||
Land at cost | 5,140 | ||||
Buildings at cost | 9,790 | ||||
Total at cost | 14,930 | ||||
Accumulated Depreciation | 432 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1980 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1980 [Member] | Nottingham, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 9,643 | ||||
Initial costs, buildings | 3,081 | ||||
Land at cost | 9,643 | ||||
Buildings at cost | 3,081 | ||||
Total at cost | 12,724 | ||||
Accumulated Depreciation | 129 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1980 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1980 [Member] | Poplar Bluff, MO [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,659 | ||||
Initial costs, buildings | 38,694 | ||||
Land at cost | 2,659 | ||||
Buildings at cost | 38,694 | ||||
Total at cost | 41,353 | ||||
Accumulated Depreciation | 14,217 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1980 | ||||
Date Acquired | Apr. 22, 2008 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1980 [Member] | Romford, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 5,082 | ||||
Initial costs, buildings | 8,319 | ||||
Land at cost | 5,082 | ||||
Buildings at cost | 8,319 | ||||
Total at cost | 13,401 | ||||
Accumulated Depreciation | 394 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1980 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1980 [Member] | Sharon, PA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 6,179 | ||||
Initial costs, buildings | 9,066 | ||||
Additions subsequent to acquisition, Improvements | 5,428 | ||||
Land at cost | 6,179 | ||||
Buildings at cost | 14,494 | ||||
Total at cost | 20,673 | ||||
Accumulated Depreciation | 3,091 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1980 | ||||
Date Acquired | May 01, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 41 years | ||||
1980 [Member] | Usk, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 1,641 | ||||
Initial costs, buildings | 21,072 | ||||
Land at cost | 1,641 | ||||
Buildings at cost | 21,072 | ||||
Total at cost | 22,713 | ||||
Accumulated Depreciation | 838 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1980 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1980 [Member] | West Valley City, UT [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 5,260 | ||||
Initial costs, buildings | 58,314 | ||||
Additions subsequent to acquisition, Improvements | 6,644 | ||||
Land at cost | 5,260 | ||||
Buildings at cost | 64,958 | ||||
Total at cost | 70,218 | ||||
Accumulated Depreciation | 22,415 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1980 | ||||
Date Acquired | Apr. 22, 2008 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1980 [Member] | York, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 20,534 | ||||
Initial costs, buildings | 68,118 | ||||
Land at cost | 20,534 | ||||
Buildings at cost | 68,118 | ||||
Total at cost | 88,652 | ||||
Accumulated Depreciation | 2,699 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1980 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 hours | ||||
1985 [Member] | Aberdeen, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 4,036 | ||||
Initial costs, buildings | 95,595 | ||||
Land at cost | 4,036 | ||||
Buildings at cost | 95,595 | ||||
Total at cost | 99,631 | ||||
Accumulated Depreciation | 7,194 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1985 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1985 [Member] | Hot Springs, AR [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 5,622 | ||||
Initial costs, buildings | 59,432 | ||||
Additions subsequent to acquisition, Improvements | 21,221 | ||||
Land at cost | 5,622 | ||||
Buildings at cost | 80,653 | ||||
Total at cost | 86,275 | ||||
Accumulated Depreciation | 15,232 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1985 | ||||
Date Acquired | Aug. 31, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1985 [Member] | Lawton, OK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 3,944 | ||||
Initial costs, buildings | 63,031 | ||||
Land at cost | 3,944 | ||||
Buildings at cost | 63,031 | ||||
Total at cost | 66,975 | ||||
Accumulated Depreciation | 5,077 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1985 | ||||
Date Acquired | Dec. 17, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1985 [Member] | Southampton, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 6,116 | ||||
Initial costs, buildings | 17,961 | ||||
Land at cost | 6,116 | ||||
Buildings at cost | 17,961 | ||||
Total at cost | 24,077 | ||||
Accumulated Depreciation | 835 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1985 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1985 [Member] | St. Albans Park, Australia [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,562 | ||||
Initial costs, buildings | 20,786 | ||||
Additions subsequent to acquisition, Improvements | 10,700 | ||||
Land at cost | 2,562 | ||||
Buildings at cost | 31,486 | ||||
Total at cost | 34,048 | ||||
Accumulated Depreciation | 2,420 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1985 | ||||
Date Acquired | Jun. 07, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1985 [Member] | Strathpine, Australia [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,755 | ||||
Initial costs, buildings | 34,489 | ||||
Land at cost | 2,755 | ||||
Buildings at cost | 34,489 | ||||
Total at cost | 37,244 | ||||
Accumulated Depreciation | 3,177 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1985 | ||||
Date Acquired | Jun. 07, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1997 [Member] | Algeciras, Spain [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 505 | ||||
Initial costs, buildings | 7,973 | ||||
Land at cost | 505 | ||||
Buildings at cost | 7,973 | ||||
Total at cost | 8,478 | ||||
Accumulated Depreciation | 146 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1997 | ||||
Date Acquired | Apr. 29, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1997 [Member] | Floridablanca, Colombia [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 651 | ||||
Initial costs, buildings | 20,392 | ||||
Land at cost | 651 | ||||
Buildings at cost | 20,392 | ||||
Total at cost | 21,043 | ||||
Accumulated Depreciation | 214 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1997 | ||||
Date Acquired | Jul. 29, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1982 [Member] | Bedford, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,462 | ||||
Initial costs, buildings | 7,122 | ||||
Land at cost | 1,462 | ||||
Buildings at cost | 7,122 | ||||
Total at cost | 8,584 | ||||
Accumulated Depreciation | 544 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1982 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1982 [Member] | Birmingham, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 9,360 | ||||
Initial costs, buildings | 89,090 | ||||
Land at cost | 9,360 | ||||
Buildings at cost | 89,090 | ||||
Total at cost | 98,450 | ||||
Accumulated Depreciation | 6,751 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1982 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1982 [Member] | Bossier City, LA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Long term acute care hospital | ||||
Initial costs, land | $ 900 | ||||
Initial costs, buildings | 17,818 | ||||
Additions subsequent to acquisition, Improvements | 944 | ||||
Land at cost | 900 | ||||
Buildings at cost | 18,762 | ||||
Total at cost | 19,662 | ||||
Accumulated Depreciation | 6,692 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1982 | ||||
Date Acquired | Apr. 01, 2008 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1982 [Member] | Cheraw, SC [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 657 | ||||
Initial costs, buildings | 19,576 | ||||
Land at cost | 657 | ||||
Buildings at cost | 19,576 | ||||
Total at cost | 20,233 | ||||
Accumulated Depreciation | 12,409 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1982 | ||||
Date Acquired | Apr. 01, 2008 | ||||
Life on which depreciation in latest income statements is computed (Years) | 42 years | ||||
1982 [Member] | Caterham, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 10,015 | ||||
Initial costs, buildings | 19,785 | ||||
Land at cost | 10,015 | ||||
Buildings at cost | 19,785 | ||||
Total at cost | 29,800 | ||||
Accumulated Depreciation | 1,748 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1982 | ||||
Date Acquired | Aug. 16, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1982 [Member] | Canterbury, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 8,718 | ||||
Initial costs, buildings | 26,185 | ||||
Land at cost | 8,718 | ||||
Buildings at cost | 26,185 | ||||
Total at cost | 34,903 | ||||
Accumulated Depreciation | 1,980 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1982 | ||||
Date Acquired | Jan. 09, 2020 | ||||
1982 [Member] | Warren, OH [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 5,385 | ||||
Initial costs, buildings | 47,588 | ||||
Additions subsequent to acquisition, Improvements | 10,486 | ||||
Land at cost | 5,385 | ||||
Buildings at cost | 58,074 | ||||
Total at cost | 63,459 | ||||
Accumulated Depreciation | 9,460 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1982 | ||||
Date Acquired | May 01, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 41 years | ||||
2018 [Member] | Birmingham, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, buildings | $ 16,477 | ||||
Buildings at cost | 16,477 | ||||
Total at cost | 16,477 | ||||
Accumulated Depreciation | 1,030 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2018 | ||||
Date Acquired | Jun. 29, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2018 [Member] | Conroe, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 3,855 | ||||
Initial costs, buildings | 38,892 | ||||
Land at cost | 3,855 | ||||
Buildings at cost | 38,892 | ||||
Total at cost | 42,747 | ||||
Accumulated Depreciation | 1,278 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2018 | ||||
Date Acquired | Oct. 19, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2018 [Member] | Darlington, United Kingdom [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 20,165 | ||||
Initial costs, buildings | 45,806 | ||||
Land at cost | 20,165 | ||||
Buildings at cost | 45,806 | ||||
Total at cost | 65,971 | ||||
Accumulated Depreciation | 2,012 | ||||
Encumbrances | $ 0 | ||||
Date Acquired | Jun. 25, 2021 | ||||
2018 [Member] | Darlington UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Date of Construction | 2018 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2018 [Member] | El Paso, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 4,268 | ||||
Initial costs, buildings | 21,345 | ||||
Land at cost | 4,268 | ||||
Buildings at cost | 21,345 | ||||
Total at cost | 25,613 | ||||
Accumulated Depreciation | 1,240 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2018 | ||||
Date Acquired | Dec. 17, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 38 years | ||||
2018 [Member] | Malaga, SP [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 726 | ||||
Initial costs, buildings | 11,364 | ||||
Land at cost | 726 | ||||
Buildings at cost | 11,364 | ||||
Total at cost | 12,090 | ||||
Accumulated Depreciation | 193 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2018 | ||||
Date Acquired | Apr. 29, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2018 [Member] | Olathe, KS [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 3,485 | ||||
Initial costs, buildings | 14,484 | ||||
Land at cost | 3,485 | ||||
Buildings at cost | 14,484 | ||||
Total at cost | 17,969 | ||||
Accumulated Depreciation | 1,127 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2018 | ||||
Date Acquired | Jun. 10, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 50 years | ||||
2018 [Member] | Preston, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 8,296 | ||||
Initial costs, buildings | 24,677 | ||||
Land at cost | 8,296 | ||||
Buildings at cost | 24,677 | ||||
Total at cost | 32,973 | ||||
Accumulated Depreciation | 991 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2018 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2018 [Member] | Raleigh, NC [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 3,469 | ||||
Initial costs, buildings | 27,514 | ||||
Land at cost | 3,469 | ||||
Buildings at cost | 27,514 | ||||
Total at cost | 30,983 | ||||
Accumulated Depreciation | 952 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2018 | ||||
Date Acquired | Oct. 19, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2018 [Member] | Roeland Park, KS [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,569 | ||||
Initial costs, buildings | 15,103 | ||||
Land at cost | 1,569 | ||||
Buildings at cost | 15,103 | ||||
Total at cost | 16,672 | ||||
Accumulated Depreciation | 1,152 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2018 | ||||
Date Acquired | Jun. 10, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 50 years | ||||
2018 [Member] | Shawnee, KS [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 3,076 | ||||
Initial costs, buildings | 14,945 | ||||
Land at cost | 3,076 | ||||
Buildings at cost | 14,945 | ||||
Total at cost | 18,021 | ||||
Accumulated Depreciation | 1,328 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2018 | ||||
Date Acquired | Jun. 10, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 50 years | ||||
2018 [Member] | Turku, Finland [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,171 | ||||
Initial costs, buildings | 57,048 | ||||
Land at cost | 1,171 | ||||
Buildings at cost | 57,048 | ||||
Total at cost | 58,219 | ||||
Accumulated Depreciation | 1,206 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2018 | ||||
Date Acquired | Mar. 11, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1900 [Member] | Birmingham, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 391 | ||||
Initial costs, buildings | 18,188 | ||||
Land at cost | 391 | ||||
Buildings at cost | 18,188 | ||||
Total at cost | 18,579 | ||||
Accumulated Depreciation | 731 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1900 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1900 [Member] | Glasgow, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Date of Construction | 1900 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1900 [Member] | London, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Date of Construction | 1900 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1972 [Member] | Bellflower, CA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 2,563 | ||||
Land at cost | 2,563 | ||||
Total at cost | 2,563 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1972 | ||||
Date Acquired | Aug. 23, 2019 | ||||
1972 [Member] | Glen Waverly, Australia [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 29,641 | ||||
Initial costs, buildings | 22,296 | ||||
Land at cost | 29,641 | ||||
Buildings at cost | 22,296 | ||||
Total at cost | 51,937 | ||||
Accumulated Depreciation | 2,848 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1972 | ||||
Date Acquired | Jun. 07, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 32 years | ||||
1972 [Member] | Los Angeles, CA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 12,562 | ||||
Initial costs, buildings | 40,164 | ||||
Land at cost | 12,562 | ||||
Buildings at cost | 40,164 | ||||
Total at cost | 52,726 | ||||
Accumulated Depreciation | 1,556 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1972 | ||||
Date Acquired | Jul. 06, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1957 [Member] | Blackburn, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,526 | ||||
Initial costs, buildings | 48,405 | ||||
Land at cost | 2,526 | ||||
Buildings at cost | 48,405 | ||||
Total at cost | 50,931 | ||||
Accumulated Depreciation | 3,652 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1957 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2006 [Member] | Dallas, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Long term acute care hospital | ||||
Initial costs, land | $ 1,421 | ||||
Initial costs, buildings | 13,536 | ||||
Land at cost | 1,421 | ||||
Buildings at cost | 13,536 | ||||
Total at cost | 14,957 | ||||
Accumulated Depreciation | 5,527 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2006 | ||||
Date Acquired | Sep. 05, 2006 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2006 [Member] | Dahlen, Germany [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 1,303 | ||||
Initial costs, buildings | 10,996 | ||||
Land at cost | 1,303 | ||||
Buildings at cost | 10,996 | ||||
Total at cost | 12,299 | ||||
Accumulated Depreciation | 730 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2006 | ||||
Date Acquired | Aug. 28, 2018 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2006 [Member] | Dormagen Germany [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 1,852 | ||||
Initial costs, buildings | 5,477 | ||||
Land at cost | 1,852 | ||||
Buildings at cost | 5,477 | ||||
Total at cost | 7,329 | ||||
Accumulated Depreciation | 631 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2006 | ||||
Date Acquired | Aug. 28, 2018 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2006 [Member] | Petersburg, VA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 1,302 | ||||
Initial costs, buildings | 9,121 | ||||
Land at cost | 1,302 | ||||
Buildings at cost | 9,121 | ||||
Total at cost | 10,423 | ||||
Accumulated Depreciation | 3,306 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2006 | ||||
Date Acquired | Jul. 01, 2008 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1930 [Member] | Blackburn, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 19,010 | ||||
Initial costs, buildings | 51,573 | ||||
Land at cost | 19,010 | ||||
Buildings at cost | 51,573 | ||||
Total at cost | 70,583 | ||||
Accumulated Depreciation | 2,120 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1930 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1952 [Member] | Boonton Township, NJ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 6,712 | ||||
Initial costs, buildings | 17,031 | ||||
Land at cost | 6,712 | ||||
Buildings at cost | 17,031 | ||||
Total at cost | 23,743 | ||||
Accumulated Depreciation | 1,033 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1952 | ||||
Date Acquired | Sep. 30, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2009 [Member] | Bath, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,432 | ||||
Initial costs, buildings | 29,685 | ||||
Land at cost | 1,432 | ||||
Buildings at cost | 29,685 | ||||
Total at cost | 31,117 | ||||
Accumulated Depreciation | 6,308 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2009 | ||||
Date Acquired | Jul. 01, 2014 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2009 [Member] | Folsom, CA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Long term acute care hospital | ||||
Initial costs, land | $ 3,291 | ||||
Initial costs, buildings | 21,293 | ||||
Land at cost | 3,291 | ||||
Buildings at cost | 21,293 | ||||
Total at cost | 24,584 | ||||
Accumulated Depreciation | 2,106 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2009 | ||||
Date Acquired | Aug. 30, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1983 [Member] | Bassenheim, Germany [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 1,095 | ||||
Initial costs, buildings | 5,129 | ||||
Land at cost | 1,095 | ||||
Buildings at cost | 5,129 | ||||
Total at cost | 6,224 | ||||
Accumulated Depreciation | 557 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1983 | ||||
Date Acquired | Feb. 09, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 39 years | ||||
1983 [Member] | Glasgow, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 6,114 | ||||
Initial costs, buildings | 124,874 | ||||
Land at cost | 6,114 | ||||
Buildings at cost | 124,874 | ||||
Total at cost | 130,988 | ||||
Accumulated Depreciation | 9,392 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1983 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1983 [Member] | Grefath, Germany [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 1,164 | ||||
Initial costs, buildings | 2,937 | ||||
Land at cost | 1,164 | ||||
Buildings at cost | 2,937 | ||||
Total at cost | 4,101 | ||||
Accumulated Depreciation | 346 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1983 | ||||
Date Acquired | Aug. 28, 2018 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1983 [Member] | Lander, WY [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 761 | ||||
Initial costs, buildings | 42,849 | ||||
Land at cost | 761 | ||||
Buildings at cost | 42,849 | ||||
Total at cost | 43,610 | ||||
Accumulated Depreciation | 3,434 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1983 | ||||
Date Acquired | Dec. 17, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1983 [Member] | Nottingham, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 4,700 | ||||
Initial costs, buildings | 43,612 | ||||
Land at cost | 4,700 | ||||
Buildings at cost | 43,612 | ||||
Total at cost | 48,312 | ||||
Accumulated Depreciation | 3,317 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1983 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1983 [Member] | Milton Keynes, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 4,979 | ||||
Initial costs, buildings | 34,035 | ||||
Land at cost | 4,979 | ||||
Buildings at cost | 34,035 | ||||
Total at cost | 39,014 | ||||
Accumulated Depreciation | 2,570 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1983 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1983 [Member] | Port Huron, MI | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,531 | ||||
Initial costs, buildings | 14,252 | ||||
Land at cost | 2,531 | ||||
Buildings at cost | 14,252 | ||||
Total at cost | 16,783 | ||||
Accumulated Depreciation | 3,408 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1983 | ||||
Date Acquired | Dec. 31, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 30 years | ||||
1983 [Member] | Remscheid, Germany [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 1,017 | ||||
Initial costs, buildings | 2,451 | ||||
Land at cost | 1,017 | ||||
Buildings at cost | 2,451 | ||||
Total at cost | 3,468 | ||||
Accumulated Depreciation | 282 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1983 | ||||
Date Acquired | Aug. 28, 2018 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1983 [Member] | Riverton, WY [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,163 | ||||
Initial costs, buildings | 29,647 | ||||
Land at cost | 1,163 | ||||
Buildings at cost | 29,647 | ||||
Total at cost | 30,810 | ||||
Accumulated Depreciation | 2,756 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1983 | ||||
Date Acquired | Dec. 17, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 36 years | ||||
1983 [Member] | Watsonville, CA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 16,488 | ||||
Initial costs, buildings | 17,800 | ||||
Land at cost | 16,488 | ||||
Buildings at cost | 17,800 | ||||
Total at cost | 34,288 | ||||
Accumulated Depreciation | 2,126 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1983 | ||||
Date Acquired | Sep. 30, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 39 years | ||||
1983 [Member] | West Jordan, UT [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 16,897 | ||||
Initial costs, buildings | 233,256 | ||||
Additions subsequent to acquisition, Improvements | 4,078 | ||||
Land at cost | 16,897 | ||||
Buildings at cost | 237,334 | ||||
Total at cost | 254,231 | ||||
Accumulated Depreciation | 16,101 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1983 | ||||
Date Acquired | Sep. 29, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2016 [Member] | Bad Salzuflen, Germany [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 6,922 | ||||
Initial costs, buildings | 22,669 | ||||
Land at cost | 6,922 | ||||
Buildings at cost | 22,669 | ||||
Total at cost | 29,591 | ||||
Accumulated Depreciation | 2,992 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2016 | ||||
Date Acquired | Nov. 30, 2017 | ||||
2010 [Member] | Bad Oeynhausen, Germany [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 1,092 | ||||
Initial costs, buildings | 2,669 | ||||
Land at cost | 1,092 | ||||
Buildings at cost | 2,669 | ||||
Total at cost | 3,761 | ||||
Accumulated Depreciation | 379 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2010 | ||||
Date Acquired | Nov. 30, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2010 [Member] | Layton, UT [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 14,360 | ||||
Initial costs, buildings | 370,154 | ||||
Additions subsequent to acquisition, Improvements | 5,481 | ||||
Land at cost | 14,360 | ||||
Buildings at cost | 375,635 | ||||
Total at cost | 389,995 | ||||
Accumulated Depreciation | 22,737 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2010 | ||||
Date Acquired | Sep. 29, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2010 [Member] | Newburgh, IN [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 1,215 | ||||
Initial costs, buildings | 7,212 | ||||
Land at cost | 1,215 | ||||
Buildings at cost | 7,212 | ||||
Total at cost | 8,427 | ||||
Accumulated Depreciation | 254 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2010 | ||||
Date Acquired | Oct. 19, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2010 [Member] | Sherman, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 3,363 | ||||
Initial costs, buildings | 10,932 | ||||
Land at cost | 3,363 | ||||
Buildings at cost | 10,932 | ||||
Total at cost | 14,295 | ||||
Accumulated Depreciation | 3,940 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2010 | ||||
Date Acquired | Oct. 31, 2014 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2022 [Member] | Bakersfield, CA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 2,178 | ||||
Initial costs, buildings | 45,253 | ||||
Land at cost | 2,178 | ||||
Buildings at cost | 45,253 | ||||
Total at cost | 47,431 | ||||
Accumulated Depreciation | 930 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2022 | ||||
Date Acquired | May 15, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1922 [Member] | Lewiston, ID [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 5,389 | ||||
Initial costs, buildings | 75,435 | ||||
Land at cost | 5,389 | ||||
Buildings at cost | 75,435 | ||||
Total at cost | 80,824 | ||||
Accumulated Depreciation | 14,455 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1922 | ||||
Date Acquired | May 01, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1922 [Member] | Warren, OH [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 2,417 | ||||
Initial costs, buildings | 15,857 | ||||
Additions subsequent to acquisition, Improvements | 1,737 | ||||
Land at cost | 2,417 | ||||
Buildings at cost | 17,594 | ||||
Total at cost | 20,011 | ||||
Accumulated Depreciation | 3,150 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1922 | ||||
Date Acquired | May 01, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 46 years | ||||
2013 [Member] | Hausman, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,500 | ||||
Initial costs, buildings | 8,957 | ||||
Land at cost | 1,500 | ||||
Buildings at cost | 8,957 | ||||
Total at cost | 10,457 | ||||
Accumulated Depreciation | 2,183 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2013 | ||||
Date Acquired | Mar. 01, 2013 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2013 [Member] | Helsinki, Finland [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 3,962 | ||||
Initial costs, buildings | 65,927 | ||||
Land at cost | 3,962 | ||||
Buildings at cost | 65,927 | ||||
Total at cost | 69,889 | ||||
Accumulated Depreciation | 1,384 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2013 | ||||
Date Acquired | Mar. 11, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2013 [Member] | Lafayette, IN [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 800 | ||||
Initial costs, buildings | 14,968 | ||||
Additions subsequent to acquisition, Improvements | (25) | ||||
Land at cost | 800 | ||||
Buildings at cost | 14,943 | ||||
Total at cost | 15,743 | ||||
Accumulated Depreciation | 3,694 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2013 | ||||
Date Acquired | Feb. 01, 2013 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2013 [Member] | Little Elm, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 1,241 | ||||
Initial costs, buildings | 3,491 | ||||
Land at cost | 1,241 | ||||
Buildings at cost | 3,491 | ||||
Total at cost | 4,732 | ||||
Accumulated Depreciation | 790 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2013 | ||||
Date Acquired | Dec. 01, 2013 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2013 [Member] | Post Falls Idaho | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 417 | ||||
Initial costs, buildings | 12,175 | ||||
Additions subsequent to acquisition, Improvements | 1,905 | ||||
Land at cost | 767 | ||||
Buildings at cost | 13,730 | ||||
Total at cost | 14,497 | ||||
Accumulated Depreciation | 3,099 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2013 | ||||
Date Acquired | Dec. 31, 2013 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2013 [Member] | Spartanburg, SC [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 1,135 | ||||
Initial costs, buildings | 15,717 | ||||
Land at cost | 1,135 | ||||
Buildings at cost | 15,717 | ||||
Total at cost | 16,852 | ||||
Accumulated Depreciation | 3,685 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2013 | ||||
Date Acquired | Aug. 01, 2013 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2013 [Member] | West Chester, OH [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 3,670 | ||||
Initial costs, buildings | 61,338 | ||||
Land at cost | 3,670 | ||||
Buildings at cost | 61,338 | ||||
Total at cost | 65,008 | ||||
Accumulated Depreciation | 1,976 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2013 | ||||
Date Acquired | Oct. 19, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1971 [Member] | Boonton Township, NJ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 6,712 | ||||
Initial costs, buildings | 17,031 | ||||
Land at cost | 6,712 | ||||
Buildings at cost | 17,031 | ||||
Total at cost | 23,743 | ||||
Accumulated Depreciation | 1,033 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1971 | ||||
Date Acquired | Sep. 30, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1978 [Member] | Boonton Township, NJ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 6,712 | ||||
Initial costs, buildings | 17,031 | ||||
Land at cost | 6,712 | ||||
Buildings at cost | 17,031 | ||||
Total at cost | 23,743 | ||||
Accumulated Depreciation | 1,033 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1978 | ||||
Date Acquired | Sep. 30, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1978 [Member] | Phoenix, AZ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 12,695 | ||||
Initial costs, buildings | 73,773 | ||||
Additions subsequent to acquisition, Improvements | 4,499 | ||||
Land at cost | 12,695 | ||||
Buildings at cost | 78,272 | ||||
Total at cost | 90,967 | ||||
Accumulated Depreciation | 10,931 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1968 | ||||
Date Acquired | Sep. 29, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 43 years | ||||
2007 [Member] | Campbelltown, Australia [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,037 | ||||
Initial costs, buildings | 51,364 | ||||
Additions subsequent to acquisition, Improvements | 312 | ||||
Land at cost | 1,037 | ||||
Buildings at cost | 51,676 | ||||
Total at cost | 52,713 | ||||
Accumulated Depreciation | 4,621 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2007 | ||||
Date Acquired | Jun. 07, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2007 [Member] | Godalming, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 8,880 | ||||
Initial costs, buildings | 18,014 | ||||
Land at cost | 8,880 | ||||
Buildings at cost | 18,014 | ||||
Total at cost | 26,894 | ||||
Accumulated Depreciation | 783 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2007 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2007 [Member] | Hinckley, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 2,340 | ||||
Initial costs, buildings | 15,949 | ||||
Land at cost | 2,340 | ||||
Buildings at cost | 15,949 | ||||
Total at cost | 18,289 | ||||
Accumulated Depreciation | 648 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2007 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2007 [Member] | Northland, MO [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Long term acute care hospital | ||||
Initial costs, land | $ 834 | ||||
Initial costs, buildings | 17,182 | ||||
Land at cost | 834 | ||||
Buildings at cost | 17,182 | ||||
Total at cost | 18,016 | ||||
Accumulated Depreciation | 5,119 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2007 | ||||
Date Acquired | Feb. 14, 2011 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2007 [Member] | Mesa, AZ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 6,534 | ||||
Initial costs, buildings | 100,042 | ||||
Additions subsequent to acquisition, Improvements | 4,135 | ||||
Land at cost | 6,534 | ||||
Buildings at cost | 104,177 | ||||
Total at cost | 110,711 | ||||
Accumulated Depreciation | 24,726 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2007 | ||||
Date Acquired | Sep. 26, 2013 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2015 [Member] | Chandler, AZ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, land | $ 750 | ||||
Initial costs, buildings | 3,853 | ||||
Land at cost | 750 | ||||
Buildings at cost | 3,853 | ||||
Total at cost | 4,603 | ||||
Accumulated Depreciation | 698 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2015 | ||||
Date Acquired | Oct. 07, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2015 [Member] | Hoover, AL [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Freestanding ER | ||||
Initial costs, buildings | $ 1,034 | ||||
Additions subsequent to acquisition, Improvements | 296 | ||||
Buildings at cost | 1,330 | ||||
Total at cost | 1,330 | ||||
Accumulated Depreciation | 268 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2015 | ||||
Date Acquired | May 01, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 34 years | ||||
1978 [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Date of Construction | 1978 | ||||
Date Acquired | Jul. 06, 2021 | ||||
1978 [Member] | Kansas City, MO [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 10,497 | ||||
Initial costs, buildings | 64,419 | ||||
Land at cost | 10,497 | ||||
Buildings at cost | 64,419 | ||||
Total at cost | 74,916 | ||||
Accumulated Depreciation | 12,996 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1978 | ||||
Date Acquired | Feb. 13, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1978 [Member] | Norwalk, CA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 7,946 | ||||
Initial costs, buildings | 30,465 | ||||
Land at cost | 7,946 | ||||
Buildings at cost | 30,465 | ||||
Total at cost | 38,411 | ||||
Accumulated Depreciation | 1,221 | ||||
Encumbrances | $ 0 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1978 [Member] | San Antonio, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 8,053 | ||||
Initial costs, buildings | 29,333 | ||||
Additions subsequent to acquisition, Improvements | 7,981 | ||||
Land at cost | 8,053 | ||||
Buildings at cost | 37,314 | ||||
Total at cost | 45,367 | ||||
Accumulated Depreciation | 4,701 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1978 | ||||
Date Acquired | Sep. 29, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 41 years | ||||
1977 [Member] | Braunfels, Germany [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,109 | ||||
Initial costs, buildings | 13,138 | ||||
Land at cost | 2,109 | ||||
Buildings at cost | 13,138 | ||||
Total at cost | 15,247 | ||||
Accumulated Depreciation | 2,490 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1977 | ||||
Date Acquired | Jun. 30, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1977 [Member] | London, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 11,817 | ||||
Initial costs, buildings | 77,130 | ||||
Land at cost | 11,817 | ||||
Buildings at cost | 77,130 | ||||
Total at cost | 88,947 | ||||
Accumulated Depreciation | 5,790 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1977 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1965 [Member] | Perth, Australia [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 99,659 | ||||
Initial costs, buildings | 35,321 | ||||
Additions subsequent to acquisition, Improvements | 2,165 | ||||
Land at cost | 99,659 | ||||
Buildings at cost | 37,486 | ||||
Total at cost | 137,145 | ||||
Accumulated Depreciation | 4,456 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1965 | ||||
Date Acquired | Jun. 07, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 30 years | ||||
1965 [Member] | Rochdale, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 3,395 | ||||
Initial costs, buildings | 38,679 | ||||
Land at cost | 3,395 | ||||
Buildings at cost | 38,679 | ||||
Total at cost | 42,074 | ||||
Accumulated Depreciation | 2,927 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1965 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1714 [Member] | Bromley, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 6,856 | ||||
Initial costs, buildings | 14,731 | ||||
Land at cost | 6,856 | ||||
Buildings at cost | 14,731 | ||||
Total at cost | 21,587 | ||||
Accumulated Depreciation | 614 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1714 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1979 [Member] | Broomfield, CO [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Life on which depreciation in latest income statements is computed (Years) | 37 years | ||||
1979 [Member] | Bundoora, Australia [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 6,510 | ||||
Initial costs, buildings | 60,125 | ||||
Additions subsequent to acquisition, Improvements | 3,935 | ||||
Land at cost | 6,510 | ||||
Buildings at cost | 64,060 | ||||
Total at cost | 70,570 | ||||
Accumulated Depreciation | 6,090 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1979 | ||||
Date Acquired | Jun. 07, 2019 | ||||
1979 [Member] | Godalming, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Date of Construction | 1796 | ||||
1979 [Member] | Phoenix, AZ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 2,396 | ||||
Initial costs, buildings | 26,521 | ||||
Additions subsequent to acquisition, Improvements | 2,985 | ||||
Land at cost | 2,396 | ||||
Buildings at cost | 29,506 | ||||
Total at cost | 31,902 | ||||
Accumulated Depreciation | 4,062 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1979 | ||||
Date Acquired | Sep. 29, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 42 years | ||||
1979 [Member] | Sunnybank, Australia [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 5,982 | ||||
Initial costs, buildings | 42,915 | ||||
Land at cost | 5,982 | ||||
Buildings at cost | 42,915 | ||||
Total at cost | 48,897 | ||||
Accumulated Depreciation | 4,580 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1979 | ||||
Date Acquired | Jun. 07, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 34 years | ||||
2012 [Member] | Carrollton, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 4,941 | ||||
Initial costs, buildings | 52,227 | ||||
Land at cost | 4,941 | ||||
Buildings at cost | 52,227 | ||||
Total at cost | 57,168 | ||||
Accumulated Depreciation | 1,663 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2012 | ||||
Date Acquired | Oct. 19, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2012 [Member] | Casper, WY [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 1,734 | ||||
Land at cost | 1,734 | ||||
Total at cost | 1,734 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2012 | ||||
Date Acquired | Feb. 29, 2012 | ||||
2012 [Member] | Dublin, OH [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 5,118 | ||||
Initial costs, buildings | 69,346 | ||||
Land at cost | 5,118 | ||||
Buildings at cost | 69,346 | ||||
Total at cost | 74,464 | ||||
Accumulated Depreciation | 2,185 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2012 | ||||
Date Acquired | Oct. 19, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2012 [Member] | Florence, AZ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 900 | ||||
Initial costs, buildings | 28,462 | ||||
Additions subsequent to acquisition, Improvements | 105 | ||||
Land at cost | 900 | ||||
Buildings at cost | 28,567 | ||||
Total at cost | 29,467 | ||||
Accumulated Depreciation | 7,674 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2012 | ||||
Date Acquired | Feb. 07, 2012 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2012 [Member] | Lafayette, IN [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 2,829 | ||||
Initial costs, buildings | 10,795 | ||||
Land at cost | 2,829 | ||||
Buildings at cost | 10,795 | ||||
Total at cost | 13,624 | ||||
Accumulated Depreciation | 421 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2012 | ||||
Date Acquired | Oct. 19, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2012 [Member] | Overlook, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,452 | ||||
Initial costs, buildings | 9,666 | ||||
Additions subsequent to acquisition, Improvements | 7 | ||||
Land at cost | 2,452 | ||||
Buildings at cost | 9,673 | ||||
Total at cost | 12,125 | ||||
Accumulated Depreciation | 2,383 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2012 | ||||
Date Acquired | Feb. 01, 2013 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2012 [Member] | Mount Pleasant, SC [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Long term acute care hospital | ||||
Initial costs, land | $ 597 | ||||
Initial costs, buildings | 2,198 | ||||
Land at cost | 597 | ||||
Buildings at cost | 2,198 | ||||
Total at cost | 2,795 | ||||
Accumulated Depreciation | 213 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2012 | ||||
Date Acquired | Aug. 30, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2012 [Member] | San Antonio, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,248 | ||||
Initial costs, buildings | 5,880 | ||||
Land at cost | 2,248 | ||||
Buildings at cost | 5,880 | ||||
Total at cost | 8,128 | ||||
Accumulated Depreciation | 1,494 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2012 | ||||
Date Acquired | Oct. 02, 2012 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2012 [Member] | Reading, United Kingdom [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 24,672 | ||||
Initial costs, buildings | 79,057 | ||||
Land at cost | 24,672 | ||||
Buildings at cost | 79,057 | ||||
Total at cost | 103,729 | ||||
Accumulated Depreciation | 4,028 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2012 | ||||
Date Acquired | Dec. 18, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2003 [Member] | Bury, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 8,076 | ||||
Initial costs, buildings | 18,404 | ||||
Land at cost | 8,076 | ||||
Buildings at cost | 18,404 | ||||
Total at cost | 26,480 | ||||
Accumulated Depreciation | 796 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2003 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2003 [Member] | Newark, NJ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 32,957 | ||||
Initial costs, buildings | 24,553 | ||||
Land at cost | 32,957 | ||||
Buildings at cost | 24,553 | ||||
Total at cost | 57,510 | ||||
Accumulated Depreciation | 1,381 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2003 | ||||
Date Acquired | May 02, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2003 [Member] | Youngstown, OH [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 4,334 | ||||
Initial costs, buildings | 3,565 | ||||
Additions subsequent to acquisition, Improvements | 488 | ||||
Land at cost | 4,334 | ||||
Buildings at cost | 4,053 | ||||
Total at cost | 8,387 | ||||
Accumulated Depreciation | 2,527 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2003 | ||||
Date Acquired | May 01, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 41 years | ||||
1990 [Member] | Carmarthen, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 864 | ||||
Initial costs, buildings | 24,274 | ||||
Land at cost | 864 | ||||
Buildings at cost | 24,274 | ||||
Total at cost | 25,138 | ||||
Accumulated Depreciation | 1,839 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1990 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1990 [Member] | Darlington, United Kingdom [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 4,962 | ||||
Initial costs, buildings | 25,007 | ||||
Land at cost | 4,962 | ||||
Buildings at cost | 25,007 | ||||
Total at cost | 29,969 | ||||
Accumulated Depreciation | 988 | ||||
Encumbrances | $ 0 | ||||
Date Acquired | Jun. 25, 2021 | ||||
1990 [Member] | Darlington UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Date of Construction | 1990 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1990 [Member] | Gloucester, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 5,296 | ||||
Initial costs, buildings | 58,249 | ||||
Land at cost | 5,296 | ||||
Buildings at cost | 58,249 | ||||
Total at cost | 63,545 | ||||
Accumulated Depreciation | 5,142 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1990 | ||||
Date Acquired | Aug. 16, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1990 [Member] | Hemel Hempstead, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 11,854 | ||||
Initial costs, buildings | 5,983 | ||||
Land at cost | 11,854 | ||||
Buildings at cost | 5,983 | ||||
Total at cost | 17,837 | ||||
Accumulated Depreciation | 313 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1990 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1990 [Member] | Leeds, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 2,163 | ||||
Initial costs, buildings | 9,037 | ||||
Land at cost | 2,163 | ||||
Buildings at cost | 9,037 | ||||
Total at cost | 11,200 | ||||
Accumulated Depreciation | 379 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1990 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1990 [Member] | Melton Mowbray, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 5,411 | ||||
Initial costs, buildings | 15,169 | ||||
Land at cost | 5,411 | ||||
Buildings at cost | 15,169 | ||||
Total at cost | 20,580 | ||||
Accumulated Depreciation | 651 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1990 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1990 [Member] | Reading, United Kingdom [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 33,024 | ||||
Initial costs, buildings | 43,823 | ||||
Land at cost | 33,024 | ||||
Buildings at cost | 43,823 | ||||
Total at cost | 76,847 | ||||
Accumulated Depreciation | 3,816 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1990 | ||||
Date Acquired | Aug. 16, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1956 [Member] | Detroit, MI [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Long term acute care hospital | ||||
Initial costs, land | $ 1,220 | ||||
Initial costs, buildings | 8,323 | ||||
Land at cost | 1,220 | ||||
Buildings at cost | 8,323 | ||||
Total at cost | 9,543 | ||||
Accumulated Depreciation | 3,099 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1956 | ||||
Date Acquired | May 22, 2008 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1953 [Member] | Denville, NJ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 15,709 | ||||
Initial costs, buildings | 55,772 | ||||
Land at cost | 15,709 | ||||
Buildings at cost | 55,772 | ||||
Total at cost | 71,481 | ||||
Accumulated Depreciation | 3,308 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1953 | ||||
Date Acquired | Sep. 30, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1953 [Member] | Port Huron, MI | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,531 | ||||
Initial costs, buildings | 14,252 | ||||
Land at cost | 2,531 | ||||
Buildings at cost | 14,252 | ||||
Total at cost | 16,783 | ||||
Accumulated Depreciation | 3,408 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1953 | ||||
Date Acquired | Dec. 31, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 30 years | ||||
1976 [Member] | Layton, UT [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 14,360 | ||||
Initial costs, buildings | 370,154 | ||||
Additions subsequent to acquisition, Improvements | 5,481 | ||||
Land at cost | 14,360 | ||||
Buildings at cost | 375,635 | ||||
Total at cost | 389,995 | ||||
Accumulated Depreciation | 22,737 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1976 | ||||
Date Acquired | Sep. 29, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1976 [Member] | Phoenix, AZ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 12,695 | ||||
Initial costs, buildings | 73,773 | ||||
Additions subsequent to acquisition, Improvements | 4,499 | ||||
Land at cost | 12,695 | ||||
Buildings at cost | 78,272 | ||||
Total at cost | 90,967 | ||||
Accumulated Depreciation | 10,931 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1976 | ||||
Date Acquired | Sep. 29, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 43 years | ||||
2019 [Member] | Clarksville, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 2,460 | ||||
Initial costs, buildings | 25,540 | ||||
Land at cost | 2,460 | ||||
Buildings at cost | 25,540 | ||||
Total at cost | 28,000 | ||||
Accumulated Depreciation | 1,420 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2019 | ||||
Date Acquired | Dec. 17, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 39 years | ||||
2019 [Member] | Mesa, AZ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,604 | ||||
Initial costs, buildings | 16,400 | ||||
Land at cost | 2,604 | ||||
Buildings at cost | 16,400 | ||||
Total at cost | 19,004 | ||||
Accumulated Depreciation | 283 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2019 | ||||
Date Acquired | Apr. 18, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2019 [Member] | Overland Park, KS [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 3,191 | ||||
Initial costs, buildings | 14,263 | ||||
Land at cost | 3,191 | ||||
Buildings at cost | 14,263 | ||||
Total at cost | 17,454 | ||||
Accumulated Depreciation | 1,172 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2019 | ||||
Date Acquired | Jun. 10, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 50 years | ||||
2011 [Member] | Cologne Germany [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
2011 [Member] | New Braunfels, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 1,853 | ||||
Initial costs, buildings | 10,622 | ||||
Land at cost | 1,853 | ||||
Buildings at cost | 10,622 | ||||
Total at cost | 12,475 | ||||
Accumulated Depreciation | 574 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2011 | ||||
Date Acquired | Feb. 29, 2012 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1959 [Member] | Canterbury, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1959 [Member] | Coral Gables, FL [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 26,215 | ||||
Initial costs, buildings | 84,584 | ||||
Land at cost | 26,215 | ||||
Buildings at cost | 84,584 | ||||
Total at cost | 110,799 | ||||
Accumulated Depreciation | 3,104 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1959 | ||||
Date Acquired | Aug. 01, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1959 [Member] | Norwalk, CA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,811 | ||||
Initial costs, buildings | 5,940 | ||||
Land at cost | 2,811 | ||||
Buildings at cost | 5,940 | ||||
Total at cost | 8,751 | ||||
Accumulated Depreciation | 278 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1959 | ||||
Date Acquired | Jul. 06, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1994 [Member] | Cheadle, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 28,297 | ||||
Initial costs, buildings | 89,982 | ||||
Land at cost | 28,297 | ||||
Buildings at cost | 89,982 | ||||
Total at cost | 118,279 | ||||
Accumulated Depreciation | 3,652 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1994 | ||||
Date Acquired | Jul. 08, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1994 [Member] | Worthing, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 6,374 | ||||
Initial costs, buildings | 28,612 | ||||
Land at cost | 6,374 | ||||
Buildings at cost | 28,612 | ||||
Total at cost | 34,986 | ||||
Accumulated Depreciation | 2,164 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1994 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2001 [Member] | Cologne Germany [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Initial costs, land | $ 4,292 | ||||
Initial costs, buildings | 14,512 | ||||
Land at cost | 4,292 | ||||
Buildings at cost | 14,512 | ||||
Total at cost | 18,804 | ||||
Accumulated Depreciation | 2,031 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2001 | ||||
Date Acquired | Aug. 07, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2001 [Member] | Darlington, United Kingdom [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,981 | ||||
Initial costs, buildings | 33,995 | ||||
Land at cost | 1,981 | ||||
Buildings at cost | 33,995 | ||||
Total at cost | 35,976 | ||||
Accumulated Depreciation | 2,106 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2001 | ||||
Date Acquired | Aug. 07, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2001 [Member] | Hope, AR [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,651 | ||||
Initial costs, buildings | 3,359 | ||||
Additions subsequent to acquisition, Improvements | 2,733 | ||||
Land at cost | 1,651 | ||||
Buildings at cost | 6,092 | ||||
Total at cost | 7,743 | ||||
Accumulated Depreciation | 1,146 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2001 | ||||
Date Acquired | Sep. 29, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 41 years | ||||
2001 [Member] | Norwood, MA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 6,373 | ||||
Additions subsequent to acquisition, Improvements | 69,916 | ||||
Land at cost | 6,373 | ||||
Buildings at cost | 69,916 | ||||
Total at cost | 76,289 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2001 | ||||
Date Acquired | Jun. 27, 2018 | ||||
Life on which depreciation in latest income statements is computed (Years) | 46 years | ||||
1925 [Member] | Dover NJ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 3,865 | ||||
Initial costs, buildings | 8,693 | ||||
Land at cost | 3,865 | ||||
Buildings at cost | 8,693 | ||||
Total at cost | 12,558 | ||||
Accumulated Depreciation | 549 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1925 | ||||
Date Acquired | Sep. 30, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1935 [Member] | Darlington UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 20,165 | ||||
Initial costs, buildings | 45,806 | ||||
Land at cost | 20,165 | ||||
Buildings at cost | 45,806 | ||||
Total at cost | 65,971 | ||||
Accumulated Depreciation | 2,012 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1935 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1960 [Member] | Darlington UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 4,962 | ||||
Initial costs, buildings | 25,007 | ||||
Land at cost | 4,962 | ||||
Buildings at cost | 25,007 | ||||
Total at cost | 29,969 | ||||
Accumulated Depreciation | 988 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1960 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1960 [Member] | Houston, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 3,274 | ||||
Initial costs, buildings | 27,324 | ||||
Additions subsequent to acquisition, Improvements | 32,499 | ||||
Land at cost | 3,274 | ||||
Buildings at cost | 59,823 | ||||
Total at cost | 63,097 | ||||
Accumulated Depreciation | 19,503 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1960 | ||||
Date Acquired | Aug. 10, 2007 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1960 [Member] | Huntington Park, CA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 3,935 | ||||
Initial costs, buildings | 6,103 | ||||
Land at cost | 3,935 | ||||
Buildings at cost | 6,103 | ||||
Total at cost | 10,038 | ||||
Accumulated Depreciation | 276 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1960 | ||||
Date Acquired | Jul. 06, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1960 [Member] | London, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 5,848 | ||||
Initial costs, buildings | 14,858 | ||||
Land at cost | 5,848 | ||||
Buildings at cost | 14,858 | ||||
Total at cost | 20,706 | ||||
Accumulated Depreciation | 613 | ||||
Encumbrances | $ 0 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1960 [Member] | London, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Date of Construction | 1960 | ||||
1960 [Member] | Meyersdale, PA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 390 | ||||
Initial costs, buildings | 4,280 | ||||
Land at cost | 390 | ||||
Buildings at cost | 4,280 | ||||
Total at cost | 4,670 | ||||
Accumulated Depreciation | 548 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1960 | ||||
Date Acquired | Dec. 17, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 30 years | ||||
1960 [Member] | Sherman, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 3,363 | ||||
Initial costs, buildings | 10,932 | ||||
Land at cost | 3,363 | ||||
Buildings at cost | 10,932 | ||||
Total at cost | 14,295 | ||||
Accumulated Depreciation | 3,940 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1960 | ||||
Date Acquired | Oct. 31, 2014 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1840 [Member] | Diss, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 2,762 | ||||
Initial costs, buildings | 9,849 | ||||
Land at cost | 2,762 | ||||
Buildings at cost | 9,849 | ||||
Total at cost | 12,611 | ||||
Accumulated Depreciation | 453 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1840 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1993 [Member] | Dahlen, Germany [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 1,303 | ||||
Initial costs, buildings | 10,996 | ||||
Land at cost | 1,303 | ||||
Buildings at cost | 10,996 | ||||
Total at cost | 12,299 | ||||
Accumulated Depreciation | 730 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1993 | ||||
Date Acquired | Aug. 28, 2018 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1993 [Member] | Dormagen Germany [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 1,852 | ||||
Initial costs, buildings | 5,477 | ||||
Land at cost | 1,852 | ||||
Buildings at cost | 5,477 | ||||
Total at cost | 7,329 | ||||
Accumulated Depreciation | 631 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1993 | ||||
Date Acquired | Aug. 28, 2018 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1993 [Member] | San Bernardino, CA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,209 | ||||
Initial costs, buildings | 37,498 | ||||
Land at cost | 2,209 | ||||
Buildings at cost | 37,498 | ||||
Total at cost | 39,707 | ||||
Accumulated Depreciation | 3,415 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1993 | ||||
Date Acquired | Aug. 30, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1830 [Member] | Bromley, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 6,856 | ||||
Initial costs, buildings | 14,731 | ||||
Land at cost | 6,856 | ||||
Buildings at cost | 14,731 | ||||
Total at cost | 21,587 | ||||
Accumulated Depreciation | 614 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1830 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1969 [Member] | Denville, NJ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 15,709 | ||||
Initial costs, buildings | 55,772 | ||||
Land at cost | 15,709 | ||||
Buildings at cost | 55,772 | ||||
Total at cost | 71,481 | ||||
Accumulated Depreciation | 3,308 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1969 | ||||
Date Acquired | Sep. 30, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1969 [Member] | Hialeah, FL [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 75,339 | ||||
Initial costs, buildings | 222,271 | ||||
Additions subsequent to acquisition, Improvements | 75,494 | ||||
Land at cost | 75,339 | ||||
Buildings at cost | 297,765 | ||||
Total at cost | 373,104 | ||||
Accumulated Depreciation | 8,995 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1969 | ||||
Date Acquired | Aug. 01, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1969 [Member] | Huntington Park, CA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 3,935 | ||||
Initial costs, buildings | 6,103 | ||||
Land at cost | 3,935 | ||||
Buildings at cost | 6,103 | ||||
Total at cost | 10,038 | ||||
Accumulated Depreciation | 276 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1969 | ||||
Date Acquired | Jul. 06, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1997 [Member] | Dover NJ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 3,865 | ||||
Initial costs, buildings | 8,693 | ||||
Land at cost | 3,865 | ||||
Buildings at cost | 8,693 | ||||
Total at cost | 12,558 | ||||
Accumulated Depreciation | 549 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1927 | ||||
Date Acquired | Sep. 30, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2021 [Member] | Bromley, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 6,856 | ||||
Initial costs, buildings | 14,731 | ||||
Land at cost | 6,856 | ||||
Buildings at cost | 14,731 | ||||
Total at cost | 21,587 | ||||
Accumulated Depreciation | 614 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2021 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2021 [Member] | McKinney, Texas [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 2,934 | ||||
Land at cost | 2,934 | ||||
Total at cost | 2,934 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2021 | ||||
Date Acquired | Oct. 19, 2021 | ||||
2021 [Member] | Preston, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 8,296 | ||||
Initial costs, buildings | 24,677 | ||||
Land at cost | 8,296 | ||||
Buildings at cost | 24,677 | ||||
Total at cost | 32,973 | ||||
Accumulated Depreciation | 991 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2021 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2021 [Member] | Stockton, California [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 2,841 | ||||
Land at cost | 2,841 | ||||
Total at cost | 2,841 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2021 | ||||
Date Acquired | Nov. 23, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2020 [Member] | Darlington, United Kingdom [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 20,165 | ||||
Initial costs, buildings | 45,806 | ||||
Land at cost | 20,165 | ||||
Buildings at cost | 45,806 | ||||
Total at cost | 65,971 | ||||
Accumulated Depreciation | 2,012 | ||||
Encumbrances | $ 0 | ||||
Date Acquired | Jun. 25, 2021 | ||||
2020 [Member] | Darlington UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Date of Construction | 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2020 [Member] | Gilbert, AZ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 4,790 | ||||
Initial costs, buildings | 45,076 | ||||
Land at cost | 4,790 | ||||
Buildings at cost | 45,076 | ||||
Total at cost | 49,866 | ||||
Accumulated Depreciation | 1,408 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2020 | ||||
Date Acquired | Oct. 19, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2020 [Member] | Houston, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2020 [Member] | Idaho Falls, ID [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,880 | ||||
Initial costs, buildings | 107,608 | ||||
Land at cost | 1,880 | ||||
Buildings at cost | 107,608 | ||||
Total at cost | 109,488 | ||||
Accumulated Depreciation | 7,835 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2020 | ||||
Date Acquired | Dec. 19, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2020 [Member] | Houston, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 6,063 | ||||
Initial costs, buildings | 19,881 | ||||
Additions subsequent to acquisition, Improvements | 2,565 | ||||
Land at cost | 6,063 | ||||
Buildings at cost | 22,446 | ||||
Total at cost | 28,509 | ||||
Accumulated Depreciation | 1,122 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2020 | ||||
Date Acquired | Oct. 25, 2019 | ||||
2020 [Member] | Tadley, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 19,853 | ||||
Initial costs, buildings | 18,090 | ||||
Land at cost | 19,853 | ||||
Buildings at cost | 18,090 | ||||
Total at cost | 37,943 | ||||
Accumulated Depreciation | 891 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2020 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2020 [Member] | Woking, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 6,871 | ||||
Initial costs, buildings | 4,442 | ||||
Land at cost | 6,871 | ||||
Buildings at cost | 4,442 | ||||
Total at cost | 11,313 | ||||
Accumulated Depreciation | 204 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2020 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1986 [Member] | Halsall, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,912 | ||||
Initial costs, buildings | 29,573 | ||||
Land at cost | 1,912 | ||||
Buildings at cost | 29,573 | ||||
Total at cost | 31,485 | ||||
Accumulated Depreciation | 2,618 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1986 | ||||
Date Acquired | Aug. 16, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1986 [Member] | Rowley, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,760 | ||||
Initial costs, buildings | 17,370 | ||||
Land at cost | 2,760 | ||||
Buildings at cost | 17,370 | ||||
Total at cost | 20,130 | ||||
Accumulated Depreciation | 1,585 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1986 | ||||
Date Acquired | Aug. 16, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1999 [Member] | Hartsville, SC [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,050 | ||||
Initial costs, buildings | 43,970 | ||||
Land at cost | 2,050 | ||||
Buildings at cost | 43,970 | ||||
Total at cost | 46,020 | ||||
Accumulated Depreciation | 9,332 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1999 | ||||
Date Acquired | Aug. 31, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 34 years | ||||
1924 [Member] | Hastings, PA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 603 | ||||
Initial costs, buildings | 8,834 | ||||
Land at cost | 603 | ||||
Buildings at cost | 8,834 | ||||
Total at cost | 9,437 | ||||
Accumulated Depreciation | 1,090 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1924 | ||||
Date Acquired | Dec. 17, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 30 years | ||||
1924 [Member] | Johnstown, PA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 8,877 | ||||
Initial costs, buildings | 247,158 | ||||
Land at cost | 8,877 | ||||
Buildings at cost | 247,158 | ||||
Total at cost | 256,035 | ||||
Accumulated Depreciation | 25,076 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1924 | ||||
Date Acquired | Dec. 17, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 30 years | ||||
1924 [Member] | Roaring Springs, PA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,446 | ||||
Initial costs, buildings | 9,549 | ||||
Land at cost | 1,446 | ||||
Buildings at cost | 9,549 | ||||
Total at cost | 10,995 | ||||
Accumulated Depreciation | 1,216 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1924 | ||||
Date Acquired | Dec. 17, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 30 years | ||||
1950 [Member] | Hialeah, FL [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 18,802 | ||||
Initial costs, buildings | 107,783 | ||||
Land at cost | 18,802 | ||||
Buildings at cost | 107,783 | ||||
Total at cost | 126,585 | ||||
Accumulated Depreciation | 4,043 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1950 | ||||
Date Acquired | Aug. 01, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1950 [Member] | Houston, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 28,687 | ||||
Initial costs, buildings | 104,028 | ||||
Additions subsequent to acquisition, Improvements | 78,415 | ||||
Land at cost | 28,687 | ||||
Buildings at cost | 182,443 | ||||
Total at cost | 211,130 | ||||
Accumulated Depreciation | 12,756 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1950 | ||||
Date Acquired | Sep. 29, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 41 years | ||||
1950 [Member] | Lynwood, CA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 30,116 | ||||
Initial costs, buildings | 148,527 | ||||
Land at cost | 30,116 | ||||
Buildings at cost | 148,527 | ||||
Total at cost | 178,643 | ||||
Accumulated Depreciation | 9,018 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1940 | ||||
Date Acquired | Aug. 13, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1950 [Member] | Ottumwa, IA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,377 | ||||
Initial costs, buildings | 48,697 | ||||
Land at cost | 2,377 | ||||
Buildings at cost | 48,697 | ||||
Total at cost | 51,074 | ||||
Accumulated Depreciation | 5,434 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1950 | ||||
Date Acquired | Dec. 17, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 30 years | ||||
1950 [Member] | Rockledge, FL [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 13,919 | ||||
Initial costs, buildings | 23,282 | ||||
Additions subsequent to acquisition, Improvements | 8,338 | ||||
Land at cost | 13,919 | ||||
Buildings at cost | 31,620 | ||||
Total at cost | 45,539 | ||||
Accumulated Depreciation | 5,521 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1950 | ||||
Date Acquired | May 01, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 42 years | ||||
1950 [Member] | Sharon, PA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 6,179 | ||||
Initial costs, buildings | 9,066 | ||||
Additions subsequent to acquisition, Improvements | 5,428 | ||||
Land at cost | 6,179 | ||||
Buildings at cost | 14,494 | ||||
Total at cost | 20,673 | ||||
Accumulated Depreciation | 3,091 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1950 | ||||
Date Acquired | May 01, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 41 years | ||||
1950 [Member] | Surrey, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 14,280 | ||||
Initial costs, buildings | 8,741 | ||||
Land at cost | 14,280 | ||||
Buildings at cost | 8,741 | ||||
Total at cost | 23,021 | ||||
Accumulated Depreciation | 25 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1950 | ||||
Date Acquired | Dec. 09, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1991 [Member] | Fresno, CA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 5,507 | ||||
Initial costs, buildings | 70,473 | ||||
Land at cost | 5,507 | ||||
Buildings at cost | 70,473 | ||||
Total at cost | 75,980 | ||||
Accumulated Depreciation | 6,329 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1991 | ||||
Date Acquired | Aug. 30, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1991 [Member] | Heidelberg, Germany [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 6,049 | ||||
Initial costs, buildings | 34,547 | ||||
Land at cost | 6,049 | ||||
Buildings at cost | 34,547 | ||||
Total at cost | 40,596 | ||||
Accumulated Depreciation | 5,644 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1991 | ||||
Date Acquired | Jun. 22, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1700 [Member] | Frome, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 10,340 | ||||
Initial costs, buildings | 10,166 | ||||
Land at cost | 10,340 | ||||
Buildings at cost | 10,166 | ||||
Total at cost | 20,506 | ||||
Accumulated Depreciation | 567 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1700 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1966 [Member] | Gardena, CA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 14,010 | ||||
Initial costs, buildings | 65,282 | ||||
Land at cost | 14,010 | ||||
Buildings at cost | 65,282 | ||||
Total at cost | 79,292 | ||||
Accumulated Depreciation | 2,646 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1966 | ||||
Date Acquired | Jul. 06, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1900 [Member] | Glasgow, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 1,355 | ||||
Initial costs, buildings | 14,824 | ||||
Land at cost | 1,355 | ||||
Buildings at cost | 14,824 | ||||
Total at cost | 16,179 | ||||
Accumulated Depreciation | 603 | ||||
Encumbrances | $ 0 | ||||
Date Acquired | Jun. 25, 2021 | ||||
1900 [Member] | London, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 5,848 | ||||
Initial costs, buildings | 14,858 | ||||
Land at cost | 5,848 | ||||
Buildings at cost | 14,858 | ||||
Total at cost | 20,706 | ||||
Accumulated Depreciation | 613 | ||||
Encumbrances | $ 0 | ||||
Date Acquired | Jun. 25, 2021 | ||||
1900 [Member] | York, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 20,534 | ||||
Land at cost | 20,534 | ||||
Buildings at cost | 68,118 | ||||
Total at cost | 88,652 | ||||
Accumulated Depreciation | 2,699 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1900 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 hours | ||||
1796 [Member] | Godalming, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 8,880 | ||||
Initial costs, buildings | 18,014 | ||||
Land at cost | 8,880 | ||||
Buildings at cost | 18,014 | ||||
Total at cost | 26,894 | ||||
Accumulated Depreciation | 783 | ||||
Encumbrances | $ 0 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1886 [Member] | Grefath, Germany [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 1,164 | ||||
Initial costs, buildings | 2,937 | ||||
Land at cost | 1,164 | ||||
Buildings at cost | 2,937 | ||||
Total at cost | 4,101 | ||||
Accumulated Depreciation | 346 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1886 | ||||
Date Acquired | Aug. 28, 2018 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1998 [Member] | Hassocks, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 5,205 | ||||
Initial costs, buildings | 27,215 | ||||
Land at cost | 5,205 | ||||
Buildings at cost | 27,215 | ||||
Total at cost | 32,420 | ||||
Accumulated Depreciation | 1,255 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1998 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1885 [Member] | Heidelberg, Germany [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 6,049 | ||||
Initial costs, buildings | 34,547 | ||||
Land at cost | 6,049 | ||||
Buildings at cost | 34,547 | ||||
Total at cost | 40,596 | ||||
Accumulated Depreciation | 5,644 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1885 | ||||
Date Acquired | Jun. 22, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1901 [Member] | Hemel Hempstead, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 11,854 | ||||
Initial costs, buildings | 5,983 | ||||
Land at cost | 11,854 | ||||
Buildings at cost | 5,983 | ||||
Total at cost | 17,837 | ||||
Accumulated Depreciation | 313 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1901 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2005 [Member] | Port Arthur, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 12,972 | ||||
Initial costs, buildings | 78,051 | ||||
Additions subsequent to acquisition, Improvements | 6,877 | ||||
Land at cost | 12,972 | ||||
Buildings at cost | 84,928 | ||||
Total at cost | 97,900 | ||||
Accumulated Depreciation | 18,823 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2005 | ||||
Date Acquired | Sep. 26, 2013 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2005 [Member] | Tomball, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Long term acute care hospital | ||||
Initial costs, land | $ 1,299 | ||||
Initial costs, buildings | 23,982 | ||||
Land at cost | 1,299 | ||||
Buildings at cost | 23,982 | ||||
Total at cost | 25,281 | ||||
Accumulated Depreciation | 7,195 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2005 | ||||
Date Acquired | Dec. 21, 2010 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2002 [Member] | Idaho Falls, ID [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,822 | ||||
Initial costs, buildings | 37,467 | ||||
Additions subsequent to acquisition, Improvements | 15,921 | ||||
Land at cost | 1,822 | ||||
Buildings at cost | 53,388 | ||||
Total at cost | 55,210 | ||||
Accumulated Depreciation | 16,455 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2002 | ||||
Date Acquired | Apr. 01, 2008 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2002 [Member] | Melbourne, FL [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 5,642 | ||||
Initial costs, buildings | 17,087 | ||||
Additions subsequent to acquisition, Improvements | 21,818 | ||||
Land at cost | 5,642 | ||||
Buildings at cost | 38,905 | ||||
Total at cost | 44,547 | ||||
Accumulated Depreciation | 4,054 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2002 | ||||
Date Acquired | May 01, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 42 years | ||||
2002 [Member] | San Antonio, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 8,053 | ||||
Initial costs, buildings | 29,333 | ||||
Additions subsequent to acquisition, Improvements | 7,981 | ||||
Land at cost | 8,053 | ||||
Buildings at cost | 37,314 | ||||
Total at cost | 45,367 | ||||
Accumulated Depreciation | 4,701 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2002 | ||||
Date Acquired | Sep. 29, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 41 years | ||||
1892 [Member] | Hinckley, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 2,340 | ||||
Initial costs, buildings | 15,949 | ||||
Land at cost | 2,340 | ||||
Buildings at cost | 15,949 | ||||
Total at cost | 18,289 | ||||
Accumulated Depreciation | 648 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1892 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2000 [Member] | Cadiz Spain [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 290 | ||||
Initial costs, buildings | 6,593 | ||||
Land at cost | 290 | ||||
Buildings at cost | 6,593 | ||||
Total at cost | 6,883 | ||||
Accumulated Depreciation | 118 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2000 | ||||
Date Acquired | Apr. 29, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2000 [Member] | Kingswood, Australia [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 23,216 | ||||
Initial costs, buildings | 75,501 | ||||
Additions subsequent to acquisition, Improvements | 11,829 | ||||
Land at cost | 23,216 | ||||
Buildings at cost | 87,330 | ||||
Total at cost | 110,546 | ||||
Accumulated Depreciation | 6,888 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2000 | ||||
Date Acquired | Jun. 07, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2000 [Member] | Lynwood, CA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 30,116 | ||||
Initial costs, buildings | 148,527 | ||||
Land at cost | 30,116 | ||||
Buildings at cost | 148,527 | ||||
Total at cost | 178,643 | ||||
Accumulated Depreciation | 9,018 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2000 | ||||
Date Acquired | Aug. 13, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2000 [Member] | Montclair, NJ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2000 [Member] | Nottingham, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 9,502 | ||||
Initial costs, buildings | 8,504 | ||||
Land at cost | 9,502 | ||||
Buildings at cost | 8,504 | ||||
Total at cost | 18,006 | ||||
Accumulated Depreciation | 419 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2000 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
2000 [Member] | Montclair New Jersey [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 7,900 | ||||
Initial costs, buildings | 99,640 | ||||
Additions subsequent to acquisition, Improvements | 577 | ||||
Land at cost | 8,477 | ||||
Buildings at cost | 99,640 | ||||
Total at cost | 108,117 | ||||
Accumulated Depreciation | 22,329 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2000 | ||||
Date Acquired | Apr. 01, 2014 | ||||
2000 [Member] | Warren, OH [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 2,417 | ||||
Initial costs, buildings | 15,857 | ||||
Additions subsequent to acquisition, Improvements | 1,737 | ||||
Land at cost | 2,417 | ||||
Buildings at cost | 17,594 | ||||
Total at cost | 20,011 | ||||
Accumulated Depreciation | 3,150 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2000 | ||||
Date Acquired | May 01, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 46 years | ||||
2000 [Member] | Willenhall, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 6,917 | ||||
Initial costs, buildings | 15,434 | ||||
Land at cost | 6,917 | ||||
Buildings at cost | 15,434 | ||||
Total at cost | 22,351 | ||||
Accumulated Depreciation | 626 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 2000 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1967 [Member] | Huntington Park, CA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 3,132 | ||||
Initial costs, buildings | 5,002 | ||||
Land at cost | 3,132 | ||||
Buildings at cost | 5,002 | ||||
Total at cost | 8,134 | ||||
Accumulated Depreciation | 231 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1967 | ||||
Date Acquired | Jul. 06, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1975 [Member] | Liverpool, Australia [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 13,022 | ||||
Initial costs, buildings | 40,532 | ||||
Additions subsequent to acquisition, Improvements | 196 | ||||
Land at cost | 13,022 | ||||
Buildings at cost | 40,728 | ||||
Total at cost | 53,750 | ||||
Accumulated Depreciation | 4,879 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1975 | ||||
Date Acquired | Jun. 07, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 30 years | ||||
1975 [Member] | Lauderdale Lakes, FL [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 10,657 | ||||
Initial costs, buildings | 150,313 | ||||
Land at cost | 10,657 | ||||
Buildings at cost | 150,313 | ||||
Total at cost | 160,970 | ||||
Accumulated Depreciation | 6,038 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1975 | ||||
Date Acquired | Aug. 01, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1987 [Member] | London, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 3,117 | ||||
Initial costs, buildings | 3,937 | ||||
Land at cost | 3,117 | ||||
Buildings at cost | 3,937 | ||||
Total at cost | 7,054 | ||||
Accumulated Depreciation | 300 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1987 | ||||
Date Acquired | Jan. 09, 2020 | ||||
1987 [Member] | London, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1987 [Member] | Orpington, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 9,811 | ||||
Initial costs, buildings | 40,540 | ||||
Land at cost | 9,811 | ||||
Buildings at cost | 40,540 | ||||
Total at cost | 50,351 | ||||
Accumulated Depreciation | 3,069 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1987 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1987 [Member] | Salt Lake City, UT [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 13,590 | ||||
Initial costs, buildings | 101,915 | ||||
Additions subsequent to acquisition, Improvements | 15,268 | ||||
Land at cost | 13,590 | ||||
Buildings at cost | 117,183 | ||||
Total at cost | 130,773 | ||||
Accumulated Depreciation | 14,618 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1987 | ||||
Date Acquired | Sep. 29, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 41 years | ||||
1926 [Member] | Norwood, MA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 6,373 | ||||
Additions subsequent to acquisition, Improvements | 69,916 | ||||
Land at cost | 6,373 | ||||
Buildings at cost | 69,916 | ||||
Total at cost | 76,289 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1926 | ||||
Date Acquired | Jun. 27, 2018 | ||||
Life on which depreciation in latest income statements is computed (Years) | 46 years | ||||
1996 [Member] | Mcminnville, OR [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 5,000 | ||||
Initial costs, buildings | 97,900 | ||||
Land at cost | 5,000 | ||||
Buildings at cost | 97,900 | ||||
Total at cost | 102,900 | ||||
Accumulated Depreciation | 16,630 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1996 | ||||
Date Acquired | Aug. 31, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 41 years | ||||
1996 [Member] | Poole, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,206 | ||||
Initial costs, buildings | 36,429 | ||||
Land at cost | 2,206 | ||||
Buildings at cost | 36,429 | ||||
Total at cost | 38,635 | ||||
Accumulated Depreciation | 3,538 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1996 | ||||
Date Acquired | Apr. 03, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1955 [Member] | Miami, FL [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 44,400 | ||||
Initial costs, buildings | 107,203 | ||||
Land at cost | 44,400 | ||||
Buildings at cost | 107,203 | ||||
Total at cost | 151,603 | ||||
Accumulated Depreciation | 4,744 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1955 | ||||
Date Acquired | Aug. 01, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1955 [Member] | Windsor, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 11,564 | ||||
Initial costs, buildings | 99,395 | ||||
Land at cost | 11,564 | ||||
Buildings at cost | 99,395 | ||||
Total at cost | 110,959 | ||||
Accumulated Depreciation | 7,474 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1955 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1988 [Member] | Miami, FL [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 20,430 | ||||
Initial costs, buildings | 33,881 | ||||
Additions subsequent to acquisition, Improvements | 10,364 | ||||
Land at cost | 20,430 | ||||
Buildings at cost | 44,245 | ||||
Total at cost | 64,675 | ||||
Accumulated Depreciation | 593 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1988 | ||||
Date Acquired | Apr. 25, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1988 [Member] | Palestine, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 1,848 | ||||
Initial costs, buildings | 95,257 | ||||
Land at cost | 1,848 | ||||
Buildings at cost | 95,257 | ||||
Total at cost | 97,105 | ||||
Accumulated Depreciation | 7,489 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1988 | ||||
Date Acquired | Dec. 17, 2019 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1920 [Member] | Montclair, NJ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 7,900 | ||||
Initial costs, buildings | 99,640 | ||||
Additions subsequent to acquisition, Improvements | 577 | ||||
Land at cost | 8,477 | ||||
Buildings at cost | 99,640 | ||||
Total at cost | 108,117 | ||||
Accumulated Depreciation | 22,329 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1920 | ||||
Date Acquired | Apr. 01, 2014 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1920 [Member] | Pasco, WA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,594 | ||||
Initial costs, buildings | 13,195 | ||||
Land at cost | 2,594 | ||||
Buildings at cost | 13,195 | ||||
Total at cost | 15,789 | ||||
Accumulated Depreciation | 1,953 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1920 | ||||
Date Acquired | Aug. 31, 2018 | ||||
Life on which depreciation in latest income statements is computed (Years) | 30 years | ||||
1920 [Member] | Newark, NJ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 32,957 | ||||
Initial costs, buildings | 24,553 | ||||
Land at cost | 32,957 | ||||
Buildings at cost | 24,553 | ||||
Total at cost | 57,510 | ||||
Accumulated Depreciation | 1,381 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1920 | ||||
Date Acquired | May 02, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1920 [Member] | Sussex, NJ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 477 | ||||
Initial costs, buildings | 2,097 | ||||
Land at cost | 477 | ||||
Buildings at cost | 2,097 | ||||
Total at cost | 2,574 | ||||
Accumulated Depreciation | 130 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1920 | ||||
Date Acquired | Sep. 30, 2015 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1919 [Member] | Newark, NJ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 32,957 | ||||
Initial costs, buildings | 24,553 | ||||
Land at cost | 32,957 | ||||
Buildings at cost | 24,553 | ||||
Total at cost | 57,510 | ||||
Accumulated Depreciation | 1,381 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1919 | ||||
Date Acquired | May 02, 2016 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1958 [Member] | Miami, FL [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 20,430 | ||||
Initial costs, buildings | 33,881 | ||||
Additions subsequent to acquisition, Improvements | 10,364 | ||||
Land at cost | 20,430 | ||||
Buildings at cost | 44,245 | ||||
Total at cost | 64,675 | ||||
Accumulated Depreciation | 593 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1958 | ||||
Date Acquired | Apr. 25, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1958 [Member] | Norwalk, CA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 7,946 | ||||
Initial costs, buildings | 30,465 | ||||
Land at cost | 7,946 | ||||
Buildings at cost | 30,465 | ||||
Total at cost | 38,411 | ||||
Accumulated Depreciation | 1,221 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1958 | ||||
Date Acquired | Jul. 06, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1995 [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 2,811 | ||||
Initial costs, buildings | 5,940 | ||||
Land at cost | 2,811 | ||||
Buildings at cost | 5,940 | ||||
Total at cost | 8,751 | ||||
Accumulated Depreciation | 278 | ||||
Encumbrances | $ 0 | ||||
1995 [Member] | Norwalk, CA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Date of Construction | 1995 | ||||
Date Acquired | Jul. 06, 2021 | ||||
1906 [Member] | Salt Lake City, UT [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 13,590 | ||||
Initial costs, buildings | 101,915 | ||||
Additions subsequent to acquisition, Improvements | 15,268 | ||||
Land at cost | 13,590 | ||||
Buildings at cost | 117,183 | ||||
Total at cost | 130,773 | ||||
Accumulated Depreciation | 14,618 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1906 | ||||
Date Acquired | Sep. 29, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 41 years | ||||
1906 [Member] | Royston, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 6,391 | ||||
Initial costs, buildings | 19,028 | ||||
Land at cost | 6,391 | ||||
Buildings at cost | 19,028 | ||||
Total at cost | 25,419 | ||||
Accumulated Depreciation | 899 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1906 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1850 [Member] | Preston, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 8,296 | ||||
Initial costs, buildings | 24,677 | ||||
Land at cost | 8,296 | ||||
Buildings at cost | 24,677 | ||||
Total at cost | 32,973 | ||||
Accumulated Depreciation | 991 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1850 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1850 [Member] | Usk, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 1,641 | ||||
Initial costs, buildings | 21,072 | ||||
Land at cost | 1,641 | ||||
Buildings at cost | 21,072 | ||||
Total at cost | 22,713 | ||||
Accumulated Depreciation | 838 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1850 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1951 [Member] | Remscheid, Germany [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Rehabilitation hospital | ||||
Initial costs, land | $ 1,017 | ||||
Initial costs, buildings | 2,451 | ||||
Land at cost | 1,017 | ||||
Buildings at cost | 2,451 | ||||
Total at cost | 3,468 | ||||
Accumulated Depreciation | 282 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1951 | ||||
Date Acquired | Aug. 28, 2018 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1913 [Member] | Sherman, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 3,363 | ||||
Initial costs, buildings | 10,932 | ||||
Land at cost | 3,363 | ||||
Buildings at cost | 10,932 | ||||
Total at cost | 14,295 | ||||
Accumulated Depreciation | 3,940 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1913 | ||||
Date Acquired | Oct. 31, 2014 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1820 [Member] | Southampton, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 6,116 | ||||
Initial costs, buildings | 17,961 | ||||
Land at cost | 6,116 | ||||
Buildings at cost | 17,961 | ||||
Total at cost | 24,077 | ||||
Accumulated Depreciation | 835 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1820 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1940 [Member] | Houston, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, buildings | $ 104,028 | ||||
Additions subsequent to acquisition, Improvements | 78,415 | ||||
Land at cost | 28,687 | ||||
Buildings at cost | 182,443 | ||||
Total at cost | 211,130 | ||||
Accumulated Depreciation | 12,756 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1940 | ||||
Date Acquired | Sep. 29, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 41 years | ||||
1940 [Member] | Houston, TX [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Initial costs, land | $ 28,687 | ||||
1940 [Member] | Tempe, AZ [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 6,050 | ||||
Initial costs, buildings | 10,986 | ||||
Additions subsequent to acquisition, Improvements | 5,084 | ||||
Land at cost | 6,050 | ||||
Buildings at cost | 16,070 | ||||
Total at cost | 22,120 | ||||
Accumulated Depreciation | 2,410 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1940 | ||||
Date Acquired | Sep. 29, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 41 years | ||||
1770 [Member] | Usk, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 1,641 | ||||
Initial costs, buildings | 21,072 | ||||
Land at cost | 1,641 | ||||
Buildings at cost | 21,072 | ||||
Total at cost | 22,713 | ||||
Accumulated Depreciation | 838 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1770 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1962 [Member] | Miami, FL [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 20,430 | ||||
Initial costs, buildings | 33,881 | ||||
Additions subsequent to acquisition, Improvements | 10,364 | ||||
Land at cost | 20,430 | ||||
Buildings at cost | 44,245 | ||||
Total at cost | 64,675 | ||||
Accumulated Depreciation | 593 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1962 | ||||
Date Acquired | Apr. 25, 2022 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1962 [Member] | West Monroe, LA [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 11,702 | ||||
Initial costs, buildings | 69,433 | ||||
Additions subsequent to acquisition, Improvements | 19,116 | ||||
Land at cost | 12,254 | ||||
Buildings at cost | 87,997 | ||||
Total at cost | 100,251 | ||||
Accumulated Depreciation | 18,622 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1962 | ||||
Date Acquired | Sep. 26, 2013 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1911 [Member] | Winchester, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 6,156 | ||||
Initial costs, buildings | 9,754 | ||||
Land at cost | 6,156 | ||||
Buildings at cost | 9,754 | ||||
Total at cost | 15,910 | ||||
Accumulated Depreciation | 754 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1911 | ||||
Date Acquired | Jan. 09, 2020 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1800 [Member] | Woking, UK [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Behavioral health facility | ||||
Initial costs, land | $ 6,871 | ||||
Initial costs, buildings | 4,442 | ||||
Land at cost | 6,871 | ||||
Buildings at cost | 4,442 | ||||
Total at cost | 11,313 | ||||
Accumulated Depreciation | 204 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1800 | ||||
Date Acquired | Jun. 25, 2021 | ||||
Life on which depreciation in latest income statements is computed (Years) | 40 years | ||||
1929 [Member] | Youngstown, OH [Member] | |||||
SEC Schedule III, Real Estate and Accumulated Depreciation [Line Items] | |||||
Type of property | Acute care general hospital | ||||
Initial costs, land | $ 4,334 | ||||
Initial costs, buildings | 3,565 | ||||
Additions subsequent to acquisition, Improvements | 488 | ||||
Land at cost | 4,334 | ||||
Buildings at cost | 4,053 | ||||
Total at cost | 8,387 | ||||
Accumulated Depreciation | 2,527 | ||||
Encumbrances | $ 0 | ||||
Date of Construction | 1929 | ||||
Date Acquired | May 01, 2017 | ||||
Life on which depreciation in latest income statements is computed (Years) | 41 years | ||||
[1] Includes $ 1.1 billion of land and building cost reflected in real estate held for sale at December 31, 2021. Excludes intangible lease assets that are included in real estate held for sale of $ 125.1 million at December 31, 2021. |
Schedule III - Real Estate In_3
Schedule III - Real Estate Investments and Accumulated Depreciation (Parenthetical) (Detail) $ in Billions | Dec. 31, 2022 USD ($) |
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Abstract] | |
Aggregate cost for federal income tax purposes | $ 11 |
Schedule III - Changes in Total
Schedule III - Changes in Total Real Estate Assets (Detail) - USD ($) $ in Thousands | 12 Months Ended | |||||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | ||||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Abstract] | ||||||
Balance at beginning of period | $ 13,628,749 | [1] | $ 10,749,707 | $ 7,312,486 | ||
Acquisitions | 622,999 | 3,023,966 | 2,912,594 | |||
Transfers from construction in progress | 47,431 | 202,999 | ||||
Additions | 150,290 | 167,164 | 55,137 | |||
Dispositions | (1,471,529) | (229,584) | (105,360) | |||
Other | [2] | (677,416) | (82,504) | 371,851 | ||
Balance at end of period | $ 12,300,524 | $ 13,628,749 | [1] | $ 10,749,707 | ||
[1] Includes $ 1.1 billion of land and building cost reflected in real estate held for sale at December 31, 2021. Excludes intangible lease assets that are included in real estate held for sale of $ 125.1 million at December 31, 2021. Includes foreign currency fluctuations for all years and $ 13.8 million of right-of-use assets in 2020. |
Schedule III - Changes in Accum
Schedule III - Changes in Accumulated Depreciation (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |||
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Abstract] | |||||
Balance at beginning of period | $ 950,369 | [1] | $ 728,176 | $ 504,651 | |
Depreciation | 277,032 | 262,063 | 222,580 | ||
Depreciation on disposed property | (185,519) | (35,551) | (6,653) | ||
Other | (33,542) | (4,319) | 7,598 | ||
Balance at end of period | $ 1,008,340 | $ 950,369 | [1] | $ 728,176 | |
[1] Includes $ 96.5 million of accumulated depreciation reflected in real estate held for sale at December 31, 2021. Excludes accumulated amortization related to intangible lease assets that are included in real estate held for sale of $ 17.5 million at December 31, 2021. |
Schedule III - Changes in Acc_2
Schedule III - Changes in Accumulated Depreciation (Parenthetical) (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Abstract] | |||
Changes in right-of-use asset | $ 23,066 | $ 1,120 | $ 13,800 |
Land and building cost | 1,100,000 | ||
Intangible lease assets included in real estate held for sale | 125,100 | ||
Real estate held for sale accumulated depreciation | 96,500 | ||
Accumulated amortization included in real estate held for sale | $ 17,500 |
Schedule IV - Schedule of Mortg
Schedule IV - Schedule of Mortgage Loans on Real Estate (Detail) - USD ($) $ in Thousands | 12 Months Ended | |||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Mortgage Loans on Real Estate [Line Items] | ||||
Face Amount of Mortgages | $ 364,420 | |||
Carrying Amount of Mortgages | $ 364,420 | $ 213,320 | $ 248,335 | $ 1,274,995 |
Long-Term First Mortgage Loan [Member] | ||||
Mortgage Loans on Real Estate [Line Items] | ||||
Periodic Payment Terms | Payable in monthlyinstallments of interest plusprincipal payable in full at maturity | |||
Long-Term First Mortgage Loan [Member] | Colombia [Member] | ||||
Mortgage Loans on Real Estate [Line Items] | ||||
Interest Rate | 8.95% | |||
Final Maturity Date | 2035 | |||
Face Amount of Mortgages | $ 117,360 | |||
Carrying Amount of Mortgages | $ 117,360 | |||
Long-Term First Mortgage Loan [Member] | Springstone Inc. [Member] | ||||
Mortgage Loans on Real Estate [Line Items] | ||||
Interest Rate | 7% | |||
Final Maturity Date | 2041 | |||
Face Amount of Mortgages | $ 22,900 | |||
Carrying Amount of Mortgages | $ 22,900 | |||
Long-Term First Mortgage Loan [Member] | Vibra [Member] | ||||
Mortgage Loans on Real Estate [Line Items] | ||||
Interest Rate | 11.50% | |||
Final Maturity Date | 2024 | |||
Face Amount of Mortgages | $ 7,986 | |||
Carrying Amount of Mortgages | $ 7,986 | |||
Long-Term First Mortgage Loan [Member] | Prospect [Member] | ||||
Mortgage Loans on Real Estate [Line Items] | ||||
Interest Rate | 7.96% | |||
Final Maturity Date | 2034 | |||
Face Amount of Mortgages | $ 151,267 | |||
Carrying Amount of Mortgages | $ 151,267 | |||
Long-Term First Mortgage Loan [Member] | Infracore [Member] | ||||
Mortgage Loans on Real Estate [Line Items] | ||||
Interest Rate | 4.20% | |||
Final Maturity Date | 2023 | |||
Face Amount of Mortgages | $ 64,907 | |||
Carrying Amount of Mortgages | $ 64,907 |
Schedule IV - Schedule of Mor_2
Schedule IV - Schedule of Mortgage Loans on Real Estate (Parenthetical) (Detail) | Dec. 31, 2022 USD ($) Property |
Mortgage Loans on Real Estate [Line Items] | |
Prior Liens | $ 0 |
Carrying amount of mortgages, federal income tax purposes | 364,400,000 |
Unamortized loan issue costs | $ 300,000 |
Colombia [Member] | Long-Term First Mortgage Loan [Member] | |
Mortgage Loans on Real Estate [Line Items] | |
Number of properties | Property | 3 |
Schedule IV - Changes in Mortga
Schedule IV - Changes in Mortgage Loans Excluding Allowance for Credit Loss (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract] | |||
Balance at beginning of year | $ 213,320 | $ 248,335 | $ 1,274,995 |
New mortgage loans and additional advances on existing loans | 177,924 | 1,128,695 | 193,590 |
Exchange rate fluctuations | (15,824) | (3,640) | 9,785 |
Mortgage loans on real estate including additions during year | 375,420 | 1,373,390 | 1,478,370 |
Collection of principal | (11,000) | (1,160,070) | (1,230,035) |
Deductions during year | (11,000) | (1,160,070) | (1,230,035) |
Balance at end of year | $ 364,420 | $ 213,320 | $ 248,335 |
Schedule IV - Changes in Mort_2
Schedule IV - Changes in Mortgage Loans Excluding Allowance for Credit Loss (Parenthetical) (Detail) $ in Thousands, £ in Millions | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | Mar. 31, 2021 GBP (£) | Dec. 31, 2020 USD ($) | |
Mortgage Loans on Real Estate [Line Items] | |||||
Advanced to the mortgage loan | [1] | $ 1,103,410 | $ 834,743 | ||
Mortgage Loans [Member] | |||||
Mortgage Loans on Real Estate [Line Items] | |||||
Advanced to the mortgage loan | $ 835,000 | ||||
Mortgage Loans [Member] | Priory Group [Member] | |||||
Mortgage Loans on Real Estate [Line Items] | |||||
Advanced to the mortgage loan | £ | £ 800 | ||||
[1] The 2021 column includes an £ 800 million mortgage loan advanced to the Priory Group (“Priory”) in the first quarter of 2021 and converted to fee simple ownership of 35 properties in the second quarter of 2021 as described below. The 2020 column includes approximately $ 740 million of loans advanced to Steward in 2017 and exchanged for the fee simple real estate of two hospitals as described below, as well as approximately $ 100 million of loans advanced to Ernest Health, Inc. (“Ernest”) in 2012 and exchanged for the fee simple real estate of four hospitals as described below. |